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Abstract: This dissertation describes the development of various palladium-catalyzed 
syntheses of organoboron compounds with the 1,2-metallate shift of organoboron “ate” 
complexes as a common mechanistic feature. Chapter one discusses the history of the 1,2-
metallate shift with a focus on reactions promoted by transition metals, followed by my 
work on the palladium-catalyzed, enantioselective, halide-tolerant conjunctive cross-
coupling reaction to enable the use of Grignard reagents and arylbromides. Chapter two 
discusses the attempt to engage allylic electrophiles in the conjunctive cross-coupling 
reaction and the discovery and optimization of the vinylidenation reaction to access 1,1-
disubstituted boryl alkenes. Unlike other palladium-catalyzed reactions that proceed by a 
1,2-metallate shift, the vinylidenation proceeds by a β-hydride elimination rather than a 
reductive elimination as the final step in the catalytic cycle. Chapter three discusses the 
development of the enantioselective conjunctive cross-coupling of propargylic 
electrophiles to access enantioenriched β-boryl allenes. Methanol additive was found to 
improve both the yield and enantioselectivity of the reaction. 1H NMR studies show that 
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The Halide-Tolerant Conjunctive Cross-Coupling Reaction 
1.1. Introduction 
1.1.1. The Structure and Utility of Organoboron Compounds 
Organoboron compounds are valuable reagents in modern organic chemistry. 
Recent research efforts have been made investigating their roles in Brønsted and Lewis 
acid catalysis,1 optoelectronics,2 and chemical biology and medicinal chemistry,3 including 
1 (a) Stephan, D. W.; Erker, G. Angew. Chem. Int. Ed. 2015, 54, 6400. (b) Stephan, D. W. Science 2016, 354, 
aaf7229. (c) Hall, D. G. Chem. Soc. Rev. 2019, 48, 3475. 
2 (a) von Grotthuss, E.; John, A.; Kaese, T.; Wagner, M. Asian J. Org. Chem. 2018, 7, 37. (b) Mellerup, S. 
K.; Wang, S. Trends in Chemistry 2019, 1, 77. 
3 (a) Baker, S. J.; Tomsho, J. W.; Benkovic, S. J. Chem. Soc. Rev. 2011, 40, 4279. (b) Touchet, S.; Carreaux, 
F.; Carboni, B.; Bouillon, A.; Boucher, J.-L. Chem. Soc. Rev. 2011, 40, 3895. (c) Smoum, R.; Rubinstein, 
A.; Dembitsky, V. M.; Srebnik, M. Chem. Rev. 2012, 112, 4156. (d) Adamczyk-Woźniak, A.; Borys, K. 
M.; Sporzyński, A. Chem. Rev. 2015, 115, 5224. 
1
the anticancer drugs Velcade (bortezomib),4 Ninlaro (ixazomib),5 and delanzomib6 
(Scheme 1.1). However, organoboron compounds in synthetic organic chemistry serve 
mainly as intermediates to access a variety of other compounds via stereospecific 
transformations. These transformations include carbon–heteroatom bond-forming 
reactions such as oxidation,7 amination,8 and halogenation,9 as well as carbon–carbon 
bond-forming reactions such as the Suzuki–Miyaura cross-coupling,10 the Zweifel–Evans–
4 Bross, P. F. Kane, R.; Farrell, A. T.; Abraham, S.; Benson, K.; Brower, M. E.; Bradley, S.; Gobburu, J. V.; 
Goheer, A.; Lee, S.-L.; Leighton, J.; Liang, C. Y.; Lostritto, R. T.; McGuinn, W. D.; Morse, D. E.; Rahman, 
A.; Rosario, L. A.; Verbois, S. L.; Williams, G.; Wang, Y.-C.; Pazdur, R. Clin. Cancer Res. 2004, 10, 
3954. 
5 Kupperman, E.; Lee, E. C.; Cao, Y.; Bannerman, B.; Fitzgerald, M.; Berger, A.; Yu, J.; Yang, Y.; Hales, 
P.; Bruzzese, F.; Liu, J.; Blank, J.; Garcia, K.; Tsu, C.; Dick, L.; Fleming, P.; Yu, L.; Manfredi, M.; Rolfe, 
M.; Bolen, J. Cancer Res. 2010, 70, 1970. 
6 Gallerani, E.; Zucchetti, M.; Brunelli, D.; Marangon, E.; Noberasco, C.; Hess, D.; Delmonte, A.; Martinelli, 
G.; Böhm, S.; Driessen, C.; De Braud, F.; Marsoni, S.; Cereda, R.; Sala, F.; D’Incalci, M.; Sessa, C. Eur. 
J. Cancer 2013, 49, 290.
7 Brown, H. C.; Snyder, C.; Rao, B. C. S.; Zweifel, G. Tetrahedron 1986, 42, 5505. 
8 (a) Mlynarski, S. N.; Karns, A. S.; Morken, J. P. J. Am. Chem. Soc. 2012, 134, 16449. (b) Edelstein, E. K.; 
Grote, A. C.; Palkowitz, M. D.; Morken, J. P. Synlett 2018, 29, 1749. 
9 (a) Larouche-Gauthier, R.; Elford, T. G.; Aggarwal, V. K. J. Am. Chem. Soc. 2011, 133, 16794. (b) 
Sandford, C.; Rasappan, R.; Aggarwal, V. K. J. Am. Chem. Soc. 2015, 137, 10100. 
10 (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457. (b) Lennox, A. J. J.; Lloyd-Jones, G. C. Chem. 
Soc. Rev. 2014, 43, 412. (c) Cherney, A. H.; Kadunce, N. T.; Reisman, S. E. Chem. Rev. 2015, 115, 9587. 
(d) Rygus, J. P. G.; Crudden, C. M. J. Am. Chem. Soc. 2017, 139, 18124.
2
Matteson olefination,11 the Matteson homologation,12 and recent reports from the 
Aggarwal group in alkynylation13 and arylation14 (Scheme 1.2). 
Many reactions of organoboron compounds proceed by nucleophilic attack onto the 
vacant p-orbital of an sp2-hybridized, neutral, tricoordinate boron center 1.4 to give an sp3-
hybridized, anionic, tetracoordinate organoboron “ate” species 1.5 (Scheme 1.3). In the 
case of most of the reactions in Scheme 1.2, formation of the “ate” complex is followed by 
a 1,2-metallate shift of one of the groups on boron onto another, forging a new carbon–
carbon or carbon–heteroatom bond while simultaneously reverting boron back to its neutral 
state.  
11 (a) Zweifel, George.; Polston, N. L.; Whitney, C. C. J. Am. Chem. Soc. 1968, 90, 6243. (b) Matteson, D. 
S. Synthesis 1975, 147. (c) Matteson, D. S.; Jesthi, P. K. J. Organomet. Chem. 1976, 110, 25. (d) Evans,
D. A.; Thomas, R. C.; Walker, J. A. Tetrahedron Lett. 1976, 18, 1427. (e) Evans, D. A.; Crawford, T. C.;
Thomas, R. C.; Walker, J. A. J. Org. Chem. 1976, 41, 3947. (f) Armstrong, R. J.; Niwetmarin, W.;
Aggarwal, V. K. Org. Lett. 2017, 19, 2762.
12 Matteson, D. S.; Sadhu, K. M. J. Am. Chem. Soc. 1983, 105, 2077. 
13 Wang, Y.; Noble, A.; Myers, E. L.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2016, 55, 4270. 
14 (a) Bonet, A.; Odachowski, M.; Leonori, D.; Essafi, S.; Aggarwal, V. K. Nature Chem. 2014, 6, 584. (b) 
Leonori, D.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2015, 54, 1082. (c) Llaveria, J.; Leonori, D.; 
Aggarwal, V. K. J. Am. Chem. Soc. 2015, 137, 10958. (d) Odachowski, M.; Bonet, A.; Essafi, S.; Conti-
Ramsden, P.; Harvey, J. N.; Leonori, D.; Aggarwal, V. K. J. Am. Chem. Soc. 2016, 138, 9521. (e) Aichhorn, 
S.; Bigler, R.; Myers, E. L.; Aggarwal, V. K. J. Am. Chem. Soc. 2017, 139, 9519. (f) Ganesh, V.; 
Odachowski, M.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2017, 56, 9752. (g) Wang, Y.; Noble, A.; 
Sandford, C.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2017, 56, 1810. (h) Wilson, C. M.; Ganesh, V.; 
Noble, A.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2017, 56, 16318. (i) Bigler, R.; Aggarwal, V. K. Angew. 
Chem. Int. Ed. 2018, 57, 1082. 
3
   
 
Conceptually, the 1,2-metallate shift can be divided into two main classes 
depending on the hybridization of the migration terminus. The first class involves 
migration onto an sp3-hybridized atom A with concomitant displacement of a pendant 
leaving group X, forming a new carbon–A bond (1.6→1.7, Scheme 1.4a). Oxidation with 
hydrogen peroxide,7 amination with methoxyamine,8 and Matteson homologation with 
chloroiodomethane treated with n-butyllithium12 all proceed by this class of 1,2-metallate 
shift. With the oxidation reaction, hydroperoxide anion attacks the vacant p-orbital on 1.4 
to give “ate” complex 1.8, which triggers a 1,2-metallate shift to displace hydroxide anion 
4
to form a new carbon–oxygen bond (1.9); hydrolysis of the boron–oxygen bond gives 
alcohol 1.10 (Scheme 1.4b). The other reactions proceed via analogous mechanisms 
(Scheme 1.4c and d). 
The second class involves migration onto an sp2- or sp-hybridized center via 
electrophilic activation of an appended π-system (1.11→1.13, Scheme 1.5a). The Zweifel–
Evans–Matteson olefination,11 the Aggarwal alkynylation,13 and the Aggarwal arylation14 
proceed by this type of mechanism. With the olefination and alkynylation mechanisms, 
electrophilic iodination of the pendant olefin reagent generates a bridged iodonium cation 
5
1.14, which triggers the 1,2-metallate shift to form a new carbon–carbon bond (1.15); 
subsequent boron–iodine elimination affords the unsaturated product 1.16 (Scheme 1.5b). 
The Aggarwal arylation reactions involve electrophilic bromination of the pendant 
aromatic ring on “ate” complex 1.17 to form Wheland intermediate 1.18, which similarly 
undergoes 1,2-metallate shift to form the new carbon–carbon bond; boron–bromine 
elimination (1.19) restores aromaticity and gives the arylated product 1.20 (Scheme 1.5c). 
Inspired by this mode of reactivity, the Morken group recently began to explore the 
possibility of using π-acidic transition metals such as organopalladium or organonickel to 
activate the pendant π-systems of organoboron “ate” complexes (1.21) (Scheme 1.5d). It 
was hypothesized that rather than undergo boron–metal elimination, the newly formed 
carbon–metal σ-bond in intermediate 1.22 could undergo catalytic reactions such as cross-
coupling with electrophilic organo(pseudo)halides. This proposed three-component 
conjunctive cross-coupling reaction would forge new carbon–carbon bonds between a 
migrating group, an olefin, and an electrophile with the advantage of retaining the boron 
atom to serve as a handle for further functionalization. Additionally, appropriate choice of 
a chiral ligand for the transition metal could render this conjunctive cross-coupling reaction 
enantioselective, which would further increase the synthetic value of such a transformation. 
1.1.2. Transition Metal-Promoted 1,2-Metallate Shifts 
Transition metal-promoted 1,2-metallate shifts have some precedence in the 
literature. One of the earliest examples was reported by the Wrackmeyer group in 1983 in 
which dialkynylated platinum complex 1.23 reacts with triethylborane to form cationic 
platinum species 1.24 and trialkylalkynylboron “ate” 1.25. Electrophilic activation of the 
π bond of 1.25 by the cationic platinum center triggers a 1,2-metallate shift of one of the 
6
   
 
alkyl groups, giving alkenyl platinum complex 1.26 (Scheme 1.6).15 Although 
Wrackmeyer and coworkers do not report any synthetic utility of these complexes, this is 
nonetheless the first demonstration of a late transition metal effecting a 1,2-metallate shift 
on an unsaturated boron “ate” complex. 
 
In 2004, the Fillion group reported the Pd-catalyzed intramolecular arylation of 
alkenylalanes 1.27 to form fused carbocycles 1.28 (Scheme 1.7a).16 They propose that after 
1.27 undergoes oxidative addition, intermediate 1.29 undergoes an intramolecular 
migratory insertion to give 1.30, which is followed by reductive displacement of palladium 
via 1,2-methyl shift from aluminum to the α carbon (Scheme 1.7b, left). Compound 1.31 
then undergoes protodemetallation to give product 1.28. While their proposed mechanism 
is reasonable, this reaction could conceivably operate by an alternative pathway involving 
Pd-induced 1,2-metallate shift to form 1.32, which would undergo reductive elimination to 
give 1.31 (Scheme 1.7b, right). Fillion and coworkers observe that 2,6-disubstituted 
aryltriflates give superior yields to monosubstituted aryltriflates, which lends support for 
their 5-exo-dig migratory insertion–reductive displacement mechanism. Regardless, 
without extensive mechanistic studies, the alternative Pd-induced 1,2-metallate shift 
pathway remains a possibility. 
                                                            
15 Sebald, A.; Wrackmeyer, B. J. Chem. Soc., Chem. Commun. 1983, 12, 309. 




In 2007, the laboratory of Murakami reported the Pd-catalyzed arylation of 
tetramethylammonium trialkylalkynylboron “ate” complexes 1.33.17 They proposed that 
(aryl)Pd species 1.34 undergoes migratory insertion with 1.33 to give (alkenyl)Pd species 
1.35. This species could then undergo an intramolecular transmetallation of one of the 
phenyl groups on boron to palladium to give 1.36, which furnishes (Z)-alkenylboronate 
1.37 as the major diastereomer of the reaction following reductive elimination (Scheme 
1.8a, left). To rationalize the formation of the minor E diastereomer 1.39, they propose a 
reductive displacement of the palladium atom via a 1,2-metallate shift of one of the boron 
“ate” phenyl groups (1.38, Scheme 1.8a, right). This reductive displacement is similar to 
Fillion’s proposal in his Pd-catalyzed intramolecular arylation of alkenylalanes (vide 
supra). 
Like Fillion, Murakami and coworkers do not conduct mechanistic studies to 
support their proposed pathways. It is possible that two alternative mechanisms could be 
operative in which the cationic (aryl)Pd species activates the alkynylboron “ate” complex 
to undergo either a syn- (1.40→1.41) or an anti-1,2-metallate shift (1.42→1.43), followed 
by reductive elimination to give 1.37 and 1.39, respectively (Scheme 1.7b). Although they 
do not propose these alternate pathways for this reaction, they do invoke them in a later 
study involving the Pd-catalyzed allylation of the same boron “ate” species 1.33.18 
17 Ishida, N.; Miura, T.; Murakami, M. Chem. Commun. 2007, 42, 4381. 
18 Ishida, N.; Shinmoto, T.; Sawano, S.; Miura, T.; Murakami, M. Bull. Chem. Soc. Jpn. 2010, 83, 1380. 
9




   
 
In 2018, the Aggarwal lab reported the coupling of enantioenriched 
organoboronates 1.44 with a variety of lithiated chromium–arene complexes 1.45 to access 
enantioenriched arylalkanes 1.46 (Scheme 1.9a).14i Following formation of the 
organoboron “ate” complex 1.47, treatment with molecular iodine oxidizes chromium(0) 
to chromium(II) (1.48). The chromium in the higher oxidation state triggers the 1,2-
metallate shift to give Meisenheimer complex 1.49, whose negative charge is stabilized by 
complexation with the chromium(II) center. Elimination of boron restores aromaticity 
while simultaneously reducing chromium(II) to chromium(0) (1.50). Intermediate 1.50 
undergoes decomplexation upon reaction with another equivalent of iodine to give product 
1.46 (Scheme 1.9b). 
11
   
 
It is worth mentioning that Pd-catalyzed allylation reactions of 2-indolylboron “ate” 
complexes such as 1.51 have also been developed (Scheme 1.10a).19 However, as a recent 
mechanistic study by Ready revealed, this class of boron “ate” first undergoes electrophilic 
alkylation of the C3 position of the indole moiety (1.52) independent of the subsequent 
1,2-metallate shift onto the iminium cation (1.53, Scheme 1.10b).19g Furthermore, these 
reactions are believed to proceed via an outer sphere attack of the allyl ligand on palladium 
rather than an inner sphere attack of the metal center. Because of these mechanistic 
differences, Pd-catalyzed allylation reactions of boron “ate” complexes will not be 
discussed further and will instead be elaborated upon in the following chapter.  
 
  
                                                            
19 (a) Ishida, N.; Shinmoto, T.; Sawano, S.; Miura, T.; Murakami, M. Bull. Chem. Soc. Jpn. 2010, 83, 1380. 
(b) Ishikura, M.; Terashima, M.; Okamura, K.; Date, T. J. Chem. Soc., Chem. Commun. 1991, 20, 1219. 
(c) Ishikura, M.; Agata, I. Heterocycles 1996, 43, 1591. (d) Ishikura, M.; Kato, H. Tetrahedron 2002, 58, 
9827. (e) Ishikura, M.; Ida, W.; Yanada, K. Tetrahedron 2006, 62, 1015. (f) Panda, S.; Ready, J. M. J. Am. 
Chem. Soc. 2017, 139, 6038. (g) Panda, S.; Ready, J. M. J. Am. Chem. Soc. 2018, 140, 13242. 
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1.2. The First-Generation Conjunctive Cross-Coupling Reaction 
The proposed catalytic cycle for the conjunctive cross-coupling reaction is shown 
in Scheme 1.11. Like the Suzuki–Miyaura cross coupling reaction, the cycle begins with 
an oxidative addition between palladium(0) species 1.54 and an electrophile RE–X 1.55 to 
give intermediate 1.56. A ligand exchange between the X group and the olefin moiety on 
organoboron “ate” complex 1.57 would give complex 1.58. The migrating group RM would 
then undergo a 1,2-metallate shift to give intermediate 1.59, which would undergo 




   
 
The success of the proposed reaction depends on the careful choice of the 
electrophile: the X group on 1.55 must be labile enough to dissociate from palladium 
complex 1.56 to form a cationic metal center with an open coordination site in order for 
the boron “ate” complex to bind. To this end, organotriflates were chosen as the 
electrophile in the first-generation conjunctive cross-coupling reaction. Furthermore, the 
appropriate ligand must be chosen which would stabilize cationic palladium and favor 
reductive elimination over β-hydride elimination for complex 1.59. It was hypothesized 
that electron-rich, bidentate ligands with wide bite angles would fulfill all of these 
requirements. A ligand survey revealed that the chiral bidentate bisphosphine ligand 
MandyPhos 1.64 (vide infra) was the most effective at giving conjunctive cross-coupling 
products in good yields with generally high levels of enantioselectivity.  
In 2016, the Morken group reported the first conjunctive cross-coupling reaction in 
which vinyl boron “ate” complexes 1.63—generated from C(sp3)- or C(sp2)-hybridized 
organolithium reagents 1.61 and vinylboronic acid, neopentyl glycol ester (vinylB(neo) 
1.62)—are coupled to C(sp2)-hybridized organotriflate electrophiles 1.65 catalyzed by 
Pd(OAc)2 and MandyPhos 1.64 at 60 °C for 14 hours.20  After oxidation with alkaline 
hydrogen peroxide, the secondary alcohol products 1.66 are isolated in modest to good 
yields with generally excellent levels of enantioselectivity (Scheme 1.12). Electrophiles 
bearing sensitive functional groups such as aldehydes (1.70) were found to participate well 
in the reaction. Electrophiles bearing di-ortho-substitution also worked well, but due to the 
increased steric congestion, the reaction required 80 °C for full conversion and the 
enantioselectivity was diminished (1.71). Alkenyltriflates also worked (1.72 and 1.73), 
                                                            
20 Zhang, L.; Lovinger, G. J.; Edelstein, E. K.; Szymaniak, A. A.; Chierchia, M. P.; Morken, J. P. Science 
2016, 351, 70. 
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although employing pinacolato rather than neopentyl glycolato “ate” complexes resulted 
in markedly enhanced yields and enantioselectivities; for instance, 1.72 was isolated in 
53% yield and 82:18 er when vinylB(neo) was used instead of vinylB(pin). 
A wider array of organoboron compounds are commercially-available or are readily 
synthesized compared to organolithium reagents. Thus, seeking to expand the scope of 
migrating groups in the conjunctive cross-coupling reaction, boron “ate” complexes 1.63 
derived from C(sp3)- or C(sp2)-hybridized B(neo) compounds 1.74 and vinyllithium 1.75 
were subjected to the same reaction conditions shown in Scheme 1.12 using phenyltriflate 
1.76 as the electrophile (Scheme 1.13). Employing phenylB(neo) and n-butylB(neo) gave 
15
   
 
their respective conjunctive cross-coupling products 1.67 and 1.68 with virtually identical 
yields and enantioselectivities compared to using phenyllithium and n-butyllithium with 
vinylB(neo) (Scheme 1.12, vide supra), showing that the same “ate” complex 1.63 is 
formed regardless of how it is generated. Electron-rich (1.78) and electron-deficient (1.79) 
aryl groups were found to participate in the reaction, although an arene bearing a strongly 
deactivating trifluoromethyl group gave trace product (1.80). Heterocycles were found to 
migrate (1.81), as were groups bearing ortho substitution (1.82). As demonstrated in 
Scheme 1.12 with a di-ortho-substituted aryltriflate (1.71), a di-ortho-substituted 
arylB(neo) gave product with diminished levels of enantioselectivity (1.83). 
16
   
 
In order to demonstrate the synthetic utility of the conjunctive cross-coupling 
reaction, the natural product (–)-combretastatin21 1.87 was synthesized in a rapid and 
efficient manner in high yield and enantioselectivity. The “ate” complex derived from 
3,4,5-trimethoxyphenylB(neo) 1.84 and vinyllithium 1.75 was subjected to conjunctive 
cross-coupling conditions with aryltriflate 1.85, giving enantioenriched secondary alcohol 
1.86 in high yield. Removal of the TBS group with TBAF afforded (–)-combretastatin 1.87 
in 78% overall yield (Scheme 1.14). 
 
Although this reaction was proposed to proceed through a Pd-induced 1,2-metallate 
rearrangement followed by reductive elimination (Scheme 1.15a), other mechanistic 
possibilities could not be ignored. One alternative mechanism is similar to Murakami’s 
proposal for his Pd-catalyzed arylation of trialkylalkynylboron “ate” complexes (Scheme 
1.8, left, vide supra) involving a migratory insertion mechanism to give α-palladated 
                                                            
21 Pettit, G. R.; Cragg, G. M.; Herald, D. L.; Schmidt, J. M.; Lohavanijaya, P. Can. J. Chem. 1982, 60, 
1374. 
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species 1.91, which could undergo intramolecular transmetallation and reductive 
elimination to give 1.93 (Scheme 1.15b). Another plausible mechanism similar to 
Murakami’s proposal (Scheme 1.8, right) involves the same α-palladated species 1.91, 
which could trigger a 1,2-metallate shift from boron to reductively displace palladium 
(Scheme 1.15c).   
18
   
 
In order to ascertain which in the likely pathway, trans-deuterium-labeled 
vinyllithium 1.95 was employed in the conjunctive cross-coupling reaction with 
phenylB(pin) 1.94 and alkenyltriflate electrophile 1.96 to give deuterium-labeled 
secondary alcohol 1.97. 1H NMR analysis shows that the hydroxyl group and the deuterium 
atom are anti to each other (Scheme 1.16), ruling out the intramolecular transmetallation 
mechanism in Scheme 1.15b which would result in a syn configuration.  
Although this labeling experiment does not distinguish between the other two 
mechanistic possibilities, both of which would result in an anti-configuration, unpublished 
DFT calculations conducted in our group suggest a prohibitively high energy barrier 
associated with aligning the palladium–carbon σ-bond parallel to the carbon–carbon π-
bond on the boron “ate” complex, the configuration required for migratory insertion 
(Scheme 1.15c). This high barrier arises from steric repulsion between the ligand set on 
boron and the large MandyPhos ligand on palladium. 
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1.3. The Halide-Tolerant Conjunctive Cross-Coupling Reaction  
The conjunctive cross-coupling reaction was shown to be a modular and efficient 
method to construct enantioenriched organoboronic esters. However, the first-generation 
reaction suffers from limitations that prevent this reaction from being more general, 
limitations that my research efforts aimed to address. Firstly, the reaction requires the use 
of vinyllithium free from halide impurities. Lithium-halogen exchange between either 
vinyl halides and either n-butyllithium or t-butyllithium to generate vinyllithium in situ led 
to greatly diminished yields (Table 1.1, entries 1–4). Preparing vinyllithium by lithium-
halogen exchange and then conducting the conjunctive cross-coupling reaction with 5 mol 
% catalyst loading rather than 1 mol % led to enhanced yield (Table 1.1, entry 5). 
Ultimately, vinyllithium that had been recrystallized from pentane and dissolved in Et2O 
20
   
 
was found to be optimal in the first-generation conjunctive cross-coupling (Table 1.1, entry 
6). These data suggest that the presence of halides in the reaction medium was detrimental 
to the reaction. 
In fact, exogenous addition of 1 mol % lithium halide salts to the reaction of n-
butyl(vinyl)B(neo) “ate” complex 1.100 with phenyltriflate 1.76 using 1 mol % catalyst 
loading led to a significant drop in yield, although the enantioselectivity is not greatly 
affected (Table 1.2, entry 1 vs. entries 2–5). Raising the catalyst loading from 1 mol % to 
5 mol % in the presence of 1 mol % lithium iodide led to a partial recovery of the yield, 
although the yield was not as high compared to standard halide-free conditions (Table 1.2, 
entry 6). Employing iodobenzene 1.101 or bromobenzene 1.102 instead of phenyltriflate 
1.76 resulted in greatly diminished yield, although the enantioselectivity was not greatly 
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affected (Table 1.2, entries 7 and 8). Chlorobenzene 1.103 gave trace product (Table 1.2, 
entry 9), presumably due to the higher activation barrier associated with oxidative addition 
into carbon–chloride bonds.22 These results show that, in addition to avoiding the time-
consuming and cumbersome synthesis of halide-free vinyllithium, solving the problem of 
halide inhibition would also allow for the use of aryl halide electrophiles. This would 
greatly expand the generality of this reaction, as aryl halides are more readily available and 
in greater variety compared to aryl triflates. 
In order for the 1,2-metallate shift to occur, the olefin on the “ate” complex 1.57 
must bind to the cationic palladium center in species 1.58 (Scheme 1.17). This is favored 
when the electrophile is an aryl triflate. We hypothesize that in the presence of halide salts 
in solution, this equilibrium favors neutral palladium species 1.56; without an open 
coordination site on the metal center, the catalytic conjunctive cross-coupling reaction is 
arrested.23 Although halide additives have been known to accelerate Pd-catalyzed Heck 
reactions,24  it is believed that this is due to an acceleration of the rate-determining oxidative 
addition step. In Heck reactions in which oxidative addition is not the rate-determining 
step, halides inhibit the reaction.25 
                                                            
22 Littke, A. F.; Fu, G. C. Angew. Chem. Int. Ed. 2002, 41, 4176. 
23 (a) Kawataka, F.; Shimizu, I.; Yamamoto, A. Bull. Chem. Soc. Jpn. 1995, 68, 654. (b) Kayaki, Y.; Shimizu, 
I.; Yamamoto, A. Chem. Lett. 1995, 24, 1089. (c) Amatore, C.; Carre, E.; Jutand, A.; M’Barki, M. A.; 
Meyer, G. Organometallics 1995, 14, 5605. (d) Amatore, C.; Godin, B.; Jutand, A.; Lemaître, F. 
Organometallics 2007, 26, 1757. (e) Amatore, C.; Godin, B.; Jutand, A.; Lemaître, F. Chem. Eur. J. 2007, 
13, 2002. 
24 (a) Jeffery, T. J. Chem. Soc., Chem. Commun. 1984, 19, 1287. (b) Jeffery, T. Tetrahedron Lett. 1985, 26, 
2667. (c) Grigg, R.; Stevenson, P.; Worakun, T. Tetrahedron 1988, 44, 2033. (d) Andersson, C. M.; 
Hallberg, A. J. Org. Chem. 1988, 53, 2112 
25 (a) Ozawa, F.; Kubo, A.; Hayashi, T. J. Am. Chem. Soc. 1991, 113, 1417. (b) Jutand, A. Appl. Organomet. 
Chem. 2004, 18, 574. 
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We also sought to improve the generality of the conjunctive cross-coupling reaction 
by being able to employ Grignard reagents in addition to organolithium reagents, 
particularly commercially-available vinylmagnesium halides. Although it was anticipated 
that the halides present in Grignard reagents would inhibit catalysis, we discovered that 
employing these reagents come with their own challenges with respect to reactivity. 11B 
NMR studies on the reaction between phenylB(pin) 1.94 (δ = 30.9 ppm, Figure 1.1a) and 
vinyllithium 1.75 showed that organoboron “ate” complex 1.104 was formed cleanly and 
with full conversion (δ = 5.8 ppm, Figure 1.1b). However, when vinylmagnesium bromide 
1.105 was used, “ate” complex 1.104 was only formed in approximately 20% conversion 
(Figure 1.1c). In line with these findings, a previous report by Blakemore suggests that 
formation of boron “ate” complexes from Grignard reagents is more difficult compared to 
the analogous reaction using organolithium reagents, which probably stems from their 
diminished nucleophilicity.26 We then explored the use of additives which, in addition to 
enhancing the formation of “ate” complexes from Grignard reagents, may also serve as 
halide scavengers to allow for the 1,2-metallate shift to occur. 
  
                                                            
26 Blakemore, P. R.; Marsden, S. P.; Vater, H. D. Org. Lett. 2006, 8, 773. 
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Figure 1.1. 11B NMR studies of the formation of organoboron “ate” complexes with vinylmetal 
reagents. 11B NMR spectra of (a) phenylB(pin) 1.94; (b) the reaction of phenylB(pin) 1.94 and 
vinyllithium 1.75 to form “ate” complex 1.104; and (c) the reaction of phenylB(pin) 1.94 and 
vinylmagnesium bromide 1.105 to form “ate” complex 1.104. 
 
 
We began our additive survey with lithium chloride, as Knochel and coworkers 
have shown than lithium chloride enhances the reactivity of Grignard reagents in 
magnesium-halogen exchange reactions as well as the reactivity of Hauser bases, giving 
so-called “turbo Grignard reagents”27 and “turbo Hauser bases,”28 respectively. Although 
                                                            
27 (a) Krasovskiy, A.; Knochel, P. Angew. Chem. Int. Ed. 2004, 43, 3333. (b) Klatt, T.; Markiewicz, J. T.; 
Sämann, C.; Knochel, P. J. Org. Chem. 2014, 79, 4253. (c) Tilly, D.; Chevallier, F.; Mongin, F.; Gros, P. 
C. Chem. Rev. 2014, 114, 1207. (d) Li-Yuan Bao, R.; Zhao, R.; Shi, L. Chem. Commun. 2015, 51, 6884. 
28 (a) Krasovskiy, A.; Krasovskaya, V.; Knochel, P. Angew. Chem. Int. Ed. 2006, 45, 2958. (b) Lin, W.; 
Baron, O.; Knochel, P. Org. Lett. 2006, 8, 5673. (c) Neufeld, R.; Teuteberg, T. L.; Herbst-Irmer, R.; Mata, 
R. A.; Stalke, D. J. Am. Chem. Soc. 2016, 138, 4796. 
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lithium chloride would undoubtedly inhibit the subsequent conjunctive cross-coupling 
reaction, we thought learning about the effect of additives on “ate” complex formation was 
a good starting point to improve the reaction. Indeed, lithium chloride additive led to full 




Figure 1.2. 11B NMR studies of the effect of additives on the formation of aryl boron “ate” 
complexes. 11B NMR spectra of the reaction of phenylB(pin) 1.94 and vinylmagnesium 
bromide 1.105 to form “ate” complex 1.104 (a) without additive; (b) with one equivalent of 
lithium chloride; (c) with one equivalent of lithium triflate; (d) with one equivalent of sodium 
triflate; (e) with two equivalents of sodium triflate; (f) with two equivalents of 





   
 
Other weakly basic metal salts were investigated. We found that lithium triflate 
(Figure 1.2c) can also promote full conversion to the “ate” complex, but under conjunctive 
cross-coupling conditions, this additive gave low yield of the product. We attribute this to 
the poor sequestration of halide anions by lithium cation and hypothesized that a larger 
alkali metal cation would be more effective. In line with this hypothesis, we found that 
sodium triflate can also promote full conversion to the “ate” complex, although requiring 
two equivalents to be effective (Figure 1.2d and e). Importantly, this additive gave the 
conjunctive cross-coupling product in high yield and enantioselectivity (vide infra).  
We were also eager to ascertain the role of sodium cation and triflate anion in “ate” 
complex formation. Two equivalents of tetrabutylammonium triflate are able to promote 
“ate” complex formation in approximately 85% conversion (Figure 1.2f), while sodium 
tetraphenylborate does so in about 40% conversion (Figure 1.2g). From these two 
experiments, we hypothesize that sodium triflate facilitates “ate” complex formation from 
vinylmagnesium bromide 1.105 via both nucleophilic activation of the Grignard reagent 
by the triflate anion (Scheme 1.18 left)29 and via electrophilic activation of phenylB(pin) 
1.94 by coordination of one of the pinacolato oxygen atoms to sodium cation (Scheme 1.18 
right).30 
                                                            
29 (a) Kendall, A. J.; Salazar, C. A.; Martino, P. F.; Tyler, D. R. Organometallics 2014, 33, 6171. (b) Reetz, 
M. T.; Harmat, N.; Mahrwald, R. Angew. Chem., Int. Ed. Engl. 1992, 31, 342. 
30 (a) Corey, E. J.; Barnes-Seeman, D.; Lee, T. W. Tetrahedron: Asymmetry 1997, 8, 3711. (b) Midland, M. 
M. J. Org. Chem. 1998, 63, 914. (c) Rauniyar, V.; Hall, D. G. J. Am. Chem. Soc. 2004, 126, 4518. 
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Using alkyl boronic esters such as 3-butenylB(pin) 1.106 presents its own 
problems. When treated with vinyllithium 1.75 in THF, the “ate” complex 1.107 remains 
stable at room temperature even after 24 hours (Figure 1.3a). As demonstrated above with 
phenylB(pin) 1.94, treating 1.106 with Grignard reagent 1.108 without an additive led to 
poor conversion to the “ate” complex (Figure 1.3b). Unfortunately, the presence of two 
equivalents of sodium triflate gave only about 50% conversion in THF after one hour 
(Figure 1.3c), and after 24 hours, the “ate” complex had reverted to 1.106 (Figure 1.3d), 
indicating that alkyl boron “ate” complexes derived from Grignard reagents are unstable 
in THF. We found that a 1:1 THF:DMSO solvent mixture allowed for high conversion to 
1.107, which was stable to decomposition after 24 hours at 40 °C (Figure 1.3e).  
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Figure 1.3. 11B NMR studies of the effect of additives on the formation of alkyl boron “ate” 
complexes. 11B NMR spectra of the conversion of 3-butenylB(pin) 1.106 to “ate” complex 1.107 
(a) with vinyllithium 1.75 in THF for 24 hours without additive; (b) with vinylmagnesium chloride 
1.108 in THF for one hour without additive; (c) with vinylmagnesium chloride 1.108 in THF for 
one hour with two equivalents of sodium triflate; (d) with vinylmagnesium chloride 1.108 in THF 
for 24 hours with two equivalents of sodium triflate; and (e) with vinylmagnesium chloride 1.108 
in 1:1 THF:DMSO for 24 hours at 40 °C with two equivalents of sodium triflate. 
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With these data in hand, we commenced on the optimization studies shown in Table 
1.3. Sodium triflate was found to be the optimal additive in the halide-tolerant conjunctive 
cross-coupling reaction with phenyltriflate 1.76, which was superior to both lithium and 
potassium triflate. We attribute this to the tight sodium halide ion pairs that are formed in 
solution, sequestering halide impurities which would otherwise inhibit catalysis; solubility 
studies of various salts in THF and THF:DMSO support this hypothesis.31 Furthermore, 
we found that using vinylmagnesium chloride 1.108 and a 1:1 mixture of THF:DMSO as 
                                                            
31 Lovinger, G. J.; Aparece, M. D.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 3153. 
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the solvent system gave optimal yields and enantioselectivities, although reaction times of 
24 hours were required for full conversion, as DMSO retards the rate of conjunctive cross-
coupling (entry 8). Gratifyingly, we found that we were able to employ bromobenzene 
1.102 as the electrophile with the modification that the reaction requires a third equivalent 
of sodium triflate to sequester bromide ion and a temperature of 60 °C for full conversion 
(entry 13). 
With the optimized conditions in Table 1.3, entry 8, we examined the scope of the 
conjunctive cross-coupling reaction using vinylmagnesium chloride 1.108 and 
organotriflates (Scheme 1.19). Several of sp2-hybridized organotriflate electrophiles were 
successfully coupled (1.109–1.116, 1.134, 1.137, and 1.138). We also expanded the scope 
of aryl migrating groups to encompass boronic esters bearing various electron-donating 
(1.117–1.119) groups, electron-withdrawing groups (1.120, 1.123, 1.124, and 1.133), and 
heterocycles (1.121 and 1.122). The scope of aliphatic migrating groups was also expanded 
to include monosubstituted alkenes (1.126), silyl ethers (1.128), Boc-protected piperidines 
(1.129), amides (1.130), esters (1.131 and 1.138), primary bromides (1.132), and acetals 
(1.136). We were surprised to find that a boronic ester bearing an unprotected alcohol 
(1.135) was able to participate in the reaction, so long as an additional equivalent of 
vinylmagnesium chloride was used to deprotonate the alcohol prior to formation of the 
“ate” complex. As in the first-generation conjunctive cross-coupling reaction, we also 
demonstrated that boron “ate” complexes generated from organomagnesium chlorides and 
vinylB(pin) 1.139 gave virtually identical results as those generated in Scheme 1.19 
(Scheme 1.20). 
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 With the optimized conditions in Table 1.3, entry 13, we examined the scope of 
the conjunctive cross-coupling reaction using vinylmagnesium chloride 1.108 and aryl 
bromides (Scheme 1.21). Aryl bromides gave similar results as their corresponding triflate 
counterparts from Scheme 1.19 (1.109–1.111, 1.113–1.115), as did coupling arylboronates 
to bromobenzene instead of phenyltriflate (1.117, 1.118, and 1.121). As mentioned earlier, 
aryl halides are available in greater variety compared to aryl triflates. Capitalizing on this 
diversity, we were able to synthesize a wider array of conjunctive cross-coupling products 
from numerous aryl bromides compared to the first-generation reaction. The scope of 
electrophiles encompasses nitro groups (1.140), ketones (1.141, 1.145, and 1.148), furans 
(1.142 and 1.144), benzofurans (1.143), thiophenes (1.145 and 1.148), benzothiazoles 
(1.146 and 1.151), indoles (1.147), quinolines (1.149), and pyrimidines (1.150).  
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1.4. Further Developments in the Conjunctive Cross-Coupling Reaction 
Following this report,31 the Morken group has fostered a fruitful research program 
centered on metal-induced 1,2-metallate shifts of organoboron compounds. Pd-catalyzed 
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conjunctive cross-coupling reactions bisalkenyl boron “ate” complexes such as 1.152 to 
synthesize allylic boronates (1.153) have been reported (Scheme 1.22a),32 as well as 
reactions with migration termini bearing substituents at the α position (1.154) to synthesize 
enantioenriched tertiary boronic esters (1.155) (Scheme 1.22b).33 A novel methylated 
acenaphthoquinone (mac) boron ligand 1.158 was developed for Pd-catalyzed conjunctive 
cross-coupling reactions with β susbtituted migration termini (1.156) to access 
enantioenriched organoboronates bearing contiguous stereocenters with high levels 
diastereoselectivity (1.157) (Scheme 1.22c).34 Propargylic carbonate electrophiles such as 
1.159 have been shown to give enantioenriched β-boryl allenes (1.160); methanol additive 
has been shown to enhance both yields and enantioselectivities (Scheme 1.22d).35 
Ni-catalyzed conjunctive cross-coupling reactions have also been developed, the 
earliest of which involves the coupling of 9-BBN boron “ate” derivatives (1.161) and aryl 
iodides in the presence of a chiral 1,2-diamine ligand 1.162 to give enantioenriched 
secondary alcohols (1.163) following oxidation (Scheme 1.23a).36 Later, a radical–ionic 
mechanistic dichotomy was discovered depending on the type of sp3-hybridized 
electrophile used: with primary aliphatic iodides such as 1.164 in the presence of a chiral 
PyBox ligand 1.165, the reaction proceeds through a polar mechanism similar to that of the 
first-generation conjunctive cross coupling to give enantioenriched boronic esters (1.166), 
whereas with α-halocarbonyls such as 1.167 or perfluorinated alkyl iodides, the reaction 
proceeds through a radical-polar crossover mechanism similar to other reactions in  
                                                            
32 Edelstein, E. K.; Namirembe, S.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 5027. 
33 Myhill, J. A.; Zhang, L.; Lovinger, G. J.; Morken, J. P. Angew. Chem. Int. Ed. 2018, 57, 12799. 
34 Myhill, J. A.; Wilhelmsen, C. A.; Zhang, L.; Morken, J. P. J. Am. Chem. Soc. 2018, 140, 15181. 
35 Aparece, M. D.; Hu, W.; Morken, J. P. ACS Catal. 2019, 9, 11381. 
36 Chierchia, M.; Law, C.; Morken, J. P. Angew. Chem. Int. Ed. 2017, 56, 11870. 
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contemporaneous reports by Studer37 and Aggarwal38 in which a stabilized sp3-hybridized 
radical (1.168) is formed, which undergoes radical addition onto the boron “ate” complex 
to give an α-boryl radical (1.169); oxidation of this species to an α-boryl carbocation 
triggers the 1,2-metallate shift to give racemic boronic esters (1.170) (Scheme 1.23b).39 
9-BBN boron “ate” derivatives were also shown to undergo Ni-catalyzed 
conjunctive cross-coupling with acyl electrophiles such as 1.172 in the presence of a 
bipyridine ligand 1.173 to give β-hydroxycarbonyls 1.174 (Scheme 1.23c).40 Most 
recently, alkyl B(mac) “ate” complexes such as 1.175 were shown to react with primary 
alkyl iodides in the presence of chiral PyBox ligand 1.176 to give conjunctive cross-
coupling products (1.177) with excellent levels of enantioselectivity (Scheme 1.23d).41 
In conclusion, we have developed a halide-tolerant conjunctive cross-coupling 
reaction that employs commercially available vinyl Grignard reagents as opposed to halide-
free vinyllithium that was synthesized in-house for the first-generation conjunctive cross-
coupling reaction. Two equivalents of sodium triflate additive were required to not only 
enhance the nucleophilicity of Grignard reagents to form boron “ate” complexes but also 
to sequester halide ions that would bind to palladium and arrest catalysis. Aryl bromides 
could also be used as electrophiles, provided an additional equivalent of sodium triflate is 
used, thus expanding the diversity of products that can be formed. DMSO was added as a 
co-solvent to stabilize alkyl boron “ate” complexes derived from Grignard reagents, which 
would otherwise decompose in THF alone.  
  
                                                            
37 Kischkewitz, M.; Okamoto, K.; Mück-Lichtenfeld, C.; Studer, A. Science 2017, 355, 936. 
38 Silvi, M.; Sandford, C.; Aggarwal, V. K. J. Am. Chem. Soc. 2017, 139, 5736. 
39 Lovinger, G. J.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 17293. 
40 Law, C.; Meng, Y.; Koo, S. M.; Morken, J. P. Angew. Chem. 2019, 131, 6726. 
41 Koo, S. M.; Vendola, A. J.; Momm, S. N.; Morken, J. P. Org. Lett. 2020, 22, 666. 
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1.5. Experimental 
1.5.1. General Information 
1H NMR spectra were recorded on either a Varian Gemini-500 (500 MHz), Varian 
Gemini-600 (600 MHz), or Varian Inova-500 (500 MHz) spectrometer. Chemical shifts 
are reported in ppm with the solvent resonance as the internal standard (CDCl3: 7.24 
ppm). Data are reported as follows: chemical shift, integration, multiplicity (s = singlet, 
d = doublet, t = triplet, q = quartet, p = pentet, m = multiplet, app = apparent), and 
coupling constants (Hz). 13C NMR spectra were recorded on either a Varian Gemini-500 
(125 MHz), Varian Gemini-600 (150 MHz) or a Varian Inova-500 (125 MHz) 
spectrometer with complete proton decoupling. Chemical shifts are reported in ppm with 
the solvent resonance as the internal standard (CDCl3: 77.24 ppm). Chemical shifts are 
reported in ppm using phosphoric acid as the external standard (H3PO4: 0.0 ppm). 11B 
NMR spectra were recorded on a Varian Gemini-500 (128 MHz) spectrometer. Chemical 
shifts are reported in ppm using boron trifluoride diethyl etherate as the external standard 
(BF·OEt2: 0.0 ppm). 19F NMR spectra were recorded on a Varian Gemini-500 (470 MHz) 
spectrometer. Infrared (IR) spectra were recorded on a Bruker alpha-P Spectrometer. 
Frequencies are reported in wavenumbers (cm-1) as follows: strong (s), broad (br), 
medium (m), and weak (w). Optical rotations were measured on a Rudolph Analytical 
Research Autopol IV Polarimeter and the values reported are averages of seven 
measurements. High-resolution mass spectrometry (DART) was performed at the Mass 
Spectrometry Facility, Boston College, Chestnut Hill, MA. Liquid chromatography was 
performed using forced flow (flash chromatography) on silica gel (SiO2, 230 x 450 Mesh, 
purchased from Silicycle) either manually or using an automated column (Biotage). Thin 
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layer chromatography (TLC) was performed on 25 μm silica gel aluminum backed plates 
from Silicycle. Visualization was performed using ultraviolet light (254 nm), ceric 
ammonium molybdate (CAM) in ethanol or phosphomolybdic acid, and cerium(IV) 
sulfate in ethanol with sulfuric acid (Seebach). 
Analytical supercritical fluid chromatography (SFC) was performed on a TharSFC 
Method Station II equipped with Waters 2998 Photodiode Array Detector with isopropanol 
or methanol as the modifier.  
Tetrahydrofuran (THF), diethyl ether (Et2O), dichloromethane (DCM) and toluene 
were purified using Pure Solv MD-4 solvent purification system, from Innovative 
Technology, Inc., by passing the solvent through two activated alumina columns after 
purging with argon. Palladium (II) acetate, (Sp,Sp)-3.3, 1,1′-Bis(dicyclohexyl-
phosphino)ferrocene, and 1,1′-Bis(diisopropylphosphino)ferrocene were purchased from 
Strem Chemicals, Inc. and used without further purification. Pinacol was purchased from 
Aldrich. All pinacol esters were purchased from Combi Blocks, Oakwood Chemicals, or 
Frontier Scientific and used without further purification. All arylbromides were purchased 
from Combi Blocks, Oakwood Chemicals, or Frontier Scientific and used without further 
purification. Phenyl trifluoromethanesulfonate, 4-methoxyphenyltrifluoro methane-
sulfonate, and trifluoromethane-sulfonic anhydride were purchased from Oakwood 
Chemicals and used without further purification. All other reagents were purchased from 
either Aldrich, Alfa Aesar or Acros and used without further purification. 
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1.5.2. General Procedure for the Preparation of Boronate Esters 
 
To an oven-dried round bottom flask with magnetic stir bar was added boronic acid (1.0 
equiv) and pentane. The suspension was allowed to cool to 0 °C and 2,3-dimethylbutane-
2,3-diol (pinacol) (1.05 equiv) was added neat and the solution was allowed to warm to 
room temperature and stir for 3 h. If a water layer was observed it was removed and the 
resulting pentane solution was dried with with Na2SO4, filtered with diethyl ether, and the 
solvent was removed in vacuo. The resulting residue was purified on silica gel (plug with 
CH2Cl2 as the eluent). 
 
5,5-dimethyl-2-phenyl-1,3,2-dioxaborinane (1.94). Prepared 
according to the general procedure above with phenylboronic acid 
(0.268 g, 22.0 mmol, 1.0 equiv), pinacol (2.41 g, 23.1 mmol, 1.05 equiv), and pentane (60 
mL). The resulting white solid (4.18 g, quantitative yield) was used without further 
purification. All spectroscopic data were in accord with the literature.42 
 
2-(4-bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(1.178). Prepared according to the general procedure  above with 
4-bromophenylboronic acid (1.00 g, 5.0 mmol, 1.0), pinacol (0.620 g, 5.25 mmol, 1.05), 
                                                            
42 Clary, J. W.; Rettenmaier, T. J.; Snelling, R.; Bryks, W.; Banwell, J.; Wipke, W. T.; Singaram, B. J. Org.  
Chem. 2011, 76, 9602. 
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and pentane (15 mL). The resulting white solid (1.19 g, 84% yield) was used without 
further purification. All spectroscopic data were in accord with the literature.43 
 
1.5.3. Procedures for Preparation of Alkenyl Trifluoromethanesulfonates 
 cyclohexylidenemethyl trifluoromethanesulfonate (1.179). The title 
compound was prepared according to the procedure reported in the 
literature.44 All spectroscopic data were in accord with the literature.45 
 
cyclohex-1-en-1-yl trifluoromethanesulfonate (1.180). The title compound 
was prepared according to the procedure reported in the literature.89 All 
spectroscopic data were in accord with the literature.45 
 
 5-((tert-butyldimethylsilyl)oxy) pent-1-en-2-yl trifluoro-
methanesulfonate (1.181). The title compound was prepared 
according to the procedure reported in the literature.20 All spectroscopic data were in 
accord with the literature. 
  
                                                            
43 Zhu, W.; Ma, D. Org. Lett. 2006, 8, 261. 
44 Stang, P. J.; Treptow, W. Synthesis 1980, 4, 283. 
45 Al-huniti, M. H.; Lepore, S. D. Org. Lett. 2014, 16, 4154. 
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1.5.4. General Procedure for the Synthesis of Aryl Trifluoromethanesulfonates  
 
Aryl trifluoromethanesulfonates were made according to literature procedure with slight 
modification.46 To a solution of the corresponding phenol and pyridine in CH2Cl2 at 0 °C, 
a solution of trifluoromethanesulfonic anhydride in CH2Cl2 was added dropwise. The 
mixture was then allowed to warm to room temperature and stir for 1 h. The mixture was 
diluted with Et2O, quenched with a 3 M solution of aquious HCl and washed successively 
with a saturated solution of aqueous NaHCO3 and brine. The solution was dried over 
Na2SO4, filtered with Et2O, and the solvent was removed in vacuo. The residue was 
purified by silica gel chromatography to afford aryl trifluoromethanesulfones. 
 
 4-(trifluoromethyl)phenyl trifluoromethanesulfonate (1.182). 
Prepared according to the general procedure above with 4-
trifluoromethylphenol (0.630 g, 3.8 mmol, 1.0 equiv), trifluoromethanesulfonic anyhydride 
(0.774 mL, 4.6 mmol, 1.21 equiv), pyridine (0.615 mL, 7.6 mmol, 2.0 equiv), and CH2Cl2 
(6.0 mL). The unpurified residue was purified by silica gel chromatography (10% ethyl 
acetate/Hexanes) to afford the product as colorless oil (1.180 g, 98% yield). All 
spectroscopic data were in accord with the literature.47 
 
                                                            
46 Goosen, L. J.; Linder, C.; Rodríguez, N.; Lange, P. P. Chem. Eur. J. 2009, 15, 9336. 
47 Gill, D.; Hester, A. J.; Lloyd-Jones, G. C. Org. Biomol. Chem. 2004, 4, 2547. 
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 2,4-dimethylphenyl trifluoromethanesulfonate (1.183). Prepared 
according to the general procedure above with 2,4-dimethylphenol 
(0.906 mL, 7.5 mmol, 1.0 equiv), trifluoromethanesulfonic anhydride (1.50 mL, 9.0 mmol, 
1,2 equiv), pyridine (1.2 mL, 15.0 mmol, 2.0 equiv), and CH2Cl2 (13.0 mL). The unpurified 
residue was purified by silica gel chromatography (5% ethyl acetate/Hexanes) to afford the 
product as colorless oil (1.680 g, 88% yield). All spectroscopic data were in accord with 
the literature.48 
 
 4-formylphenyl trifluoromethanesulfonate (1.184). Prepared 
according to the general procedure above with 4-hydroxybenzaldehyde 
(0.488 g, 4.0 mmol, 1.0 equiv), trifluoromethanesulfonic anhydride (0.81 mL, 4.8 mmol, 
1.2 equiv), pyridine (0.65 mL, 8.0 mmol, 2.0 equiv), and CH2Cl2 (7.0 mL). Following 
quenching, extraction, drying, and concentrating in vacuo, the unprurified residue was 
passed through a Celite pad, which was washed with copious amounts of CH2Cl2, to afford 
the product as colorless oil (0.60 g, 60% yield); the product decomposes upon exposure to 
silica gel. All spectroscopic data were in accord with the literature.49 
 
 pyridin-3-yl trifluoromethanesulfonate (1.185). Prepared according to the 
general procedure above with 3-hydroxypyridine (0.380 g, 4.0 mmol, 1.0 
equiv), trifluoromethanesulfonic anhydride (0.81 mL, 4.8 mmol, 1.2 equiv), pyridine (0.65 
mL, 8.0 mmol, 1.2 equiv), and CH2Cl2 (20.0 mL). The reaction was quenched with water 
(20 mL) instead of HCl. Following quenching, extraction, drying, and concentrating in 
                                                            
48 Radivoy, G.; Alonso, F.; Yus, M. Tetrahedron 1999, 55, 14479. 
49 Echavarren, A. M.; Stille, J. K. J. Am. Chem. Soc. 1987, 109, 5478. 
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vacuo, the unpurified residue was purified by silica gel chromatography (30% 
ethylacetate/Hexanes) to afford the product as yellow oil (0.69 g, 76% yield). All 
spectroscopic data were in accord with the literature.49 
 
4-chlorophenyl trifluoromethanesulfonate (1.186). Prepared according 
to the general procedure above with 4-chlorophenol (0.514 g, 4.0 mmol, 
1.0 equiv), trifluoromethanesulfonic anhydride (0.81 mL, 4.8 mmol, 1.2 equiv), pyridine 
(0.65 mL, 8.0 mmol, 2.0 equiv), and CH2Cl2 (7.0 mL). The unpurified residue was purified 
by silica gel chromatography (30% ethyl acetate/Hexanes) to afford the product as 
colorless oil (0.877 g, 84% yield). All spectroscopic data were in accord with the 
literature.50 
1.5.5. General Procedures for Conjunctive Cross-Coupling  
1.5.5.1. Method A 
 
In a glovebox under argon an oven-dried 2-dram vial equipped with a magnetic stir 
bar was charged with 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane (0.30 mmol, 1.00 
equiv), sodium trifluoromethanesulfonate (0.60 mmol, 2.00 equiv), and tetrahydrofuran 
(0.5 mL), sealed with a septum cap, and removed from the glovebox. Under positive 
nitrogen pressure the vial was allowed to cool to 0 ºC, and organomagnesium chloride 
                                                            
50 Murai, N.; Yonaga, M.; Tanaka, K. Org. Lett. 2012, 14, 1278.  
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solution in tetrahydrofuran (0.30 mmol, 1.0 equiv) was added dropwise. The vial was 
allowed to warm to room temperature and stir for 30 min before being brought back into 
the glovebox. In the glovebox a second oven-dried 2-dram vial equipped with a magnetic 
stir bar was charged with Pd(OAc)2 (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 
0.03 equiv), and MandyPhos 1.64 (0.0108 mmol, 0.036 equiv). The Pd(OAc)2/MandyPhos 
1.64 solution was allowed to stir for 15 min at room temperature. The 
Pd(OAc)2/MandyPhos 1.64 solution was then transferred into the vial, followed by 
tetrahydrofuran (0.2 mL) (used to rinse the Pd(OAc)2/MandyPhos 1.64 vial), and aryl/vinyl 
trifluoromethanesulfonate (0.36 mmol, 1.20 equiv). The vial was sealed with a 
polypropylene cap, taped, and brought out of the glovebox where it was allowed to stir at 
40 ºC for 24 h. To the resulting mixture was added water (10 mL) and the product was 
extracted from the aqueous layer with ethyl acetate (3 x 20 mL).  The combined organic 
layers were dried over Na2SO4, concentrated under reduced pressure, filtered through a 
silica gel plug with diethyl ether, reconcentrated, and subsequently purified by silica gel 
chromatography to provide the desired products.  
1.5.5.2. Method B 
 
In a glovebox under argon an oven-dried 2-dram l equipped with a magnetic stir 
bar was charged with boronate (0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate 
(0.60 mmol, 2.00 equiv), and tetrahydrofuran (0.5 mL), sealed with a septum cap, and 
removed from the glovebox. Under positive nitrogen pressure the vial was allowed to cool 
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to 0 ºC and vinylmagnesium chloride solution in tetrahydrofuran (0.30 mmol, 1.0 equiv) 
was added dropwise. The vial was allowed to warm to room temperature and stir for 30 
min before being brought back into the glovebox. In the glovebox a second oven-dried 2-
dram vial equipped with a magnetic stir bar was charged with Pd(OAc)2 ((0.90 mL, 0.01 
M in dimethyl sulfoxide, 0.009 mmol, 0.03 equiv), and MandyPhos 1.64 (0.0108 mmol, 
0.036 equiv.). The Pd(OAc)2/MandyPhos 1.64 solution was allowed to stir for 15 min at 
room temperature. The Pd(OAc)2/MandyPhos 1.64 solution was then transferred into the 
vial, followed by tetrahydrofuran (0.2 mL) (used to rinse the Pd(OAc)2/MandyPhos 1.64 
vial), and aryl/vinyl trifluoromethanesulfonate (0.36 mmol, 1.20 equiv). The vial was 
sealed with a polypropylene cap, taped, and brought out of the glovebox where it was 
allowed to stir at 40 ºC for 24 h. To the resulting mixture was added water (10 mL) and the 
aqueous layer was extracted with ethyl acetate (3 x 20 mL).  The combined organic layers 
were dried over Na2SO4, concentrated under reduced pressure, filtered through a silica gel 
plug with diethyl ether, reconcentrated, and subsequently purified by silica gel 
chromatography to provide the desired products.  
1.5.5.3. Method C 
 
In a glovebox under argon an oven-dried 2-dram vial equipped with a magnetic stir 
bar was charged with boronate (0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate 
(0.60 mmol, 2.00 equiv), and tetrahydrofuran (0.5 mL), sealed with a septum cap, and 
removed from the glovebox. Under positive nitrogen pressure the vial was allowed to cool 
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to 0 ºC, and vinylmagnesium chloride solution in tetrahydrofuran (0.30 mmol, 1.0 equiv) 
was added dropwise. The vial was allowed to warm to room temperature and stir for 30 
min before being brought back into the glovebox. In the glovebox a second oven-dried 2-
dram vial equipped with a magnetic stir bar was charged with Pd(OAc)2 ((0.90 mL, 0.01 
M in dimethyl sulfoxide, 0.009 mmol, 0.03 equiv), and MandyPhos 1.64 (0.0108 mmol, 
0.036 equiv). The Pd(OAc)2/MandyPhos 1.64 solution was allowed to stir for 15 min at 
room temperature. The Pd(OAc)2/MandyPhos 1.64 solution was then transferred into the 
vial, followed by tetrahydrofuran (0.2 mL) (used to rinse the Pd(OAc)2/MandyPhos 1.64 
vial), and arylbromide (0.36 mmol, 1.20 equiv). The vial was sealed with a polypropylene 
cap, taped, and brought out of the glovebox where it was allowed to stir at 60 ºC for 24 h. 
To the resulting mixture was added water (10 mL) and the product was extracted from the 
aqueous layer with ethyl acetate (3 x 20 mL).  The combined organic layers were dried 
over Na2SO4, concentrated under reduced pressure, filtered through a silica gel plug with 
diethyl ether, reconcentrated, and subsequently purified by silica gel chromatography to 
provide the desired products. 
1.5.5.4. General Method for Oxidation of Boronic Ester Products 
Note: Where appropriate, boronic ester products were oxidized. In these cases, 
the procedure used was the same as that described in the corresponding method 
A/B/C but with the modification that: After the reaction was completed the mixture was 
filtered through a silica gel plug with diethyl ether, concentrated under reduced pressure, 
and diluted with tetrahydrofuran (3 mL).  The unpurified mixture was allowed to cool to 0 
ºC and a 3 M solution of aqueous NaOH (2 mL) was added, followed by 30% H2O2 (1.0 
mL), dropwise.  The mixture was allowed to warm to room temperature, and stir for 3 h.  
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The mixture was allowed to cool to 0 ºC and a saturated solution of aqueous Na2S2O3 (3 
mL) was added dropwise. After warming to room temperature the product was extracted 
from the aqueous layer with ethyl acetate (3 x 20 mL).  The combined organic layers were 
dried over Na2SO4, concentrated under reduced pressure, and subsequently purified by 
silica gel chromatography to provide the desired products. 
1.5.6. Characterization of Conjunctive Cross-Coupling Products 
(R)-2-(1,2-diphenylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lane (1.109). The reaction was performed according to the general 
procedure (Method A) with 4,4,5,5-tetramethyl-2-vinyl-1,3,2-
dioxaborolane (46.2 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), phenylmagnesium chloride 
(0.17 mL, 1.77 M in tetrahydrofuan, 0.30 mmol, 1.00 equiv), phenyl 
trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.9 
mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
0.0108 mmol). The unpurified product was purified by automated silica gel 
chromatography (Biotage 1% → 5% ethyl acetate in hexanes, stained in CAM) to afford 
white solid (74.9 mg, 81% yield). 
 
(Method B) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv) sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 
phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate 
(0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 
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mg, 0.0108 mmol, 0.036 equiv). The unpurified product was purified by automated silica 
gel chromatography (Biotage 1% → 5% ethyl acetate in hexanes, stained in CAM) to afford 
white solid (74.9 mg, 81% yield). 
 
(Method C) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv 
bromobenzene (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.9 mL, 0.01 M 
dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 
0.036 equiv). The unpurified product was purified by automated silica gel chromatography 
(Biotage 1% → 5% ethyl acetate in hexanes, stained in CAM) to afford white solid (77.7 
mg, 84% yield). 
 
1H NMR (600 MHz, CDCl3) δ 7.31 – 7.17 (m, 10H), 3.21 (dd, J = 13.5, 9.8 Hz, 1H), 3.02 
(dd, J = 13.5, 6.9 Hz, 1H), 2.74 (dd, J = 9.8, 6.9 Hz, 1H), 1.17 (s, 6H), 1.16 (s, 6H). 11B 
NMR (160 MHz, CDCl3) δ 33.00. 13C NMR (151 MHz, CDCl3) δ 142.78 , 141.95 , 129.09 
, 128.61 , 128.53 , 128.23 , 125.95 , 125.59 , 83.60 , 39.07 , 34.64 , 24.80 , 24.72. IR (neat) 
νmax 2977.30 (w), 2929.44 (w), 1493.68 (w), 1452.33 (w), 1361.52 (s), 1325.25 (s), 1140.53 
(s), 967.43 (w), 853.72 (w), 761.56 (w), 698.98 (s), 528.85 (w) cm-1. HRMS (DART) for 
C20H26BO2 [M+H]+ calculated: 309.2026, found: 309.2025. [α]20D: -49.358 (c 3.69, CHCl3, 
l =50 mm). 
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Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-2-(1,2-diphenylethyl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.109). 




methyl-1,3,2-dioxaborolane (1.110). The reaction was 
performed according to the general procedure (Method B) 
with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 
61.2 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 
mmol, 2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 
mmol, 1.00 equiv), 4-methoxyphenyl trifluoromethanesulfonate (92.2 mg, 0.36 mmol, 1.20 
equiv), palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 
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equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product 
was purified by automated silica gel chromatography (Biotage 1% → 5% ethyl acetate in 
hexanes, stained in CAM) to afford white solid (91.3 mg, 90% yield).  
 
(Method C) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 4-
bromoanisole (67.3 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 0.01 M 
in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 
mmol, 0.036 equiv).  The unpurified product was purified by automated silica gel 
chromatography (Biotage 1% → 5% ethyl acetate in hexanes, stained in CAM) to afford 
white solid (93.4 mg, 92% yield). 
 
1H NMR (600 MHz, CDCl3) δ 7.26 – 7.20 (m, 4H), 7.14 – 7.10 (m, 1H), 7.08 (d, J = 8.6 
Hz, 2H), 6.75 (d, J = 8.6 Hz, 2H), 3.75 (s, 3H), 3.08 (dd, J = 13.6, 9.7 Hz, 1H), 2.89 (dd, J 
= 13.6, 6.9 Hz, 1H), 2.63 (dd, J = 9.6, 7.0 Hz, 1H), 1.11 (s, 6H), 1.10 (s, 6H). 11B NMR 
(128 MHz, CDCl3) δ 32.97. 13C NMR (151 MHz, CDCl3) δ 157.92, 142.83, 134.07, 
129.95, 128.59, 128.48, 125.52, 113.62, 83.53, 55.38, 38.14, 34.91, 24.78, 24.73. IR (neat) 
νmax 3060.40 (w), 3025.37 (w), 2976.85 (m), 2932.81 (w), 2834.43 (w), 1611.11 (m), 
1510.56 (s), 1360.56 (s), 1324.02 (s), 1243.26 (s), 1139.26 (s), 1034.86 (m), 967.45 (m), 
829.03 (m), 700.16 (s) cm-1. HRMS (DART) for C21H28BO3 [M+H]+: calculated: 
339.21315, found: 339.21403. [α]D20 = – 46.292 (c 1.73, CHCl3, l = 50 mm). 
 
51
   
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-2-(2-(4-
methoxyphenyl)-1-phenylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.110). 
 
Racemic Material                               Standard Conditions 
      
 
(R)-4,4,5,5-tetramethyl-2-(1-phenyl-2-(4-(trifluoromethyl) 
phenyl) ethyl)-1,3,2-dioxaborolane (1.111). The reaction was 
performed according to the general procedure (Method B) with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 
mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 
2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 
1.00 equiv), 4-(trifluoromethyl)phenyl trifluoromethanesulfonate (1.182, 105.9 mg, 0.36 
mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 
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mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The 
unpurified product was purified by automated silica gel chromatography (Biotage 1% → 
5% ethyl acetate in hexanes, stained in CAM) to afford colorless oil (95.9 mg, 85% yield).  
 
(Method C) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 4-
bromobenzotrifluoride (81.0 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 
0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
0.0108 mmol, 0.036 equiv). The unpurified product was purified by automated silica gel 
chromatography (Biotage 1% → 5% ethyl acetate in hexanes, stained in CAM) to afford 
colorless oil (85.8 mg, 76% yield). 
 
1H NMR (600 MHz, CDCl3) δ 7.46 (d, J = 8.0 Hz, 2H), 7.29 – 7.23 (m, 4H), 7.21 (d, J = 
6.9 Hz, 2H), 7.15 (t, J = 7.2 Hz, 1H), 3.20 (dd, J = 13.6, 9.3 Hz, 1H), 3.00 (dd, J = 13.6, 
7.3 Hz, 1H), 2.66 (dd, J = 8.9, 7.6 Hz, 1H), 1.12 (s, 6H), 1.12 (s, 6H). 11B NMR (128 MHz, 
CDCl3) δ 32.68. 13C NMR (151 MHz, CDCl3) δ 146.14, 142.11, 129.37, 128.66, 128.59, 
128.33 (partially buried, q, 2JC–F = 32.2 Hz), 125.85, 125.14 (q, 3JC–F = 3.7 Hz), 124.62 (q, 
1JC–F = 271.7 Hz), 83.80, 38.81, 34.38, 24.76, 24.74. IR (neat) νmax 3061.55 (w), 3025.45 
(w), 2979.30 (m), 2932.67 (w), 1362.99 (m), 1321.35 (s), 1162.23 (m), 1139.06 (s), 
1120.38 (s), 1066.83 (s), 842.37 (m), 700.83 (m) cm-1. HRMS (DART) for C21H28BF3NO2 
[M+NH4]+: calculated: 394.21652, found: 394.21675. [α]D20 = – 41.075 (c 2.58, CHCl3, l 
= 50 mm). 
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Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-4,4,5,5-tetramethyl-2-
(1-phenyl-2-(4-(trifluoromethyl)phenyl)ethyl)-1,3,2-dioxaborolane (1.111). 
 
Racemic Material                              Standard Conditions 
     
 
 (R)-2-(2-(2,4-dimethylphenyl)-1-phenylethyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (1.112). The reaction was 
performed according to the general procedure (Method B, with 
the modification: the reaction was run at 60 ºC instead of 40 
ºC) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 mmol, 
1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 
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2,4-dimethylphenyl trifluoromethanesulfonate (1.183, 91.5 mg, 0.36 mmol, 1.20 equiv), 
palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), 
MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was 
purified by silica gel chromatography (0% → 20% ethyl acetate in hexanes, stained in 
CAM) to afford colorless oil (71.1 mg, 70% yield). 1H NMR (500 MHz, CDCl3) δ 7.24 (d, 
J = 3.9 Hz, 4H), 7.16 – 7.09 (m, 1H), 7.04 (d, J = 7.7 Hz, 1H), 6.90 (s, 1H), 6.85 (d, J = 
7.6 Hz, 1H), 3.11 (dd, J = 13.7, 10.1 Hz, 1H), 2.85 (dd, J = 13.8, 6.2 Hz, 1H), 2.62 (dd, J 
= 9.8, 6.2 Hz, 1H), 2.24 (s, 3H), 2.22 (s, 3H), 1.11 (s, 6H), 1.10 (s, 6H). 11B NMR (128 
MHz, CDCl3) δ 32.79.  13C NMR (126 MHz, CDCl3) δ 143.21, 137.00, 136.23, 135.36, 
131.05, 129.28, 128.63, 128.53, 126.35, 125.57, 83.60, 35.95, 33.27, 24.86, 24.74, 21.12, 
19.57. IR (neat) νmax 3082.50 (w), 3057.14 (w), 3023.76 (w), 2976.78 (m), 2926.55 (m), 
2863.88 (w), 1600.81 (w), 1493.07 (m), 1451.70 (m), 1359.49 (s), 1324.47 (s), 1141.37 
(s), 967.98 (m), 853.68 (m), 700.02 (m) cm-1. HRMS (DART) for C22H30BO2 [M+H]+: 
calculated: 337.2339, found: 337.2337. [α]D20 = – 22.542 (c 1.02, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-H, 
2% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-2-(2-(2,4-
dimethylphenyl)-1-phenylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.112). 
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1,3,2-dioxaborolane (1.113). The reaction was performed 
according to the general procedure (Method B) with 4,4,5,5-
tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 4-
chlorophenyl trifluoromethanesulfonate (1.186, 93.8 mg, 0.36 mmol, 1.20 equiv), 
palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), 
MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was 
purified by silica gel chromatography (0% → 20% CH2Cl2 in hexanes, stained in CAM) to 
afford white solid (77.1 mg, 75% yield).  
 
(Method C) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 1-
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bromo-4-chlorobenzene (68.9 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 
mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
0.0108 mmol, 0.036 equiv). The unpurified product was purified by silica gel 
chromatography (0% → 20% CH2Cl2 in hexanes, stained in CAM) to afford white solid 
(54.5 mg, 53% yield). 
 
1H NMR (500 MHz, CDCl3) δ 7.23 – 7.09 (m, 7H), 7.06 (d, J = 8.4 Hz, 2H), 3.09 (dd, J = 
13.6, 9.3 Hz, 1H), 2.89 (dd, J = 13.6, 7.2 Hz, 1H), 2.60 (dd, J = 9.2, 7.4 Hz, 1H), 1.10 (s, 
6H), 1.10 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 32.68. 13C NMR (126 MHz, CDCl3) δ 
142.31, 140.41, 131.64, 130.42, 128.59, 128.57, 128.28, 125.72, 83.69, 38.33, 34.57, 
24.77, 24.76. IR (neat) νmax 3062.99 (w), 3028.92 (w), 2992.58 (m), 2974.97 (m), 2926.86 
(w), 2866.56 (w), 2854.54 (w), 1599.48 (w), 1491.98 (m), 1451.90 (m), 1361.24 (s), 
1325.22 (m), 1137.88 (s), 840.95 (m), 698.86 (s), 526.61 (m) cm-1. HRMS (DART) for 
C20H28BClNO2 [M+NH4]+: calculated: 360.19016, found: 360.18982. [α]D20 = – 51.441 (c 
2.55, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-H, 





   
 
Racemic Material                       Standard Conditions 
               
 
(R)-4-(2-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl) benzaldehyde (1.114). The reaction was performed 
according to the general procedure (Method B) with 4,4,5,5-
tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 4-
formylphenyl trifluoromethanesulfonate (1.184, 91.5 mg, 0.36 mmol, 1.20 equiv), 
palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), 
MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv.). The unpurified product was 
purified by silica gel chromatography (0% → 50% → 100% CH2Cl2 in hexanes, stained in 
CAM) to afford white solid (74.6 mg, 74% yield).  
 
(Method C) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
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vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 4-
bromobenzaldehyde (66.6 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 
0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
0.0108 mmol, 0.036 equiv). The unpurified product was purified by silica gel 
chromatography (0% → 50% → 100% CH2Cl2 in hexanes, stained in CAM) to afford white 
solid (58.5 mg, 58% yield).  
 
1H NMR (500 MHz, CDCl3) δ 9.92 (s, 1H), 7.71 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 
2H), 7.25 – 7.20 (m, 2H), 7.18 (d, J = 6.9 Hz, 2H), 7.13 (app t, J = 7.2 Hz, 1H), 3.21 (dd, 
J = 13.5, 9.3 Hz, 1H), 3.01 (dd, J = 13.5, 7.5 Hz, 1H), 2.66 (app t, J = 8.1 Hz, 1H), 1.11 (s, 
6H), 1.10 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 33.00. 13C NMR (126 MHz, CDCl3) δ 
192.23, 149.53, 141.97, 134.63, 129.82, 129.73, 128.61, 128.55, 125.83, 83.78, 39.18, 
34.24, 24.74, 24.72. IR (neat) νmax 3059.19 (w), 3025.78 (w), 2977.21 (m), 2929.43 (w), 
2861.26 (w), 2826.64 (w), 2733.18 (w), 1698.39 (s), 1604.87 (m), 1361.01 (s), 1326.41 (s), 
1139.63 (s), 844.14 (m), 701.29 (m), 538.21 (m) cm-1. HRMS (DART) for C21H26BO3 
[M+H]+: calculated: 337.1975, found: 337.1981. [α]D20 = – 57.821 (c 2.62, CHCl3, l = 50 
mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-H, 
10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-4-(2-phenyl-2-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)benzaldehyde (1.114). 
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yl)ethyl) pyridine (1.115). The reaction was performed according to 
the general procedure (Method B) with 4,4,5,5-tetramethyl-2-phenyl-
1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 3-pyridyl 
trifluoromethanesulfonate (1.185, 81.8 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate 
(0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 
11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was purified by silica gel 
chromatography (0% → 50% → 100% CH2Cl2 in hexanes, stained in CAM) to afford pink 
oil (47.3 mg, 51% yield).  
 
(Method C) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 3-
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bromopyridine (56.9 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 0.01 M 
in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 
mmol, 0.036 equiv). The unpurified product was purified by silica gel chromatography 
(0% → 50% → 100% CH2CH2 in hexanes, stained in CAM) to afford pink oil (45.5 mg, 
49% yield).  
 
1H NMR (500 MHz, CDCl3) δ 8.38 (s, 1H), 8.34 (d, J = 3.3 Hz, 1H), 7.41 (d, J = 7.8 Hz, 
1H), 7.26 – 7.18 (m, 2H), 7.16 (d, J = 7.1 Hz, 2H), 7.13 – 7.05 (m, 2H), 3.11 (dd, J = 13.7, 
9.2 Hz, 1H), 2.90 (dd, J = 13.7, 7.4 Hz, 1H), 2.59 (app t, J = 8.3 Hz, 1H), 1.10 (s, 6H), 1.09 
(s, 6H). 11B NMR (128 MHz, CDCl3) δ 32.81.  13C NMR (126 MHz, CDCl3) δ 150.34, 
147.24, 141.87, 137.25, 136.54, 128.64, 128.59, 125.87, 123.19, 83.81, 36.08, 34.37, 
25.03, 24.73. IR (neat) νmax 3083.23 (w), 3058.15 (w), 3025.24 (w), 2977.72 (m), 2929.39 
(w), 2861.19 (w), 1600.02 (w), 1574.63 (w), 1493.42 (m), 1478.78 (m), 1451.31 (m), 
1422.39 (m), 1364.27 (s), 1328.41 (s), 1141.17 (s), 968.05 (m), 853.25 (m), 701.71 (m) 
cm-1. HRMS (DART) for C19H25BNO2 [M+H]+: calculated: 310.1978, found: 310.1990. 
[α]D20 = – 39.247 (c 1.76, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (3 mol%), (Sp, Sp)-MandyPhos 1.64 
(1.8 mol%), and (Rp, Rp)-MandyPhos 1.64 (1.8 mol%) as the catalyst. Chiral SFC (Chiracel 




   
 




tetramethyl-1,3,2-dioxaborolane (1.116). The reaction was 
performed according to general procedure (Method B) with 4,4,5,5-
tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv) sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 
cyclohex-1-en-1-yl trifluoromethanesulfonate (1.180, 82.9 mg, 0.36 mmol, 1.20 equiv), 
palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), 
MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was 
purified by automated silica gel chromatography (Biotage 1% →5% ethyl acetate in 
hexanes, stained in CAM) to afford white solid (71.2 mg, 76% yield). 1H NMR (600 MHz, 
CDCl3) δ 7.25 – 7.19 (m, 4H), 7.13 – 7.08 (m, 1H), 5.42 (s, 1H), 2.56 (dd, J = 10.5, 5.9 
Hz, 1H), 2.49 (app t, 1H), 2.22 (dd, J = 13.7, 5.6 Hz, 1H), 2.02 – 1.83 (m, 4H), 1.63 – 1.42 
(m, 4H), 1.17 (s, 6H), 1.15 (s, 6H). 11B NMR (160 MHz, CDCl3) δ 32.89. 13C NMR (151 
MHz, CDCl3) δ 143.42 , 137.42 , 128.48 , 128.41 , 125.32 , 121.77 , 83.43 , 41.14 , 30.86 
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, 28.84 , 25.46 , 24.86 , 24.82 , 23.26 , 22.77. IR (neat) νmax 2976.74 (w), 2925.87 (w), 
1359.22 (m), 1323.98 (m), 1141.45 (m), 969.45 (w), 850.07 (w), 699.65 (m) cm-1. HRMS 
(DART) for C20H30BO2 [M+H]+ calculated: 313.23388, found: 313.23507. [α]20D: -6.100 
(c 1.215, CHCl3, l =50 mm). 
 
(R)-2-(cyclohex-1-en-1-yl)-1-phenylethan-1-ol (1.116-OH) 
Product 1.116 was oxidized according to General Method for 
Oxidation of Boronic Ester Products. All spectroscopic data were in 
accord with the literature.20 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-





   
 




Dioxa-borolane (1.117). The reaction was performed according 
to the general procedure (Method B) with 4,4,5,5-tetramethyl-2-
(p-tolyl)-1,3,2-dioxaborolane (65.4 mg, 0.30 mmol, 1.00 equiv), 
sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium 
chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl 
trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv) palladium (II) acetate (0.90 
mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
0.0108 mmol, 0.036 equiv). The unpurified product was purified by silica gel 
chromatography (0% → 30% CH2Cl2 in hexanes, stained in CAM) to afford white solid 
(78.3 mg, 81% yield).  
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(Method C) with 4,4,5,5-tetramethyl-2-(p-tolyl)-1,3,2-dioxaborolane (65.4 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 
bromobenzene (56.5 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 0.01 M 
in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 
mmol, 0.036 equiv). The unpurified product was purified by silica gel chromatography 
(0% → 30% CH2Cl2 in hexanes, stained in CAM) to afford white solid (75.4 mg, 78% 
yield).  
 
1H NMR (500 MHz, CDCl3) δ 7.30 – 7.21 (m, 4H), 7.21 – 7.14 (m, 3H), 7.10 (d, J = 7.8 
Hz, 2H), 3.17 (dd, J = 13.4, 10.0 Hz, 1H), 2.98 (dd, J = 13.5, 6.8 Hz, 1H), 2.69 (dd, J = 
9.8, 6.9 Hz, 1H), 2.33 (s, 3H), 1.14 (s, 6H), 1.13 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 
32.91. 13C NMR (126 MHz, CDCl3) δ 142.04, 139.64, 134.89, 129.24, 129.07, 128.43, 
128.19, 125.89, 83.49, 39.26, 34.09, 24.79, 24.70, 21.20. IR (neat) νmax 3085.45 (w), 
3060.29 (w), 3025.44 (w), 2977.10 (m), 2924.49 (w), 2861.47 (w), 1603.87 (w), 1510.16 
(m), 1359.23 (s), 1321.39 (s), 1140.06 (s), 967.33 (m), 855.65 (m), 815.57 (m), 698.19 (s), 
537.31 (m) cm-1. HRMS (DART) for C21H28BO2 [M+H]+: calculated: 323.21823, found: 




   
 
 (R)-2-phenyl-1-(p-tolyl)ethan-1-ol (1.117-OH). Product 1.117 
was oxidized according to General Method for Oxidation of 
Boronic Ester Products. All spectroscopic data were in accord 
with the literature.51 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-H, 
10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-2-phenyl-1-(p-
tolyl)ethan-1-ol (1.117-OH). 
 
    Racemic Material                      Standard Conditions 
    
  
                                                            
51 Zhou, C.; Wang, Z. Synthesis 2005, 10, 1649. 
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(R)-4,4,5,5-tetramethyl-2-(2-phenyl-1-(o-tolyl)ethyl)-1,3,2-
dioxaborolane (1.118). The reaction was performed according to the 
general procedure (Method B) with 4,4,5,5-tetramethyl-2-(o-tolyl)-
1,3,2-dioxaborolane (65.4 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl 
trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 
mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
0.0108 mmol, 0.036 equiv). The unpurified product was purified by silica gel 
chromatography (0% → 20% CH2Cl2 in hexanes, stained in CAM) to afford white solid 
(86.3 mg, 89% yield).  
 
(Method C) with 4,4,5,5-tetramethyl-2-(o-tolyl)-1,3,2-dioxaborolane (65.4 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 
bromobenzene (56.5 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 0.01 M 
in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 
mmol, 0.036 equiv). The unpurified product was purified by silica gel chromatography 
(0% → 20% CH2Cl2 in hexanes, stained in CAM) to afford white solid (68.6 mg, 71% 
yield). 
 
1H NMR (500 MHz, CDCl3) δ 7.40 (d, J = 7.6 Hz, 1H), 7.29 – 7.22 (m, 4H), 7.22 – 7.16 
(m, 2H), 7.15 (d, J = 7.0 Hz, 1H), 7.10 (app t, J = 7.3 Hz, 1H), 3.21 (dd, J = 12.7, 9.0 Hz, 
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1H), 3.02 – 2.87 (m, 2H), 2.31 (s, 3H), 1.17 (s, 12H). 11B NMR (128 MHz, CDCl3) δ 33.00. 
13C NMR (126 MHz, CDCl3) δ 142.16, 141.23, 136.29, 130.39, 129.05, 128.21, 128.14, 
126.16, 125.93, 125.46, 83.49, 38.85, 30.42, 24.79, 24.77, 20.18. IR (neat) νmax 3060.95 
(w), 3026.24 (w), 2976.72 (m), 2928.80 (w), 2860.41 (w), 1601.71 (w) 1492.63 (m), 
1453.84 (m), 1356.48 (s), 1322.40 (s), 1139.82 (s), 967.09 (m), 852.83 (m), 727.68 (s), 
698.05 (s) cm-1. HRMS (DART) for C21H28BO2 [M+H]+: calculated: 323.21823, found: 
323.21834. [α]D20 = – 28.296 (c 3.07, CHCl3, l = 50 mm). 
 
 (R)-2-phenyl-1-(o-tolyl)ethan-1-ol (1.118-OH). Product 1.118 was 
oxidized according to General Method for Oxidation of Boronic 
Ester Products. All spectroscopic data were in accord with the 
literature.20 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-H, 





   
 





tetramethyl-1,3,2-dioxaborolane (1.119). The reaction was 
performed according to general procedure (Method B) with 
2-(4-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaboro-
lane (70.23 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 
mmol, 2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 
mmol, 1.00 equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), 
palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), 
MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036). The unpurified product was purified 
by automated silica gel chromatography (Biotage 1% → 5% ethyl acetate in hexanes, 
stained in CAM) to afford white solid (91.3 mg, 90% yield). 1H NMR (600 MHz, CDCl3) 
δ 7.21 (t, J = 7.3 Hz, 1H), 7.19 – 7.11 (m, 3H), 6.80 (d, J = 8.7 Hz, 1H), 3.77 (s, 1H), 3.11 
(dd, J = 13.5, 9.7 Hz, 1H), 2.92 (dd, J = 13.5, 7.0 Hz, 1H), 2.62 (dd, J = 9.6, 7.1 Hz, 1H), 
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1.11 (s, 3H), 1.11 (s, 3H). 11B NMR (160 MHz, CDCl3) δ 32.75. 13C NMR (126 MHz, 
CDCl3) δ 157.67 , 142.01 , 134.76 , 129.48 , 129.08 , 128.19 , 125.88 , 113.97 , 83.51 , 
55.36 , 39.36 , 33.56 , 24.80 , 24.72. IR (neat) νmax 3337.49 (br), 3027.54 (w), 2976.97 (w), 
1607.00 (w), 1508.51 (s), 1360.39 (m), 1322.59 (m), 1242.35 (s), 1139.13 (s), 1034.72 (m), 
966.96 (m). 828.44 (m), 697.81 (m), 541.36 (m) cm-1. HRMS (DART) for C21H27BO3 
[M+NH4]+ calculated: 356.23970, found: 356.23969. [α]20D: -49.358 (c 3.69, CHCl3, l =50 
mm). 
 
 (R)-1-(4-methoxyphenyl)-2-phenylethan-1-ol (1.119-OH). 
Product 1.119 was oxidized according to General Method for 
Oxidation of Boronic Ester Products. All spectroscopic data 
were in accord with the literature.20 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-





   
 
Racemic Material               Standard Conditions 
 
 
 (R)-1-(4-bromophenyl)-2-phenylethan-1-ol (1.120-OH). The 
reaction was performed according to the general procedure 
(Method B) with 4,4,5,5-tetramethyl-2-(4-bromophenyl)-1,3,2-
dioxaborolane (1.178, 84.9 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate 
(103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in 
tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 
mmol, 1.20 equiv) palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 
mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). Unpurified 
product 1.120 was oxidized according to General Method for Oxidation of Boronic Ester 
Products. The unpurified product was purified by silica gel chromatography (0% → 20% 
→ 50% CH2Cl2 in hexanes, stained in CAM) to afford colorless oil (75.9 mg, 91% yield). 
1H NMR (500 MHz, CDCl3) δ 7.45 (d, J = 8.4 Hz, 2H), 7.29 (app t, J = 7.3 Hz, 2H), 7.24 
(d, J = 7.3 Hz, 1H), 7.20 (d, J = 8.2 Hz, 2H), 7.15 (d, J = 6.8 Hz, 2H), 4.84 (dd, J = 8.2, 
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5.1 Hz, 1H), 2.99 (dd, J = 13.6, 5.0 Hz, 1H), 2.93 (dd, J = 13.6, 8.3 Hz, 1H), 2.01 (s, 1H). 
13C NMR (126 MHz, CDCl3) δ 142.94, 137.68, 131.66, 129.71, 128.80, 127.85, 126.99, 
121.53, 74.87, 46.26. IR (neat) νmax 3373.67 (m, br), 3084.72 (w), 3060.88 (w), 3027.32 
(m), 2918.60 (m), 1591.86 (m), 1488.45 (s), 1453.70 (m), 1070.49 (s), 1044.49 (m), 
1009.03 (s), 822.90 (s), 744.58 (s), 699.39 (s), 543.23 (s) cm-1. HRMS (DART) for 
C14H12Br [M+H–H2O]+: calculated: 259.01224, found: 259.01212. [α]D20 = – 3.182 (c 2.28, 
CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-H, 
6% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-1-(4-bromophenyl)-2-
phenylethan-1-ol (1.120-OH). 
 




   
 
 (R)-2-(1-(benzo[d][1,3]dioxol-5-yl)-2-phenylethyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (1.121). The reaction was 
performed according to the general procedure (Method B) with 
2-(benzo[d][1,3]dioxol-5-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (74.4 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 
mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in 
tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 
mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 
mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The 
unpurified product was purified by automated silica gel chromatography (Biotage 1% → 
10% ethyl acetate in hexanes, stained in CAM) to afford white solid (91.9 mg, 87% yield).  
 
(Method C) with 2-(benzo[d][1,3]dioxol-5-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(74.4 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 
mmol, 3.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 
mmol, 1.00 equiv), bromobenzene (56.5 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate 
(0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 
11.37 mg, 0.0108 mmol, 0.036 equiv). Purification by automated silica gel chromatography 
(Biotage 1% → 10% ethyl acetate in hexanes, stained in CAM) to afford white solid (80.3 
mg, 76% yield). 
 
1H NMR (600 MHz, CDCl3) δ 7.20 (app t, J = 7.6 Hz, 2H), 7.15 (d, J = 7.4 Hz, 2H), 7.12 
(app t, J = 7.2 Hz, 1H), 6.75 (d, J = 1.4 Hz, 1H), 6.68 (d, J = 8.0 Hz, 1H), 6.64 (dd, J = 8.0, 
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1.4 Hz, 1H), 5.89 (s, 2H), 3.07 (dd, J = 13.5, 9.5 Hz, 1H), 2.89 (dd, J = 13.5, 7.2 Hz, 1H), 
2.58 (dd, J = 9.2, 7.4 Hz, 1H), 1.11 (s, 6H), 1.10 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 
32.82. 13C NMR (151 MHz, CDCl3) δ 147.71, 145.51, 141.80, 136.59, 129.08, 128.24, 
125.97, 121.46, 109.12, 108.37, 100.87, 83.63, 39.43, 34.24, 24.82, 24.75. IR (neat) νmax 
3063.47 (w), 3027.13 (w), 2977.09 (m), 2925.36 (m), 2897.27 (m), 1486.69 (s), 1370.75 
(s), 1327.09 (s), 1241.03 (s), 1142.13 (s), 1040.12 (s), 937.94 (m), 861.96 (m), 810.61 (m), 
699.61 (m) cm-1. HRMS (DART) for C21H26BO4 [M+H]+: calculated: 353.19241, found: 
353.19152. [α]D20 = – 53.108 (c 1.79, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
H, 0% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-2-(1-
(benzo[d][1,3]dioxol-5-yl)-2-phenylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(1.121). 
       Racemic Material          Standard Conditions 
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 (R)-1-(1-methyl-1H-indol-5-yl)-2-phenylethan-1-ol (1.122-
OH). The reaction was performed according to general 
procedure (Method B) with 1-methyl-5-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)-1H-indole (77.1 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl 
trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.9 
mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
0.0108 mmol. 0.036). Unpurified product 1.122 was oxidized according to General Method 
for Oxidation of Boronic Ester Products.  The unpurified product was purified by 
automated silica gel chromatography (Biotage 1% → 20% ethyl acetate in hexanes, stained 
in CAM) to afford white solid (37.7 mg, 50% yield). All spectroscopic data were in accord 
with the literature.52 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
H, 30% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-1-(1-methyl-1H-
indol-5-yl)-2-phenylethan-1-ol (1.122-OH). 
                    
  
                                                            
52 Seyferth, D. Organometallics 2009, 28, 1598. 
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yl)ethyl) benzonitrile (1.123). The reaction was performed 
according to general procedure (Method B) with 3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)benzonitrile (68.7 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 
0.60 mmol, 2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53M in tetrahydrofuran, 
0.30 mmol, 1.00 equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 
equiv), palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 
equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol). The unpurified product was purified 
by automated silica gel chromatography (Biotage 1% → 5% ethyl acetate in hexanes, 
stained in CAM) to afford white solid (69.9 mg, 70% yield). 1H NMR (600 MHz, CDCl3) 
δ 7.49 (app t, J = 1.5 Hz, 1H), 7.40 (app dd, J = 7.8, 1.6 Hz, 2H), 7.30 (app t, 1H), 7.20 
(app t, J = 7.4 Hz, 2H), 7.16 – 7.07 (m, 3H), 3.13 (dd, J = 13.6, 8.8 Hz, 1H), 2.91 (dd, J = 
13.6, 7.8 Hz, 1H), 2.70 (app t, J = 8.3 Hz, 1H), 1.12 (s, 6H), 1.11 (s, 6H). 11B NMR (160 
MHz, CDCl3) δ 32.59. 13C NMR (151 MHz, CDCl3) δ 144.25, 140.80, 133.35, 132.16, 
76
   
 
129.43, 129.16, 128.94, 128.36, 126.27, 119.37, 112.40, 84.00, 38.64, 34.37, 24.77, 24.70. 
IR (neat) νmax 3027.61 (w), 2931.10 (w), 2228.22 (w), 1599.68 (w), 1579.48 (w), 1480.71 
(w), 1359.55 (m), 1332.50 (m), 1139.37 (w), 969.24 (w), 859.19 (w). 798.94 (w), 699.91 
(s) cm-1. HRMS (DART) for C21H28BO3N2 [M+NH4]+ calculated: 351.22438, found: 
351.22411. [α]20D: -57.715 (c 2.83, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-3-(2-phenyl-1-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)benzonitrile (1.123). 
 




   
 
 (R)-4,4,5,5-tetramethyl-2-(2-phenyl-1-(3-(trifluoromethyl) 
phenyl)ethyl)-1,3,2-dioxaborolane (1.124). The reaction was 
performed according to general procedure (Method B, with the 
modification that the reaction was run at 60 ºC instead of 40 ºC) 
with 4,4,5,5-tetramethyl-2-(3-(trifluoromethyl)phenyl)-1,3,2-dioxa-
borolane (81.6 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 
0.60 mmol, 2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 
0.30 mmol, 1.00 equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 
equiv), palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 
equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036). The unpurified product was 
purified by automated silica gel chromatography (Biotage 1% → 5% ethyl acetate in 
hexanes, stained in CAM) to afford white solid (65.5 mg, 58% yield). 1H NMR (500 MHz, 
CDCl3) δ 7.49 (s, 1H), 7.41 – 7.36 (m, 2H), 7.36 – 7.30 (m, 1H), 7.26 – 7.18 (m, 2H), 7.17 
– 7.11 (m, 3H), 3.15 (dd, J = 13.5, 9.5 Hz, 1H), 2.95 (dd, J = 13.5, 7.2 Hz, 1H), 2.80 – 2.68 
(m, 1H), 1.12 (s, 6H), 1.10 (s, 6H). 11B NMR (160 MHz, CDCl3) δ 32.79. 13C NMR (126 
MHz, CDCl3) δ 143.77 , 141.27 , 132.15 , 130.75 (q, J = 31.8 Hz), 129.05 , 128.87 , 128.36 
, 126.20 , 125.41 (q, J = 3.8 Hz), 124.56 (q, J = 272.3 Hz), 122.51 (q, J = 3.9 Hz), 83.91 , 
38.97 , 34.69 , 24.81 , 24.67. IR (neat) νmax 2979.24 (w), 2929.51 (w), 1370.49 (m), 
1328.10 (s), 1162.98 (m), 1140.73 (s), 1075.10 (w), 6.98.96 (w) cm-1. HRMS (DART) for 
C21H25BF3O2 [M+H]+ calculated: 377.19, found: 377.1915. [α]20D: -34.893 (c 1.720, 
CHCl3, l =50 mm). 
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Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run a t60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel ODR-
H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-4,4,5,5-tetramethyl-2-
(2-phenyl-1-(3-(trifluoromethyl)phenyl)ethyl)-1,3,2-dioxaborolane (1.124). 
                    Racemic Material                                         Standard Conditions 
 
 
(S)-1-phenylhexan-2-ol (1.125-OH). The reaction was 
performed according to general procedure (Method B) with 2-
butyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (55.2 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl 
trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.9 
mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
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0.0108 mmol, 0.036). Unpurified product 1.125 was oxidized according to General Method 
for Oxidation of Boronic Ester Products.  The unpurified product was purified by 
automated silica gel chromatography (Biotage 1% → 5% ethyl acetate in hexanes, stained 
in CAM) to afford colorless oil (31.0 mg, 58% yield). All spectroscopic data were in accord 
with the literature.20 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-
H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (S)-1-phenylhexan-2-ol 
(1.125-OH). 
 
               Racemic Material                            Standard Conditions 
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dioxaborolane (1.126). The reaction was performed according to 
the general procedure (Method B) with 2-(3-buten-1-yl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (54.6 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl 
trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 
mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
0.0108 mmol, 0.036 equiv). The unpurified product was purified by automated silica gel 
chromatography (Biotage 1% → 4% ethyl acetate in hexanes, stained in CAM) to afford 
colorless oil (62.7 mg, 73% yield). 1H NMR (600 MHz, CDCl3) δ 7.24 – 7.17 (m, 4H), 
7.13 (app t, J = 7.1 Hz, 1H), 5.78 (dddd, J = 16.9, 10.2, 6.7, 6.7 Hz, 1H), 4.98 (dd, J = 17.1, 
1.8 Hz, 1H), 4.91 (dd, J = 10.2, 1.1 Hz, 1H), 2.71 (dd, J = 13.6, 8.7 Hz, 1H), 2.66 (dd, J = 
13.6, 7.5 Hz, 1H), 2.14 – 2.00 (m, 2H), 1.58 – 1.43 (m, 2H), 1.43 – 1.35 (m, 1H), 1.15 (s, 
6H), 1.12 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 33.82. 13C NMR (151 MHz, CDCl3) δ 
142.36, 139.16, 129.07, 128.24, 125.81, 114.61, 83.21, 37.44, 33.58, 30.63, 25.56, 25.01, 
24.93. IR (neat) νmax 3063.58 (w), 3026.57 (w), 2977.20 (m), 2925.82 (m), 2855.22 (w), 
1729.94 (w), 1380.67 (s), 1318.76 (s), 1143.00 (s), 908.95 (m), 860.66 (m), 743.50 (m), 
698.71 (m) cm-1. HRMS (DART) for C18H31BNO2 [M+NH4]+: calculated: 304.24478, 
found: 304.24478. [α]D20 = – 3.876 (c 1.84, CHCl3, l = 50 mm). 
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Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel ODR-
H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (S)-4,4,5,5-tetramethyl-2-
(1-phenylhex-5-en-2-yl)-1,3,2-dioxaborolane (1.126). 
 




dioxaboro lane (1.127). The reaction was performed according to the 
general procedure (Method B) with 2-cyclopropyl-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (50.4 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl 
trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 
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mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
0.0108 mmol, 0.036 equiv). The unpurified product was purified by automated silica gel 
chromatography (Biotage 1% → 5% ethyl acetate in hexanes, stained in CAM) to afford 
colorless oil (62.1 mg, 76% yield). 1H NMR (500 MHz, CDCl3) δ 7.23 – 7.17 (m, 4H), 
7.14 – 7.09 (m, 1H), 2.85 – 2.74 (m, 2H), 1.14 (s, 6H), 1.12 (s, 6H), 0.79 – 0.67 (m, 2H), 
0.44 – 0.34 (m, 2H), 0.16 – 0.11 (m, 1H), 0.03 – -0.02 (m, 1H). 11B NMR (128 MHz, 
CDCl3) δ 33.49. 13C NMR (151 MHz, CDCl3) δ 142.60, 129.09, 128.17, 125.72, 83.21, 
37.89, 31.51, 24.92, 24.86, 12.87, 5.52, 3.82. IR (neat) νmax 3074.67 (w), 3027.59 (w), 
2977.93 (m), 2928.94 (w), 2855.57 (w), 1603.16 (w), 1377.91 (s), 1320.03 (s), 1216.53 
(m), 1142.57 (s), 977.86 (m), 865.02 (m), 744.32 (m), 698.31 (s) cm-1. HRMS (DART) for 
C17H26BO2 [M+H]+: calculated: 273.20258, found: 273.20328. [α]D20 = – 10.575 (c 2.89, 
CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel ODR-





   
 




2-ol (1.128-OH). The reaction was performed according 
to general procedure (Method B) with tert-
butyldimethyl((5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentyl)oxy)silane (98.6 
mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 
2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 
1.00 equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), 
palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), 
MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036). Unpurified product 1.128 was oxidized 
according to General Method for Oxidation of Boronic Ester Products. The unpurified 
product was purified by automated silica gel chromatography (Biotage 1% → 20% ethyl 
acetate in hexanes, stained in CAM) to afford colorless oil (80.3 mg, 83% yield). 1H NMR 
(600 MHz, CDCl3) δ 7.33 – 7.27 (m, 2H), 7.23 – 7.17 (m, 3H), 3.87 – 3.73 (m, 1H), 3.59 
(t, J = 6.6 Hz, 2H), 2.81 (dd, J = 13.6, 4.2 Hz, 1H), 2.63 (dd, J = 13.6, 8.4 Hz, 1H), 1.56 – 
84
   
 
1.45 (m, 6H), 1.40 – 1.28 (m, 3H), 0.88 (s, 9H), 0.03 (s, 6H). 13C NMR (151 MHz, CDCl3) 
δ 138.83, 129.63, 128.78, 126.66, 72.85, 63.42, 44.31, 37.07, 33.06, 26.22, 26.10, 25.80, 
18.60, -5.02. IR (neat) νmax 3410.16 (br), 2928.75 (s), 2856.29 (s), 1253.25 (m), 1094.72 
(m), 832.61 (m), 773.80 (m), 698.82 (m) cm-1. HRMS (DART) for C19H34O2Si [M+H]+ 
calculated: 323.2406, found: 323.2418. [α]20D: +5.549 (c 1.135, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-
H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (S)-7-((tert-
butyldimethylsilyl)oxy)-1-phenylheptan-2-ol (1.128-OH). 
 








(1.129). The reaction was performed according to the 
general procedure (Method B) with tert-butyl 4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate (70.2 mg, 0.30 mmol, 1,00 
equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 
phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate 
(0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 
mg, 0.0108 mmol, 0.036). The unpurified product was purified by automated silica gel 
chromatography (Biotage 1% →10% ethyl acetate in hexanes, stained in CAM) to afford 
white solid (42.9 mg, 46% yield). 1H NMR (600 MHz, CDCl3) δ 7.23 – 7.14 (m, 4H), 7.11 
(app t, J = 7.1 Hz, 1H), 4.25 – 3.90 (m, 2H), 2.75 (dd, J = 13.5, 6.4 Hz, 1H), 2.63 (m, 3H), 
1.79 – 1.63 (m, 2H), 1.58 – 1.49 (m, 1H), 1.42 (s, 9H), 1.32 (ddd, J = 10.6, 6.4, 6.4 Hz, 
1H), 1.29 – 1.21 (m, 2H), 1.08 (s, 6H), 1.03 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 155.10, 
142.24, 129.04, 128.26, 125.87, 83.28, 79.30, 44.65, 38.29, 34.99, 32.24, 31.19, 28.67, 
25.04, 24. IR (neat) νmax 2975.99 (w), 2930.24 (w), 2853.01 (w), 1690.68 (s), 1417.52 (m), 
1364.98 (m), 1243.51 (m), 1164.62 (s), 1142.25 (s), 864.31 (w), 698.70 (w) cm-1.  HRMS 
(DART) for C24H38BNO4 [M+H]+ calculated: 416.29721, found: 416.29674. [α]20D: -3.644 
(c 3.065, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
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bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel ODR-
H, 3% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of tert-buryl (R)-4-(2-phenyl-
1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)piperidine-1-carboxylate (1.129). 
 




dioxaborolan-2-yl)pentanamide (1.130). The reaction was 
performed according to general procedure (Method B) with N,N-
dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) 
propanamide (68.1 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 
mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53M in 
tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 
mmol, 1.20 equiv), palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 
mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036). The unpurified 
product was purified by automated silica gel chromatography (Biotage 1% → 5 → 10% 
ethyl acetate in hexanes, stained in CAM) to afford colorless oil (63.6 mg, 64% yield). 1H 
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NMR (600 MHz, CDCl3) δ 7.23 – 7.15 (m, 4H), 7.13 – 7.08 (m, 1H), 2.93 (s, 3H), 2.89 (s, 
3H), 2.74 (dd, J = 13.7, 8.4 Hz, 1H), 2.65 (dd, J = 13.7, 7.7 Hz, 1H), 2.39 – 2.28 (m, 1H), 
2.30 – 2.22 (m, 1H), 1.78 – 1.66 (m, 2H), 1.36 (p, J = 8.1 Hz, 1H), 1.14 (s, 6H), 1.12 (s, 
6H). 11B NMR (160 MHz, CDCl3) δ 33.41. 13C NMR (126 MHz, CDCl3) δ 173.27, 142.08, 
129.04, 128.25, 125.85, 83.28, 37.41, 35.51, 33.33, 26.73, 25.76, 25.01, 24.95.  IR (neat) 
νmax 2976.10 (w), 2927.55 (w), 1643.88 (s), 1380.86 (m), 1320.38 (m), 11141.62 (s), 
700.02 (w) cm-1. HRMS (DART) for C19H31BNO3 [M+H]+ calculated: 332.23970, found: 
332.24058. [α]20D: -8.9656 (c 1.010, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-
H, 3% MeOH, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (S)-N,N-dimethyl-5-
phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanamide (1.130). 
                          Racemic Material                                   Standard Conditions 
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 Methyl (S)-5-phenyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaboro 
lan-2-yl)pentanoate (1.131). The reaction was performed 
according to general procedure (Method B) with methyl 3-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate (64.2 
mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 
2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 
1.00 equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), 
palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), 
MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was 
purified by automated silica gel chromatography (Biotage 1% → 5 → 10% ethyl acetate 
in hexanes, stain in CAM) to afford colorless solid (77.3 mg, 81% yield). 1H NMR (600 
MHz, CDCl3) δ 7.23 – 7.19 (m, 2H), 7.19 – 7.15 (m, 2H), 7.15 – 7.10 (m, 1H), 3.62 (s, 
3H), 2.73 (dd, J = 13.7, 8.4 Hz, 1H), 2.64 (dd, J = 13.7, 7.6 Hz, 1H), 2.42 – 2.22 (m, 2H), 
1.72 (q, J = 7.9 Hz, 2H), 1.35 (p, J = 7.8 Hz, 1H), 1.15 (s, 6H), 1.12 (s, 6H). 11B NMR 
(160 MHz, CDCl3) δ 33.67. 13C NMR (151 MHz, CDCl3) δ 174.25, 141.88, 129.05, 
128.29, 125.94, 83.38, 51.63, 37.21, 33.75, 26.25, 25.43, 24.99, 24.92. IR (neat) νmax 
2977.22 (w), 2929.20 (w), 1737.15 (s), 1381.23 (m), 1320.47 (m), 1213.06 (m), 1132.14 
(s), 699.57 (w) cm-1. HRMS (DART) for C18H28BO4 [M+H]+ calculated: 319.2081, 
found: 319.2095. [α]20D: -8.385 (c 2.555, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel ODR-
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H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of methyl (S)-5-phenyl-4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanoate (1.131). 




1,3,2-dioxaborolane (1.132). The reaction was performed 
according to the general procedure (Method B) with 2-(5-
bromopentyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (83.1 mg, 
0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 
equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 
equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) 
acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos 
(1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was purified by 
automated silica gel chromatography (Biotage 1% → 5% ethyl acetate in hexanes, stain in 
CAM) to afford colorless oil (76.6 mg, 67% yield). 1H NMR (600 MHz, CDCl3) δ 7.22 
(app t, J = 7.5 Hz, 2H), 7.18 (d, J = 7.0 Hz, 2H), 7.12 (app t, J = 7.2 Hz, 1H), 3.36 (t, J = 
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6.9 Hz, 2H), 2.70 (dd, J = 13.6, 8.5 Hz, 1H), 2.63 (dd, J = 13.6, 7.3 Hz, 1H), 1.81 (app p, 
J = 7.2 Hz, 2H), 1.48 – 1.26 (m, 7H), 1.15 (s, 6H), 1.12 (s, 6H). 11B NMR (128 MHz, 
CDCl3) δ 33.86. 13C NMR (151 MHz, CDCl3) δ 144.84, 131.48, 130.68, 128.25, 85.65, 
39.96, 36.53, 35.34, 33.49, 30.98, 30.87, 28.44, 27.45, 27.37. IR (neat) νmax 3025.93 (w), 
2977.04 (m), 2927.75 (m), 2854.50 (m), 1454.40 (m), 1380.74 (m), 1319.26 (m), 1142.84 
(s), 966.64 (m), 861.78 (m), 746.57 (m), 699.08 (m) cm-1. HRMS (DART) for 
C19H34BBrNO2 [M+NH4]+: calculated: 398.1866, found: 398.1847. [α]D20 = – 6.243 (c 
2.92, CHCl3, l = 50 mm). 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel ODR-
H, 2% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (S)-2-(7-bromo-1-
phenylheptan-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.132). 
  Racemic Material                       Standard Conditions 
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(R)-4,4,5,5-tetramethyl-2-(2-phenyl-1-(4-(trifluoromethyl) 
phenyl) ethyl)-1,3,2-dioxaborolane (1.133). The reaction was 
performed according to general procedure (Method B, with the 
modification that the reaction was run at 60 ºC instead of 40 
ºC) with 4,4,5,5-tetramethyl-2-(4-(trifluoromethyl)phenyl)-1,3,2-dioxaborolane (81.6 mg, 
0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 
equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 
equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) 
acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos 
(1.64, 11.37 mg, 0.0108 mmol, 0.036). The unpurified product was purified by automated 
silica gel chromatography (Biotage 1% → 5% ethyl acetate in hexanes, stained in CAM) 
to afford white solid (77.9 mg, 69% yield). 1H NMR (600 MHz, CDCl3) δ 7.49 (d, J = 8.1 
Hz, 2H), 7.33 (d, J = 8.1 Hz, 2H), 7.23 – 7.19 (m, 2H), 7.17 – 7.12 (m, 3H), 3.17 (dd, J = 
13.6, 9.2 Hz, 1H), 2.96 (dd, J = 13.6, 7.4 Hz, 1H), 2.76 (app t, 1H), 1.12 (s, 6H), 1.11 (s, 
6H). 11B NMR (160 MHz, CDCl3) δ 32.59. 13C NMR (151 MHz, CDCl3) δ 147.07, 141.26, 
129.01, 128.88, 128.36, 127.90 (q, J = 32.2 Hz), 126.20, 125.41 (q, J = 3.8 Hz), 124.68 (q, 
J = 271.7 Hz), 83.90, 38.70, 34.77, 24.80, 24.72. IR (neat) νmax 2979.33 (w), 2931.73 (w), 
1616.08 (w), 1370.55 (w), 1321.35 (m), 1161.97 (w), 1135.95 (m), 1109.00 (m), 1067.27 
(m), 843.69 (w), 698.28 (m) cm-1. HRMS (DART) for C21H25BF3O2 [M+H]+ calculated: 
377.19, found: 377.1898. [α]20D: -42.814 (c 3.20, CHCl3, l =50 mm). 
 
92
   
 
 (R)-2-phenyl-1-(4-(trifluoromethyl)phenyl)ethan-1-ol 
(1.133-OH). Product 1.133 was oxidized according to General 
Method for Oxidation of Boronic Ester Products. 1H NMR 
(600 MHz, CDCl3) δ 7.59 (d, J = 8.2 Hz, 2H), 7.45 (d, J = 8.1 Hz, 2H), 7.31 (app t, J = 7.5 
Hz, 2H), 7.25 (app t, 1H), 7.17 (app d, J = 7.1 Hz, 2H), 4.96 – 4.91 (m, 1H), 3.03 (dd, J = 
13.7, 4.7 Hz, 1H), 2.95 (dd, J = 13.7, 8.7 Hz, 1H), 2.09 – 2.01 (m, 1H). 13C NMR (151 
MHz, CDCl3) δ 147.86, 137.48, 129.97 (q, J = 32.1 Hz), 129.72, 128.89, 127.13, 126.39, 
125.54 (q, J = 3.7 Hz), 124.38 (q, J = 271.9 Hz), 74.87, 46.36. IR (neat) νmax 3327.52 (br), 
2920.13 (w), 1325.74 (s), 1153.77 (m), 1120.51 (s), 1066.42 (s), 832.69 (w), 737.84 (w), 
701.37 (w) cm-1. HRMS (DART) for C15H12F [M+H-H2O]+ calculated: 249.0891, found: 
249.0881. [α]20D: +7.565 (c 1.465, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-





   
 
           Racemic Material                  Standard Conditions 
 
 
(R)-3-Cyclohexylidene-1-phenylpropan-1-ol (1.134-OH). The 
reaction was performed according to the general procedure 
(Method B) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 
cyclohexylidenemethyl trifluoromethanesulfonate (1.179, 87.9 mg, 0.36 mmol, 1.20 
equiv), palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 
equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). Unpurified product 1.134 
was oxidized according to General Method for Oxidation of Boronic Ester Products. The 
unpurified product was purified by silica gel chromatography (0% → 20% ethyl acetate in 
hexanes, stained in CAM) to afford a colorless oil (26.6 mg, 41% yield). All spectroscopic 
data were in accord with the literature.20 
 
Analysis of Stereochemistry: Racemic compound was prepared and reported previously49 
with 4,4,5,5-tetramethyl-2-vinyl-1,3,2-dioxaborolane, and Pd(OAc)2 (5 mol%) and 1,1′-
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bis(dicyclohexylphosphino) ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-
H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-3-cyclohexylidene-1-
phenylpropan-1-ol (1.134-OH). 
 
Racemic Material                    Standard Conditions 
                        
          
 
(R)-(4-(2-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)ethyl)phenyl)methanol (1.135). The reaction was performed 
according to the general procedure (Method B) with (4-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanol (70.2 mg, 
0.30 mmol, 1,00 equiv), sodium trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 
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equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 
equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 mmol, 1.20 equiv), palladium (II) 
acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos 
(1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was purified by 
automated silica gel chromatography (Biotage 1% → 10% ethyl acetate in hexanes, stained 
in CAM) to afford white solid (75.1 mg, 74% yield). 1H NMR (600 MHz, CDCl3) δ 7.25 
– 7.14 (m, 8H), 7.12 (app t, J = 7.1 Hz, 1H), 4.62 (d, J = 5.3 Hz, 2H), 3.13 (dd, J = 13.5, 
9.6 Hz, 1H), 2.93 (dd, J = 13.5, 7.1 Hz, 1H), 2.67 (dd, J = 9.3, 7.3 Hz, 1H), 1.59 (app t, J 
= 5.6 Hz, 1H), 1.09 (s, 6H), 1.09 (s, 6H). 11B NMR (160 MHz, CDCl3) δ 32.87. 13C NMR 
(151 MHz, CDCl3) δ 142.37, 141.83, 138.09, 129.07, 128.82, 128.26, 127.43, 125.99, 
83.66, 65.57, 39.07, 34.39, 24.82, 24.74. IR (neat) νmax 3412.74 (br), 2976.75 (w), 2928.81 
(w), 2863.18 (w), 1360.14 (m), 1325.38 (s), 1139.99 (s), 967.34 (w), 854.84 (w), 742.70 
(w), 698.84 (w) cm-1.  HRMS (DART) for C21H26BO2 [M+ H-H2O]+ calculated: 321.2026, 
found: 321.2017. [α]20D: -43.381 (c 3.18, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and (Sp,Sp)-MandyPhos 1.64 
(1.8 mol%), and (Rp,Rp)-MandyPhos 1.64 (1.8 mol%) as the catalyst. Chiral SFC (Chiracel 





   
 
                       Racemic Material                               Standard Conditions 
 
 
(S)-5,5-dimethoxy-1-phenylpentan-2-ol (1.136-OH). The 
reaction was performed according to the general procedure 
(Method B) with 4,4,5,5-tetramethyl-2-(3,3-dimethoxypropyl)-
1,3,2-dioxaborolane (69.0 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate 
(103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in 
tetrahydrofuran, 0.30 mmol, 1.00 equiv), phenyl trifluoromethanesulfonate (81.4 mg, 0.36 
mmol, 1.20 equiv) palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 
mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). Unpurified 
product 1.136 was oxidized according to General Method for Oxidation of Boronic Ester 
Products. The unpurified product was purified by automated silica gel chromatography 
(Biotage 1% → 20% ethyl acetate in hexanes, stained in CAM) to afford colorless oil (49.0 
mg, 73% yield). 1H NMR (600 MHz, CDCl3) δ 7.30 (app t, J = 7.4 Hz, 2H), 7.24 – 7.19 
(m, 3H), 4.38 (app t, J = 5.5 Hz, 1H), 3.82 (dddd, J = 8.4, 8.4, 4.3, 4.3 Hz, 1H), 3.32 (s, 
3H), 3.32 (s, 3H), 2.79 (dd, J = 13.6, 4.7 Hz, 1H), 2.69 (dd, J = 13.6, 8.1 Hz, 1H), 2.17 (s, 
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1H), 1.81 (dddd, J = 14.4, 9.0, 6.0, 6.0 Hz, 1H), 1.72 (dddd, J = 15.0, 9.0, 6.0, 6.0 Hz, 1H), 
1.63 (dddd, J = 15.0, 13.2, 9.0, 3.6 Hz, 1H), 1.52 (dddd, J = 18.0, 9.0, 9.0, 6.0 Hz, 1H). 13C 
NMR (151 MHz, CDCl3) δ 138.76, 129.57, 128.68, 126.58, 104.82, 72.57, 53.22, 52.96, 
44.31, 31.76, 29.17. IR (neat) νmax 3453.77 (m, br), 3026.59 (w), 2935.82 (s), 2830.25 (m), 
1495.30 (m), 1453.48 (m), 1385.15 (m), 1362.68 (m), 1127.88 (s), 1055.47 (s), 961.97 (m), 
744.01 (s), 700.87 (s) cm-1. HRMS (DART) for C13H19O2 [M+H–H2O]+: calculated: 
207.1385, found: 207.1379. [α]D20 = + 7.783 (c 2.14, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (3 mol%), (Sp,Sp)-MandyPhos 1.64 
(1.8 mol%), and (Rp,Rp)-MandyPhos 1.64 (1.8 mol%) as the catalyst. Chiral SFC (Chiracel 
OD-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (S)-5,5-dimethoxy-
1-phenylpentan-2-ol (1.136-OH). 
 








dimethylsilane (1.137). The reaction was performed 
according to general procedure (Method B, with the modification that tetrahydrofuran 
was used instead of 1:1 dimethyl sulfoxide:tetrahydrofuran) with 2-cyclopropyl-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (50.4 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 5-((tert-
butyldimethylsilyl)oxy)pent-1-en-2-yl trifluoromethanesulfonate (1.181, 125.3 mg, 0.36 
mmol, 1.20 equiv), palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 
mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The 
unpurified product was purified by automated silica gel chromatography (Biotage 1% → 
5% ethyl acetate in hexanes, stained in CAM) to afford colorless oil (66.2 mg, 56% yield). 
1H NMR (600 MHz, CDCl3) δ 4.70 (s, 1H), 4.66 (s, 1H), 3.57 (dddd, J = 6.6, 1.6 Hz, 2H), 
2.27 – 2.14 (m, 2H), 2.01 (app t, J = 7.7 Hz, 2H), 1.69 – 1.53 (m, 2H), 1.20 (s, 12H), 0.87 
(s, 9H), 0.71 – 0.61 (m, 1H), 0.61 – 0.54 (m, 1H), 0.44 – 0.31 (m, 2H), 0.12 (dddd, J = 9.3, 
5.0 Hz, 1H), 0.05 – -0.03 (m, 7H). 11B NMR (160 MHz, THF-d8) δ 33.55. 13C NMR (151 
MHz, CDCl3) δ 155.10, 142.24, 129.04, 128.26, 125.87, 83.28, 79.30, 45.08, 44.21, 38.29, 
34.99, 32.21, 31.17, 28.67, 25.04, 24.95. IR (neat) νmax 2928.91 (w), 1378.20 (w), 1319.33 
(w), 1144.04 (m), 1099.98 (m), 834.98 (m), 774.57 (w) cm-1. HRMS (DART) for 
C22H44BO3Si [M+H]+ calculated: 395.3179, found: 395.319397 [α]20D: -12.203 (c = 1.360, 
CHCl3, l =50 mm). 
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(R)-6-((tert-butyldimethylsilyl)oxy)-1-cyclopropyl-3-
methylenehexan-1-ol (1.137-OH). Product 1.137 was 
oxidized according to General Method for Oxidation of 
Boronic Ester Products. 1H NMR (600 MHz, CDCl3) δ 4.88 – 4.85 (m, 1H), 4.85 – 4.82 
(m, 1H), 3.59 (dddd, J = 10.1, 6.3, 3.7, 1.6 Hz, 2H), 2.99 (ddd, J = 9.3, 3.3 Hz, 1H), 2.38 
(dd, J = 14.0, 3.3 Hz, 1H), 2.23 (app dd, 1H), 2.12 – 2.01 (m, 2H), 1.76 (s, 1H), 1.70 – 1.58 
(m, 2H), 0.91 – 0.83 (m, 10H), 0.54 – 0.44 (m, 2H), 0.36 – 0.29 (m, 1H), 0.21 – 0.14 (m, 
1H), 0.04 – -0.00 (m, 6H). 13C NMR (151 MHz, CDCl3) δ 146.54, 112.39, 74.11, 62.89, 
44.55, 32.26, 31.14, 26.17, 18.55, 17.72, 3.13, 2.51, -5.06. IR (neat) νmax 3390.94 (br), 
3077.98 (w), 2928.92 (s), 2856.84 (s), 1471.51 (w), 1254.11 (m), 1100.10 (s), 834.26 (s), 
774.57 (m) cm-1. HRMS (DART) for C16H31BOSi [M+H-H2O]+ calculated: 267.2144, 
found: 267.2153 [α]20D: -4.404 (c 2.050, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-





   
 





dioxaborolan-2-yl)pentanoate (1.138). The reaction 
was performed according to general procedure (Method 
B) with methyl 3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propanoate (64.2 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (103.2 mg, 0.60 mmol, 2.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 3-((tert-
butyldimethylsilyl)oxy)-4-methoxyphenyl trifluoromethanesulfonate (139.1 mg, 0.36 
mmol, 1.20 equiv), palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 
mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The 
unpurified product was purified by automated silica gel chromatography (Biotage 1% → 
5 →10% ethyl acetate in hexanes, stain in CAM) to afford white solid (99.0 mg, 69% 
yield). 1H NMR (600 MHz, CDCl3) δ 6.72 – 6.67 (m, 3H), 3.73 (s, 3H), 3.61 (s, 3H), 2.63 
(dd, J = 13.8, 8.2 Hz, 1H), 2.51 (dd, J = 13.8, 7.8 Hz, 1H), 2.39 – 2.22 (m, 2H), 1.71 – 1.63 
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(m, 2H), 1.27 (app p, J = 8.0 Hz, 1H), 1.16 (s, 6H), 1.14 (s, 6H), 0.96 (s, 9H), 0.11 (s, 6H). 
11B NMR (160 MHz, CDCl3) δ 33.73. 13C NMR (151 MHz, CDCl3) δ 174.30, 149.26, 
144.82, 134.60, 122.05, 121.87, 112.19, 83.36, 55.82, 51.62, 36.37, 33.81, 26.12, 25.97, 
25.52, 25.05, 24.97, 18.66, -4.41, -4.42. IR (neat) νmax 2929.47 (w), 2857.37 (w), 1738.36 
(s), 1509.32 (s), 1317.69 (m), 1140.73 (s), 987.08 (m), 838.67 (s), 782.09 (m) cm-1. HRMS 
(DART) for C25H44BO6Si [M+H]+ calculated: 479.3, found: 479.2983. [α]20D: -7.689 (c 
1.865, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method B, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
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(R)-4,4,5,5-tetramethyl-2-(2-(4-nitrophenyl)-1-
phenylethyl)-1,3,2-dioxaborolane (1.140). The reaction was 
performed according to the general procedure (Method C) 
with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 
61.2 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 
mmol, 3.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 
mmol, 1.00 equiv), 4-bromonitrobenzene (72.7 mg, 0.36 mmol, 1.20 equiv), palladium (II) 
acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos 
(1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was purified by silica 
gel chromatography (30% → 60% → 100% CH2Cl2 in hexanes, stained in CAM) to afford 
yellow solid (59.6 mg, 56% yield). 1H NMR (600 MHz, CDCl3) δ 8.12 (d, J = 8.6 Hz, 2H), 
7.34 (d, J = 8.5 Hz, 2H), 7.31 (app t, J = 7.6 Hz, 2H), 7.27 – 7.18 (m, 3H), 3.31 (dd, J = 
13.6, 8.7 Hz, 1H), 3.10 (dd, J = 13.6, 7.8 Hz, 1H), 2.71 (app t, J = 8.2 Hz, 1H), 1.21 (s, 
6H), 1.19 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 31.17. 13C NMR (151 MHz, CDCl3) δ 
149.97, 146.48, 141.58, 129.84, 128.70, 128.57, 125.99, 123.47, 83.90, 38.82, 34.20, 
24.77, 24.75. IR (neat) νmax 2973.89 (m), 2928.27 (w), 1600.99 (m), 1514.68 (s), 1344.29 
(s), 1137.89 (s), 963.97 (m), 847.21 (s), 703.28 (s) cm-1. HRMS (DART) for C20H25BNO4 
[M+H]+: calculated: 354.1877, found: 354.1892. [α]D20 = – 56.087 (c 2.10, CHCl3, l = 50 
mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-H, 
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8% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-4,4,5,5-tetramethyl-2-(2-
(4-nitrophenyl)-1-phenylethyl)-1,3,2-dioxaborolane (1.140). 
 




2-yl) ethyl)-2,3-dihydro-1H-inden-1-one (1.141). The reaction 
was performed according to the general procedure (Method C) 
with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 
61.2 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 
mmol, 3.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 
mmol, 1.00 equiv), 6-bromoindanone (76.0 mg, 0.36 mmol, 1.20 equiv), palladium (II) 
acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos 
(1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was purified by 
automated silica gel chromatography (Biotage 1% →40% ethyl acetate in hexanes, stained 
in CAM) to afford white solid (90.2 mg, 83% yield). 1H NMR (500 MHz, CDCl3) δ 7.59 
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(s, 1H), 7.35 (dd, J = 7.8, 1.6 Hz, 1H), 7.28 (d, J = 7.8 Hz, 1H), 7.24 – 7.16 (m, 4H), 7.10 
(app t, J = 7.0 Hz, 1H), 3.20 (dd, J = 13.5, 9.3 Hz, 1H), 3.04 (app t, J = 5.8 Hz, 2H), 2.96 
(dd, J = 13.5, 7.1 Hz, 1H), 2.66 – 2.59 (m, 3H), 1.11 (s, 12H). 11B NMR (128 MHz, CDCl3) 
δ 32.58. 13C NMR (126 MHz, CDCl3) δ 207.13, 153.04, 142.25, 141.46, 137.23, 135.90, 
128.56, 128.54, 126.32, 125.70, 123.85, 83.70, 38.56, 36.73, 34.81, 25.61, 24.76, 24.73. 
IR (neat) νmax 3024.40 (w), 2976.54 (m), 2926.69 (m), 2862.22 (w), 1707.07 (s), 1361.02 
(s), 1325.34 (s), 1279.18 (m), 1139.02 (s), 967.44 (m), 840.00 (m), 757.28 (m), 700.39 (s) 
cm-1. HRMS (DART) for C23H28BO3 [M+H]+: calculated: 363.21315, found: 363.21350. 
[α]D20 = – 61.409 (c 3.37, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-H, 




   
 




dioxaborolane (1.142). The reaction was performed according to 
general procedure (Method C) with 4,4,5,5-tetramethyl-2-phenyl-
1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 3-bromofuran (52.9 mg, 0.36 
mmol, 1.20 equiv), palladium (II) acetate (0.9 mL, 0.01 M in dimethyl sulfoxide, 0.009 
mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The 
unpurified product was purified by automated silica gel chromatography (Biotage 1% 
→5% ethyl acetate in hexanes, stained in CAM) to afford white solid (71.4 mg, 65% yield). 
1H NMR (600 MHz, CDCl3) δ 7.29 – 7.22 (m, 5H), 7.18 – 7.12 (m, 2H), 6.22 (s, 1H), 2.98 
(dd, J = 14.4, 9.5 Hz, 1H), 2.75 (dd, J = 14.4, 7.0 Hz, 1H), 2.59 (dd, J = 9.3, 7.1 Hz, 1H), 
1.15 (s, 6H), 1.14 (s, 6H). 11B NMR (160 MHz, THF-d8) δ 32.78. 13C NMR (151 MHz, 
CDCl3) δ 142.73, 142.52, 139.55, 128.56, 128.51, 125.66, 124.75, 111.55, 83.65, 33.46, 
106
   
 
28.03, 24.80, 24.75. IR (neat) νmax 2977.58 (w), 2930.86 (w), 1493.42. (w), 1451.59.88 
(w), 1351.13 (w), 1325.48 (s), 1140.24 (s), 1023.50 (m), 966.20 (m), 872.27 (m), 850.44 
(m). 775.04 (m), 700.20 (m) cm-1. HRMS (DART) for C18H24BO3 [M+H]+ calculated: 
299.18185, found: 299.18238. [α]20D: -35.466 (c 1.550, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-2-(2-(furan-3-yl)-1-
phenylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.142). 
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tetramethyl-1,3,2-dioxaborolane (1.143). The reaction was 
performed according to the general procedure (Method C) with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 mmol, 1.00 equiv), 
sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), vinylmagnesium 
chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 5-bromobenzofuran 
(70.9 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 0.01 M in dimethyl 
sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 
equiv). The unpurified product was purified by automated silica gel chromatography 
(Biotage 0% →10% ethyl acetate in hexanes, stained in CAM) to afford colorless oil (79.4 
mg, 76% yield). 1H NMR (500 MHz, CDCl3) δ 7.52 (s, 1H), 7.39 (s, 1H), 7.33 (d, J = 8.5 
Hz, 1H), 7.28 – 7.18 (m, 4H), 7.11 (d, J = 8.2 Hz, 2H), 6.63 (s, 1H), 3.24 (dd, J = 13.2, 
10.1 Hz, 1H), 3.04 (dd, J = 13.4, 6.8 Hz, 1H), 2.70 (dd, J = 9.0, 7.0 Hz, 1H), 1.08 (s, 6H), 
1.06 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 33.20. 13C NMR (126 MHz, CDCl3) δ 153.78, 
145.05, 142.81, 136.41, 128.59, 128.52, 127.42, 125.61, 125.57, 121.20, 110.87, 106.57, 
83.55, 38.96, 35.34, 24.74, 24.73. IR (neat) νmax 3058.01 (w), 3024.78 (w), 2976.61 (m), 
2929.75 (m), 2859.41 (w), 1467.87 (m), 1360.28 (s), 1323.53 (s), 1139.59 (s), 1031.41 (m), 
968.33 (m), 850.72 (m), 765.57 (m), 734.35 (m), 700.04 (s) cm-1. HRMS (DART) for 
C22H26BO3 [M+H]+: calculated: 349.1975, found: 349.1980. [α]D20 = – 43.515 (c 3.495, 
CHCl3, l = 50 mm). 
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Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-H, 
5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-2-(2-(benzofuran-5-yl)-
1-phenylethyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.143). 
 




dioxaboro lane (1.144). The reaction was performed according to the 
general procedure (Method C) with 4,4,5,5-tetramethyl-2-phenyl-
1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 2-bromofuran (52.9 mg, 0.36 
mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 
mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The 
unpurified product was purified by automated silica gel chromatography (Biotage 1% 
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→5% Ethyl acetate in hexanes, stained in CAM) to afford white solid (65.3 mg, 73% yield). 
1H NMR (600 MHz, CDCl3) δ 7.29 – 7.20 (m, 5H), 7.17 – 7.11 (m, 1H), 6.22 (dd, J = 3.1, 
1.8 Hz, 1H), 5.94 (dd, J = 3.2, 0.9 Hz, 1H), 3.19 (dd, J = 15.1, 9.9 Hz, 1H), 2.95 (dd, J = 
15.1, 6.6 Hz, 1H), 2.75 (dd, J = 9.9, 6.6 Hz, 1H), 1.17 (s, 6H), 1.14 (s, 6H). 11B NMR (128 
MHz, CDCl3) δ 32.64. 13C NMR (151 MHz, CDCl3) δ 155.81, 142.31, 140.85, 128.58, 
128.42, 125.73, 110.19, 105.53, 83.70, 31.22, 24.77, 24.74 (methine C adjacent to B not 
observed). IR (neat) νmax 3026.86 (w), 2977.47 (m), 2928.74 (w), 2854.97 (w), 1599.24 
(m), 1360.95 (s), 1326.42 (s), 1140.45 (s), 1008.03 (m), 967.54 (m), 850.12 (m), 729.28 
(m), 699.69 (s) cm-1. HRMS (DART) for C18H24BO3 [M+H]+: calculated: 299.18185, 
found: 299.18327. [α]D20 = – 30.982 (c 1.19, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-H, 





   
 




lan-2-yl)ethyl)thiophen-2-yl)ethan-1-one (1.145). The 
reaction was performed according to general procedure (Method 
C) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 
61.2 mg, 0.30 mmol, 1.00 equiv.), sodium trifluoromethanesulfonate (154.9 mg, 0.90 
mmol, 3.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 
mmol, 1.00 equiv), 1-(4-bromothiophen-2-yl)ethan-1-one (73.8 mg, 0.36 mmol, 1.20 
equiv), palladium (II) acetate (0.9 mL, 0.01 M dimethyl sulfoxide, 0.009 mmol, 0.030 
equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product 
was purified by automated silica gel chromatography (Biotage 1% →5% ethyl acetate in 
hexanes, stained in CAM) to afford off-white solid (82.3 mg, 77% yield). 1H NMR (600 
MHz, CDCl3) δ 7.44 (app d, J = 1.3 Hz, 1H), 7.26 (app t, J = 7.6 Hz, 2H), 7.20 (app d, J = 
6.9 Hz, 3H), 7.15 (app t, J = 6.9 Hz, 1H), 3.15 (dd, J = 14.2, 9.3 Hz, 1H), 2.93 (dd, J = 
14.2, 7.2 Hz, 1H), 2.63 (dd, J = 9.2, 7.2 Hz, 1H), 2.48 (s, 3H), 1.14 (s, 6H), 1.13 (s, 6H). 
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11B NMR (160 MHz, CDCl3) δ 32.59. 13C NMR (151 MHz, CDCl3) δ 190.91, 143.93, 
143.62, 142.06, 134.28, 130.11, 128.64, 128.54, 125.87, 83.76, 33.93, 33.43, 26.89, 24.76, 
24.74. IR (neat) νmax 2975.69 (w), 2933.00 (w), 1661.22. (s), 11356.74 (s), 1324.69 (s), 
1138.00 (s), 848.18 (m), 764.63 (w), 700.66 (m) cm-1. HRMS (DART) for C20H25BO3S 
[M+H]+ calculated: 357.16957, found: 357.16935. [α]20D: -40.579 (c 3.890, CHCl3, l =50 
mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-1-(4-(2-phenyl-2-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)thiophen-2-yl)ethan-1-one (1.145). 
 




   
 
(R)-5-(2-phenyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-
2-yl)ethyl)benzo[d]thiazole (1.146). The reaction was 
performed according to the general procedure (Method C) with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 
mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 
3.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 
1.00 equiv), 5-bromobenzothiazole (77.1 mg, 0.36 mmol, 1.20 equiv), palladium (II) 
acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos 
(1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was purified by 
automated silica gel chromatography (Biotage 0% →50% CH2Cl2 in hexanes, stained in 
CAM) to afford colorless oil (71.2 mg, 65% yield). 1H NMR (500 MHz, CDCl3) δ 8.94 (s, 
1H), 7.96 (s, 1H), 7.79 (d, J = 8.2 Hz, 1H), 7.29 – 7.21 (m, 5H), 7.14 (app hept, J = 3.7 Hz, 
1H), 3.34 (dd, J = 13.5, 9.3 Hz, 1H), 3.12 (dd, J = 13.6, 7.2 Hz, 1H), 2.74 (dd, J = 9.0, 7.5 
Hz, 1H), 1.12 (s, 6H), 1.11 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 33.00. 13C NMR (126 
MHz, CDCl3) δ 153.97, 153.58, 142.34, 140.49, 131.14, 128.55, 128.52, 127.18, 125.65, 
123.67, 121.31, 83.65, 38.78, 34.90, 24.72, 24.68. IR (neat) νmax 3060.66 (w), 3025.02 (w), 
2976.11 (m), 2928.50 (m), 2860.23 (w), 1440.95 (s), 1359.88 (s), 1324.95 (s), 1139.88 (s), 
969.17 (m), 845.81 (s), 700.65 (s) cm-1. HRMS (DART) for C21H25BNO2S [M+H]+: 
calculated: 366.16990, found: 366.17111. [α]D20 = – 41.788 (c 3.77, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-H, 
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10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-5-(2-phenyl-2-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)benzo[d]thiazole (1.146). 
 





carboxylate (1.147). The reaction was performed 
according to the general procedure (Method C) with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 mmol, 1.00 equiv), 
sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), vinylmagnesium 
chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), t-butyl 5-
bromoindole-1-carboxylate (106.6 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate 
(0.90 mL, 0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 
11.37 mg, 0.0108 mmol, 0.036 equiv). The unpurified product was purified by automated 
silica gel chromatography (Biotage 0% →50% CH2Cl2 in hexanes, stained in CAM) to 
afford white solid (105.1 mg, 78% yield). 1H NMR (600 MHz, CDCl3) δ 8.01 (s, 1H), 7.55 
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(s, 1H), 7.39 (s, 1H), 7.31 – 7.25 (m, 4H), 7.21 – 7.11 (m, 2H), 6.48 (d, J = 3.7 Hz, 1H), 
3.29 (dd, J = 13.5, 9.8 Hz, 1H), 3.07 (dd, J = 13.5, 6.8 Hz, 1H), 2.75 (dd, J = 9.7, 6.8 Hz, 
1H), 1.67 (s, 9H),  1.13 (s, 6H), 1.12 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 32.64. 13C 
NMR (151 MHz, CDCl3) δ 149.96, 142.88, 136.31, 133.81, 130.68, 128.57, 128.47, 
125.90, 125.60, 125.50, 121.00, 114.79, 107.34, 83.51, 38.92, 35.17, 28.38, 24.75, 24.73 
(quaternary C of tert-butyl group not observed). IR (neat) νmax 2976.84 (w), 2931.15 (m), 
1730.38 (s), 1469.06 (m), 1369.70 (s), 1348.51 (s), 1325.08 (s), 1255.59 (m), 1217.42 (m), 
1162.60 (s), 1128.89 (s), 1082.05 (m), 1023.09 (m), 764.85 (m), 700.63 (m) cm-1. HRMS 
(DART) for C27H35BNO4 [M+H]+: calculated: 448.26591, found: 448.26791. [α]D20 = – 
39.460 (c 4.03, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(diisopropylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OD-H, 
2% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of tert-butyl (R)-5-(2-phenyl-2-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)-1H-indole-1-carboxylate (1.147). 
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The reaction was performed according to general 
procedure (Method C) with methyl 3-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)propanoate (64.2 mg, 0.30 mmol, 1.00 equiv), sodium 
trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), vinylmagnesium chloride 
(0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 1-(4-bromothiophen-2-
yl)ethan-1-one (73.8 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.9 mL, 0.01 M 
in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 
mmol, 0.036 equiv). The unpurified product was purified by automated silica gel 
chromatography (Biotage 1% →5% ethyl acetate in hexanes, stained in CAM) to afford 
white solid (71.4 mg, 65% yield). 1H NMR (600 MHz, CDCl3) δ 7.52 (s, 1H), 7.26 (s, 1H), 
3.63 (s, 3H), 2.73 (dd, J = 14.4, 8.8 Hz, 1H), 2.65 (dd, J = 14.4, 6.9 Hz, 1H), 2.49 (s, 3H), 
2.42 – 2.23 (m, 2H), 1.73 (q, J = 7.7 Hz, 2H), 1.32 (p, J = 7.5 Hz, 1H), 1.14 (s, 6H), 1.13 
(s, 6H). 11B NMR (128 MHz, CDCl3) δ 33.49. 13C NMR (151 MHz, CDCl3) δ 190.95, 
174.11, 144.18, 143.67, 134.19, 130.04, 83.58, 51.73, 33.54, 31.67, 26.98, 26.28, 24.98, 
24.97, 24.72. IR (neat) νmax 2976.61 (w), 2927.68 (w), 1734.68 (s), 1662.98 (s), 1417.13 
(m), 1371.65 (m), 1270.26 (m), 1140.38 (s) cm-1. HRMS (DART) for C18H28BO5S [M+H]+ 
calculated: 367.1751, found: 367.176. [α]20D: +2.173 (c 1.900, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and (Sp, Sp)-MandyPhos 1.64 
(1.8 mol%), and (Rp, Rp)-MandyPhos 1.64 (1.8 mol%) as the catalyst. Chiral SFC (Chiracel 
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OJ-H, 1% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of methyl (S)-5-(5-
acetylthiophen-3-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pentanoate (1.148). 
 




2-yl) ethyl)quinolone (1.149). The reaction was performed 
according to general procedure (Method C) with 4,4,5,5-
tetramethyl-2-phenyl-1,3,2-dioxaborolane (1.94, 61.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 3-
bromoquinoline (74.5 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.9 mL, 0.01 M 
in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 
mmol, 0.036). The unpurified product was purified by automated silica gel 
chromatography (Biotage 2% →20% ethyl acetate in hexanes, stained in CAM) to afford 
white solid (82.9 mg, 77% yield). 1H NMR (500 MHz, CDCl3) δ 8.75 (d, J = 1.8 Hz, 1H), 
8.05 (app d, J = 8.4 Hz, 1H), 7.87 (app s, 1H), 7.69 (app d, J = 8.2 Hz, 1H), 7.62 (app t, J 
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= 7.7 Hz, 1H), 7.47 (app t, J = 7.5 Hz, 1H), 7.25 (app t, 4H), 7.15 (app t, J = 6.5 Hz, 1H), 
3.34 (dd, J = 13.8, 9.1 Hz, 1H), 3.12 (dd, J = 13.9, 7.3 Hz, 1H), 2.75 (app t, 1H), 1.11 (s, 
12H). 11B NMR (160 MHz, CDCl3) δ 32.86. 13C NMR (126 MHz, CDCl3) δ 152.59, 
146.96, 141.91, 134.94, 134.63, 129.30, 128.70, 128.68, 128.64, 128.17, 127.50, 126.57, 
125.93, 83.84, 36.27, 34.42, 24.80, 24.74. IR (neat) νmax 2976.63 (m), 2929.93 (w), 
1726.48 (w), 1493.83 (m), 1327.42 (m), 1141.06 (s), 967.37 (w), 849.21 (w), 751.75 (w), 
701.56 (w) cm-1.  HRMS (DART) for C23H27BNO2 [M+ H]+ calculated: 360.21348, found: 
360.21532. [α]20D: -46.5119 (c 3.18, CHCl3, l =50 mm). 
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and 1,1′-
bis(dicyclohexylphosphino)ferrocene (6 mol%) as the catalyst. Chiral SFC (Chiracel OJ-
H, 7% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of (R)-3-(2-phenyl-2-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)quinolone (1.149). 
 
                                Racemic Material        Standard Conditions 
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-2-yl)ethyl)-2-(piperidin-1-yl)pyrimidine (1.150). The 
reaction was performed according to the general procedure 
(Method C) with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-
dioxaborolane (1.94, 61.2 mg, 0.30 mmol, 1.00 equiv), sodium trifluoromethanesulfonate 
(154.9 mg, 0.90 mmol, 3.00 equiv), vinylmagnesium chloride (0.20 mL, 1.53 M in 
tetrahydrofuran, 0.30 mmol, 1.00 equiv), 5-bromo-2-(piperidin-1-yl)pyrimidine (87.2 mg, 
0.36 mmol, 1.20 equiv), palladium (II) acetate (0.90 mL, 0.01 M in dimethyl sulfoxide, 
0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 0.0108 mmol, 0.036 equiv). The 
unpurified product was purified by automated silica gel chromatography (Biotage 0% 
→15% ethyl acetate in hexanes, stained in CAM) to afford white solid (83.8 mg, 71% 
yield). 1H NMR (500 MHz, CDCl3) δ 8.04 (s, 2H), 7.21 (app t, J = 7.6 Hz, 2H), 7.18 – 
7.14 (m, 2H), 7.11 (app t, J = 7.3 Hz, 1H), 3.71 – 3.65 (m, 4H), 2.91 (dd, J = 14.1, 8.5 Hz, 
1H), 2.72 (dd, J = 14.1, 7.9 Hz, 1H), 2.50 (app t, J = 8.2 Hz, 1H), 1.61 (p, J = 5.7 Hz, 2H), 
1.54 (app p, J = 5.6 Hz, 4H), 1.14 (s, 6H), 1.13 (s, 6H). 11B NMR (128 MHz, CDCl3) δ 
32.75. 13C NMR (126 MHz, CDCl3) δ 161.03, 158.01, 141.92, 128.66, 128.64, 125.82, 
121.64, 83.76, 45.19, 34.53, 32.58, 25.85, 25.09, 24.82, 24.79. IR (neat) νmax 3348.31 (w, 
br), 2977.12 (m), 2931.39 (m), 2853.55 (m), 1604.14 (s), 1498.41 (s), 1444.64 (s), 1361.24 
(s), 1328.15 (s), 1140.94 (s), 946.09 (m), 851.03 (m), 755.50 (m), 699.52 (s), 673.07 (m) 
cm-1. HRMS (DART) for C23H33BN3O2 [M+H]+: calculated: 394.26658, found: 
394.26775. [α]D20 = – 20.812 (c 3.78, CHCl3, l = 50 mm). 
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Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and (Sp,Sp)-MandyPhos 1.64 
(1.8 mol%), and (Rp,Rp)-MandyPhos 1.64 (1.8 mol%) as the catalyst. Chiral SFC (Chiracel 
OJ-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis (R)-5-(2-phenyl-2-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)ethyl)-2-(piperidin-1-yl)pyrimidine (1.150). 
 




methyl-1,3,2-dioxaborolan-2-yl)pentanoate (1.151). The 
reaction was performed according to general procedure 
(Method C, with modification: reaction conducted at 55 
 ͦC) with methyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propanoate (64.2 mg, 0.30 
mmol, 1.00 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.90 mmol, 3.00 equiv), 
vinylmagnesium chloride (0.20 mL, 1.53 M in tetrahydrofuran, 0.30 mmol, 1.00 equiv), 5-
bromobenzo[d]thiazole (77.1 mg, 0.36 mmol, 1.20 equiv), palladium (II) acetate (0.9 mL, 
0.01 M in dimethyl sulfoxide, 0.009 mmol, 0.030 equiv), MandyPhos (1.64, 11.37 mg, 
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0.0108 mmol. 0.036 equiv). The unpurified product was purified by automated silica gel 
chromatography (Biotage 1% →5% ethyl acetate in hexanes, stained in CAM) to afford 
white solid (82.2 mg, 73% yield). 1H NMR (600 MHz, CDCl3) δ 8.91 (s, 1H), 7.93 (s, 1H), 
7.79 (d, J = 8.2 Hz, 1H), 7.28 (d, J = 9.7 Hz, 1H), 3.60 (s, 3H), 2.91 (dd, J = 13.7, 8.2 Hz, 
1H), 2.78 (dd, J = 13.7, 7.7 Hz, 1H), 2.38 (ddd, J = 15.7, 8.0, 8.0 Hz, 1H), 2.29 (ddd, J = 
15.9, 7.9, 7.9 Hz, 1H), 1.73 (app q, J = 7.8 Hz, 2H), 1.40 (app q, J = 7.7 Hz, 1H), 1.14 (s, 
6H), 1.11 (s, 6H). 11B NMR (160 MHz, CDCl3) δ 33.51. 13C NMR (151 MHz, CDCl3) δ 
174.14, 154.01, 153.73, 140.47, 131.23, 127.13, 123.73, 121.50, 83.48, 51.63, 37.09, 
33.67, 26.12, 25.72, 24.97, 24.95. IR (neat) νmax 2977.05 (w), 2929.89 (w), 1734.75 (s), 
1440.78 (m), 1380.71 (m), 1319.51 (m), 1141.49 (s), 846.47 (m) cm-1. HRMS (DART) for 
C19H26BNO4S [M+H]+ calculated: 376.1754, found: 376.1753. [α]20D: -7.957 (c 2.075, 
CHCl3, l =50 mm).  
 
Analysis of Stereochemistry: Racemic compound was prepared according to the general 
procedure (Method C, run at 60 ºC) with Pd(OAc)2 (5 mol%) and (Sp,Sp)-MandyPhos 1.64 
(1.8 mol%), and (Rp, Rp)-MandyPhos 1.64 (1.8 mol%) as the catalyst. Chiral SFC (Chiracel 





   
 
























































































   
CHAPTER TWO 
Allyl Electrophiles in the Conjunctive Cross-Coupling Reaction and the Discovery 
of the Vinylidenation of Boronic Esters 
 
2.1. Introduction 
To expand the scope of conjunctive cross-coupling reactions, we investigated the 
possibility of using allyl electrophiles, which would give γ-boryl alkenes 2.1. We 
envisioned that these compounds could be oxidized or aminated to the corresponding 
amine 2.2 or alcohol 2.3, respectively (Scheme 2.1a), which are valuable intermediates in 
the synthesis of more complex structures. Although allyl electrophiles never gave the 
conjunctive cross-coupling products in greater than 15% yield, in some cases we observed 
products consistent with vinylidene insertion between the boron and the carbon of the 
migrating group 2.4 (Scheme 2.1b). In the presence of the large monodentate ligand 
tricyclohexylphosphine (PCy3), the reaction favors this new homologation pathway. 
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2.2. Background 
2.2.1. Utility of γ-Boryl Alkenes 
γ-Boryl alkenes could be transformed to γ-amino or γ-hydroxyl alkenes, which are 
intermediates in the synthesis of pyrrolidine and tetrahydrofuran rings, respectively.  
Examples of pyrrolidine formation include aminoarylation,1 aminoalkenylation,2 
aminoacylation,3 and hydroamination4 (Scheme 2.2). Examples of THF ring formation 
include oxyarylation;5 oxyalkynylation;6 oxy-,7 amino-,8 thio-,9 and haloetherifications;10 
and oxidative lactonization to afford γ-butyrolactones11 (Scheme 2.3). As for a medicinal 
chemistry application, Jaudzems and Jirgenson used the bromoetherification of γ-hydroxyl 
alkenes followed by Gabriel amine synthesis to access THF structures 2.5, which have been 
used to synthesize a library of nonpeptidomimetic plasmepsin inhibitors 2.6 as potential 
treatment for malaria (Scheme 2.3f).12 
 
                                                            
1 (a) Bertrand, M. B.; Wolfe, J. P. Tetrahedron 2005, 61, 6447. (b) Yang, Q.; Ney, J. E.; Wolfe, J. P. Org. 
Lett. 2005, 7, 2575. (c) Bertrand, M. B.; Neukom, J. D.; Wolfe, J. P. J. Org. Chem. 2008, 73, 8851. (d) 
Rosewall, C. F.; Sibbald, P. A.; Liskin, D. V.; Michael, F. E. J. Am. Chem. Soc. 2009, 131, 9488. (e) 
Brenzovich, W. E.; Benitez, D.; Lackner, A. D.; Shunatona, H. P.; Tkatchouk, E.; Goddard, W. A.; Toste, 
F. D. Angew. Chem. Int. Ed. 2010, 49, 5519. (f) Zhang, G.; Cui, L.; Wang, Y.; Zhang, L. J. Am. Chem. 
Soc. 2010, 132, 1474. (g) Peterson, L. J.; Wolfe, J. P. Adv. Synth. Catal. 2015, 357, 2339. (h) Sun, B.; Liu, 
S.; Zhang, M.; Zhao, J.; Zhang, Q. Org. Chem. Front. 2019, 6, 388. 
2 Ney, J. E.; Hay, M. B.; Yang, Q.; Wolfe, J. P. Adv. Synth. Catal. 2005, 347, 1614. 
3 Ambrosini, L.; Cernak, T.; Lambert, T. Synthesis 2010, 2010, 870. 
4 Crimmin, M. R.; Arrowsmith, M.; Barrett, A. G. M.; Casely, I. J.; Hill, M. S.; Procopiou, P. A. J. Am. Chem. 
Soc. 2009, 131, 9670. 
5 Hay, M. B.; Hardin, A. R.; Wolfe, J. P. J. Org. Chem. 2005, 70, 3099. 
6 (a) Nicolai, S.; Waser, J. Org. Lett. 2011, 13, 6324. (b) Nicolai, S.; Sedigh-Zadeh, R.; Waser, J. J. Org. 
Chem. 2013, 78, 3783. 
7 (a) Palmer, C.; Morra, N. A.; Stevens, A. C.; Bajtos, B.; Machin, B. P.; Pagenkopf, B. L. Org. Lett. 2009, 
11, 5614. (b) Theodorou, A.; Kokotos, C. G. Green Chem. 2017, 19, 670. 
8 Sequeira, F. C.; Chemler, S. R. Org. Lett. 2012, 14, 4482. 
9 Fries, P.; Müller, M. K.; Hartung, J. Org. Biomol. Chem. 2013, 11, 2630. 
10 (a) Lee, A. S.-Y.; Tsao, K.-W.; Chang, Y.-T.; Chu, S.-F. Tetrahedron Lett. 2007, 48, 6790. (b) Brücher, 
O.; Hartung, J. Tetrahedron 2014, 70, 7950. (c) Moriyama, K.; Nishinohara, C.; Togo, H. Chem. Eur. J. 
2016, 22, 11934. (d) Tomizuka, A.; Moriyama, K. Adv. Synth. Catal. 2019, 361 (6), 1447. 
11 Gao, R.; Fan, R.; Canney, D. Synlett 2015, 26, 661. 
12 Rasina, D.; Otikovs, M.; Leitans, J.; Recacha, R.; Borysov, O. V.; Kanepe-Lapsa, I.; Domraceva, I.; 
Pantelejevs, T.; Tars, K.; Blackman, M. J.; Jaudzems, K.; Jirgensons, A. J. Med. Chem. 2016, 59, 374. 
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The laboratory of M. Christina White has found that the carbamates or sulfamates 
of γ-hydroxyl alkenes such as 2.6 could be utilized in the Pd-,13 Fe-,14 or Mn-catalyzed15 
C–H activation of the proximal allylic position to synthesize 1,3-amino alcohol motifs 2.7 
(Scheme 2.4). Remarkably, they showed stereodivergent behavior with two different 
sulfoxide (SOX) ligands: the electron-deficient (CF3)-SOX ligand 2.8 afforded the syn-1,3-
                                                            
13 (a) Rice, G. T.; White, M. C. J. Am. Chem. Soc. 2009, 131, 11707. (b) Qi, X.; Rice, G. T.; Lall, M. S.; 
Plummer, M. S.; White, M. C. Tetrahedron 2010, 66, 4816. 
14 Paradine, S. M.; White, M. C. J. Am. Chem. Soc. 2012, 134, 2036. 
15 Paradine, S. M.; Griffin, J. R.; Zhao, J.; Petronico, A. L.; Miller, S. M.; White, M. C. Nat. Chem. 2015, 7, 
987. 
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amino alcohol motif 2.9 in high yield and diastereoselectivity, while the electron-rich 
(MeO)-SOX ligand 2.10 afforded the anti-1,3-amino alcohol 2.11 with comparable levels 
of yield and diastereoselectivity (Scheme 2.4b).16 
2.2.2. Allylation of Organoboron “Ate” Complexes 
Pelter and coworkers reported the earliest example of β-allylation of unsaturated 
organoboron “ate” complexes in which trialkylalkynylboron “ate” complexes such as 2.12 
were treated with allyl bromide, followed by protodeborylation with AcOH, to afford 
trisubstituted alkenes 2.13 in moderate to excellent yields, albeit with low levels of 
diastereoselectivity (Scheme 2.5a).17 Replacing one of the alkyl groups with a non-
migrating thexyl group (2.14) resulted in improved diastereoselectivities (Scheme 2.5b). 
Deng and coworkers used palladium catalysts and allyl ethyl carbonates to facilitate alkyl 
group migration on alkynylboron “ate” complexes (Scheme 2.6a),18 and twenty years later, 
                                                            
16 Ma, R.; Young, J.; Promontorio, R.; Dannheim, F. M.; Pattillo, C. C.; White, M. C. J. Am. Chem. Soc. 
2019, 141, 9468. 
17 Pelter, A.; Bentley, T. W.; Harrison, C. R.; Subrahmanyam, C.; Laub, R. J. J. Chem. Soc. Perkin Trans. I 
1976, 2419. 
18 Chen, Y.; Li, N.-S.; Deng, M.-Z. Tetrahedron Lett. 1990, 31, 2405. 
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Murakami and coworkers extended this reactivity to include aryl group migration (Scheme 
2.6b).19 
Although allyl electrophile-induced 1,2-metallate shifts of organoboron “ate” 
complexes with sp-hybridized migration termini are well-precedented, analogous 
examples with sp2-hybridized migration termini are limited to 2-indolyl derivatives. As an 
example, the Ishikura group reported Pd(π-allyl)-induced 1,2-metallate shifts of 
                                                            
19 Ishida, N.; Shinmoto, T.; Sawano, S.; Miura, T.; Murakami, M. Bull. Chem. Soc. Jpn. 2010, 83, 1380. 
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trialkylindolylboron “ate” complexes (Scheme 2.7a and b),20 while the Ready group 
reported enantioselective variants of the same reaction using pinacol boron ester 




                                                            
20 (a) Ishikura, M.; Terashima, M.; Okamura, K.; Date, T. J. Chem. Soc., Chem. Commun. 1991, 20, 1219. 
(b) Ishikura, M.; Agata, I. Heterocycles 1996, 43, 1591. (c) Ishikura, M.; Kato, H. Tetrahedron 2002, 58, 
9827. (d) Ishikura, M.; Ida, W.; Yanada, K. Tetrahedron 2006, 62, 1015. 
21 (a) Panda, S.; Ready, J. M. J. Am. Chem. Soc. 2017, 139, 6038. (b) Panda, S.; Ready, J. M. J. Am. Chem. 
Soc. 2018, 140, 13242. 
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As stated in the introduction to this chapter, our attempts to engage non-indole-
derived sp2-hybridized migration termini such as olefins were met with failure. We 
speculated that the presence of the indole moiety in the examples by Ishikura and Ready 
was crucial to the success of those reactions. It was hypothesized that rather than a 
concerted 1,2-metallate shift triggered by electrophilic activation of the olefin by 
palladium, the indole first undergoes electrophilic allylation at the C3 position. The 
resulting iminium cation then triggers the 1,2-metallate shift from the boron “ate” at the 
C2 position. In other words, with more nucleophilic alkenes such as indoles, the allylation 
is mechanistically independent from the 1,2-metallate shift. 
Indeed, the Ready group themselves proposes a concerted Pd-induced 1,2-metallate 
shift mechanism in their allylation of 2-indolylboron “ate” complexes.21a However, when 
they later expanded their Pd-catalyzed indole allylation reaction to synthesize 
enantioenriched quaternary centers using a phosphoramidite ligand, trends in the substrate 
scope caused them to doubt their initial mechanistic proposal.21b When they investigated 
substituents larger than a methyl group at the C3 position of the indole, they observed lower 
levels of diastereoselectivity, although the enantioselectivities of both diastereomers 
remained high (Scheme 2.8a, compare 2.14 vs. 2.15 and 2.16). To probe the mechanism 
further, the n-propyl-bearing boronic ester product 2.16, which was isolated with 96:4 er 
and 3:1 dr, was hydrogenated to give compound 2.17 as a pair of enantiomers bearing two 
n-propyl groups at the C3 position (Scheme 2.8b). This study shows that the pair of 
enantioenriched diastereomers 2.16 is epimeric at C2: hydrogenated compound 2.17 was 
isolated with 75:25 er, which is identical to the ratio of diastereomers for allyl compound 
2.16. Had 2.16 been epimeric at C3, the enantiomeric ratio of 2.17 should be higher than 
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96:4. These results are consistent with a stepwise mechanism in which a highly 
enantioselective Pd-catalyzed indole allylation (2.18) is followed by a 1,2-metallate shift 
(2.19): if R = Me, the faces of the iminium cation are well-differentiated and the migrating 
group adopts a position opposite to that of the allyl group; if R ≠ Me, steric discrimination 
between the R group and the allyl group is poorer, so 1,2-migration can occur on either 




   
2.2.3. Previous Syntheses of 1,1-Disubstituted Boryl Alkenes 
In 2002, Miyaura and coworkers reported the Pd-catalyzed borylation of C(sp2) 
(pseudo)halides (Scheme 2.9),22 an elaboration on a reaction first reported by Eastwood.23 
An alternative to the Miyaura borylation is the Markovnikov hydroboration of terminal 
alkynes. Hoveyda and coworkers reported a Ni-catalyzed hydroalumination of alkynes 
using DIBAL, followed by borylation with methoxyB(pin) (Scheme 2.10).24 
 
                                                            
22 Takagi, J.; Takahashi, K.; Ishiyama, T.; Miyaura, N. J. Am. Chem. Soc. 2002, 124, 8001. 
23 Eastwood, P. R. Tetrahedron Lett. 2000, 41, 3705. 
24 Gao, F.; Hoveyda, A. H. J. Am. Chem. Soc. 2010, 132, 10961. 
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Methods have also been developed for the direct Markovnikov hydroboration of 
terminal alkynes using transition metal catalysis. The Hoveyda group reported a borylation 
protocol with B2(pin)2 catalyzed by an N-heterocyclic carbene (NHC)-Cu complex 
(Scheme 2.11a).25 Prabhu and coworkers developed a Pd-catalyzed variant and found that 
employing PCy3 as the ligand generally afforded Markovnikov products (Scheme 2.11b), 
while employing an NHC ligand afforded anti-Markovnikov products.26 The Hoveyda 
                                                            
25 Jang, H.; Zhugralin, A. R.; Lee, Y.; Hoveyda, A. H. J. Am. Chem. Soc. 2011, 133, 7859. 
26 Ojha, D. P.; Prabhu, K. R. Org. Lett. 2016, 18, 432. 
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group similarly developed a Cu-catalyzed hydroboration of monosubstituted allenes, 
affording a variety of products in good yields (Scheme 2.12).27 
 
 
Burke and coworkers invented (1-bromovinyl)-MIDA boronate 2.21, a versatile 
reagent to access 1,1-disubstituted alkenyl boronates.28 Synthesis of this reagent began with 
nucleophilic attack of trimethylborate by vinylmagnesium bromide followed by 
transesterification with N-methyliminodiacetic acid (MIDA) to give vinyl-MIDA boronate 
2.20; treatment of 2.20 with molecular bromine followed by elimination gave 2.21 in good 
yield over two steps (Scheme 2.13a). The α-bromine atom could then be coupled to a 




                                                            
27 Meng, F.; Jung, B.; Haeffner, F.; Hoveyda, A. H. Org. Lett. 2013, 15, 4. 
28 (45)  Woerly, E. M.; Miller, J. E.; Burke, M. D. Tetrahedron 2013, 69, 7732. 
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The Morken group developed a boron–Wittig olefination of gem-bisboronates 2.22 
to synthesize a variety of alkenyl boronates.29 While alkyl, alkenyl, and alkynyl aldehydes 
gave E-trisubstituted alkenyl boronates, employing methylene iodide (CH2I2) as a 
formaldehyde equivalent gave 1,1-disubstituted alkenyl boronates (Scheme 2.14a). With 
respect to the mechanism, lithium tetramethylpiperidide (LiTMP) deprotonates the methine 
hydrogen α to both boron atoms. The resulting anion attacks CH2I2 in an SN2 fashion 
followed by boron–iodine elimination to afford the alkenyl boronate product (Scheme 
2.14b).  
 
                                                            
29 Coombs, J. R.; Zhang, L.; Morken, J. P. Org. Lett. 2015, 17, 1708. 
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Shortly after we reported our present Pd-catalyzed vinylidenation reaction, 
Aggarwal and coworkers reported their own vinylidenation reaction of organoboronic 
esters. Rather than employing transition metal catalysis, their reaction design involved the 
use of lithiated silyl epoxide 2.23 to form “ate” complex 2.24, which would then undergo 
a 1,2-metallate shift to open the epoxide; the oxyanion and silyl groups on 2.25 would then 
undergo a Peterson-type silcon–oxygen elimination to forge the new carbon–carbon double 
bond (Scheme 2.15a).30 Treating trimethylsilyl epoxide 2.26 with lithiation conditions 
reported previously by their group,31 followed by addition of the organoboronic ester, gave 
a variety of vinylidenation products (Scheme 2.15b). Primary boronic esters such as those 
bearing sensitive functional groups like an azide were homologated successfully (2.27). 
Secondary (2.28) and tertiary boronic esters (2.29 amd 2.30) also fared well in the reaction; 
30 Fordham, J. M.; Grayson, M. N.; Aggarwal, V. K. Angew. Chem. Int. Ed. 2019, 58, 15268. 
31 Florio, S.; Aggarwal, V.; Salomone, A. Org. Lett. 2004, 6, 4191. 
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notably, compounds with defined relative stereochemical configurations such as 2.28 and 
2.29 reacted with complete retention of configuration.  
Examining the scope of aryl boronic esters in the Aggarwal vinylidenation revealed 
an interesting trend in chemoselectivity, namely that the electron-rich p-methoxyphenyl 
gave exclusively the homologated boronic ester 2.31, whereas the electron-poor p-
trifluoromethylphenyl yielded exclusively the 1,1-disubstituted alkenyl silane 2.36 with 
none of the expected boronic ester 2.35. An arene of intermediate electron density such as 
p-chlorophenyl gave a mixture of alkenyl boronic ester 2.33 and alkenyl silane 2.34 
products. Attempting the vinylidene homologation of either trans-1,2-disubstituted or 1,1-
disubstituted alkenyl boronic esters gave exclusively alkenyl silane products (2.38 and 
2.40). 
One advantage the Aggarwal vinylidenation has over our method is that it 
accommodates more substituted alkenyl boronic esters. For example, the vinylidene 
homologation reaction of 2-phenylethylB(pin) 2.41 with trans-alkyl(trimethylsilyl) 
epoxides 2.42 and 2.43 gave E-trisubstituted alkenyl boronic esters 2.44 and 2.45, 
respectively, with high diastereoselectivity, which was confirmed by NOESY (Scheme 
2.15c). The Aggarwal group applied their method to the synthesis of the proposed structure 
of machillene 2.48, a cytotoxic natural product isolated from the wood stem of the 
Taiwanese flowering plant Machilus zuihoensis.32 Performing their vinylidenation on 
enantioenriched 1,3-bisboronate 2.46 gave the doubly-homologated compound 2.47. 
Following a four-step sequence involving a Pd-catalyzed coupling of both boronic ester  
  
                                                            
32 Cheng, M.-J.; Tsai, I.-L.; Lee, S.-J.; Jayaprakasam, B.; Chen, I.-S. Phytochemistry 2005, 66, 1180. 
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groups with a cinnamyl acetate derivative,33 two sequential Sharpless dihydroxylations,34 
and epoxidation of both vicinal diol groups,35 afforded 2.48 in 5% overall yield over six 
steps (Scheme 2.15d). Although the spectra of synthetic 2.48 did not match those of the 
isolated natural product, the synthesis was nevertheless a demonstration of their method’s 
synthetic utility. 
2.3. The Palladium-Catalyzed Vinylidenation of Organoboron “Ate” Complexes 
2.3.1. Discovery of the Vinylidenation Reaction 
Several attempts were made to promote the conjunctive cross-coupling of 
organoboron “ate” complexes with allyl electrophiles. Standard conjunctive cross-coupling 
conditions with Pd(OAc)2 and MandyPhos failed to give any of the desired product with 
either allyl acetate or substituted electrophiles such as cinnamyl acetate. Surveying other 
ligands or other metals such as nickel,36 copper,37 and iridium38 were likewise met with 
failure or low amounts of the desired product. In all of these cases, conversion of the “ate” 
complex back to the original organoboronic ester was observed, as was direct cross-
coupling between one or both groups on the boron “ate” and the allyl electrophile. 
                                                            
33 Ortar, G. Tetrahedron Lett. 2003, 44, 4311. 
34 Kolb, H. C.; VanNieuwenhze, M. S.; Sharpless, K. B. Chem. Rev. 1994, 94, 2483. 
35 Kolb, H. C.; Sharpless, K. B. Tetrahedron 1992, 48, 10515. 
36 (a) Didiuk, M. T.; Morken, J. P.; Hoveyda, A. H. J. Am. Chem. Soc. 1995, 117, 7273. (b) Chung, K.-G.; 
Miyake, Y.; Uemura, S. J. Chem. Soc. Perkin 1 2000, 1, 15. (c) Kita, Y.; Kavthe, R. D.; Oda, H.; Mashima, 
K. Angew. Chem. Int. Ed. 2016, 55, 1098. (d) Ngamnithiporn, A.; Jette, C. I.; Bachman, S.; Virgil, S. C.; 
Stoltz, B. M. Chem. Sci. 2018, 9, 2547. 
37 (a) Malda, H.; van Zijl, A. W.; Arnold, L. A.; Feringa, B. L. Org. Lett. 2001, 3, 1169. (b) Van Veldhuizen, 
J. J.; Campbell, J. E.; Giudici, R. E.; Hoveyda, A. H. J. Am. Chem. Soc. 2005, 127, 6877. (c) Yoshikai, N.; 
Zhang, S.-L.; Nakamura, E. J. Am. Chem. Soc. 2008, 130, 12862. (d)  Shi, Y.; Jung, B.; Torker, S.; 
Hoveyda, A. H. J. Am. Chem. Soc. 2015, 137, 8948. (e) You, H.; Rideau, E.; Sidera, M.; Fletcher, S. P. 
Nature 2015, 517, 351. 
38 (a) Takeuchi, R.; Kashio, M. Angew. Chem. Int. Ed. Engl. 1997, 36, 263. (b) Miyabe, H.; Takemoto, Y. 
Synlett 2005, 11, 1641. (c) Hartwig, J. F.; Stanley, L. M. Acc. Chem. Res. 2010, 43, 1461. (d) Hethcox, J. 
C.; Shockley, S. E.; Stoltz, B. M. ACS Catal. 2016, 6, 6207. (e) Qu, J.; Helmchen, G. Acc. Chem. Res. 




After careful analysis of the products of one of these low yielding reactions, namely 
the reaction of phenyl(vinyl)B(pin) “ate” complex 2.51, formed from phenyllithium 2.49 
and vinylB(pin) 2.50, with cinnamyl acetate 2.53 catalyzed by Pd(OAc)2 and XantPhos 
2.52, we identified two unexpected products that gave us insight into the mechanism of the 
reaction (Scheme 2.16a). In addition to the desired conjunctive cross-coupling product 2.54 
(8% yield), the direct cross-coupling products 2.55 and 2.56 (40% and 5% yield, 
respectively), and a small amount of biphenyl 2.57, acetophenone 2.58 and allyl benzene 
2.59 were formed (6% yield each). The fact that these latter two compounds were formed 
in equal amounts indicates that following Pd-induced 1,2-metallate shift of 2.60 and 
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formation of the carbon–palladium σ-bond to give 2.61, a β-hydride elimination event 
occurred rather than reductive elimination to give 1-phenylvinylB(pin) 2.62 and allyl 
benzene, and 2.62 would be converted to acetophenone upon oxidation (Scheme 2.16b). 
Since the results from this experiment suggested that Pd(π-allyl)-promoted β-
hydride elimination39 was a possible pathway following Pd-induced 1,2-metallate 
rearrangement, we decided to undertake a ligand survey in search of conditions that would 
favor this mechanism as the 1,1-disubstituted alkenyl boronate products are themselves 
valuable synthetic intermediates. We hypothesized that monodentate phosphine ligands 
would favor the desired reactivity over bidentate ligands as π-allyl ligands in their η3 
configuration on palladium would occupy a coordination site required for binding by the 
boron “ate.”40 
2.3.2. Optimization 
We commenced our optimization studies by conducting a ligand survey using 
phenylB(pin) 2.63, vinylmagnesium chloride, NaOTf, and allyl acetate 2.64 (Table 2.1). 
We found that, indeed, monodentate phosphine ligands provided higher yields of the 
vinylidenation products compared to bidentate ligands (Table 2.1, entries 1 and 2). The 
ratio of vinylidenation product to recovered phenylB(pin) starting material generally 
increases with increasing cone angle of the phosphine ligand (Table 2.1, entries 3–13).41 
Although PPhCy2 gave the best yields in this series (Table 2.1, entry 11), we settled on 
PCy3 as it is less expensive and gives similar results to PPhCy2 (Table 2.1, entry 13). 
                                                            
39 (a) Shvo, Y.; Arisha, A. H. I. J. Org. Chem. 1998, 63, 5640. (b) Chen, Y.; Romaire, J. P.; Newhouse, T. R. 
J. Am. Chem. Soc. 2015, 137, 5875. (c) Chen, Y.; Turlik, A.; Newhouse, T. R. J. Am. Chem. Soc. 2016, 
138, 1166. (d) Chen, Y.; Huang, D.; Zhao, Y.; Newhouse, T. R. Angew. Chem. Int. Ed. 2017, 56, 8258. (e) 
Huang, D.; Zhao, Y.; Newhouse, T. R. Org. Lett. 2018, 20, 684. (f) Murray, S. A.; Luc, E. C. M.; Meek, 
S. J. Org. Lett. 2018, 20, 469. 
40 Minami, I.; Takahashi, K.; Shimizu, I.; Kimura, T.; Tsuji, J. Tetrahedron 1986, 42, 2971. 
41 Tolman, C. A. Chem. Rev. 1977, 77, 313. 
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Further modifications were made by making minor changes to the equivalents of 
vinylmagnesium chloride and NaOTf, lowering the catalyst loading to 2.5 mol %, and 
shortening the reaction time from 18 hours to one hour (Table 2.1, entry 16). 
225
We were also curious about the effect of the allyl oxidant on the reaction (Table 
2.2). The nature of the leaving group did not significantly affect the reactivity (Table 2.2, 
entries 1–6). However, electrophiles with substituents at the position γ to the leaving group 
such as one or two methyl groups (2.69 and 2.71) or a phenyl group (2.70) diminished the 
yield of the reaction (Table 2.2, entries 7–9). In order to exclude the possibility of a more 
hindered SN2' oxidative addition of Pd onto the more substituted γ-position of the allyl 
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group, we synthesized α,α-dimethyl allyl acetate 2.72 and used it in the reaction. This 
oxidant would give the same Pd(π-allyl) complex as γ,γ-dimethyl allyl acetate 2.71 via a 
less hindered SN2' oxidative addition. We found that 2.71 and 2.72 behaved similarly 
(Table 2.2, entries 9 and 10), showing that the nature of the oxidative addition is not 
responsible for the low yields when γ-substituted allyl oxidants are used. In contrast, having 
substituents at the β-position to the acetate leaving group did not significantly affect the 
yield of the reaction (Table 2.2, entries 11–13). 
We hypothesized that the vinylidenation reaction is governed by steric interactions 
and that substituents on the allyl moiety of the [(η3-allyl)Pd(PR3)]+ complex could inhibit 
binding between the boron “ate” and the cationic palladium center. As shown in Scheme 
2.17a, having substituents at either the α- or γ-positions on the allyl oxidant would lead to 
increased steric penalty with either the “ate” complex (2.76) or the phosphine ligand (2.77). 
However, β-substituents would not interact with either the “ate” complex or the phosphine 
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in any significant way, which explains why β-substituted allyl oxidants behave similarly 
to allyl acetate 2.64 (Scheme 2.17b). 
We conducted additional experiments to investigate the effect of different 
palladium sources on the vinylidenation reaction of phenylB(pin) with PCy3 as the ligand. 
Pd(OAc)2 was found to be the best palladium source at 2.5 mol % catalyst loading (Table 
2.3, entry 1). Pd(PtBu3)2, Pd2(dba)3, and [PdCl(allyl)]2 gave significantly lower yields 
(Table 2.3, entries 4–6). 
When optimizing the reaction to encompass aliphatic migrating groups, 3-
phenylpropylB(pin) 2.79 was used as a model substrate along with vinylmagnesium 
chloride. We used a 1:1 THF:DMSO solvent system and extended the reaction time to 18 
hours, as in a previous study, we found that DMSO stabilizes alkyl(vinyl)B(pin) “ate” 
complexes generated from Grignard reagents, albeit at the price of retarding the rate of 
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conjunctive cross-coupling.42 We found that 10% Pd loadings were required to give yields 
greater than 50% (Table 2.4 entry 1 vs. entries 2–5). The best conditions for the vinylidene 
homologation of aliphatic boronic esters used 5 mol % Pd2(dba)3 and 20 mol % PCy3 
(Table 2.4, entry 5). Attempts to change the Pd:ligand ratio and/or lower the catalyst 
loading resulted in inferior yields (Table 2.4 entries 6–8). 
2.3.3. Substrate Scope and Demonstration of Synthetic Utility 
Using the optimized conditions for phenylB(pin) 2.63 described in Table 2.3, entry 
1, we tested the scope of the vinylidenation reaction with other aryl migrating groups. As 
shown in Scheme 2.18, p-methoxyphenyl 2.81 and p-bromophenyl 2.82 migrating groups 
performed well under these reaction conditions, although the reaction with m-
trifluoromethylphenylB(pin) required three hours for full conversion to 2.83.  
42 Lovinger, G. J.; Aparece, M. D.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 3153. 
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The scope of alkyl boronic esters was examined with vinylmagnesium chloride 
using the optimized conditions for 3-phenylpropylB(pin) 2.79 described in Table 2.4, entry 
5. As shown in Scheme 2.19, we found that a variety of sp3-hybridized boronic esters 
engaged in the reaction, including carbocyclic (2.86 and 2.87) and heterocyclic (2.88)   
migrating groups. Furthermore, migrating groups bearing sensitive functional groups such 
as terminal olefins (2.89), amides (2.90), esters (2.91), and acetals (2.92) were tolerated 
under the reaction conditions. 
Although vinylmagnesium chloride is commercially available, we found that “ate” 
complexes generated from vinyllithium gave superior reactivity: yields were often higher 
compared to the analogous reactions with vinylmagnesium chloride, catalyst loadings 
could be reduced to 1 mol %, all reactions achieved full conversion in one hour, and DMSO 
and NaOTf additives were not required (Scheme 2.20). Furthermore, tertiary (2.93) and 
cycloalkenyl (2.94–2.96) boronic esters, which were unreactive in the Grignard-based 
protocol, could now undergo vinylidenation. Even an α-(trimethylsilyl)vinyl group (2.97) 
could participate in the reaction, although the yield is modest. Unfortunately, other acyclic 
alkenyl migrating groups such as trans-alkenyl boronic esters (2.98 and 2.99) were 
unsuccessful, and 1,1-disubstituted alkenyl boronates gave an inseparable ~1:1 mixture of 
vinylidenation product and starting material (2.100 and 2.101).  
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To demonstrate the stereospecificity of the vinylidenation, the enantioenriched 
substrate 2.102, prepared by an enantioselective Pt-catalyzed hydrosilylation of trans-
alkenyl boronic ester,43 underwent vinylidenation to give 2.103 in good yield without loss 
of enantiopurity (Scheme 2.21a). To demonstrate the scalability of this reaction, the 
vinylidenation of cyclopentylB(pin) was conducted on gram scale and was found to occur 
in good yield (Scheme 2.21b).  
                                                            
43 Szymaniak, A. A.; Zhang, C.; Coombs, J. R.; Morken, J. P. ACS Catal. 2018, 8, 2897. 
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We also sought to demonstrate the utility of this reaction by synthesizing 7-deoxy-
7,14-didehydrosydonol 2.113, a sesquiterpenoid natural product produced by the fungus 
Aspergillus sydowii.44 Vinylidenation of 4-methylpentylB(pin) 2.104 with 
vinylmagnesium chloride gave alkenyl boronic ester 2.105 in 62% yield (Scheme 2.22a), 
which we then coupled with aryl triflate 2.107 via the Suzuki–Miyaura reaction to give 
2.108 in 77% yield (Scheme 2.22c). We were eager to employ 2.107 because it can be 
derived from inexpensive, naturally abundant vanillin 2.106 in a single step in high yield 
(Scheme 2.22b). However, all attempts to demethylate the methoxy group in 2.108 led to 
decomposition of the starting material; reduction of the aldehyde prior to the demethylation 
step also led to decomposition (Scheme 2.22d and e). 
 
                                                            
44 Chung, Y.-M.; Wei, C.-K.; Chuang, D.-W.; El-Shazly, M.; Hsieh, C.-T.; Asai, T.; Oshima, Y.; Hsieh, T.-
J.; Hwang, T.-L.; Wu, Y.-C.; Chang, F.-R. Bioorg. Med. Chem. 2013, 21, 3866. 
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In lieu of vanillin-derived 2.107, we decided to couple 2.105 with bromoarene 
2.111, which was synthesized in one step from commercially available 4-bromo-3-
hydroxybenzaldehyde 2.110 (Scheme 2.23a). The Suzuki–Miyaura reaction was conducted 
at 80 °C for 18 hours, and following quenching with ammonium chloride, liquid–liquid 
extraction, silica gel filtration, and removal of the solvent under reduced pressure, the crude 
reaction mixture was immediately dissolved in methanol and treated with NaBH4 to give 
2.112 in 57% yield. Deprotection of the TBS ether with TBAF gave 7-deoxy-7,14-
didehydrosydonol 2.113 in 90% yield (32% yield over three steps) (Scheme 2.23b), whose 
1H and 13C NMR spectra are consistent with those reported for the isolated compound. 
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2.3.4. Mechanism 
The mechanism of the first-generation conjunctive cross-coupling was studied by 
DFT calculations.45 However, the vinylidenation reaction conditions are quite different 
from those of the conjunctive cross-coupling. Most notably, the use of a monodentate PCy3 
ligand rather than a chiral bidentate MandyPhos ligand, in conjunction with an allyl 
electrophile, means that the allyl ligand could fluctuate between η1 and η3 bonding modes. 
Therefore, we studied the kinetic and thermodynamic profile of the vinylidenation reaction 
by DFT calculations, which were conducted by former group member Gabriel Lovinger 
(Scheme 2.24).  
Using the complex between (phenyl)(vinyl)B(pin) “ate” and [(η3-allyl)Pd(PCy3)]+ 
2.114 as the starting point, calculations show that the reaction proceeds with a 1,2-metallate 
shift via transition state 2.115 (activation barrier of 11.5 kcal/mol), giving intermediate 
2.116 in a process that is energetically downhill. The allyl ligand then changes its bonding 
mode from η3 to η1 (2.116 → 2.117), which, although 12 kcal/mol higher in energy, opens 
a coordination site on palladium to allow for an agostic interaction with the β-hydrogen of 
the substrate.46 This agostic interaction is required for the subsequent β-hydride elimination 
via transition state 2.118 (activation barrier of 8.8 kcal/mol). Although these calculations 
show that the β-hydride elimination is endothermic, dissociation of complex 2.119 to give 
(η3-allyl)PdH(PCy3) 2.120 and the free vinylidenation product 2.62 is 17.1 kcal/mol 
downhill, presumably due to release of steric congestion around the palladium center in 
2.119. Alternatively, reductive elimination between the allyl and hydride ligands on 
palladium in 2.119 gives complex 2.121, which is even more exothermic. 
                                                            
45 Myhill, J. A.; Zhang, L.; Lovinger, G. J.; Morken, J. P. Angew. Chem. Int. Ed. 2018, 57, 12799. 
46 Brookhart, M.; Green, M. L. H.; Parkin, G. Proc. Natl. Acad. Sci. U.S.A. 2007, 104, 6908. 
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Scheme 2.24. DFT calculations for the Pd-induced vinylidenation reaction 
 
 
2.3.5. Outlook and Future Directions 
Based on what we learned from this vinylidenation reaction, we then attempted to 
expand this mode of reactivity to encompass β-substituted migration termini 2.122: β-
hydride elimination following Pd-induced 1,2-metallate shift (2.123) would give 
trisubstituted alkenyl boronic esters 2.124 (Scheme 2.25a). Subjecting organoboron “ate”  
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complexes, derived from either phenyllithium or n-butyllithium and phenyl- or methyl-
substituted alkenylB(pin) compounds 2.125, to the optimized vinylidenation conditions 
resulted in recovery of boronic esters 2.126 and/or 2.127 (Scheme 2.25b). We also 
attempted to engage “ate” complexes derived from methylated acenaphthoquinone (mac, 
2.128). This boron ligand was developed in our laboratory to enhance palladium binding β 
to the boron atom on β-substituted olefins of the “ate” complex, which has the effect of 
promoting the Pd-induced 1,2-metallate shift while also retarding the Suzuki–Miyaura 
cross-coupling reaction.47 Unfortunately, using mac-derived boron “ate” complexes did not 
give the desired trisubstituted alkenyl boronic esters; organoB(mac) and alkenylB(mac) 
compounds from “ate” complex decomposition resulted instead. 
We also attempted to engage α-substituted migration termini 2.129: if the Pd-
induced 1,2-metallate shift were to occur with these boron “ate” complexes, we 
hypothesized that the lack of a hydrogen atom required for β-hydride elimination may force 
intermediate 2.130 to undergo reductive elimination to give γ-boryl alkene products 2.131 
(Scheme 2.26a)—in other words, we had hoped that using boron “ate” complexes with α-
substituted migration termini would be the solution to our failed conjunctive cross-
coupling reaction with allyl electrophiles. Unfortunately, using “ate” complexes 2.132 
derived from pinacol or mac, phenyllithium or n-butyllithium, and alkenylboronic esters 
with phenyl- or methyl-substitution at the α position did not result in the desired 
conjunctive cross-coupling products when treated with the optimized vinylidenation 
conditions, the outcome once again being reversion to boronic esters 2.126 and/or 2.133 
(Scheme 2.26b). 
                                                            
47 Myhill, J. A.; Wilhelmsen, C. A.; Zhang, L.; Morken, J. P. J. Am. Chem. Soc. 2018, 140, 15181. 
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We attribute the failure of both of these new directions to the acute sensitivity the 
[Pd(η3-allyl)(PCy3)]+ complex has to steric influences: the presence of an additional 
substituent on the migration terminus is enough to inhibit “ate” complex binding to the 
palladium center. The fact that we failed to observed products derived from the direct cross-
coupling between the boron “ate” and the allyl electrophile fragment lends support to this 
hypothesis. Unfortunately, attempts to use smaller phosphine ligands such as those in Table 
2.1 (vide supra) were not successful. 
In conclusion, we have developed the Pd-catalyzed vinylidene homologation of 
organoboronic esters using allyl acetate as the oxidant. This reaction proceeds through a 
Pd-induced 1,2-metallate shift followed by β-hydride elimination, the energetics of which 
was studied by DFT calculations. We have shown that a variety of aryl, alkyl, and alkenyl 
boronates could undergo vinylidenation and have applied this method to the total synthesis 
of the sesquiterpenoid natural product 7-deoxy-7,14-didehydrosydonol 2.113. Although 
we were unsuccessful in our attempts to engage “ate” complexes bearing α- or β-
substituents, we have applied the lessons learned in this project to successfully couple to a 
related class of electrophiles, namely, propargyl electrophiles to synthesize β-boryl allenes 




   
2.4. Experimental 
2.4.1. General Information 
1H NMR spectra were recorded on a Varian Gemini-400 (400 MHz), Varian 
Gemini-500 (500 MHz), or Varian Gemini-600 (600 MHz) spectrometer. Chemical shifts 
are reported in ppm with the solvent resonance as the internal standard (CDCl3: 7.26 ppm). 
Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, t = triplet, 
q = quartet, p = pentet, m = multiplet, app = apparent), coupling constants (Hz), and 
integration. 13C NMR spectra were recorded on a Varian Gemini-400 (100 MHz), Varian 
Gemini-500 (125 MHz), or Varian Gemini-600 (150 MHz) spectrometer with complete 
proton decoupling. Chemical shifts are reported in ppm with the solvent resonance as the 
internal standard (CDCl3: 77.16 ppm). 11B NMR spectra were recorded on a Varian Inova-
500 (128 MHz) spectrometer. Chemical shifts are reported in ppm using boron trifluoride 
diethyl etherate as the external standard (BF3·O(C2H5)2: 0.0 ppm). Infrared (IR) spectra 
were recorded on a Bruker Alpha-P Spectrometer. Frequencies are reported in 
wavenumbers (cm-1) as follows: strong (s), broad (br), medium (m), and weak (w). Optical 
rotations were measured on a Rudolph Analytical Research Autopol IV Polarimeter and 
the values reported are averages of seven measurements. Direct analysis in real time-high 
resolution mass spectrometry (DART-HRMS) was performed at the Mass Spectrometry 
Facility, Boston College, Chestnut Hill, MA. Flash column chromatography was 
performed using silica gel (SiO2, 230 x 450 Mesh, purchased from Silicycle). Thin layer 
chromatography (TLC) was performed on 25 μm silica gel aluminum backed plates from 
Silicycle. Visualization was performed using ultraviolet light (254 nm) and ceric 
ammonium molybdate (CAM) in ethanol. 
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Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector with 
isopropanol as the modifier. 
Anhydrous tetrahydrofuran (THF), diethyl ether (Et2O), and dichloromethane 
(DCM) were purified using a Pure Solv MD-4 solvent purification system, from Innovative 
Technology, Inc., by passing the solvent through two activated alumina columns after 
purging with argon. Anhydrous dimethyl sulfoxide (DMSO) and allyl acetate were 
purchased from Aldrich. Palladium (II) acetate (Pd(OAc)2), 
tris(dibenzylideneacetone)dipalladium(0) (Pd2(dba)3), and tricyclohexylphosphine (PCy3) 
purchased from Strem Chemicals, Inc. and used without further purification. Pinacol was 
purchased from Oakwood Chemicals. All pinacol boronic esters not synthesized in-house 
were purchased from Combi Blocks, Oakwood Chemicals, or Frontier Scientific and used 
without further purification. All other reagents were purchased from Aldrich, Alfa Aesar, 
or Acros and used without further purification.  
2.4.2. General Procedure for the Preparation of Pinacol Boronic Esters from Olefins 
 
Following a literature procedure48 with slight modification: In a glovebox filled 
with argon, a flame-dried round bottom flask equipped with a magnetic stir bar was charged 
with [Ir(cod)Cl]2 (0.01 equiv) and 1,1-bis(diphenylphosphino)methane (dppm, 0.02 equiv) 
as solids. The solids were dissolved in anhydrous DCM (0.67 M) and allowed to stir for 
                                                            
48 Yamamoto, Y.; Fujikawa, R.; Umemoto, T.; Miyaura, N. Tetrahedron 2004, 60, 10695. 
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five minutes. To this solution was added the olefin (1 equiv), followed by dropwise 
addition of 4,4,5,5-tetramethyl-1,3,2-dioxaborolane (pinacolborane, HB(pin), 1 equiv). 
The reaction flask was sealed with a septum, brought out of the glove box, and was allowed 
to stir at room temperature for 18 hours. Upon completion, the reaction was quenched with 
methanol and water and then partitioned between brine and DCM. The aqueous layer was 
extracted with DCM (4 x) and the combined organic phases were dried over Na2SO4, 




(2.79). Prepared according to the general procedure  above with 
allylbenzene (355 mg, 3 mmol, 1 equiv). The crude product was purified by silica gel 
column chromatography (10% EtOAc in hexanes, stained in CAM) to afford a clear, 




(2.134). Prepared according to the general procedure  above with oct-1-ene (337 mg, 3 
mmol, 1 equiv). The crude product was purified by silica gel column chromatography (10% 
EtOAc in hexanes, stained in CAM) to afford a clear, colorless oil (700 mg, 97% yield). 
All spectroscopic data were in accord with the literature.48 
 
                                                            
49 Bose, S. K.; Brand, S.; Omoregie, H. O.; Haehnel, M.; Maier, J.; Bringmann, G.; Marder, T. B. ACS 
Catal. 2016, 6, 8332. 
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 (but-3-enyloxy)(tert-butyl)dimethylsilane (2.135). The title 
compound was prepared according to the procedure reported in the literature, and all 
spectroscopic data were in accord with the literature.50 
 
tert-butyldimethyl-[4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl) butoxy]silane (2.136). Prepared according to the general procedure 
above with (but-3-enyloxy)(tert-butyl)dimethylsilane (2.135) (410 mg, 2.2 mmol, 1 equiv). 
The crude product was purified by silica gel column chromatography (10% EtOAc in 
hexanes, stained in CAM) to afford a clear, colorless oil (627 mg, 91% yield).  All 
spectroscopic data were in accord with the literature.51 
 
2-(3,3-dimethoxypropyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.137).  Prepared according to the general 
procedure above with 3,3-dimethoxyprop-1-ene (1.02 g, 10 mmol, 1 equiv). The crude 
product was purified by silica gel column chromatography (10% EtOAc in hexanes, stained 
in CAM) to afford a clear, colorless oil (660 mg, 29% yield). 1H NMR (600 MHz, CDCl3) 
δ 4.11 (t, J = 5.7 Hz, 1H), 3.11 (s, 6H), 1.51 (app q, J = 7.0 Hz, 2H), 1.05 (s, 12H), 0.59 (t, 
J = 7.8 Hz, 2H). 11B NMR (128 MHz, CDCl3) δ 33.59. 13C NMR (150 MHz, CDCl3) δ 
105.6, 82.7, 52.4, 26.7, 24.6. IR (neat) νmax 2978.20 (m), 2932.75 (m), 2829.35 (w), 
1369.68 (s), 1324.19 (m), 1304.96 (m), 1214.91 (m), 1144.61 (s), 1121.35 (s), 1053.55 (s), 
                                                            
50 Ghosh, A. K.; Li, J. Org. Lett., 2009, 11, 4164. 
51 Fan, D.; Jarvest, R. L.; Lazarides, L.; Li, Q.; Li, X.; Liu, Y.; Liao, L.; Mordaunt, J. E.; Ni, Z.-J.; Plattner, 
J.; Qian, X.; Slater, M. J.; White, G. V.; Zhang, Y. K. Novel Cyclic Boronate Inhibitors of HCV 
Replication. WO2009046098A1, April 9, 2009. 
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968.06 (m), 846.38 (m), 733.17 (m) cm-1. HRMS (DART+) for C11H27BNO4 [M+NH4]+ 
calculated: 248.2028, found: 248.2034. 
 
2-(4-methylpentyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.104). Prepared according to the general procedure  above with 
4-methylpent-1-ene (505 mg, 6 mmol, 1 equiv). The crude product was purified by silica 
gel column chromatography (10% EtOAc in hexanes, stained in CAM) to afford a clear, 
colorless oil (1.20 g, 94% yield). All spectroscopic data were in accord with the literature.52 
 
2.4.3. General Procedures for the Vinylidenation of Pinacol Boronic Esters 
2.4.3.1. Method A: Vinylmagnesium Chloride with Aryl Boronic Esters 
 
In a glovebox filled with argon, an oven-dried 2-dram vial equipped with a 
magnetic stir bar was charged with 2-aryl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.3 
mmol, 1 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.9 mmol, 3 equiv), and 
anhydrous THF (1 mL). The vial was sealed with a septum cap and removed from the 
glovebox. Under positive nitrogen pressure, the reaction vial was cooled to 0 ºC in an ice-
water bath, and vinylmagnesium chloride solution in THF (0.36 mmol, 1.2 equiv) was 
added dropwise with stirring. The reaction vial was allowed to warm to room temperature 
and stir for 30 minutes before being brought back into the glovebox. In the glovebox, a 
                                                            
52 Pang, M.; Wu, C.; Zhuang, X.; Zhang, F.; Su, M.; Tong, Q.; Tung, C.-H.; Wang, W. Organometallics 
2018, 37, 1462. 
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second oven-dried 2-dram vial equipped with a magnetic stirbar was charged with 
Pd(OAc)2 solution in anhydrous THF (0.75 mL, 0.01 M, 0.0075 mmol, 0.025 equiv) and 
PCy3 (4.2 mg, 0.015 mmol, 0.05 equiv). The Pd(OAc)2/PCy3 solution was allowed to stir 
for 10 minutes at room temperature inside the glovebox. The Pd(OAc)2/PCy3 solution was 
then transferred into the reaction vial, followed by allyl acetate (36.0 mg, 0.36 mmol, 1.2 
equiv) and anhydrous THF (1.25 mL, used to rinse the Pd(OAc)2/PCy3 vial). The reaction 
vial was sealed with a polypropylene cap and electrical tape, brought out of the glovebox, 
and stirred at 60 ºC for 1 hour. After cooling to room temperature, the reaction solution 
was filtered through a silica gel plug with Et2O washing, concentrated in vacuo, and 
purified by silica gel column chromatography to provide the desired products. 
2.4.3.2. Method B: Vinylmagnesium Chloride with Alkyl Boronic Esters 
 
In a glovebox filled with argon, an oven-dried 2-dram vial equipped with a 
magnetic stir bar was charged with 2-alkyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.3 
mmol, 1 equiv), sodium trifluoromethanesulfonate (154.9 mg, 0.9 mmol, 3 equiv), 
anhydrous THF (0.5 mL), and anhydrous DMSO (0.5 mL). The vial was sealed with a 
septum cap and removed from the glovebox. Under positive nitrogen pressure, the reaction 
vial was cooled to 0 ºC in an ice-water bath, and vinylmagnesium chloride solution in THF 
(0.36 mmol, 1.2 equiv) was added dropwise with stirring. The reaction vial was allowed to 
warm to room temperature and stir for 30 minutes before being brought back into the 
glovebox. In the glovebox, a second oven-dried 2-dram vial equipped with a magnetic 
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stirbar was charged with Pd2(dba)3 (13.7 mg, 0.015 mmol, 0.05 equiv), PCy3 (16.8 mg, 
0.06 mmol, 0.2 equiv), anhydrous DMSO (1 mL), and anhydrous THF (0.5 mL). The 
Pd2(dba)3/PCy3 solution was allowed to stir for 10 minutes at room temperature inside the 
glovebox. The Pd2(dba)3/PCy3 solution was then transferred into the reaction vial, followed 
by allyl acetate (36.0 mg, 0.36 mmol, 1.2 equiv) and anhydrous THF (0.5 mL, used to rinse 
the Pd2(dba)3/PCy3 vial). The reaction vial was sealed with a polypropylene cap and 
electrical tape, brought out of the glovebox, and stirred at 60 ºC for 18 hours. After cooling 
to room temperature, the resulting mixture was transferred to a separatory funnel with the 
aid of EtOAc (5 mL). The organic phase was washed with water (2 x 10 mL), and the 
combined aqueous phases were extracted with EtOAc (20 mL). The combined organic 
phases were dried over Na2SO4, filtered, concentrated in vacuo, filtered through a silica gel 
plug with EtOAc, re-concentrated, and purified by silica gel column chromatography to 
provide the desired products. 
2.4.3.3. Method C: Halide-free Vinyllithium with Alkyl/Alkenyl Boronic Esters at 1 mol 
% Pd/PCy3 Loading 
 
In a glovebox filled with argon, an oven-dried 2-dram vial equipped with a 
magnetic stir bar was charged with 2-alkyl(or alkenyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (0.3 mmol, 1 equiv) and anhydrous THF (1 mL). The vial was sealed with 
a septum cap and removed from the glovebox. Under positive nitrogen pressure, the 
reaction vial was cooled to 0 ºC in an ice-water bath, and vinyllithium solution in THF 
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(0.36 mmol, 1 equiv) was added dropwise with stirring. The reaction vial was allowed to 
warm to room temperature and stir for 30 minutes before being brought back into the 
glovebox. In the glovebox, a second oven-dried 2-dram vial equipped with a magnetic 
stirbar was charged with Pd(OAc)2 solution in anhydrous THF (0.3 mL, 0.01 M, 0.003 
mmol, 0.01 equiv) and PCy3 (1.7 mg, 0.006 mmol, 0.02 equiv). The Pd(OAc)2/PCy3 
solution was allowed to stir for 10 minutes at room temperature inside the glovebox. The 
Pd(OAc)2/PCy3 solution was then transferred into the reaction vial, followed by allyl 
acetate (36.0 mg, 0.36 mmol, 1.2 equiv) and anhydrous THF (1.7 mL, used to rinse the 
Pd(OAc)2/PCy3 vial). The reaction vial was sealed with a polypropylene cap and electrical 
tape, brought out of the glovebox, and stirred at 60 ºC for 1 hour. After cooling to room 
temperature, the reaction solution was filtered through a silica gel plug with Et2O washing, 
concentrated in vacuo, and purified by silica gel column chromatography to provide the 
desired products. 
2.4.3.4. Method D: Halide-free Vinyllithium with Alkyl/Alkenyl Boronic Esters at 5 mol 
% Pd/PCy3 Loading 
 
In a glovebox filled with argon, an oven-dried 2-dram vial equipped with a 
magnetic stir bar was charged with 2-alkyl(or alkenyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (0.3 mmol, 1 equiv) and anhydrous THF (1 mL), sealed with a septum cap, 
and removed from the glovebox. Under positive nitrogen pressure, the reaction vial was 
cooled to 0 ºC in an ice-water bath, and vinyllithium solution in THF (0.36 mmol, 1 equiv) 
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was added dropwise. The reaction vial was allowed to warm to room temperature and stir 
for 30 minutes before being brought back into the glovebox. In the glovebox, a second 
oven-dried 2-dram vial equipped with a magnetic stirbar was charged with Pd(OAc)2 
solution in anhydrous THF (1.5 mL, 0.01 M, 0.015 mmol, 0.05 equiv) and PCy3 (8.4 mg, 
0.03 mmol, 0.1 equiv). The Pd(OAc)2/PCy3 solution was allowed to stir for 10 minutes at 
room temperature inside the glovebox. The Pd(OAc)2/PCy3 solution was then transferred 
into the reaction vial, followed by allyl acetate (36.0 mg, 0.36 mmol, 1.2 equiv) and 
anhydrous THF (0.5 mL, used to rinse the Pd(OAc)2/PCy3 vial). The reaction vial was 
sealed with a polypropylene cap and electrical tape, brought out of the glovebox, and stirred 
at 60 ºC for 1 hour. After cooling to room temperature, the reaction solution was filtered 
through a silica gel plug with Et2O washing, concentrated in vacuo, and purified by silica 
gel column chromatography to provide the desired products. 
2.4.4. Characterization of Vinylidenation Products 
4,4,5,5-tetramethyl-2-(1-phenylvinyl)-1,3,2-dioxaborolane (2.62). 
The reaction was performed according to the general procedures outlined 
in Method A with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (2.63) (61.2 mg, 0.3 
mmol). The crude product was purified by silica gel column chromatography (0% → 15% 
DCM in hexanes, stained in CAM) to afford a clear, colorless oil (62.2 mg, 76% yield + 
16% unreacted starting material). All spectroscopic data were in accord with the 
literature.53 
 
                                                            
53 Guan, W.; Michael, A. K.; McIntosh, M. L.; Koren-Selfridge, L.; Scott, J. P.; Clark, T. B. J. Org. Chem. 
2014, 79, 7199. 
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 2-[1-(4-methoxyphenyl)vinyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.81). The reaction was performed according to 
the general procedures outlined in Method A with 2-(4-methoxyphenyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (70.2 mg, 0.3 mmol). The crude product was purified by 
silica gel column chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford 
a clear, colorless oil (66.0 mg, 68% yield + 19% unreacted starting material). All 
spectroscopic data were in accord with the literature.53 
 2-[1-(4-bromophenyl)vinyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.82). The reaction was performed according to the 
general procedures outlined in Method A with 2-(4-bromophenyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (S-1) (84.9 mg, 0.3 mmol). The crude product was purified by silica 
gel column chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a 
clear, colorless oil (73.8 mg, 62% yield + 19% unreacted starting material). 1H NMR (600 
MHz, CDCl3) δ 7.44 (d, J = 9.0 Hz, 2H), 7.36 (d, J = 8.4 Hz, 2H), 6.09 – 6.08 (m, 2H), 
1.33 (s, 12H). 11B NMR (128 MHz, CDCl3) δ 30.17. 13C NMR (150 MHz, CDCl3) δ 140.4, 
131.6, 131.4, 129.0, 121.2, 84.0, 24.9; carbon α to boron was not observed. 
4,4,5,5-tetramethyl-2-[1-[3-(trifluoromethyl)phenyl]vinyl]-
1,3,2-dioxaborolane (2.83). The reaction was performed according 
to the general procedures outlined in Method A with 4,4,5,5-tetramethyl-2-[3-
(trifluoromethyl)phenyl]-1,3,2-dioxaborolane (81.6 mg, 0.3 mmol) with the modification 
that the reaction was run for 3 hours. The crude product was purified by silica gel column 
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chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a clear, colorless 
oil (64.1 mg, 55% yield + 19% unreacted starting material). All spectroscopic data were in 
accord with the literature.54 
 
4,4,5,5-tetramethyl-2-(1-methylene-4-phenylbutyl)-1,3,2-
dioxaborolane (2.80). The reaction was performed according to 
the general procedures outlined in either Method B or Method C with 4,4,5,5-tetramethyl-
2-(3-phenylpropyl)-1,3,2-dioxaborolane (2.79) (73.9 mg, 0.3 mmol). The crude product 
was purified by silica gel column chromatography (0% → 15% DCM in hexanes, stained 
in CAM) to afford a clear, colorless oil (Method B: 56.8 mg, 70% yield; Method C: 59.5 
mg, 73% yield). 1H NMR (400 MHz, CDCl3) δ 7.31 – 7.26 (m, 2H), 7.22 – 7.17 (m, 3H), 
5.83 (d, J = 3.2 Hz, 1H), 5.65 (app s, 1H), 2.63 (t, J  = 7.8 Hz, 2H), 2.24 (t, J = 7.4 Hz, 
2H), 1.79 (app p, J = 7.7 Hz, 2 H), 1.29 (s, 12H). 11B NMR (128 MHz, CDCl3) δ 29.88. 
13C NMR (100 MHz, CDCl3) δ 142.9, 129.4, 128.5, 128.3, 125.7, 83.4, 35.6, 35.2, 31.0, 
24.9; carbon α to boron was not observed. IR (neat) νmax 3062.21 (w), 3026.23 (w), 2977.75 
(m), 2930.28 (m), 2859.03 (w), 1614.55 (w), 1425.20 (m), 1368.34 (s), 1307.52 (s), 
1213.03 (m), 1188.99 (m), 1142.28 (s), 968.66 (m), 940.65 (m), 858.25 (m), 741.46 (m), 




dioxaborolane (2.84). The reaction was performed according to the general procedures 
                                                            
54 Zhang, P.; Suárez, J. M.; Driant, T.; Derat, E.; Zhang, M.; Ménand, M.; Roland, S.; Sollogoub, M. Angew. 
Chem. Int. Ed. 2017, 56, 10821. 
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outlined in either Method B or Method C with 4,4,5,5-tetramethyl-2-octyl-1,3,2-
dioxaborolane (2.134) (72.1 mg, 0.3 mmol). The crude product was purified by silica gel 
column chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a clear, 
colorless oil (Method B: 54.2 mg, 68% yield; Method C: 68.0 mg, 85% yield). 1H NMR 
(400 MHz, CDCl3) δ 5.74 (d, J = 3.6 Hz, 1H), 5.58 (app s, 1H), 2.13 (t, J  = 7.4 Hz, 2H), 
1.41 – 1.38 (m, 2H), 1.26 (app s, 22H), 0.87 (t, J = 7.0 Hz, 3H). 11B NMR (128 MHz, 
CDCl3) δ 29.88. 13C NMR (100 MHz, CDCl3) δ 128.8, 83.4, 35.5, 32.1, 29.7, 29.43, 29.36, 
24.9, 22.8, 14.3; carbon α to boron was not observed. IR (neat) νmax 2977.91 (m), 2958.10 
(m), 2924.00 (s), 2854.43 (m), 1615.14 (w), 1425.63 (m), 1306.47 (s), 1141.72 (s), 969.23 
(m), 938.38 (m), 862.26 (m) cm-1. HRMS (DART+) for C16H32BO2 [M+H]+ calculated: 
267.2495, found: 267.2500. 
 
tert-butyldimethyl-[5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hex-5-enoxy]silane (2.85). The reaction 
was performed according to the general procedures outlined in either Method B or Method 
C with tert-butyldimethyl-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)butoxy]silane 
(2.136) (94.3 mg, 0.3 mmol). The crude product was purified by silica gel column 
chromatography (0% → 50% DCM in hexanes, stained in CAM) to afford a clear, yellow 
oil (Method B: 70.0 mg, 69% yield; Method C: 78.7 mg, 77% yield). 1H NMR (400 MHz, 
CDCl3) δ 5.75 (d, J = 3.6 Hz, 1H), 5.58 (d, J = 2.8 Hz, 1H), 3.59 (t, J = 6.2 Hz, 2H), 2.14 
(t, J = 7.2 Hz, 2H), 1.52 – 1.40 (m, 4H), 1.25 (s, 12H), 0.88 (s, 9H), 0.03 (s, 6H). 11B NMR 
(128 MHz, CDCl3) δ 29.88. 13C NMR (100 MHz, CDCl3) δ 129.1, 83.4, 63.3, 35.3, 32.7, 
26.1, 25.6, 24.9, 18.5, –5.1; carbon α to boron was not observed. IR (neat) νmax 2978.23 
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(w), 2954.63 (m), 2929.20 (m), 2857.28 (m), 1615.85 (w), 1370.04 (s), 1308.57 (s), 
1254.62 (m), 1142.31 (s), 1101.93 (s), 968.46 (w), 939.38 (w), 835.37 (s), 774.74 (s) cm-
1. HRMS (DART+) for C18H38BO3Si [M+H]+ calculated: 341.2683, found: 341.2698. 
 
2-(1-cyclopentylvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.86). The reaction was performed according to the general procedures 
outlined in either Method B or Method D with 2-cyclopentyl-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (58.8 mg, 0.3 mmol). The crude product was purified by silica gel column 
chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a clear, colorless 
oil (Method B: 48.0 mg, 72% yield; Method D: 58.8 mg, 88% yield). 1H NMR (400 MHz, 
CDCl3) δ 5.70 (d, J = 3.2 Hz, 1H), 5.58 (app s, 1H), 2.55 (p, J = 8.4 Hz, 1H), 1.82 – 1.75 
(m, 2H), 1.68 – 1.62 (m, 2H), 1.60 – 1.52 (m, 2H), 1.43 – 1.36 (m, 2H), 1.26 (s, 12H). 11B 
NMR (128 MHz, CDCl3) δ 30.17. 13C NMR (100 MHz, CDCl3) δ 126.1, 83.3, 45.7, 32.2, 
25.2, 24.9; carbon α to boron was not observed. IR (neat) νmax 2977.45 (m), 2952.89 (m), 
2867.84 (w), 1607.71 (w), 1370.13 (s), 1304.77 (s), 1139.61 (s), 965.63 (m), 936.84 (m), 
877.55 (w), 848.05 (w), 690.05 (w) cm-1. HRMS (DART+) for C13H24BO2 [M+H]+ 
calculated: 223.1864, found: 223.1871. 
 
2-(1-cyclohexylvinyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(2.87). The reaction was performed according to the general procedures 
outlined in either Method B or Method D with 2-cyclohexyl-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (63.0 mg, 0.3 mmol). The crude product was purified by silica gel column 
chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a clear, colorless 
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oil (Method B: 39.0 mg, 55% yield; Method D: 30.0 mg, 42% yield). 1H NMR (400 MHz, 
CDCl3) δ 5.70 (d, J = 3.2 Hz, 1H), 5.54 (d, J = 2.0 Hz, 1H), 2.09 (app t, J = 11.6 Hz, 1H), 
1.76 – 1.64 (m, 5H), 1.35 – 1.09 (m, 17H). 11B NMR (128 MHz, CDCl3) δ 30.17. 13C 
NMR (100 MHz, CDCl3) δ 126.0, 83.3, 42.9, 32.6, 26.8, 26.5, 24.9; carbon α to boron was 
not observed. IR (neat) νmax 2977.69 (m), 2923.13 (s), 2851.60 (m), 1609.50 (w), 1429.69 
(m), 1410.55 (m), 1369.56 (s), 1354.33 (s), 1304.86 (s), 1184.18 (m), 1143.17 (s), 968.38 
(m), 940.45 (m), 868.62 (m), 846.61 (m), 689.32 (m) cm-1. HRMS (DART+) for 
C14H26BO2 [M+H]+ calculated: 237.2026, found: 237.2019. 
 
tert-butyl 4-[1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)vinyl] piperidine-1-carboxylate (2.88). The reaction was 
performed according to the general procedures outlined in Method B with tert-butyl 4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)piperidine-1-carboxylate (93.4 mg, 0.3 
mmol). The crude product was purified by silica gel column chromatography (25% → 50% 
DCM in hexanes, stained in CAM) to afford a clear, yellow oil (74.1 mg, 73% yield). 1H 
NMR (400 MHz, CDCl3) δ 5.77 (d, J = 2.8 Hz, 1H), 5.57 (d, J = 1.6 Hz, 1H), 4.12 (br app 
s, 2H), 2.70 (t, J = 11.4 Hz, 2H), 2.22 (t, J = 12.0 Hz, 1H), 1.65 (d, J = 13.2 Hz, 2H), 1.45 
(s, 9H), 1.38 (td, J = 12.8, 4.7 Hz, 2H), 1.25 (s, 12H). 11B NMR (128 MHz, CDCl3) δ 
29.78. 13C NMR (100 MHz, CDCl3) δ 155.1, 127.4, 83.5, 79.3, 41.2, 31.4, 28.6, 24.9; 
carbon α to boron was not observed. IR (neat) νmax 2976.91 (w), 2931.23 (w), 2854.55 (w), 
1693.75 (s), 1417.61 (m), 1365.37 (m), 1307.72 (m), 1163.73 (s), 1141.11 (s), 1036.38 (w), 
968.80 (w), 940.12 (w), 865.50 (w) cm-1. HRMS (DART+) for C18H33BNO4 [M+H]+ 
calculated: 338.2503, found: 338.2494. 
254
   
 
4,4,5,5-tetramethyl-2-(1-methylenepent-4-enyl)-1,3,2-
dioxaborolane (2.89). The reaction was performed according to the 
general procedures outlined in Method B with 2-but-3-enyl-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (54.6 mg, 0.3 mmol). The crude product was purified by silica gel column 
chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a clear, colorless 
oil (34.4 mg, 55% yield). 1H NMR (500 MHz, CDCl3) δ 5.86 – 5.78 (m, 2H), 5.61 (app s, 
1H), 5.00 (dq, J = 17.4, 1.6 Hz, 1H), 4.93 (dq, J = 10.8, 1.3 Hz, 1H), 2.26 – 2.23 (m, 2H), 
2.21 – 2.17 (m, 2H), 1.27 (s, 12H). 11B NMR (128 MHz, CDCl3) δ 29.78. 13C NMR (100 
MHz, CDCl3) δ 138.9, 129.5, 114.5, 83.5, 34.9, 33.7, 24.9; carbon α to boron was not 
observed. IR (neat) νmax 3075.17 (w), 2977.74 (s), 2925.60 (s), 2853.27 (m), 1640.31 (w), 
1617.20 (w), 1429.14 (m), 1370.05 (s), 1308.78 (s), 1142.37 (s), 909.22 (w), 862.27 (w) 
cm-1. HRMS (DART+) for C12H22BO2 [M+H]+ calculated: 209.1713, found: 209.1713. 
 
N,N-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)pent-4-enamide (2.90). The reaction was performed 
according to the general procedures outlined in Method B with N,N-dimethyl-3-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)propanamide (68.1 mg, 0.3 mmol). The crude product 
was purified by silica gel column chromatography (25% → 50% DCM in hexanes, stained 
in CAM) to afford a clear, colorless oil (50.7 mg, 67% yield). 1H NMR (400 MHz, CDCl3) 
δ 5.76 (d, J = 3.2 Hz, 1H), 5.63 (d, J = 2.8 Hz, 1H), 2.99 (s, 3H), 2.90 (s, 3H), 2.42 (app s, 
4H), 1.23 (s, 12H). 11B NMR (128 MHz, CDCl3) δ 29.68. 13C NMR (100 MHz, CDCl3) δ 
173.0, 130.0, 83.5, 37.4, 35.4, 33.5, 31.4, 24.91, 24.86; carbon α to boron was not observed. 
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IR (neat) νmax 2977.19 (w), 2929.57 (w), 1647.69 (s), 1368.72 (s), 1308.95 (s), 1267.66 
(w), 1138.21 (s), 941.73 (w), 864.69 (w), 683.88 (w) cm-1. HRMS (DART+) for 
C13H25BNO3 [M+H]+ calculated: 254.1927, found: 254.1936. 
 
methyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pent-4-
enoate (2.91). The reaction was performed according to the 
general procedures outlined in Method B with methyl 3-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)propanoate (64.2 mg, 0.3 mmol). The crude product was purified by 
silica gel column chromatography (25% → 50% DCM in hexanes, stained in CAM) to 
afford a clear, colorless oil (34.7 mg, 48% yield). 1H NMR (400 MHz, CDCl3) δ 5.80 (d, 
J = 3.2 Hz, 1H), 5.63 (d, J = 2.8 Hz, 1H), 3.65 (s, 3H), 2.46 (app s, 4H), 1.26 (s, 12H). 11B 
NMR (128 MHz, CDCl3) δ 29.59. 13C NMR (100 MHz, CDCl3) δ 173.9, 130.2, 83.6, 51.5, 
33.9, 30.8, 24.9; carbon α to boron was not observed. IR (neat) νmax 2978.69 (m), 2950.10 
(w), 2930.31 (w), 1740.06 (s), 1618.37 (w), 1436.44 (m), 1371.02 (s), 1311.60 (s), 1139.37 




1,3,2-dioxaborolane (2.92). The reaction was performed 
according to the general procedures outlined in Method B with 2-(3,3-dimethoxypropyl)-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (2.137) (69.0 mg, 0.3 mmol). The crude product 
was purified by silica gel column chromatography (0% → 15% DCM in hexanes, stained 
in CAM) to afford a clear, colorless oil (38.8 mg, 51% yield). 1H NMR (500 MHz, CDCl3) 
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δ 5.76 (d, J = 3.5 Hz, 1H), 5.61 (app s, 1H), 4.36 (t, J = 6.0 Hz, 1H), 3.30 (s, 6H), 2.18 (t, 
J = 7.8 Hz, 2H), 1.75 – 1.70 (m, 2H), 1.25 (s, 12H). 11B NMR (128 MHz, CDCl3) δ 29.78. 
13C NMR (125 MHz, CDCl3) δ 129.4, 104.3, 83.5, 52.6, 31.9, 30.7, 24.9; carbon α to boron 
was not observed. IR (neat) νmax 2977.96 (m), 2930.15 (m), 2853.79 (w), 2829.22 (w), 
1616.58 (w), 1434.38 (m), 1368.91 (s), 1308.83 (s), 1214.52 (m), 1193.39 (m), 1141.16 
(s), 1125.45 (s), 1060.07 (s), 966.87 (m), 939.51 (m),  860.23 (m) cm-1. HRMS (DART+) 




silane (2.93). The reaction was performed according to the general procedures outlined in 
Method D with tert-butyl-[5-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)hexoxy]diphenylsilane55 (144.2 mg, 0.3 mmol). The crude product was purified by silica 
gel column chromatography (0% → 30% DCM in hexanes, stained in CAM) to afford a 
clear, colorless oil (99.0 mg, 65% yield). 1H NMR (600 MHz, CDCl3) δ 7.71 (d, J = 7.2 
Hz, 4H), 7.45 – 7.38 (m, 6H), 5.78 (d, J = 1.2 Hz, 1H), 5.55 (d, J = 1.8 Hz, 1H), 3.68 (t, J 
= 6.9 Hz, 2H), 1.57 (app p, J = 7.2 Hz, 2H), 1.52 – 1.49 (m, 2H), 1.26 (s, 12H), 1.22 – 1.16 
(m, 2H), 1.09 (s, 15H). 11B NMR (128 MHz, CDCl3) δ 30.27. 13C NMR (150 MHz, CDCl3) 
δ 136.4, 135.7, 134.4, 129.6, 129.3, 127.7, 125.7, 83.1, 64.3, 41.5, 38.6, 33.7, 27.8, 27.6, 
27.0, 24.8, 21.4, 19.4; carbon α to boron was not observed. IR (neat) νmax 3070.93 (w), 
3051.46 (w), 2957.67 (m), 2930.19 (m), 2858.25 (m), 1601.25 (w), 1472.15 (m), 1427.34 
(m), 1410.54 (m), 1361.76 (m), 1298.26 (m), 1146.40 (m), 1106.85 (s), 864.77 (m), 822.14 
                                                            
55 Edelstein, E. K.; Grote, A.; Palkowitz, M. D. Synlett 2018, 29, 1749. 
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(m), 738.70 (m), 699.48 (s), 612.25 (m), 502.72 (s) cm-1. HRMS (DART+) for 
C31H48BO3Si [M+H]+ calculated: 507.3460, found: 507.3467. 
 
2-[1-(cyclopenten-1-yl)vinyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.94). The reaction was performed according to the 
general procedures outlined in Method D with 2-(cyclopenten-1-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane90 (58.2 mg, 0.3 mmol). The crude product was purified by silica gel 
column chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a clear, 
colorless oil (30.0 mg, 45% yield). 1H NMR (500 MHz, CDCl3) δ 6.22 (app s, 1H), 5.78 
(d, J = 3.0 Hz, 1H), 5.62 (d, J = 2.5 Hz, 1H), 2.46 (app t, J = 7.8 Hz, 4H), 1.87 (app p, J = 
7.8 Hz, 2H), 1.30 (s, 12H). 11B NMR (128 MHz, CDCl3) δ 29.98. 13C NMR (150 MHz, 
CDCl3) δ 144.2, 131.5, 127.4, 83.5, 33.7, 32.3, 24.9, 22.7; carbon α to boron was not 
observed. IR (neat) νmax 2977.45 (m), 2928.70 (w), 2843.18 (w), 1410.54 (s), 1370.82 (m), 
1305.74 (s), 1253.43 (m), 1214.16 (m), 1142.39 (s), 967.36 (m), 927.01 (m), 861.12 (m), 
731.00 (w), 685.92 (w) cm-1. HRMS (DART+) for C13H22BO2 [M+H]+ calculated: 
221.1707, found: 221.1702. 
 
2-[1-(cyclohexen-1-yl)vinyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.95). The reaction was performed according to the 
general procedures outlined in Method C with 2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane90 (62.4 mg, 0.3 mmol). The crude product was purified by silica gel 
column chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a clear, 
colorless oil (49.7 mg, 71% yield). 1H NMR (500 MHz, CDCl3) δ 6.18 (app s, 1H), 5.65 
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(app s, 1H), 5.59 (d, J = 2.5 Hz, 1H), 2.17 – 2.15 (m, 4H), 1.68 (app p, J = 2.9 Hz, 2H), 
1.57 (app p, J = 2.9 Hz, 2H), 1.29 (s, 12H). 11B NMR (128 MHz, CDCl3) δ 30.66. 13C 
NMR (125 MHz, CDCl3) δ 137.4, 128.9, 123.6, 83.5, 26.2, 25.6, 24.93, 24.87, 22.9, 22.4; 
carbon α to boron was not observed. IR (neat) νmax 2981.13 (w), 2928.39 (w), 1298.87 (w), 
1264.59 (m), 1191.95 (w), 1142.87 (m), 905.82 (s), 858.09 (w), 726.46 (s), 649.27 (m) cm-
1. HRMS (DART+) for C14H24BO2 [M+H]+ calculated: 235.1864, found: 235.1857. 
 
2-[1-(cyclohepten-1-yl)vinyl]-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.96). The reaction was performed according to the 
general procedures outlined in Method D with 2-(cyclohepten-1-yl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane56 (66.6 mg, 0.3 mmol). The crude product was purified by silica gel 
column chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a clear, 
colorless oil (44.0 mg, 59% yield). 1H NMR (500 MHz, CDCl3) δ 6.09 (t, J = 6.5 Hz, 1H), 
5.63 (app s, 1H), 5.57 (d, J = 2.5 Hz, 1H), 2.34 – 2.32 (m, 2H), 2.22 – 2.19 (m, 2H), 1.75 
(app p, J = 5.9 Hz, 2H), 1.53 – 1.47 (m, 5H), 1.29 (s, 12H). 11B NMR (128 MHz, CDCl3) 
δ 30.37. 13C NMR (125 MHz, CDCl3) δ 145.9, 131.8, 124.0, 83.6, 32.6, 29.8, 28.8, 26.8, 
26.4, 24.9; carbon α to boron was not observed. IR (neat) νmax 2977.66 (m), 2919.83 (s), 
2849.31 (m), 1629.25 (w), 1576.08 (w), 1445.41 (m), 1404.81 (m), 1351.65 (s), 1300.79 
(s), 1223.40 (m), 1138.06 (s), 966.60 (m), 850.84 (m) cm-1. HRMS (DART+) for 
C15H26BO2 [M+H]+ calculated: 249.2026, found: 249.2030. 
 
                                                            
56 Rauniyar, V.; Zhai, H.; Hall, D. G. Synth. Commun. 2008, 38, 3984. 
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trimethyl-[1-methylene-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)allyl] silane (2.97). The reaction was performed according to the general 
procedures outlined in Method C with trimethyl-[1-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)vinyl]silane57 (67.86 mg, 0.3 mmol). The crude product was purified by 
silica gel column chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford 
a clear, colorless oil (27.8 mg, 37% yield). 1H NMR (500 MHz, CDCl3) δ 5.76 (d, J = 3.5 
Hz, 1H), 5.70 (d, J = 3.0 Hz, 1H), 5.56 (d, J = 2.5 Hz, 1H), 5.40 (d, J = 3.5 Hz, 1H), 1.28 
(s, 12H), 0.12 (s, 9H). 11B NMR (128 MHz, CDCl3) δ 29.78. 13C NMR (150 MHz, CDCl3) 
δ 154.5, 128.8, 125.9, 83.7, 24.9, –0.8; carbon α to boron was not observed. IR (neat) νmax 
2978.78 (w), 1345.48 (m), 1308.78 (m), 1245.94 (m), 1146.26 (m), 968.97 (w), 931.87 
(w), 835.20 (s), 757.18 (w), 644.54 (w) cm-1. HRMS (DART+) for C13H26BO2Si [M+H]+ 
calculated: 253.1790, found: 253.1811. 
 
tert-butyl-dimethyl-[5-methylene-6-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)hept-6-enoxy]silane (2.100). The reaction 
was performed according to the general procedures outlined in Method D with tert-butyl-
dimethyl-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)hex-5-.3enoxy]silane (2.85) 
(102.1 mg, 0.3 mmol). The crude product was purified by silica gel column 
chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a clear, colorless 
oil (77.4 mg, 33% yield + 40% unreacted starting material). 1H NMR (500 MHz, CDCl3) 
δ 5.78 (app s, 2H), 5.27 (d, J = 1.5 Hz, 1H), 4.95 (s, 1H), 3.60 (t, J = 6.3 Hz, 2H), 2.26 (t, 
J = 7.3 Hz, 2H), 1.54 – 1.42 (m, 4H), 1.28 (s, 12H), 0.88 (s, 9H), 0.03 (s, 6H). 11B NMR 
                                                            
57 Edelstein, E. K.; Namirembe, S.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 5027. 
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(128 MHz, CDCl3) δ 29.88. 13C NMR (150 MHz, CDCl3) δ 149.1, 128.0, 114.2, 83.6, 63.3, 
34.0, 32.8, 25.6, 24.9, 24.6, 18.5, –5.1; carbon α to boron was not observed. IR (neat) νmax 
2977.60 (w), 2929.45 (m), 2856.79 (m), 1742.64 (w), 1370.05 (s), 1307.81 (s), 1252.74 
(m), 1142.40 (s), 1101.46 (s), 835.14 (s), 774.65 (s) cm-1. HRMS (DART+) for 
C20H40BO3Si [M+H]+ calculated: 367.2834, found: 367.2840. 
 
2-(2-cyclopentyl-1-methylene-allyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (2.101). The reaction was performed according to the 
general procedures outlined in Method D with 2-(1-cyclopentylvinyl)-4,4,5,5-tetramethyl-
1,3,2-dioxaborolane (2.86) (66.6 mg, 0.3 mmol). The crude product was purified by silica 
gel column chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford a 
clear, colorless oil (22.3 mg, 24% yield + 7% unreacted starting material). 1H NMR (600 
MHz, CDCl3) δ 5.77 (app s, 2H), 5.14 (s, 1H), 4.94 (s, 1H), 2.77 (p, J = 8.3 Hz, 1H), 1.85 
– 1.77 (m, 2H), 1.70 – 1.63 (m, 2H), 1.60 – 1.54 (m, 2H), 1.44 – 1.36 (m, 2H), 1.29 (s, 
12H). 11B NMR (128 MHz, CDCl3) δ 30.17. 13C NMR (125 MHz, CDCl3) δ 128.1, 126.1, 
110.5, 83.6, 43.2, 32.0, 25.1, 24.8; carbon α to boron was not observed. IR (neat) νmax 
2977.57 (m), 2953.71 (m), 2869.15 (w), 1618.23 (w), 1406.23 (w), 1378.31 (m), 1306.59 
(s), 1131.48 (m), 967.60 (w), 859.65 (w) cm-1. HRMS (DART+) for C15H26BO2 [M+H]+ 




   
dimethylphenyl-[(1S)-1-(2-phenylethyl)-2-(4,4,5,5-
tetramethyl-1,3,2-dioxaborolan-2-yl)allyl]silane (2.103). The 
reaction was performed according to the general procedures outlined in Method C with 
dimethylphenyl-[(1R)-3-phenyl-1-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) propyl] 
silane (2.102)43 (114.1 mg, 0.3 mmol). The crude product was purified by silica gel column 
chromatography (15% → 30% DCM in hexanes, stained in CAM) to afford a clear, 
colorless oil (106.5 mg, 87% yield). 1H NMR (500 MHz, CDCl3) δ 7.52 – 7.50 (m, 2H), 
7.37 – 7.33 (m, 3H), 7.28 (t, J = 7.3 Hz, 2H), 7.19 (t, J = 7.3 Hz, 1H), 7.14 (d, J = 7.5 Hz, 
2H), 5.97 (d, J = 3.0 Hz, 1H), 5.50 (d, J = 3.0 Hz, 1H), 2.74 (ddd, J = 13.5, 10.0, 4.0 Hz, 
1H), 2.42 (ddd, J = 13.5, 9.5, 6.5 Hz, 1H), 2.20 (dd, J = 12.5, 3.5 Hz, 1H), 2.04 (dddd, J = 
18.5, 10.5, 10.5, 4.5 Hz, 1H), 1.82 (dddd, J =17.5, 7.0, 7.0, 3.5 Hz, 1H), 1.27 (s, 12H), 0.32 
(s, 3H), 0.28 (s, 3H). 11B NMR (128 MHz, CDCl3) δ 29.78. 13C NMR (125 MHz, CDCl3) 
δ 143.2, 138.5, 134.4, 128.8, 128.7, 128.2, 127.6, 127.4, 125.6, 83.4, 35.4, 33.6, 31.1, 
24.94, 24.92, –3.6, –5.0; carbon α to boron was not observed. IR (neat) νmax 3067.26 (w), 
3025.09 (w), 2976.59 (m), 2928.61 (w), 2859.19 (w), 1601.81 (w), 1426.12 (m), 1360.60 
(m), 1305.56 (s), 1246.81 (m), 1133.88 (s), 967.74 (m), 926.81 (m), 828.71 (s), 809.01 (s), 
733.56 (s), 698.13 (s), 662.58 (m) cm-1. HRMS (DART+) for C25H36BO2Si [M+H]+ 
calculated: 407.2572, found: 407.2566. [α]D20 = –23.023 (c = 4.56, CHCl3, l = 50 mm). 
 
Analysis of Stereochemistry: 




   









   
2.4.5. Procedure for the Gram-Scale Vinylidenation of Pinacol Boronic Esters 
 
In a glovebox filled with argon, an oven-dried 100-mL round-bottom flask 
equipped with a magnetic stir bar was charged with 4,4,5,5-tetramethyl-2-cyclopentyl-
1,3,2-dioxaborolane (1.37 g, 7 mmol, 1 equiv), sodium trifluoromethanesulfonate (3.61 g, 
21 mmol, 3 equiv), anhydrous THF (8 mL), and anhydrous DMSO (8 mL), sealed with a 
septum, and removed from the glovebox. Under positive nitrogen pressure, the reaction 
vial was cooled to 0 ºC in an ice-water bath, and vinylmagnesium chloride solution in THF 
(8.4 mmol, 1.2 equiv) was added dropwise with stirring. The reaction vial was allowed to 
warm to room temperature and stir for 30 minutes before being brought back into the 
glovebox. In the glovebox, an oven-dried 20-mL scintillation vial equipped with a 
magnetic stirbar was charged with Pd2(dba)3 (320.5 mg, 0.35 mmol, 0.05 equiv), PCy3 
(392.6 mg, 1.4 mmol, 0.2 equiv), anhydrous DMSO (8 mL), and anhydrous THF (4 mL). 
The Pd2(dba)3/PCy3 solution was allowed to stir for 10 minutes at room temperature inside 
the glovebox. The Pd2(dba)3/PCy3 solution was then transferred into the round-bottom 
flask, followed by allyl acetate (841.0 mg, 8.4 mmol, 1.2 equiv) and anhydrous THF (4 
mL, used to rinse the Pd2(dba)3/PCy3 vial). The round-bottom flask was sealed with the 
septum and electrical tape, brought out of the glovebox, and stirred at 60 ºC for 18 hours. 
After cooling to room temperature, the resulting mixture was transferred to a separatory 
funnel with the aid of EtOAc (25 mL). The organic phase was washed with water (2 x 50 
mL), and the combined aqueous phases were extracted with EtOAc (100 mL). The 
264
   
combined organic phases were dried over Na2SO4, filtered, concentrated in vacuo, filtered 
through a silica gel plug with EtOAc, re-concentrated, and purified by silica gel column 
chromatography (0% → 15% DCM in hexanes, stained in CAM) to afford 2.86 as a clear, 
colorless oil (1.33 g, 85% yield).  
2.4.6. Total Synthesis of 7-Deoxy-7,14-didehydrosydonol 
2.4.6.1. Vinylidenation of 4-MethylpentylB(pin) 
 
In a glovebox filled with argon, an oven-dried 25-mL round-bottom flask equipped 
with a magnetic stir bar was charged with 2-(4-methylpentyl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane 2.104 (212.1 mg, 1 mmol, 1 equiv), sodium trifluoromethanesulfonate 
(516.2 mg, 3 mmol, 3 equiv), anhydrous THF (2 mL), and anhydrous DMSO (2 mL), sealed 
with a septum, and removed from the glovebox. Under positive nitrogen pressure, the 
reaction vial was cooled to 0 ºC in an ice-water bath, and vinylmagnesium chloride solution 
in THF (1.2 mmol, 1.2 equiv) was added dropwise with stirring. The reaction vial was 
allowed to warm to room temperature and stir for 30 minutes before being brought back 
into the glovebox. In the glovebox, an oven-dried 2-dram vial equipped with a magnetic 
stirbar was charged with Pd2(dba)3 (45.8 mg, 0.05 mmol, 0.05 equiv), PCy3 (56.1 mg, 0.2 
mmol, 0.2 equiv), anhydrous DMSO (3 mL), and anhydrous THF (2 mL). The 
Pd2(dba)3/PCy3 solution was allowed to stir for 10 minutes at room temperature inside the 
glovebox. The Pd2(dba)3/PCy3 solution was then transferred into the round-bottom flask, 
followed by allyl acetate (120.1 mg, 1.2 mmol, 1.2 equiv) and anhydrous THF (1 mL, used 
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to rinse the Pd2(dba)3/PCy3 vial). The round-bottom flask was sealed with the septum and 
electrical tape, brought out of the glovebox, and stirred at 60 ºC for 18 hours. After cooling 
to room temperature, the resulting mixture was transferred to a separatory funnel with the 
aid of EtOAc (5 mL). The organic phase was washed with water (2 x 10 mL), and the 
combined aqueous phases were extracted with EtOAc (20 mL). The combined organic 
phases were dried over Na2SO4, filtered, concentrated in vacuo, filtered through a silica gel 
plug with EtOAc, re-concentrated, and purified by silica gel column chromatography (0% 
→ 15% DCM in hexanes, stained in CAM) to afford 4,4,5,5-tetramethyl-2-(5-methyl-1-




dioxaborolane (2.105). 1H NMR (600 MHz, CDCl3) δ 5.75 (s, 
1H), 5.59 (s, 1H), 2.12 (t, J = 7.2 Hz, 2H), 1.56 – 1.50 (m, 1H), 1.41 (app p, J = 7.7 Hz, 
2H), 1.26 (s, 12H), 1.16 (app q, J = 7.6 Hz, 2H), 0.86 (d, J = 6.6 Hz, 6H). 11B NMR (128 
MHz, CDCl3) δ 30.37. 13C NMR (150 MHz, CDCl3) δ 128.8, 83.4, 38.7, 35.8, 28.0, 27.1, 
24.9, 22.8; carbon α to boron was not observed. IR (neat) νmax 2955.43 (m), 2927.87 (m), 
2858.37 (w), 1697.06 (w), 1463.11 (m), 1368.61 (m), 1306.98 (m), 1142.42 (s), 1098.05 
(m), 937.43 (m), 833.92 (s), 776.12 (m), 698.66 (m) cm-1. HRMS (DART+) for C14H28BO2 
[M+H]+ calculated: 239.2177, found: 239.2185. 
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2.4.6.2. Silylation of 4-Bromo-3-hydroxybenzaldehyde 
 
A flame-dried 25 mL round-bottom flask equipped with a magnetic stir bar was 
charged with 4-bromo-3-hydroxybenzaldehyde 2.110 (500.0 mg, 2.49 mmol, 1 equiv), tert-
butylchlorodimethylsilane (449.9 mg, 2.98 mmol, 1.2 equiv), imidazole (254.0 mg, 3.73 
mmol, 1.5 equiv), and anhydrous DCM (5 mL). The solution was stirred at room 
temperature for 16 hours. Water (5 mL) was added, the phases were separated, and the 
aqueous phase was extracted with pentanes (10 mL x 2). The combined organic phases 
were dried over Na2SO4, filtered, concentrated in vacuo, filtered through a silica gel plug 
with EtOAc, re-concentrated, and purified by silica gel column chromatography (30% 
EtOAc in hexanes, stained in KMnO4) to afford 4-bromo-3-(tert-
butyldimethylsilyl)oxybenzaldehyde (2.111) as a yellow oil (718.1 mg, 92% yield). 
 
4-bromo-3-(tert-butyldimethylsilyl)oxybenzaldehyde (2.111). 1H 
NMR (500 MHz, CDCl3) δ 9.91 (s, 1H), 7.71 (d, J = 8.5 Hz, 1H), 
7.33 – 7.32 (m, 2H), 1.06 (s, 9H), 0.29 (s, 6H). 13C NMR (125 MHz, CDCl3) δ 191.1, 
153.6, 136.9, 134.3, 124.2, 123.4, 119.1, 25.8, 18.5, –4.1. IR (neat) νmax 2930.04 (w), 
2858.14 (w), 1704.63 (s), 1585.23 (m), 1568.81 (w), 1473.28 (m), 1422.16 (m), 1386.59 
(w), 1294.50 (w), 1279.38 (w), 1262.00 (w), 1035.69 (w), 852.72 (m) cm-1. HRMS 
(DART+) for C13H20O2SiBr [M+H]+ calculated: 315.0411, found: 315.0410. 
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2.4.6.3. Suzuki–Miyaura Cross-Coupling and Reduction 
 
Following a literature procedure:58 In a glovebox filled with argon, an oven-dried 
2-dram vial equipped with a magnetic stir bar was charged with 4,4,5,5-tetramethyl-2-(5-
methyl-1-methylenehexyl)-1,3,2-dioxaborolane (2.105) (47.6 mg, 0.2 mmol, 1 equiv), 4-
bromo-3-(tert-butyldimethylsilyl)oxybenzaldehyde (2.111) (63.1 mg, 0.2 mmol, 1 equiv), 
Pd(dppf)Cl2 (16.3 mg, 0.02 mmol, 0.1 equiv), Na2CO3 (42.4 mg, 0.4 mmol, 2 equiv), and 
anhydrous 1,4-dioxane (2 mL). The vial was sealed with a septum cap and removed from 
the glovebox. Under positive nitrogen pressure, water (0.2 mL) was added. The septum cap 
was quickly replaced with a polypropylene cap, sealed with electrical tape, and stirred at 
80°C for 18 hours. The reaction was allowed to cool to room temperature, partitioned with 
saturated aqueous ammonium chloride (2 mL) and EtOAc (2 mL), and the phases 
separated. The aqueous phase was extracted with EtOAc (2 mL), and the combined organic 
phases were washed with brine (4 mL), dried over Na2SO4, filtered through a silica plug, 
and concentrated in vacuo. The residue was dissolved in methanol (2 mL), sodium 
borohydride (30.3 mg, 0.8 mmol, 4 equiv) was added, and the mixture was stirred for 5 
minutes. The reaction was quenched with water (2 mL), partitioned with EtOAc (2 mL), 
and the phases separated. The aqueous phase was extracted with EtOAc (2 mL), and the 
combined organic phases were washed with brine (4 mL) dried over Na2SO4, filtered, 
                                                            
58 Higuchi, R. I.; Roach, S. L.; Zhi, L.; Adams, M. E.; Liu, Y.; Karanewsky, D. S.; Hudson, A. Intracellular 
Receptor Modulator Compounds and Methods. WO2006019716A1, February 23, 2006. 
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concentrated in vacuo, and purified by silica gel column chromatography (30% 
EtOAc/hexanes, stained in KMnO4) to afford [3-(tert-butyldimethylsilyl)oxy-4-(5-




methylene-hexyl)phenyl]methanol (2.112). 1H NMR 
(600 MHz, CDCl3) δ 7.09 (d, J = 7.2 Hz, 1H), 6.89 (d, J 
= 7.8 Hz, 1H), 6.80 (s, 1H), 5.08 (s, 1H), 4.94 (d, J = 1.2 Hz, 1H), 4.63 (d, J = 4.8 Hz, 2H), 
2.41 (t, J = 7.8 Hz, 2H), 1.57 (s, 1H), 1.53 – 1.46 (m, 1H), 1.33 (app p, J = 7.8 Hz, 2H), 
1.16 (app q, J = 7.4 Hz, 2H), 0.98 (s, 9H), 0.83 (d, J = 6.6 Hz, 6H), 0.18 (d, 6H). 13C NMR 
(150 MHz, CDCl3) δ 152.9, 149.2, 141.0, 134.6, 130.6, 119.6, 118.1, 114.0, 65.3, 38.8, 
36.8, 28.0, 25.9, 22.8, 22.7, 18.3, –4.0. IR (neat) νmax 3293.20 (m, br), 2953.27 (s), 2928.55 
(s), 2857.99 (s), 1609.68 (w), 1561.18 (w), 1498.27 (m), 1471.28 (m), 1417.71 (s), 1363.41 
(w), 1283.03 (m), 1254.25 (m), 1166.44 (w), 972.39 (w), 852.60 (m), 782.07 (m) cm-1. 
HRMS (DART+) for C21H37O2Si [M+H]+ calculated: 349.2557, found: 349.2542. 
2.4.6.4. TBAF Desilylation 
 
A 2-dram vial equipped with a magnetic stir bar was charged with [3-(tert-
butyldimethylsilyl) oxy-4-(5-methyl-1-methylenehexyl)phenyl]methanol (2.112) (27.1 
mg, 0.08 mmol, 1 equiv) and THF (0.8 mL). A 1 M solution of tetrabutylammonium 
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fluoride in THF (155 uL, 2 equiv) was added, and the mixture was stirred for 15 minutes. 
The reaction was partitioned with water (1 mL) and EtOAc (1 mL), and the phases 
separated. The aqueous phase was extracted with EtOAc (1 mL), and the combined organic 
phases were washed with brine (2 mL) dried over Na2SO4, filtered, concentrated in vacuo, 
and purified by silica gel column chromatography (0% → 30% Et2O in pentanes, stained 
in KMnO4) to afford 7-deoxy-7,14-didehydrosydonol (2.113) as a clear, colorless oil 
(16.4 mg, 90% yield). The spectral data were in accord with the literature.44 
 
7-deoxy-7,14-didehydrosydonol (2.113). 1H NMR 
(600 MHz, CDCl3) δ 7.08 (d, J = 7.8 Hz, 1H), 6.95 (s, 
1H), 6.89 (d, J = 7.8 Hz, 1H), 5.67 (s, 1H), 5.38 (d, J = 
1.8 Hz, 1H), 5.12 (s, 1H), 4.65 (d, J = 6.0 Hz, 2H), 2.38 (t, J = 7.6 Hz, 2H), 1.54 – 1.48 (m, 
1H), 1.43 (s, 1H), 1.42 – 1.37 (m, 2H), 1.20 – 1.16 (m, 2H), 0.84 (d, J = 6.6 Hz, 6H). 13C 
NMR (150 MHz, CDCl3) δ 152.6, 146.7, 141.8, 128.2, 127.8, 118.7, 115.2, 114.0, 65.2, 
38.7, 38.2, 27.9, 25.8, 22.7. IR (neat) νmax 3343.42 (m, br), 2952.94 (s), 2927.65 (m), 
2868.62 (w), 1617.44 (w), 1570.55 (w), 1423.98 (s), 1383.80 (m), 1366.18 (m), 1289.02 
(m), 1168.35 (w), 1016.96 (m), 822.42 (m) cm-1. HRMS (DART+) for C15H23O2 [M+H]+ 
calculated: 235.1693, found: 235.1685. 
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2.4.7. Density Functional Theory (DFT) Calculations  
All calculations were performed using the Gaussian09 package of programs.59 
Geometry optimizations were carried out using the density functional BP86 in conjunction 
with the def2-SVP60 basis set in tetrahydrofuran as solvent using the IEFPCM model.61 
Very tight convergence criteria and an ultrafine integration grid were applied. Stationary 
points were assessed through vibrational analysis and Gibbs free energy corrections were 
performed under standard conditions (298.15 K, 1.0 atm). Intrinsic Reaction Coordinate 
(IRC)62 calculations were performed followed by subsequent optimization of the end points 
with the previously mentioned optimization method. Gibbs free energies have been 
assessed through single point calculations with the density functional PBE0-D3BJ63 
applying the larger def2-TZVPP64 basis set and the SMD65 solvent model, followed by 
addition of thermal corrections obtained at the level of geometry optimization (denoted as 
PBE0-D3BJ /def2-TZVPPTHF(SMD)//BP86/def2-SVP)THF(PCM)). 
  
                                                            
59 Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, 
G.; Barone, V.; Mennucci, B.; Petersson, G. A.; Nakatsuji, H.; Caricato, M.; Li, X.; Hratchian, H. P.; 
Izmaylov, A. F.; Bloino, J.; Zheng, G.; Sonnenberg, J. L.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; 
Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.; Montgomery, Jr., J. 
A.; Peralta, J. E.; Ogliaro, F.; Bearpark, M.; Heyd, J. J.; Brothers, E.; Kudin, K. N.; Staroverov, V. N.; 
Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant, J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, 
M.; Rega, N.; Millam, J. M.; Klene, M.; Knox, J. E.; Cross, J. B.; Bakken, V.; Adamo, C.; Jaramillo, J.; 
Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; 
Martin, R. L.; Morokuma, K.; Zakrzewski, V. G.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Dapprich, 
S.; Daniels, A. D.; Farkas, Ö.; Foresman, J. B.; Ortiz, J. V.; Cioslowski, J.; Fox, D. J. Gaussian 09, Revision 
D.01, Gaussian, Inc., Wallingford CT, 2009. 
60 Weigend, F.; Ahlrichs, R. Phys. Chem. Chem. Phys. 2005, 7, 3297. 
61 Scalmani, G.; Frisch, M. J. J. Chem. Phys. 2010, 132, 114110. 
62 (a) Page, M.; McIver Jr., J. W. J. Chem. Phys. 1988, 88, 922. (b) Page, M.; Doubleday Jr., C.; McIver Jr., 
J. W. J. Chem. Phys. 1990, 93, 5634. 
63 (a) Grimme, S.; Ehrlich, S.; Goerigk, L. J. Comp. Chem. 2011, 32, 1456. (b) Adamo, C.; Barone, V. J. 
Chem. Phys. 1999, 110, 6158. 
64 Weigend, F. Phys. Chem. Chem. Phys. 2006, 8, 1057. 
65 Marenich, A. V.; Cramer, C. J.; Truhlar, D. G. J. Phys. Chem. B 2009, 113, 6378. 
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Scheme 2.24. Calculated reaction coordinate for metal-induced metallate shift/β-hydrogen 
elimination involved in the vinylidenation reaction.  Optimized geometries calculated 
using DFT (BP86/Def2-SVP; PCM solvent model with THF). ΔG Values are in kcal/mol, 
calculated using DFT (PBE0-D3BJ/def2-TZVPP//BP86/def2-SVP; SMD solvent model 
with THF).  Hydrogen atoms removed from structures for clarity. 
 
 
BP86 Optimization and Frequency Calculation:  
Sum of electronic and thermal Free Energies= -2011.429186 
Thermal correction to Gibbs Free Energy= 0.762606 
Lowest frequency= 10.50 cm-1 
PB86-D3BJ Single Point Calculation: 
Electronic Energy= -2012.066354 
 
0 1 
 Pd                -0.17409600   -0.19458400   -1.22661400 
 P                 -2.20033500   -0.06592900    0.04400200 
 C                  0.85358400   -1.38468900    0.34876300 
 C                  1.91998000   -1.12473700   -0.51759300 
 H                  2.08596300   -1.89746500   -1.29368300 
 H                  0.30476200   -2.34417400    0.32440700 
 H                  0.79296800   -0.82078500    1.29493800 
 B                  3.20096400   -0.15251300   -0.15041400 
 O                  3.60523300    0.76157200   -1.25444400 
 O                  2.97223300    0.73590600    1.02039700 
 C                  4.34136900   -1.31327800    0.20826900 
 C                  4.65671600   -1.65276600    1.54642900 
 C                  5.02520800   -2.02774600   -0.80698400 
 C                  5.61172000   -2.63862200    1.86182500 
 H                  4.14490800   -1.10770300    2.35842600 
 C                  5.98479600   -3.01452400   -0.50907000 
 H                  4.81252200   -1.79369000   -1.86570500 
 C                  6.28191900   -3.32622100    0.83168600 
 H                  5.83897200   -2.87255600    2.91630400 
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 H                  6.50639100   -3.54415400   -1.32485400 
 H                  7.03126300   -4.09879600    1.07166100 
 C                  1.20050900    0.00112900   -3.01919400 
 H                  1.76161400    0.88455900   -2.66878000 
 H                  1.82417000   -0.84529100   -3.34330800 
 C                 -1.04138000    0.99900700   -2.84839200 
 H                 -0.66387800    2.00409400   -2.59335000 
 H                 -2.11407200    0.94082900   -3.09029900 
 C                 -0.15776900    0.03337500   -3.40341000 
 H                 -0.58032700   -0.82219500   -3.96098500 
 C                 -2.37233000   -0.56353000    1.86088500 
 C                 -2.12373300   -2.06208000    2.15331200 
 C                 -1.52773600    0.32370200    2.80597900 
 H                 -3.44679100   -0.35870200    2.07712600 
 C                 -2.39926700   -2.39165200    3.63378700 
 H                 -1.07121800   -2.32055400    1.91592800 
 H                 -2.75832300   -2.70145500    1.50644400 
 C                 -1.78756700   -0.02164200    4.28534600 
 H                 -0.44824900    0.18736100    2.57612800 
 H                 -1.74471500    1.39762100    2.63553800 
 C                 -1.56100700   -1.51352900    4.57630900 
 H                 -2.19551100   -3.46856900    3.81743200 
 H                 -3.48177500   -2.23657700    3.84890300 
 H                 -1.13812500    0.60692400    4.93180900 
 H                 -2.83835800    0.24724500    4.54167600 
 H                 -1.80148000   -1.74224900    5.63698700 
 H                 -0.48202600   -1.75522500    4.44006800 
 C                 -2.94402400    1.68404100   -0.03761900 
 C                 -4.15899100    1.98239700    0.87293300 
 C                 -1.88410600    2.79931900    0.12759600 
 H                 -3.29886700    1.72227900   -1.09433300 
 C                 -4.75596500    3.37043000    0.55962300 
 H                 -3.84074700    1.96029400    1.93881900 
 H                 -4.94725600    1.21088500    0.76398600 
 C                 -2.47541400    4.18491000   -0.19156100 
 H                 -1.50426300    2.80054900    1.17300000 
 H                 -1.00308400    2.59467700   -0.51263900 
 C                 -3.70741200    4.48804800    0.67685600 
 H                 -5.61369400    3.56632300    1.23873400 
 H                 -5.17175300    3.36084800   -0.47419300 
 H                 -1.69676400    4.96526300   -0.05143200 
 H                 -2.76363200    4.21972900   -1.26771300 
 H                 -4.15187700    5.46702200    0.39538600 
 H                 -3.39019900    4.58248800    1.74088900 
 C                 -3.44535000   -1.13639200   -0.91495300 
 C                 -2.79887900   -2.43715800   -1.45342000 
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 C                 -4.79925300   -1.44772900   -0.23546700 
 H                 -3.65364900   -0.48762400   -1.79895900 
 C                 -3.74795700   -3.18738000   -2.40609400 
 H                 -2.53307000   -3.10377800   -0.60286600 
 H                 -1.84177900   -2.19594600   -1.96545900 
 C                 -5.74321900   -2.20386500   -1.19360400 
 H                 -4.62982700   -2.07164200    0.66955400 
 H                 -5.29642300   -0.51980900    0.11108500 
 C                 -5.10052100   -3.48826400   -1.74027200 
 H                 -3.26440500   -4.12594200   -2.75295500 
 H                 -3.91565000   -2.56647100   -3.31633100 
 H                 -6.69518000   -2.43489800   -0.66868300 
 H                 -6.00975700   -1.53455100   -2.04381500 
 H                 -5.78523200   -3.98860700   -2.45856000 
 H                 -4.94552800   -4.20699000   -0.90285700 
 C                  3.24525200    2.09116500    0.66016400 
 C                  4.12666400    1.95242500   -0.65989500 
 C                  3.95763300    2.79163100    1.82997500 
 H                  4.24680600    3.83196500    1.56849800 
 H                  3.27861100    2.84081000    2.70748400 
 H                  4.86702600    2.24130300    2.13962400 
 C                  1.90608000    2.80841300    0.38805300 
 H                  1.25737900    2.70563000    1.28220000 
 H                  2.02840900    3.89143700    0.17514800 
 H                  1.38105800    2.33372000   -0.46635200 
 C                  3.97004800    3.11033000   -1.65869400 
 H                  4.28328400    4.07727500   -1.21120700 
 H                  4.60942000    2.92738000   -2.54803300 
 H                  2.92459000    3.21097600   -2.01019100 
 C                  5.63037200    1.77353300   -0.34488100 
 H                  6.15581100    1.46958600   -1.27432200 
 H                  6.09636800    2.71186000    0.02236100 
 H                  5.79424500    0.97971800    0.40985100 
 
 
BP86 Optimization and Frequency Calculation:  
Sum of electronic and thermal Free Energies = -2011.421128 
Thermal correction to Gibbs Free Energy= 0.760387 
Lowest frequency: -329.77 cm-1 
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PB86-D3BJ Single Point Calculation: 
Electronic Energy: -2012.045885 
 
0 1 
 Pd                -0.43759900   -0.66064900    1.08696200 
 P                 -2.39669400   -0.05291400   -0.07687300 
 C                  0.89064400    0.76112900    0.15292700 
 C                  2.11278300    0.55549900    0.89027900 
 H                  2.14429900    1.00971800    1.89806300 
 H                  0.38032900    1.73456900    0.29271600 
 H                  0.92977200    0.46276800   -0.91243100 
 B                  3.43018700   -0.08407400    0.38511700 
 O                  4.37329900   -0.68914900    1.29320700 
 O                  3.52691400   -0.75009100   -0.89415300 
 C                  3.72086700    1.70170400    0.17464500 
 C                  3.57665100    2.28246700   -1.10385700 
 C                  4.40289300    2.43146300    1.17245600 
 C                  4.13747300    3.53863500   -1.39455200 
 H                  3.03176200    1.73058600   -1.88795300 
 C                  4.95766200    3.69499800    0.89363800 
 H                  4.52058000    1.99400500    2.17886000 
 C                  4.82837800    4.25089500   -0.39329100 
 H                  4.03491200    3.96940600   -2.40475100 
 H                  5.49349500    4.24942700    1.68226900 
 H                  5.26084400    5.24001100   -0.61568000 
 C                  0.99840800   -1.80310800    2.35717900 
 H                  1.34724900   -2.53138000    1.60506600 
 H                  1.79006400   -1.30316300    2.93311000 
 C                 -1.38192700   -2.41874100    2.10445800 
 H                 -1.18446400   -3.21002600    1.36052500 
 H                 -2.40821500   -2.38207100    2.50287800 
 C                 -0.31780300   -1.88988900    2.88042600 
 H                 -0.55605900   -1.35188400    3.81670400 
 C                 -2.53716800    1.43132700   -1.24009300 
 C                 -2.31319200    2.78142400   -0.51799800 
 C                 -1.62013900    1.32133500   -2.48114200 
 H                 -3.59389600    1.40770400   -1.59532500 
 C                 -2.49642100    3.97422400   -1.47647800 
 H                 -1.28539500    2.80475900   -0.09338700 
 H                 -3.00600800    2.88780800    0.34160700 
 C                 -1.81048500    2.51908400   -3.43209200 
 H                 -0.55997400    1.27836100   -2.15216600 
 H                 -1.81520400    0.37787600   -3.03090200 
 C                 -1.59011000    3.85902300   -2.71228800 
 H                 -2.29807900    4.92268900   -0.93206600 
 H                 -3.56096400    4.01835600   -1.80383600 
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 H                 -1.11920600    2.42074200   -4.29681000 
 H                 -2.84260400    2.49230600   -3.85202900 
 H                 -1.77067500    4.70791200   -3.40674100 
 H                 -0.52489700    3.93419600   -2.39448700 
 C                 -2.95137800   -1.55872500   -1.09356200 
 C                 -4.09388600   -1.35422400   -2.11477500 
 C                 -1.75565300   -2.28213500   -1.76093300 
 H                 -3.33040100   -2.23334100   -0.28952500 
 C                 -4.52145600   -2.69415200   -2.74908600 
 H                 -3.75557700   -0.66633800   -2.92128000 
 H                 -4.97361300   -0.87347200   -1.64078200 
 C                 -2.18775800   -3.61924800   -2.39087100 
 H                 -1.31821500   -1.63209400   -2.55109200 
 H                 -0.94743100   -2.44206800   -1.01487800 
 C                 -3.33575600   -3.42803200   -3.39600600 
 H                 -5.32405000   -2.51294600   -3.49646900 
 H                 -4.96924500   -3.34202400   -1.96062600 
 H                 -1.31536600   -4.10287800   -2.88104800 
 H                 -2.51752500   -4.31300000   -1.58313700 
 H                 -3.66349900   -4.40849000   -3.80437900 
 H                 -2.96707200   -2.83480300   -4.26446500 
 C                 -3.79856200    0.17748300    1.18876100 
 C                 -3.31252500    0.88588400    2.47711700 
 C                 -5.11652500    0.81531300    0.69233300 
 H                 -4.01729000   -0.88172100    1.46317100 
 C                 -4.39255700    0.86192200    3.57466900 
 H                 -3.05155000    1.94294800    2.24633600 
 H                 -2.37496600    0.41072000    2.83716300 
 C                 -6.19650900    0.79288300    1.79398900 
 H                 -4.93150300    1.87071700    0.39295700 
 H                 -5.49880300    0.29608100   -0.20975600 
 C                 -5.71456800    1.47538200    3.08439100 
 H                 -4.02401300    1.39714600    4.47642500 
 H                 -4.57035700   -0.19288900    3.88804000 
 H                 -7.12253100    1.27878300    1.41727600 
 H                 -6.46698200   -0.26524800    2.01577900 
 H                 -6.49351900    1.40479400    3.87413200 
 H                 -5.56391700    2.56235800    2.88975000 
 C                  4.50098600   -1.80566800   -0.79045400 
 C                  5.34568800   -1.39398600    0.49679000 
 C                  5.31182800   -1.86515400   -2.09292200 
 H                  6.11886800   -2.62528800   -2.03213300 
 H                  4.64635900   -2.14517400   -2.93603500 
 H                  5.76781000   -0.88558400   -2.33344100 
 C                  3.74528400   -3.13646400   -0.59920400 
 H                  3.02373900   -3.26316100   -1.43250300 
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 H                  4.42612200   -4.01274300   -0.59726900 
 H                  3.17424400   -3.13581200    0.35087200 
 C                  5.87860500   -2.57554100    1.31866800 
 H                  6.56286400   -3.20899700    0.71640200 
 H                  6.44901900   -2.19670800    2.19229900 
 H                  5.05637900   -3.20969900    1.70203600 
 C                  6.51269900   -0.44327200    0.15794000 
 H                  6.92557200   -0.03092000    1.10168200 
 H                  7.33268900   -0.96605300   -0.37634200 







BP86 Optimization and Frequency Calculation:  
Sum of electronic and thermal Free Energies= -2011.476634 
Thermal correction to Gibbs Free Energy= 0.762371 
Lowest frequency= 9.33 cm-1 
 PB86-D3BJ Single Point Calculation: 
Electronic Energy: -2012.108684 
 
0 1 
 P                  2.07776100    0.06804600    0.09698600 
 C                 -0.91348600    1.01251400   -0.75338400 
 C                 -2.42805000    0.94154900   -1.09118100 
 H                 -2.56146900    0.87768000   -2.19146300 
 H                 -0.50697200    1.97692000   -1.13392100 
 H                 -0.79689200    1.03262900    0.35170200 
 B                 -3.16840400   -0.31470600   -0.46498300 
 O                 -4.16831200   -1.00613800   -1.12347100 
 O                 -2.94715300   -0.79224000    0.81641500 
 C                 -3.16598400    2.20661600   -0.64026700 
 C                 -3.22861000    2.57976600    0.72547200 
 C                 -3.79315400    3.05669900   -1.58172100 
 C                 -3.88607200    3.75425200    1.13036600 
 H                 -2.75747600    1.93081000    1.48093700 
 C                 -4.45409300    4.23238900   -1.18110100 
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 H                 -3.75923700    2.78798800   -2.65121900 
 C                 -4.50263400    4.58858700    0.17860200 
 H                 -3.92097700    4.01940700    2.19997900 
 H                 -4.93205100    4.87567300   -1.93818300 
 H                 -5.01811000    5.50947000    0.49551500 
 C                 -0.96333300   -1.24631700   -2.97574700 
 H                 -1.63605800   -1.92897200   -2.42760300 
 H                 -1.47507800   -0.53588900   -3.64466700 
 C                  1.11789800   -2.49726300   -2.46333600 
 H                  0.62057300   -3.17044600   -1.74428800 
 H                  2.16367700   -2.73077800   -2.70868200 
 C                  0.36157500   -1.67457200   -3.31372400 
 H                  0.87628800   -1.18379300   -4.16147500 
 Pd                 0.38541600   -0.49191200   -1.46213800 
 C                  1.92693900   -0.95071700    1.67996600 
 C                  0.66685000   -0.59760300    2.50299100 
 C                  1.94430100   -2.46363200    1.36186700 
 H                  2.81950400   -0.71400200    2.30156900 
 C                  0.58940600   -1.44373800    3.78973900 
 H                 -0.24191300   -0.77668400    1.88582900 
 H                  0.65727100    0.48038600    2.76929700 
 C                  1.86889900   -3.31335600    2.64409600 
 H                  1.07323500   -2.69333700    0.70726900 
 H                  2.84912100   -2.73535200    0.77703200 
 C                  0.63641000   -2.95110900    3.48900200 
 H                 -0.33568200   -1.18800300    4.35068900 
 H                  1.44197900   -1.17515500    4.45575700 
 H                  1.85722400   -4.39335100    2.38037200 
 H                  2.79169500   -3.14951100    3.24741600 
 H                  0.62664200   -3.53648200    4.43412100 
 H                 -0.28422000   -3.23919500    2.93188200 
 C                  3.91241200   -0.07718100   -0.42684600 
 C                  4.90842700   -0.49271800    0.68138200 
 C                  4.13719200   -0.93024800   -1.69186000 
 H                  4.15192800    0.97495800   -0.70634400 
 C                  6.36624600   -0.39372700    0.18704100 
 H                  4.70500100   -1.54263300    0.98908600 
 H                  4.78200800    0.13085000    1.58983800 
 C                  5.59274100   -0.83406600   -2.18671400 
 H                  3.89549800   -1.99285900   -1.46450300 
 H                  3.43264200   -0.61660000   -2.48990100 
 C                  6.59530700   -1.22192000   -1.08748100 
 H                  7.05749400   -0.71958000    0.99455500 
 H                  6.60849500    0.67440800   -0.01922800 
 H                  5.72947700   -1.47623200   -3.08388000 
 H                  5.79613100    0.21087500   -2.51740300 
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 H                  7.63900600   -1.09725000   -1.44932800 
 H                  6.47473600   -2.30361400   -0.84706900 
 C                  1.99830300    1.86599900    0.68239800 
 C                  2.91176700    2.26191900    1.86321300 
 C                  2.19035900    2.85361800   -0.49299900 
 H                  0.94206400    1.96836200    1.01912500 
 C                  2.63823800    3.71277300    2.31080900 
 H                  3.97797300    2.17882000    1.55393500 
 H                  2.77689800    1.57335500    2.72403700 
 C                  1.91751200    4.30469500   -0.05264200 
 H                  3.23692400    2.78669100   -0.87033200 
 H                  1.53238200    2.57330300   -1.34233200 
 C                  2.79165600    4.70692800    1.14742400 
 H                  3.31909400    3.98379600    3.14696600 
 H                  1.60266100    3.77766800    2.71710500 
 H                  2.08694600    4.99634500   -0.90630800 
 H                  0.84235400    4.40374200    0.22168000 
 H                  2.54151100    5.73696400    1.48247300 
 H                  3.85965700    4.73308500    0.82886600 
 C                 -4.03771800   -1.71454200    1.14645700 
 C                 -4.56926800   -2.14191300   -0.29006900 
 C                 -5.06641400   -0.91296400    1.96064300 
 H                 -5.48450300   -0.07079400    1.37354300 
 H                 -5.90393700   -1.55296400    2.30369200 
 H                 -4.56795100   -0.48940600    2.85587900 
 C                 -3.47829400   -2.86103200    1.99111100 
 H                 -2.63123000   -3.36788400    1.49144700 
 H                 -3.11835600   -2.46926700    2.96395300 
 H                 -4.26533100   -3.61443500    2.19997400 
 C                 -6.08793200   -2.30624300   -0.39280900 
 H                 -6.36401200   -2.58814000   -1.42923700 
 H                 -6.44474600   -3.10936400    0.28422700 
 H                 -6.62144600   -1.37022000   -0.14109600 
 C                 -3.86442300   -3.38549900   -0.85467700 
 H                 -4.17907000   -4.30854900   -0.32764200 
 H                 -4.12707900   -3.49422800   -1.92625300 






   
 
BP86 Optimization and Frequency Calculation:  
Sum of electronic and thermal Free Energies= -2011.462496 
Thermal correction to Gibbs Free Energy= 0.756593 
Lowest frequency= 6.32 cm-1 
PB86-D3BJ Single Point Calculation: 
Electronic Energy= -2012.08376 
 
0 1 
 P                 -2.00307200   -0.06951300    0.30498500 
 C                  1.70895900    0.43005400   -2.02248600 
 C                  2.17933100    0.72811300   -0.59448900 
 H                  1.32024700    0.44177100    0.13765900 
 H                  1.77925200    1.29127100   -2.71605500 
 H                  2.12850400   -0.48632900   -2.48348700 
 B                  3.31360200   -0.31653500   -0.19664900 
 O                  4.66025700   -0.03972800   -0.21597800 
 O                  3.02045800   -1.61758800    0.15220200 
 C                  2.52701300    2.17675200   -0.29854200 
 C                  3.42754900    2.88589100   -1.12783600 
 C                  1.98991500    2.84852100    0.82294200 
 C                  3.77819000    4.21685900   -0.84355100 
 H                  3.86407200    2.38328600   -2.00557900 
 C                  2.33935300    4.17985900    1.11144900 
 H                  1.27942200    2.31817000    1.47887500 
 C                  3.23615100    4.87161500    0.27790700 
 H                  4.48262300    4.74716200   -1.50482500 
 H                  1.90229800    4.68071100    1.99044900 
 H                  3.50888400    5.91592900    0.49870200 
 C                 -1.04937800   -0.12593300   -3.09404700 
 H                 -0.93417300    0.89702700   -3.51475100 
 H                 -2.12314500   -0.34875100   -2.94388200 
 Pd                -0.15526900    0.09587800   -1.20619600 
 C                 -3.18298600    1.40315600    0.19479200 
 C                 -2.46738600    2.72637500    0.55222900 
 C                 -3.81283200    1.50888400   -1.21356200 
 H                 -3.99844700    1.23505200    0.93450800 
 C                 -3.41242700    3.93810600    0.43103200 
 H                 -1.59762500    2.85856000   -0.13319000 
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 H                 -2.05227300    2.68641900    1.58129100 
 C                 -4.77066400    2.71019600   -1.32209200 
 H                 -2.99475600    1.62294000   -1.95869800 
 H                 -4.34735000    0.57191600   -1.47913300 
 C                 -4.06288400    4.02578600   -0.95914800 
 H                 -2.85427400    4.87175300    0.66037500 
 H                 -4.21073600    3.85415000    1.20432600 
 H                 -5.19077600    2.76377700   -2.34992400 
 H                 -5.63668700    2.55488900   -0.63776800 
 H                 -4.77615100    4.87749300   -1.00056900 
 H                 -3.27598600    4.23831200   -1.71902000 
 C                 -3.10263300   -1.62448900    0.31914100 
 C                 -4.56859400   -1.44198300    0.77473200 
 C                 -3.04616700   -2.39796000   -1.01681600 
 H                 -2.59280400   -2.26220700    1.07966700 
 C                 -5.29310200   -2.79987700    0.87868400 
 H                 -5.10825800   -0.80381900    0.03989100 
 H                 -4.62283500   -0.91277700    1.74802600 
 C                 -3.77028900   -3.75298300   -0.91367300 
 H                 -3.52588900   -1.78839800   -1.81639700 
 H                 -1.99047400   -2.53900700   -1.33039800 
 C                 -5.22421200   -3.58735100   -0.44035700 
 H                 -6.35051800   -2.63841600    1.18204700 
 H                 -4.82353700   -3.40118200    1.69121500 
 H                 -3.73621000   -4.27557600   -1.89430800 
 H                 -3.22148500   -4.40429700   -0.19440900 
 H                 -5.71266200   -4.57939700   -0.32551300 
 H                 -5.80340000   -3.04257900   -1.22156900 
 C                 -1.36179700    0.00790200    2.09004600 
 C                 -2.41614100    0.08802600    3.21502600 
 C                 -0.35315500   -1.12829000    2.37806000 
 H                 -0.78539100    0.96305200    2.09371000 
 C                 -1.75094900    0.26648600    4.59517800 
 H                 -3.01410600   -0.85082200    3.22655800 
 H                 -3.13189800    0.91760300    3.03248500 
 C                  0.30871100   -0.95920300    3.75927500 
 H                 -0.88081200   -2.10957700    2.34923300 
 H                  0.42279400   -1.17224100    1.58351300 
 C                 -0.73455800   -0.85078000    4.88379600 
 H                 -2.53007500    0.29947200    5.38752900 
 H                 -1.23332500    1.25299200    4.62480700 
 H                  1.00144500   -1.80710200    3.95067700 
 H                  0.93686600   -0.03862100    3.74986800 
 H                 -0.23534400   -0.67845900    5.86198300 
 H                 -1.27523200   -1.82118200    4.97567100 
 C                  4.28680500   -2.36479800    0.15731600 
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 C                  5.35869700   -1.20533800    0.34504700 
 C                 -0.88975500   -2.34660800   -4.31188900 
 H                 -0.31589600   -3.03976100   -4.94901000 
 H                 -1.89223400   -2.67741000   -3.98832800 
 C                 -0.38424700   -1.14233800   -3.93904100 
 H                  0.62518500   -0.87817000   -4.30964200 
 C                  4.38880100   -3.07169500   -1.20289400 
 H                  5.29111400   -3.71268700   -1.26177000 
 H                  3.49814000   -3.71636600   -1.34414500 
 H                  4.42068200   -2.34449700   -2.03924800 
 C                  4.24225500   -3.39229900    1.28926500 
 H                  3.45545100   -4.14514000    1.08051100 
 H                  5.21076800   -3.92690700    1.37089200 
 H                  4.01628700   -2.92250300    2.26507400 
 C                  5.64891900   -0.87649300    1.81753500 
 H                  6.24314200   -1.67590700    2.30364500 
 H                  6.23001800    0.06614100    1.86918900 
 H                  4.71368900   -0.73352700    2.39535200 
 C                  6.66602600   -1.40377500   -0.42371200 
 H                  7.33769300   -0.53902700   -0.24878800 
 H                  7.19041200   -2.31723700   -0.07600200 





BP86 Optimization and Frequency Calculation:  
Sum of electronic and thermal Free Energies= -2011.446985 
Thermal correction to Gibbs Free Energy= 0.756808 
Lowest frequency= -448.75 cm-1 
PB86-D3BJ Single Point Calculation: 
Electronic Energy= -2012.069914 
 
0 1 
 P                 -1.78410600   -0.13134400    0.33212000 
 C                  1.69374900    0.72000200   -2.36219300 
 C                  2.14737200    0.88291700   -1.00611300 
 H                  0.95248600    0.24694900    0.10354100 
 H                  1.45278700    1.60734200   -2.97133000 
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 H                  2.01776700   -0.16993100   -2.92486300 
 B                  3.11460400   -0.24506700   -0.45998500 
 O                  4.18919700    0.01588400    0.36088700 
 O                  3.01617600   -1.57079100   -0.83151000 
 C                  2.31037700    2.26991300   -0.42686800 
 C                  2.63813600    3.36707400   -1.25775100 
 C                  2.22050300    2.50290800    0.96695300 
 C                  2.85438100    4.64877100   -0.71859900 
 H                  2.74541400    3.21412400   -2.34284200 
 C                  2.43832200    3.77860500    1.50844700 
 H                  1.96209600    1.66428100    1.63350500 
 C                  2.75432500    4.86239100    0.66628000 
 H                  3.10914800    5.48433800   -1.39040600 
 H                  2.35719400    3.93039700    2.59689400 
 H                  2.92229200    5.86561100    1.08935500 
 C                 -1.19087600    0.15322800   -3.04160800 
 H                 -1.15665400    1.22274900   -3.34621000 
 H                 -2.23869000   -0.12177300   -2.81912700 
 Pd                -0.02784800    0.20674600   -1.19427700 
 C                 -2.94966600    1.35485800    0.39412900 
 C                 -2.20636900    2.62878000    0.85997800 
 C                 -3.65100400    1.61740600   -0.95767200 
 H                 -3.73022500    1.10891600    1.14962200 
 C                 -3.14899800    3.84651500    0.92708600 
 H                 -1.37259500    2.83442300    0.14922300 
 H                 -1.73675000    2.47386800    1.85384400 
 C                 -4.60981100    2.82001800   -0.87195400 
 H                 -2.87700100    1.82115500   -1.72823700 
 H                 -4.20146500    0.71584300   -1.30064700 
 C                 -3.87691000    4.08820000   -0.40511300 
 H                 -2.57183500    4.74817400    1.22631700 
 H                 -3.90262200    3.67790300    1.73080900 
 H                 -5.08855700    2.98791600   -1.86101900 
 H                 -5.43522300    2.58598300   -0.16036000 
 H                 -4.58749800    4.93782400   -0.31008700 
 H                 -3.13371600    4.38584700   -1.18023100 
 C                 -2.87611600   -1.68582400    0.20148900 
 C                 -4.34417700   -1.54393200    0.66843100 
 C                 -2.81755400   -2.36681900   -1.18168600 
 H                 -2.36711100   -2.37470800    0.91603000 
 C                 -5.05169500   -2.91486500    0.68833800 
 H                 -4.88983400   -0.86692900   -0.02568700 
 H                 -4.40580200   -1.07852700    1.67323400 
 C                 -3.51682800   -3.73821600   -1.15782400 
 H                 -3.31908000   -1.71763700   -1.93346000 
 H                 -1.76407500   -2.46514600   -1.51731700 
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 C                 -4.97229500   -3.62283700   -0.67432300 
 H                 -6.11109100   -2.78384400    0.99912700 
 H                 -4.57581600   -3.55711800    1.46499300 
 H                 -3.47689000   -4.19949300   -2.16840800 
 H                 -2.95602900   -4.42291300   -0.48001500 
 H                 -5.44597100   -4.62690100   -0.61666000 
 H                 -5.56047700   -3.04231400   -1.42219600 
 C                 -1.14192500   -0.24552600    2.11574000 
 C                 -2.20166200   -0.23795000    3.23912900 
 C                 -0.17197600   -1.43275000    2.30393900 
 H                 -0.53597900    0.68584700    2.20448300 
 C                 -1.53824500   -0.20055800    4.63128200 
 H                 -2.82523800   -1.15714600    3.16748600 
 H                 -2.89311900    0.62437000    3.13223800 
 C                  0.48791800   -1.40755500    3.69611100 
 H                 -0.72587000   -2.39264600    2.18689100 
 H                  0.60216600   -1.41685700    1.50606300 
 C                 -0.55709500   -1.36803400    4.82367900 
 H                 -2.32073900   -0.21412500    5.42072600 
 H                 -0.99259400    0.76401300    4.74833600 
 H                  1.15232800   -2.29088300    3.81358100 
 H                  1.14441900   -0.51022700    3.77062900 
 H                 -0.05753400   -1.29701600    5.81412500 
 H                 -1.12614000   -2.32639900    4.82857500 
 C                  4.25951600   -2.23515900   -0.42446700 
 C                  4.80214900   -1.26979500    0.71826700 
 C                 -1.08635500   -1.90657600   -4.54234900 
 H                 -0.55360900   -2.47801900   -5.32066200 
 H                 -2.01878800   -2.34841900   -4.14947300 
 C                 -0.60996900   -0.71756100   -4.08580200 
 H                  0.32805500   -0.35156500   -4.54919600 
 C                  5.16479000   -2.27755100   -1.66584300 
 H                  6.10857900   -2.82280200   -1.46483400 
 H                  4.63105600   -2.80249900   -2.48352100 
 H                  5.41754600   -1.25839400   -2.02176600 
 C                  3.92690800   -3.65523100    0.03732100 
 H                  3.53877600   -4.24532100   -0.81738900 
 H                  4.83486600   -4.16585200    0.41864200 
 H                  3.15863500   -3.66133800    0.83329600 
 C                  4.28788400   -1.63096700    2.11943200 
 H                  4.75246600   -2.56394400    2.49619400 
 H                  4.54289200   -0.81119400    2.82081400 
 H                  3.18706800   -1.75884600    2.12855300 
 C                  6.32148500   -1.09010300    0.74211700 
 H                  6.60218800   -0.38707800    1.55234000 
 H                  6.82725400   -2.05714000    0.94042600 
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BP86 Optimization and Frequency Calculation:  
Sum of electronic and thermal Free Energies= -2011.448913 
Thermal correction to Gibbs Free Energy= 0.757938 
 Lowest frequency= 7.85 cm-1 
PB86-D3BJ Single Point Calculation: 
Electronic Energy= -2012.074021 
 
0 1 
 P                 -1.74990600   -0.18219400    0.29071800 
 C                  1.79926200    0.93705800   -2.30970100 
 C                  2.28110200    1.00343400   -0.98207500 
 H                  0.78431500   -0.08189000    0.37791600 
 H                  1.48824900    1.84532800   -2.84981800 
 H                  2.06639200    0.07047200   -2.93378000 
 B                  3.12883800   -0.22207600   -0.46895000 
 O                  4.03721700   -0.14661400    0.56919700 
 O                  3.14411300   -1.45054600   -1.11016700 
 C                  2.37153200    2.31977700   -0.25869000 
 C                  2.54930000    3.53085400   -0.97206600 
 C                  2.34778200    2.38951900    1.15724000 
 C                  2.68346300    4.75997300   -0.30172900 
 H                  2.60639900    3.51072100   -2.07168500 
 C                  2.48465900    3.61393500    1.82832500 
 H                  2.20924300    1.46127900    1.73170700 
 C                  2.65020200    4.80951400    1.10236000 
 H                  2.82355800    5.68456600   -0.88490600 
 H                  2.45871100    3.63704100    2.92990000 
 H                  2.75576600    5.77139600    1.62910100 
 C                 -1.01880200    0.62468100   -2.90819100 
 H                 -0.91806600    1.72586300   -3.02292500 
 H                 -2.08120200    0.38712200   -2.71691800 
 Pd                 0.13003100    0.27866100   -1.03901400 
285
   
 C                 -2.74562300    1.39772600    0.58434500 
 C                 -1.91549100    2.45436500    1.35068000 
 C                 -3.31361200    2.01542500   -0.71281200 
 H                 -3.60290900    1.09530100    1.22762400 
 C                 -2.74159500    3.72409100    1.63700200 
 H                 -1.01953700    2.71518000    0.74170600 
 H                 -1.53254200    2.04322600    2.30782800 
 C                 -4.16015400    3.26721400   -0.41343600 
 H                 -2.46808100    2.29759800   -1.37549600 
 H                 -3.91766900    1.27374700   -1.27646600 
 C                 -3.34798900    4.32091100    0.35670500 
 H                 -2.10344600    4.47355900    2.15317100 
 H                 -3.56193400    3.47050800    2.34766600 
 H                 -4.54748200    3.69191900   -1.36481000 
 H                 -5.05357700    2.97592600    0.18597900 
 H                 -3.98185100    5.20063500    0.60172800 
 H                 -2.52741000    4.69745300   -0.29628000 
 C                 -2.98661900   -1.55467800   -0.18273600 
 C                 -4.47103600   -1.28752500    0.16073800 
 C                 -2.85573300   -2.06581300   -1.63131900 
 H                 -2.64337500   -2.38655100    0.47554100 
 C                 -5.32113500   -2.55585500   -0.05980000 
 H                 -4.86157600   -0.47253400   -0.48788100 
 H                 -4.58791300   -0.94016800    1.20752600 
 C                 -3.69476500   -3.33921700   -1.84518700 
 H                 -3.20932500   -1.27928900   -2.33303000 
 H                 -1.78988100   -2.24644200   -1.88359900 
 C                 -5.17260400   -3.10762500   -1.48735900 
 H                 -6.38708900   -2.33340200    0.16405700 
 H                 -5.00466000   -3.33515900    0.67135500 
 H                 -3.59771100   -3.68120700   -2.89834300 
 H                 -3.28469400   -4.15967100   -1.21168300 
 H                 -5.75403900   -4.04827400   -1.60046900 
 H                 -5.61237400   -2.37981000   -2.20775900 
 C                 -1.27446500   -0.71202300    2.05180600 
 C                 -2.43095400   -0.79828700    3.07198500 
 C                 -0.45128300   -2.01846500    2.06265100 
 H                 -0.58819700    0.10684400    2.36736000 
 C                 -1.90363300   -1.11666400    4.48645700 
 H                 -3.13788200   -1.60251600    2.76791900 
 H                 -3.01475300    0.14577100    3.09773100 
 C                  0.07098300   -2.34414200    3.47518200 
 H                 -1.08172200   -2.86634400    1.70867100 
 H                  0.39443900   -1.93072000    1.34630400 
 C                 -1.06915300   -2.40711500    4.50501300 
 H                 -2.75664200   -1.19226300    5.19512000 
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 H                 -1.27689500   -0.26617600    4.84063100 
 H                  0.63233800   -3.30324000    3.45572500 
 H                  0.80108200   -1.56040600    3.78164300 
 H                 -0.66358800   -2.59277000    5.52313000 
 H                 -1.72951400   -3.27335500    4.26866600 
 C                  4.30612200   -2.19250400   -0.61857200 
 C                  4.59541700   -1.48571500    0.77624700 
 C                 -1.07583900   -1.13890300   -4.75454300 
 H                 -0.59148200   -1.58848800   -5.63738400 
 H                 -2.02919200   -1.58858800   -4.42792200 
 C                 -0.51611400   -0.08385400   -4.10456000 
 H                  0.43498800    0.29714800   -4.52624400 
 C                  5.43142000   -1.98839500   -1.64655000 
 H                  6.33609600   -2.57345200   -1.38584500 
 H                  5.07673600   -2.32684600   -2.64100200 
 H                  5.71679200   -0.92034300   -1.73109700 
 C                  3.93939000   -3.67525700   -0.52468500 
 H                  3.73739500   -4.07594000   -1.53877700 
 H                  4.77550900   -4.25967600   -0.08865100 
 H                  3.03580900   -3.83845400    0.09248100 
 C                  3.82722700   -2.11413000    1.94840100 
 H                  4.22986700   -3.11211600    2.21357400 
 H                  3.92171900   -1.45751500    2.83669300 
 H                  2.74922300   -2.22090000    1.71473300 
 C                  6.07722100   -1.34284100    1.13118900 
 H                  6.18043900   -0.82512100    2.10635600 
 H                  6.55656300   -2.33902100    1.22262700 






















































   
CHAPTER THREE 
The Conjunctive Cross-Coupling Reaction with Propargyl Electrophiles and the 
Discovery of Alcohol Exchange on Boron “Ate” Complexes 
 
3.1. Introduction 
In the previous chapter, we showed that allyl electrophiles failed to give appreciable 
yields of the desired γ-boryl alkene conjunctive cross-coupling products, but instead, after 
switching from a bidentate MandyPhos ligand to a monodentate PCy3 ligand, promoted β-
hydride elimination to give vinylidenation products 3.3 (Scheme 3.1, top).1 We reasoned 
                                                            
1 Aparece, M. D.; Gao, C.; Lovinger, G. J.; Morken, J. P. Angew. Chem. Int. Ed. 2019, 58, 592. 
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that the sp3-hybridized carbon atom of the η1-allyl group bound to palladium in complex 
3.2 is responsible for the failure of the conjunctive cross-coupling reaction with allyl 
electrophiles. Reductive elimination of alkyl groups is slow due to the increased orbital 
directionality associated with sp3-hybridized centers leading to poorer orbital overlap 
between the coupling partners in the transition state,2 in addition to the propensity for 
Pd(alkyl) species to undergo β-hydride elimination. 
To explore whether related electrophiles could engage in conjunctive cross-
coupling, we investigated the use of propargyl electrophiles. Palladium is known to 
undergo oxidative addition with these electrophiles in an SN2' fashion, which would give a 
Pd(allenyl) complex 3.4 in equilibrium with its η3-propargyl 3.5 and η1-propargyl 
tautomers 3.6 (Scheme 3.1, bottom).3 Following coordination of the boron “ate” followed 
by 1,2-metallate shift to give Pd(η1-allenyl) complex 3.7, we hypothesized that, as the 
carbon atom bound to palladium in this complex is sp2-hybridized, this moiety would 
readily undergo reductive elimination similar to aryl and alkenyl groups in earlier reports 
                                                            
2 Low, J. J.; Goddard, W. A. J. Am. Chem. Soc. 1984, 106, 8321–8322. 
3 (a) Baize, M. W.; Blosser, P. W.; Plantevin, V.; Schimpff, D. G.; Gallucci, J. C.; Wojcicki, A. 
Organometallics 1996, 15, 164. (b) Tsutsumi, K.; Ogoshi, S.; Kakiuchi, K.; Nishiguchi, S.; Kurosawa, H. 
Inorganica Chim. Acta 1999, 296, 37. (c) Canovese, L.; Visentin, F.; Biz, C.; Scattolin, T.; Santo, C.; 
Bertolasi, V. J. Organomet. Chem. 2015, 786, 21. 
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of the conjunctive cross-coupling reaction.4 Indeed, we found that methyl propargyl 
carbonates derived from internal alkynes and tertiary propargyl alcohols gave β-boryl 
tetrasubstituted allenes 3.8 with generally high levels of enantioselectivity.5 Furthermore, 
we discovered that the addition of methanol dramatically increases both the yields and 
enantioselectivities of this reaction. 1H NMR studies revealed alkoxy ligand exchange on 
the pinacolatoboron “ate” complex 3.9 to give a bis(methanolato)boron “ate” complex 
3.10. To the best of our knowledge, this is a hitherto unrecognized phenomenon that might 
be attributed to the release of strain upon displacement of the bulky pinacolato ligand. 
3.2. Background 
3.2.1. Structure and Utility of Allenes 
Allenes are the simplest of the cumulated polyenes in which the two π systems 
share an sp-hybridized atom yet are not in conjugation due to their orthogonality (Scheme 
3.3). The first allene was first synthesized in 1887 by Burton and von Pechmann,6 but due 
to the lack of more sophisticated analytical techniques at the time, its structure was not 
confirmed until 1954.7 Some allenes possess axial chirality, the first example of which was 
synthesized in 1935.8 
 
 
                                                            
4 (a) Zhang, L.; Lovinger, G. J.; Edelstein, E. K.; Szymaniak, A. A.; Chierchia, M. P.; Morken, J. P. Science 
2016, 351, 70. (b) Lovinger, G. J.; Aparece, M. D.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 3153. (c) 
Edelstein, E. K.; Namirembe, S.; Morken, J. P. J. Am. Chem. Soc. 2017, 139, 5027. (d) Myhill, J. A.; 
Zhang, L.; Lovinger, G. J.; Morken, J. P. Angew. Chem. Int. Ed. 2018, 57, 12799. (e) Myhill, J. A.; 
Wilhelmsen, C. A.; Zhang, L.; Morken, J. P. J. Am. Chem. Soc. 2018, 140, 15181. 
5 Aparece, M. D.; Hu, W.; Morken, J. P. ACS Catal. 2019, 9, 11381. 
6 Burton, B. S.; von Pechmann, H. Ber. Dtsch. Chem. Ges. 1887, 20, 145. 
7 Jones, E. R. H.; Mansfield, G. H.; Whiting, M. C. J. Chem. Soc. 1954, 3208. 
8 (a) Maitland, P.; Mills, W. H. Nature 1935, 135, 994. (b) Maitland, P.; Mills, W. H. J. Chem. Soc. 1936, 
987. 
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Due to their unique structure, allenes can undergo a diverse array of 
transformations.9 They have been shown to participate in [2+2],10 [4+2],11 and [3+2]12 
cycloadditions (Scheme 3.4). The PPh3-catalyzed [3+2] cycloaddition with 
enantioenriched Michael acceptor 3.11 was applied to the total synthesis of (–)-hinesol 
3.12 (Scheme 3.4d).12a A chiral ligand (S)-tBu-Binaphane 3.13 has been used to effect an 
asymmetric [3+2] cycloaddition between achiral allenes and achiral Michael acceptors to 
give enantioenriched cyclopentane products (Scheme 3.4e).12b 
Allenes can also undergo a variety of oxidation reactions. Treating 1,3-di-t-butyl 
allene 3.14 with mCPBA gives allene oxide 3.15, which undergoes thermal isomerization 
to trans-di-t-butylcyclopropanone 3.16 (Scheme 3.5a).13 Likewise, methoxyallene 3.17 can 
be converted to its corresponding oxide 3.18, which has been used as an enolate equivalent 
in titanium-promoted aldol addition reactions: acetal electrophiles with Brønsted acid 
additives gave predominantly syn aldol products 3.19, while aldehyde electrophiles with  
                                                            
9 (a) Ma, S. Chem. Rev. 2005, 105, 2829. (b) Yu, S.; Ma, S. Angew. Chem. Int. Ed. 2012, 51, 3074. 
10 Dauben, W. G.; Shapiro, G.; Luders, L. Tetrahedron Lett. 1985, 26, 1429. 
11 (a) Wei, L.-L.; Hsung, R. P.; Xiong, H.; Mulder, J. A.; Nkansah, N. T. Org. Lett. 1999, 1, 2145. (b) Zhu, 
X.-F.; Lan, J.; Kwon, O. J. Am. Chem. Soc. 2003, 125, 4716. 
12 (a) Du, Y.; Lu, X. J. Org. Chem. 2003, 68, 6463. (b) Schuler, M.; Voituriez, A.; Marinetti, A. Tetrahedron 
Asymmetry 2010, 21, 1569. 
13 Camp, R. L.; Greene, F. Davis. J. Am. Chem. Soc. 1968, 90, 7349. 
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Lewis acid additives gave predominantly anti aldol products 3.20 (Scheme 3.5b).14 Allenes 
are also known to undergo double epoxidation reactions with dimethyldioxirane (DMDO) 
to give l,4-dioxaspiro[2.2]pentanes such as 3.21 and 3.22 (Scheme 3.5c).15 This strategy 
has been employed by Williams and coworkers in their formal synthesis of psymberin 3.26: 
treating enantioenriched allene 3.23 with DMDO gives a l,4-dioxaspiro[2.2]pentane 
intermediate 3.24, which undergoes nucleophilic attack by the pendant hydroxyl group to 
give stereodefined pyran 3.25 (Scheme 3.5d).16 
Cyclometallation reactions of allenes have been used to rapidly build structural 
complexity. Allenes have been shown to react with alkynes in Pauson–Khand reactions 
(Scheme 3.6a)17 and Ni-catalyzed [2+2+2] arene syntheses (Scheme 3.6b).18 They have 
also been used in intramolecular cyclization reactions with alkynes (Scheme 3.6c),19 
alkenes (Scheme 3.6d),20 and aldehydes (Scheme 3.6e)21 to give a variety of densely 
functionalized ring systems. 
 
                                                            
14 Hayakawa, R.; Shimizu, M. Org. Lett. 2000, 2, 4079. 
15 Crandall, J. K.; Batal, D. J.; Sebesta, D. P.; Lin, F. J. Org. Chem. 1991, 56, 1153. 
16 Shangguan, N.; Kiren, S.; Williams, L. J. Org. Lett. 2007, 9, 1093. 
17 Ahmar, M.; Antras, F.; Cazes, B. Tetrahedron Lett. 1995, 36, 4417. 
18 (a) Shanmugasundaram, M.; Wu, M.-S.; Cheng, C.-H. Org. Lett. 2001, 3, 4233. (b) Shanmugasundaram, 
M.; Wu, M.-S.; Jeganmohan, M.; Huang, C.-W.; Cheng, C.-H. J. Org. Chem. 2002, 67, 7724. 
19 Urabe, H.; Takeda, T.; Hideura, D.; Sato, F. J. Am. Chem. Soc. 1997, 119, 11295. 
20 Makino, T.; Itoh, K. J. Org. Chem. 2004, 69, 395. 
21 Montgomery, J.; Song, M. Org. Lett. 2002, 4, 4009. 
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Like alkenes and alkynes, allenes are particularly effective substrates for silver, 
gold, and platinum catalysis due to the π-acidity of these transition metals.22 Allenes have 
been shown to undergo silver- or gold-catalyzed heterocyclization reactions. Lee and 
coworkers reported the regiodivergent hydroalkoxylation of allenynyl 1,6-diols: a gold 
catalyst promotes a 5-endo-trig cyclization onto the allenyl moiety, whereas a silver 
catalyst promotes a 5-endo-dig cyclization onto the alkynyl moiety (Scheme 3.7a).23 The 
Krause lab exploited this reactivity in their total synthesis of (–)-isocyclocapitelline 3.30, 
a natural product isolated from the Rubiaceae plant Hedyotis capitellata, which is used in 
traditional Chinese and Vietnamese medicine: treating the enantioenriched allenyl alcohol 
3.28 with low catalyst loadings of AuCl3 formed dihydrofuran 3.29 with excellent levels 
of diastereoselectivity (Scheme 3.7b).24 
Hydroamination reactions have also been developed. For example, the Toste group 
developed the enantioselective hydroamination of aminoallenes using a chiral gold catalyst 
to synthesize piperidines with high levels of enantioselectivity (Scheme 3.7c).25 Bates and 
coworkers utilized the silver-catalyzed intramolecular hydroamination of an 
enantioenriched allenyl hydroxylamine derivative 3.31 to give oxazolidine 3.32, which was 
converted several steps later to the Sedum alkaloid (–)-sedinine 3.33 (Scheme 3.7d).26 
  
                                                            
22 Fürstner, A.; Davies, P. W. Angew. Chem. Int. Ed. 2007, 46, 3410. 
23 Kim, S.; Lee, P. H. Adv. Synth. Catal. 2008, 350, 547. 
24 Volz, F.; Krause, N. Org. Biomol. Chem. 2007, 5, 1519. 
25 LaLonde, R. L.; Sherry, B. D.; Kang, E. J.; Toste, F. D. J. Am. Chem. Soc. 2007, 129, 2452. 
26 Bates, R. W.; Lu, Y. Org. Lett. 2010, 12, 3938. 
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There are numerous examples of gold- and platinum-catalyzed hydroarylations of 
allenes which include intermolecular (Scheme 3.8a)27 and intramolecular variants (Scheme 
3.8b and c),28 with the latter being more common. Hydroarylations with heterocycles are 
also known, such as Ma’s Pt-catalyzed hydroarylation of indolylallenols to synthesize 
carbazoles (Scheme 3.8d)29 and Widenhoefer’s Au-catalyzed hydroarylation of 
indolylallenes with a chiral ligand to give cyclized products with good to high levels of 
enantioselectivities (Scheme 3.8e).30 The Nelson lab reported the Au-catalyzed 
hydroarylation of enantioenriched pyrrolylallene 3.34 to give 3.35 with high 
diastereoselectivity, which was converted several steps later to (–)-rhazinilam 3.36, an 
alkaloid isolated from the poisonous plant Rhazya stricta (Scheme 3.8f).31 
                                                            
27 Skouta, R.; Li, C.-J. Can. J. Chem. 2008, 86, 616. 
28 (a) Watanabe, T.; Oishi, S.; Fujii, N.; Ohno, H. Org. Lett. 2007, 9, 4821. (b) Mo, J.; Lee, P. H. Org. Lett. 
2010, 12, 2570. 
29 Kong, W.; Fu, C.; Ma, S. Chem. Commun. 2009, 30, 4572. 
30 Liu, C.; Widenhoefer, R. A. Org. Lett. 2007, 9, 1935. 
31 Liu, Z.; Wasmuth, A. S.; Nelson, S. G. J. Am. Chem. Soc. 2006, 128, 10352. 
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3.2.2. Synthesis of Allenes 
Allenes are most commonly synthesized from propargyl electrophiles. Hydroxyl-
directed SN2' reactions such as reductions (Scheme 3.9a and b)32 and brominations (Scheme 
3.9c)33 have been reported. Carbon-based nucleophiles such as indoles (Scheme 3.9d)34 
and organometallics such as organozinc35 and organoindium36 reagents (Scheme 3.9e and 
f) have also been shown to engage with propargyl electrophiles. 
The synthesis of allenes has been tremendously expanded and improved by the use 
of transition metal catalysis. Selected examples include Cu-catalyzed borylation37 and 
alkylation38 (Scheme 3.10a and b), Ni-catalyzed intramolecular allenylation of soft 
nucleophiles such as malonates (Scheme 3.10c),39 and Rh-catalyzed arylation of propargyl 
epoxides (Scheme 3.10d).40 
                                                            
32 (a) Cowie, J. S.; Landor, P. D.; Landor, S. R. J. Chem. Soc. Perkin Trans. I 1973, 720. (b) Bungard, C. J.; 
Morris, J. C. J. Org. Chem. 2002, 67, 2361. 
33 Du, X.; Dai, Y.; He, R.; Lu, S.; Bao, M. Synth. Commun. 2009, 39, 3940. 
34 Sanz, R.; Gohain, M.; Miguel, D.; Martínez, A.; Rodríguez, F. Synlett 2009, 2009, 1985. 
35 Kobayashi, K.; Naka, H.; Wheatley, A. E. H.; Kondo, Y. Org. Lett. 2008, 10, 3375. 
36 Lee, K.; Lee, P. H. Org. Lett. 2008, 10, 2441. 
37 Ito, H.; Sasaki, Y.; Sawamura, M. J. Am. Chem. Soc. 2008, 130, 15774. 
38 Li, J.; Kong, W.; Fu, C.; Ma, S. J. Org. Chem. 2009, 74, 5104. 
39 Gou, F.-R.; Bi, H.-P.; Guo, L.-N.; Guan, Z.-H.; Liu, X.-Y.; Liang, Y.-M. J. Org. Chem. 2008, 73, 3837. 
40 Miura, T.; Shimada, M.; Ku, S.-Y.; Tamai, T.; Murakami, M. Angew. Chem. Int. Ed. 2007, 46, 7101. 
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Of the transition metal-catalyzed methods to synthesize allenes, those utilizing 
palladium are the most extensively developed. Nakano and coworkers reported the Pd-
catalyzed cross-coupling of alkenyl stannanes with propargyl bromide (Scheme 3.11a),41 
and the Liu group developed the Pd-catalyzed cross-coupling between aryl iodides and 
allenyl zirconium nucleophiles generated in situ from propargyl methyl ethers (Scheme 
3.11b).42 The Ma lab reported a ligand-dependent, regiodivergent allenylation of 2-
                                                            
41 Sasaki, F.; Endo, T.; Noguchi, M.; Kawai, K.; Nakano, T. Appl. Organomet. Chem. 2008, 22, 128. 
42 Zhang, H.; Fu, X.; Chen, J.; Wang, E.; Liu, Y.; Li, Y. J. Org. Chem. 2009, 74, 9351. 
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iodoalkenoates from organozinc reagents generated from alkyl aryl alkynes: using tri(2-
furyl)phosphine 3.37 resulted in allenylation α to the alkyl group, while employing 
BINOL-derived ligand 3.38 resulting in allenylation α to the aryl group (Scheme 3.11c).43 
                                                            
43 Zhao, J.; Yu, Y.; Ma, S. Chem. Eur. J. 2010, 16, 74. 
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Sawamura reported a ligand-dependent, regiodivergent hydrogenolysis of propargyl 
formates: dppe was selective for allene formation, whereas dpph was selective for alkyne 
formation (Scheme 3.11d).44 
Other methods to synthesize allenes include elimination reactions (Scheme 3.12a 
and b),45 the Cu-promoted Crabbé homologation of terminal alkynes with iminium cations 
generated from paraformaldehyde and secondary amines (Scheme 3.12c),46 [3,3]-
sigmatropic rearrangements such as the Ireland–Claisen rearrangement (Scheme 3.12d),47 
and the enantioselective isomerization of alkynes catalyzed by a chiral guanidine base 
(Scheme 3.12e).48 
  
                                                            
44 Ohmiya, H.; Yang, M.; Yamauchi, Y.; Ohtsuka, Y.; Sawamura, M. Org. Lett. 2010, 12, 1796. 
45 (a) Yokota, M.; Fuchibe, K.; Ueda, M.; Mayumi, Y.; Ichikawa, J. Org. Lett. 2009, 11, 3994. (b) Satoh, T.; 
Noguchi, T.; Miyagawa, T. Tetrahedron Lett. 2008, 49, 5689. 
46 (a) Searles, S.; Li, Y.; Nassim, B.; Lopes, M.-T. R.; Tran, P. T.; Crabbé, P. J. Chem. Soc. Perkin Trans. I 
1984, 747. (b) Kuang, J.; Ma, S. J. Org. Chem. 2009, 74, 1763. 
47 Baldwin, J. E.; Bennett, P. A. R.; Forrest, A. K. J. Chem. Soc., Chem. Commun. 1987, 16, 250. 
48 Liu, H.; Leow, D.; Huang, K.-W.; Tan, C.-H. J. Am. Chem. Soc. 2009, 131, 7212. 
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Our proposed Pd-catalyzed conjunctive cross-coupling reaction between 
organoboron “ate” complexes and propargyl electrophiles would give β-hydroxy allenes 
following oxidation. Other groups have previously synthesized this motif in 
diastereoselective and/or enantioselective fashion. One type of transformation involves 
diastereoselective [3,3]-sigmatropic rearrangements, including Hsung’s Saucy–Marbet 
rearrangement of chiral ynamides (Scheme 3.13a)49 and Toste’s Au-catalyzed propargyl 
Claisen rearrangement of alkenyl propargyl ethers (Scheme 3.13b).50 The Guiry group 
reported an enantioselective Nozaki–Hiyama–Kishi reaction between 4-bromo-1,2-
butadiene 3.39 and aldehydes with non-C2-symmetric bisoxazoline ligand 3.40 to 
synthesize enantioenriched β-hydroxy allenes (Scheme 3.13c).51 Liu and coworkers 
reported the conversion of conjugated enynes to zirconacyclopentenes 3.41, which were 
trapped by aldehydes to give highly-substituted β-hydroxy allene products 3.42 bearing 
multiple contiguous stereocenters with high diastereoselectivity (Scheme 3.13d).52 The 
Kimura lab developed a diastereoselective Ni-catalyzed three-component coupling of 
conjugated enynes, aldehydes, and dialkylzinc reagents (Scheme 3.13e).53 
 
 
                                                            
49 Frederick, M. O.; Hsung, R. P.; Lambeth, R. H.; Mulder, J. A.; Tracey, M. R. Org. Lett. 2003, 5, 2663. 
50 Sherry, B. D.; Toste, F. D. J. Am. Chem. Soc. 2004, 126, 15978. 
51 Coeffard, V.; Aylward, M.; Guiry, P. Angew. Chem. Int. Ed. 2009, 48, 9152. 
52 Zhou, Y.; Chen, J.; Zhao, C.; Wang, E.; Liu, Y.; Li, Y. J. Org. Chem. 2009, 74, 5326. 
53 Mori, Y.; Onodera, G.; Kimura, M. Chem. Lett. 2014, 43, 97. 
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3.3. The Palladium-Catalyzed Conjunctive Cross-Coupling Reaction with Propargyl 
Electrophiles 
3.3.1. Optimization and the Discovery of Alcohol Exchange on Boron “Ate” Complexes 
We began our optimization studies using (phenyl)(vinyl)B(pin) “ate” complex 3.43 
derived from phenylB(pin) and vinyllithium and 2-methyl-3-butynyl acetate 3.44 as the 
electrophile. Employing 3 mol % Pd(OAc)2 and 3.6 mol % MandyPhos gave 17% yield of 
the desired trisubstituted β-boryl allene 3.45 with 88:12 er (Table 3.1, entry 1), confirming 
that this electrophile class could engage in the conjunctive cross-coupling reaction. 
Switching to a chloride leaving group (3.46) did not affect the reaction in a significant way 
(Table 3.1, entry 2). Using a propargyl acetate derived from an internal alkyne 3.47 gave 
the corresponding tetrasubstituted allene product 3.48 with a boost in yield to 40%, 
although we now observed an appreciable amount of enyne 3.49 derived from 
decomposition of the electrophile (Table 3.1 entry 3). Curiously, increasing the equivalents 
of propargyl acetate 3.47 from 1.2 to 2 resulted in a decrease in yield (Table 3.1, entry 4). 
We reasoned that acetic acid could be generated from the decomposition of the propargyl 
acetate—presumably via β-hydride elimination to form the enyne, followed by reductive 
elimination of acetic acid from palladium—which would destroy the “ate” complex. 
To avoid the generation of acetic acid, we used Pd2(dba)3 and a propargylic methyl 
carbonate 3.50, which not only gave modest yield of the conjunctive cross-coupling 
product 3.48 with slightly higher enantioselectivity but also lower amounts of enyne 3.49 
(Table 3.1, entry 5). Increasing the equivalents of methyl propargyl carbonate electrophile 
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3.50 resulted in attendant increases in yields of both the desired product and the enyne 
while maintaining high levels of enantioselectivity (Table 3.1, entries 6–8). 
These results seem to imply that the methanol generated under these reaction 
conditions was not having an adverse effect on the reaction. To test this hypothesis, we 
added 2 equivalents of methanol to the reaction. To our surprise, we found a significant 
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boost in both the yield and the enantioselectivity (Table 3.1, entry 9). Increasing the amount 
of exogenous methanol not only led to further increases in yields and enantioselectivities 
but also suppression of the formation of enyne (Table 3.1, entries 10 and 11). As shown in 
Table 3.1, entries 12–15, the outcome of the reaction was dependent on the structure of the 
alcohol additive. 
At this point, it was unclear whether the boosts in yield were due to methanol 
somehow retarding electrophile decomposition to the enyne or whether methanol was 
accelerating the conjunctive cross-coupling reaction in a different way. The increase in 
enantioselectivities seemed to suggest the latter, as methanol must be involved in the 
stereodetermining transition state. In order to ascertain the role of methanol in this reaction, 
we treated (phenyl)(vinyl)B(pin) “ate” complex 3.43 (Figure 3.1a) with four equivalents 
of methanol in THF-d8 at 60 °C for 12 hours and then analyzed the reaction mixture by 1H 
NMR. We observed the formation of a new “ate” complex (phenyl)(vinyl)B(OMe)2 3.51 
in which the pinacol ligand on boron was exchanged with two methoxide ligands in 
approximately 68% conversion, in addition to peaks corresponding to free pinacol (Figure 
3.1d). This new “ate” complex 3.51 was verified by independent synthesis from 
phenylB(OMe)2 3.55 and one equivalent of vinyllithium (Figure 3.1b). It should be noted 
that synthesizing “ate” 3.51 in this manner also gives another “ate” complex 
(phenyl)(vinyl)2B(OMe) 3.52; 3.52 was also independently synthesized by treating 3.55 
with two equivalents of vinyllithium, although a ~1:1 mixture of 3.51 and 3.52 is formed 
under these conditions (Figure 3.1c). These experiments show that treating 3.43 with 
methanol is a reliable way to form 3.51 cleanly in situ as opposed to from 3.55 and 
vinyllithium, which is unsurprising given the lability of methoxide. 
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Figure 3.1. 1H NMR studies of the methanol–pinacol exchange reaction on boron “ate” 
complexes. The solvent is anhydrous THF-d8 in all cases. 1H NMR spectra of (a) 
(phenyl)(vinyl)B(pin) “ate” 3.43; (b) (phenyl)(vinyl)B(OMe)2 “ate” 3.51 (mixture with 
(phenyl)(vinyl)2B(OMe) “ate” 3.52 in ~3:1 ratio); (c) (phenyl)(vinyl)2B(OMe) “ate” 3.52 (mixture 
with (phenyl)(vinyl)B(OMe)2 “ate” 3.51 in ~1:1 ratio); (d) methanol–pinacol exchange 
experiment on 3.43 at 60 °C for 12 hours. 
 
To probe the generality of this alcohol exchange phenomenon, we also investigated 
neopentyl glycol as an additive to see if it could exchange with pinacol to give 
(phenyl)(vinyl)B(neo) “ate” complex 3.53 in situ. 3.53 was independently synthesized 
from phenylB(neo) and vinyllithium (Figure 3.2b). After treating (phenyl)(vinyl)B(pin) 
“ate” 3.43 with 1 equivalent of neopentyl glycol in THF-d8 at 60 °C for 12 hours, we 
observed the formation of 3.53 in approximately 69% conversion along with the liberation 
of pinacol (Figure 3.2c). We also treated (phenyl)(vinyl)B(neo) “ate” complex 3.53 with 1 
equivalent of pinacol (Figure 3.2d) and observed approximately the same ratio of 3.43 to 
3.53 in this experiment as in Figure 3.2c. 
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Figure 3.2. 1H NMR studies of the neopentyl glycol–pinacol exchange reaction on boron “ate” 
complexes. The solvent is anhydrous THF-d8 in all cases. 1H NMR spectra of (a) 
(phenyl)(vinyl)B(pin) “ate” 3.43; (b) (phenyl)(vinyl)B(neo) “ate” 3.53; (c) neopentyl glycol–
pinacol exchange experiment on 3.43 at 60 °C for 12 hours; (d) pinacol–neopentyl glycol 
exchange experiment on 3.53 at 60 °C for 12 hours; 
 
We hypothesized that both the methanol–pinacol and neopentyl glycol–pinacol 
exchanges are driven by strain release, as having a pinacol ligand on a tetracoordinate 
boron “ate” would be more sterically congested than these other alkoxide ligands. Notably, 
this reactivity is opposite to what is known for neutral, tricoordinate boronates which favor 
chelating ligands like pinacol.54 In fact, there are a few instances in the literature in which 
ligand exchange on tricoordinate boronic esters is a prominent feature of the reaction.55 
                                                            
54 Roy, C. D.; Brown, H. C. J. Organomet. Chem. 2007, 692, 784. 
55 (a) Pellegrinet, S. C.; Goodman, J. M. J. Am. Chem. Soc. 2006, 128, 3116. (b)  Bishop, J. A.; Lou, S.; 
Schaus, S. E. Angew. Chem. Int. Ed. 2009, 48, 4337. (c) Taylor, M. S. Acc. Chem. Res. 2015, 48, 295. (d) 
Wu, H.; Garcia, J. M.; Haeffner, F.; Radomkit, S.; Zhugralin, A. R.; Hoveyda, A. H. J. Am. Chem. Soc. 
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Indeed, treating phenylB(pin) 3.54 with 4 equivalents of methanol THF-d8 at 60 °C for 12 
hours did not result in the formation of phenylB(OMe)2 3.55 (Scheme 3.14a), whereas 
treating phenylB(OMe)2 3.55 with one equivalent of pinacol resulted in compete 
conversion to phenylB(pin) 3.54 (Scheme 3.14b). However, in 1H NMR spectra of crude 
reaction mixtures following conjunctive cross-coupling with methanol additive, free 
pinacol is almost never observed, as the conjunctive cross-coupling products we obtain 
prior to oxidation are the pinacol boronic esters. Furthermore, preliminary 1H NMR time 
course studies of the reaction show the conversion of (phenyl)(vinyl)B(pin) “ate” 3.43 to 
(phenyl)(vinyl)B(OMe)2 “ate” 3.51 with concomitant liberation of pinacol, but as the 




                                                            
2015, 137, 10585. (e) Yan, L.; Meng, Y.; Haeffner, F.; Leon, R. M.; Crockett, M. P.; Morken, J. P. J. Am. 
Chem. Soc. 2018, 140, 3663. 
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With these observations, we propose a modified conjunctive cross-coupling 
catalytic cycle that takes into account this boron “ate” alkoxide ligand exchange 
phenomenon as well as the formation of boronic pinacol ester products at the end of the 
reaction (Scheme 3.15). Palladium complex 3.56 undergoes oxidative addition with the 
propargyl electrophile in an SN2' fashion to give LnPd(allenyl)(OMe) species 3.57. 
Meanwhile, pinacolatoboron “ate” 3.9 undergoes alkoxide ligand exchange with 2 
equivalents of methanol to give bis(methanolato)boron “ate” 3.10, which coordinates to 
palladium to give 3.58. We propose that there is less of a steric clash between the smaller 
methoxy ligands on boron and the allenyl ligand on palladium compared to pinacolato 
complex 3.59, which may account for the increased yields and enantioselectivities with 
methanol additive. This may also explain why larger alcohol additives such as ethanol and 
rac-2-butanol diminish both yields and enantioselectivities (Table 3.1, entries 12 and 14, 
vide supra). Following Pd-induced 1,2-metallate shift to give 3.60 and reductive 
elimination to close the catalytic cycle, the initial tricoordinate dimethoxy boronate 3.61 
would undergo ligand exchange with the free pinacol in solution to give the more stable 
pinacolato product 3.8, which is consistent with the experiments in Scheme 3.14.  
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3.3.2. Substrate Scope and Demonstration of Synthetic Utility 
Using the conditions in Table 3.1, entry 10, we examined the scope of the 
conjunctive cross-coupling reaction with other methyl propargyl carbonate electrophiles 
(Scheme 3.16). Various aryl alkynes were tolerated under the reaction conditions, 
including electron-rich (3.63) and electron-poor aryl groups (3.64 and 3.65), 2-naphtyl 
(3.66), and heterocycles (3.67–3.69). Alkenyl- (3.70 and 3.71) and alkynyl-substituted 
electrophiles (3.72) also performed well in the reaction. Although terminal (3.73) and n-
alkyl-substituted (3.74) alkynes gave low yields of the desired products (<20% yield), 
methoxymethylene (3.75) and siloxymethylene groups (3.76) participated readily in the 
reaction with good yields and high levels of enantioselectivity. Methyl propargyl 
carbonates derived from cyclic tertiary alcohols were tolerated in the reaction as well 
(3.77–3.79). 
With respect to the scope of organoboronic esters, various C(sp2) migrating groups 
were well-tolerated (3.80–3.85). A cyclopropyl migrating group was also tolerated under 
these reaction conditions (3.86), but other alkyl migrating groups required the use of 4 
equivalents of 2,2,2-trifluoroethanol (TFE) instead of methanol to give high conversion 
(3.87–3.89). We attribute this to the electron-withdrawing fluorine atoms on TFE, which 
could stabilize alkyl-derived boron “ate” complexes following exchange with pinacol, 
although further study would have to be done to test this hypothesis. 
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Considering the aforementioned diversity of reactions allenes can undergo, we 
were interested in exploring potential transformations of our tetrasubstituted β-hydroxy 
allene products. Serendipitously, we observed that following conjunctive cross-coupling 
with 2-thiophenyl-substituted propargyl electrophile 3.90 and oxidative workup, the β-
hydroxy allene 3.91 underwent a spontaneous 6-endo-dig cyclization during silica gel 
chromatography to give pyran 3.92 (Scheme 3.17a). Inspired by this finding, we found that 
β-hydroxy allenes 3.62 and 3.76 could undergo cyclization upon treatment with a gold 
catalyst to give pyrans 3.93 and 3.94, respectively (Scheme 3.17b).56 
  
                                                            
56 Gockel, B.; Krause, N. Org. Lett. 2006, 8, 4485. 
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3.3.3 Progress Toward Utilizing Electrophiles Derived from Terminal Alkynes and/or 
Primary Propargyl Alcohols: Outlook and Future Directions 
As shown in Scheme 3.16, propargyl electrophiles derived from terminal alkynes 
(3.73) did not perform well in the reaction using the Pd2(dba)3/MandyPhos catalyst system. 
Furthermore, we discovered in the early stages of reaction optimization that electrophiles 
derived from primary propargyl alcohols did not give any of the desired conjunctive cross-
coupling product at all with reversion to the starting organoboronic ester predominating. 
However, as shown in Scheme 3.18, these two classes of propargyl electrophiles could give 
conjunctive cross-coupling products using the achiral ligand BrettPhos 3.95 to give 
racemic monosubstituted or trisubstituted β-hydroxy allenes following oxidation, and were 
equally suitable with “ate” complexes derived from both aryl and aliphatic migrating 
groups (3.96–3.101). Interestingly, we found that the electrophiles derived from internal 
alkynes (3.102 and 3.103), which were generally successful with MandyPhos, failed to 
give conjunctive cross-coupling products using BrettPhos. These reactions did not benefit 




   
 
In light of the apparent complementarity of these two ligands, as well as the 
observation that only C(sp2)- and C(sp)-substituted electrophiles and alkyl-substituted 
electrophiles bearing ethers gave high conversions using MandyPhos, we propose two 
possible rationales behind the observations we made for both systems. With respect to the 
MandyPhos-based protocol, it is possible that the sp2/sp-hybridized carbon (3.104) or the 
ether oxygen (3.105) of the allenyl substituent on the (allenyl)Pd(MandyPhos)+ complex 
coordinates to the electron-deficient palladium center to stabilize the complex (Scheme 
3.19a). This phenomenon has been demonstrated for Buchwald-type ligands such as 
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BrettPhos in which the ipso carbon of the “lower” aryl ring coordinates to the metal center 
(Scheme 3.19b, 3.106).57 Further study is required to lend support to these claims. 
 
In order to render the conjunctive cross-coupling products 3.96–3.101 in Scheme 
3.18 enantioenriched, we decided to synthesize enantioenriched chiral Buchwald-type 
ligands 3.10758 and 3.10859 possessing C- and P-chirality, respectively (Scheme 3.20). As 
of this writing, the syntheses of these ligands and their pending use in conjunctive cross-
coupling reactions is still ongoing. 
 
  
                                                            
57 Espinet, P.; Albéniz, A. C. Palladium–Carbon π-Bonded Complexes. In Comprehensive Organometallic 
Chemistry III, 3rd Ed.; Mingos, D. M. P., Crabtree, R. H., Eds.; Elsevier, Oxford, 2007, 8, 315. 
58 Spahn, E.; Albright, A.; Shevlin, M.; Pauli, L.; Pfaltz, A.; Gawley, R. E. J. Org. Chem. 2013, 78, 2731. 
59 Li, S.-G.; Yuan, M.; Topic, F.; Han, Z. S.; Senanayake, C. H.; Tsantrizos, Y. S. J. Org. Chem. 2019, 84, 
7291. 
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In conclusion, we have developed the enantioselective Pd-catalyzed conjunctive 
cross-coupling to access tetrasubstituted β-boryl allenes from organoboron “ate” 
complexes and methyl propargyl carbonate electrophiles derived from internal alkynes and 
tertiary alcohols with a Pd/MandyPhos catalyst system. During optimization studies, we 
discovered that the addition of methanol additive significantly increases both the yields 
and the enantioselectivities of the reaction. We attribute this to a novel methanol–pinacol 
exchange mechanism on the pinacolatoboron “ate” complex to generate 
bis(methanolato)boron “ate” complex in situ, a phenomenon that is opposite to what is 
known for neutral, tricoordinate boronic esters. 1H NMR studies suggest that the liberation 
of pinacol from tetracoordinate boron “ate” complexes is driven by strain release. The 
smaller ligand set on the bis(methanolato)boron “ate” complex may have less of a steric 
clash with the ligands on palladium, which may account for the beneficial effects of 
methanol in terms of yield and enantioselectivities. The reaction tolerated a variety of 
propargyl electrophiles, and we demonstrated the utility of these products by conducting a 
Au-catalyzed 6-endo-dig cyclization on a few substrates to synthesize dihydropyran rings. 
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We have also observed that the Buchwald ligand BrettPhos was effective at 
promoting the conjunctive cross-coupling reaction with propargyl acetate electrophiles 
derived from terminal alkynes and/or primary alcohols, substrates which were ineffective 
in the MandyPhos-based process. Studies to ascertain the exact origin of the apparent 
complementarity of these two catalyst systems are underway, and efforts to synthesize 
chiral Buchwald-type ligands to render the conjunctive cross-coupling reaction with these 
less-substituted propargyl electrophiles are also ongoing. 
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3.4. Experimental 
3.4.1.  General Information 
1H NMR spectra were recorded on a Varian Gemini-400 (400 MHz), Varian 
Gemini-500 (500 MHz), or Varian Gemini-600 (600 MHz) spectrometer. Chemical shifts 
are reported in ppm with the solvent resonance as the internal standard (CDCl3: 7.26 
ppm). Data are reported as follows: chemical shift, multiplicity (s = singlet, d = doublet, 
t = triplet, q = quartet, p = pentet, m = multiplet, app = apparent), coupling constants (Hz), 
and integration. 13C NMR spectra were recorded on a Varian Gemini-400 (100 MHz), 
Varian Gemini-500 (125 MHz), or Varian Gemini-600 (150 MHz) spectrometer with 
complete proton decoupling. Chemical shifts are reported in ppm with the solvent 
resonance as the internal standard (CDCl3: 77.16 ppm). 19F NMR spectra were recorded 
on a Varian Gemini-500 (470 MHz) spectrometer. Chemical shifts are reported in ppm 
using trifluoroacetic acid as the external standard (CF3COOH: -76.55 ppm). Infrared (IR) 
spectra were recorded on a Bruker Alpha-P Spectrometer. Frequencies are reported in 
wavenumbers (cm-1) as follows: strong (s), broad (br), medium (m), and weak (w). 
Optical rotations were measured on a Rudolph Analytical Research Autopol IV 
Polarimeter and the values reported are averages of seven measurements. Direct analysis 
in real time-high resolution mass spectrometry (DART-HRMS) was performed at the 
Mass Spectrometry Facility, Boston College, Chestnut Hill, MA. Flash column 
chromatography was performed using silica gel (SiO2, 230 x 450 Mesh, purchased from 
Silicycle). Thin layer chromatography (TLC) was performed on 25 μm silica gel 
aluminum backed plates from Silicycle. Visualization was performed using ultraviolet 
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light (254 nm) and ceric ammonium molybdate (CAM) in ethanol or alkaline aqueous 
potassium permanganate (KMnO4). 
Analytical chiral supercritical fluid chromatography (SFC) was performed on a 
TharSFC Method Station II equipped with Waters 2998 Photodiode Array Detector with 
isopropanol as the modifier. 
Anhydrous tetrahydrofuran (THF) and diethyl ether (Et2O) were purified using a 
Pure Solv MD-4 solvent purification system, from Innovative Technology, Inc., by passing 
the solvent through two activated alumina columns after purging with argon. Anhydrous 
deuterated THF (THF-d8) was purchased from Oakwood Chemicals and used without 
further purification. Tris(dibenzylideneacetone) dipalladium(0) (Pd2(dba)3), palladium(II) 
acetate (Pd(OAc)2), bis(triphenylphosphine) palladium(II) dichloride (PdCl2(PPh3)2), and 
(SP,SP)-MandyPhos were purchased from Strem Chemicals, Inc. and used without further 
purification. All pinacol and neopentyl glycol boronic esters not synthesized in-house 
according to literature procedures1,4ab were purchased from Combi Blocks, Oakwood 
Chemicals, or Frontier Scientific and used without further purification. Vinyllithium 
solution in THF was prepared from tetravinyltin and n-butyllithium according to the 
literature procedure.4a All other reagents were purchased from Aldrich, Alfa Aesar, or 
Acros and used without further purification.  
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3.4.2. Exchange Equilibria NMR Studies in Four-Coordinate Versus Three-Coordinate 
Organoboron Compounds 
3.4.2.1. Pinacolato Boron “Ate”–Methanol Exchange 
 
In a glovebox filled with argon, an oven-dried 2-dram vial equipped with a 
magnetic stir bar was charged with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane 
(3.54) (30.6 mg, 0.15 mmol, 1 equiv) and anhydrous Et2O (0.3 mL), sealed with a septum 
cap, and removed from the glovebox. Outside the glovebox under positive nitrogen 
pressure, the vial was cooled to 0 ºC in an ice-water bath, and vinyllithium solution in THF 
(0.15 mmol, 1 equiv) was added dropwise with stirring to form the “ate” complex 3.43. 
The reaction vial was allowed to warm to room temperature and stir for 30 minutes. The 
solvent was carefully removed from the “ate” complex under reduced pressure, and the 
“ate” residue was kept under vacuum for 30 minutes before being brought back into the 
glovebox. In the glovebox, the “ate” residue was re-dissolved in anhydrous deuterated THF 
(0.6 mL) and methanol (19.2 mg, 0.60 mmol, 4 equiv) was added. The vial was sealed with 
a polypropylene cap and electrical tape, brought out of the glovebox, and the reaction was 
stirred at 60 ºC for 12 hours. After cooling to room temperature, the contents of the vial 




   
3.4.2.2. Independent Synthesis of Bismethanolato Boron ‘Ate’  
 
Dimethyl phenylboronate (3.55) was prepared following a literature procedure:60 
an oven-dried 2-dram vial equipped with a magnetic stir bar was charged with phenyl 
boronic acid (18.3 mg, 0.15 mmol, 1.2 equiv) and sealed with a septum cap. The 
atmosphere was exchanged with nitogen, trimethyl orthoformate (39.8 mg, 0.38 mmol, 3 
equiv) and trifluoroacetic acid (2.2 mg, 0.019 mmol, 0.16 equiv) were added, and the 
reaction was allowed to stir for 15 minutes at room temperature. The volatiles were 
carefully removed under reduced pressure on the manifold vacuum, and the dimethyl 
phenylboronate residue was kept under vacuum for 30 minutes. This residue was then 
redissolved in anhydrous deuterated THF (0.6 mL), chilled to -78 °C in a dry ice-acetone 
bath, and vinyllithium solution in THF (0.13 mmol, 1 equiv) was added dropwise over ten 
minutes with stirring to form the “ate” complex. The solution was allowed to come to room 
temperature, and the contents of the vial were transferred to an NMR tube and analyzed 
using 1H NMR spectroscopy (see Figure 3.1b). The bismethanolato boron “ate” 3.51 was 
detected along with the doubly-vinylated methanolato boron “ate” 3.52 (see below) in a 
~3:1 3.51:3.52 ratio. 
  
                                                            
60 Elkin, P. K.; Levin, V. V.; Dilman, A. D.; Struchkova, M. I.; Belyakov, P. A.; Arkhipov, D. E.; Korlyukov, 
A. A.; Tartakovsky, V. A. Tetrahedron Lett. 2011, 52, 5259. 
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3.4.2.3. Independent Synthesis of Doubly-Vinylated Methanolato Boron “Ate” 
 
Dimethyl phenylboronate (3.55) was prepared following a literature procedure:60 
an oven-dried 2-dram vial equipped with a magnetic stir bar was charged with phenyl 
boronic acid (18.3 mg, 0.15 mmol, 1 equiv) and sealed with a septum cap. The atmosphere 
was exchanged with nitogen, trimethyl orthoformate (39.8 mg, 0.38 mmol, 2.5 equiv) and 
trifluoroacetic acid (2.2 mg, 0.019 mmol, 0.13 equiv) were added, and the reaction was 
allowed to stir for 15 minutes at room temperature. The volatiles were carefully removed 
under reduced pressure on the manifold vacuum, and the dimethyl phenylboronate residue 
was kept under vacuum for 30 minutes. This residue was then redissolved in anhydrous 
deuterated THF (0.6 mL), chilled to -78 °C in a dry ice-acetone bath, and vinyllithium 
solution in THF (0.30 mmol, 2 equiv) was added dropwise over ten minutes with stirring 
to form the “ate” complex. The solution was allowed to come to room temperature, and the 
contents of the vial were transferred to an NMR tube and analyzed using 1H NMR 
spectroscopy (see Figure 3.1c). The doubly-vinylated methanolato boron “ate” 3.52 was 
detected along with bismethanolato boron “ate” 3.51 (see above) in a ~1:1 ratio. 
3.4.2.4. Phenyl Boronic Acid, Pinacol Ester–Methanol Exchange 
 
An oven-dried 2-dram vial equipped with a magnetic stir bar was charged with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54) (30.6 mg, 0.15 mmol, 1 equiv) 
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and sealed with a septum cap. The atmosphere was exchanged with nitrogen, anhydrous 
deuterated THF (0.6 mL) and methanol (19.2 mg, 0.60 mmol, 4 equiv) were added, and 
the reaction was stirred at 60 ºC for 12 hours. After cooling to room temperature, the 
contents of the vial were transferred to an NMR tube and analyzed using 1H NMR 
spectroscopy. 
3.4.2.5. Pinacolato Boron “Ate”–Neopentyl Glycol Exchange 
 
In a glovebox filled with argon, an oven-dried 2-dram vial equipped with a 
magnetic stir bar was charged with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane 
(3.54) (30.6 mg, 0.15 mmol, 1 equiv) and anhydrous Et2O (0.3 mL), sealed with a septum 
cap, and removed from the glovebox. Outside the glovebox under positive nitrogen 
pressure, the vial was cooled to 0 ºC in an ice-water bath, and vinyllithium solution in THF 
(0.15 mmol, 1 equiv) was added dropwise with stirring to form the “ate” complex 3.43. 
The reaction vial was allowed to warm to room temperature and stir for 30 minutes. The 
solvent was carefully removed from the “ate” complex under reduced pressure, and the 
“ate” residue was kept under vacuum for 30 minutes before being brought back into the 
glovebox. In the glovebox, the “ate” residue was re-dissolved in anhydrous deuterated THF 
(0.6 mL) and neopentyl glycol (15.6 mg, 0.15 mmol, 1 equiv) was added. The vial was 
sealed with a polypropylene cap and electrical tape, brought out of the glovebox, and the 
reaction was stirred at 60 ºC for 12 hours. After cooling to room temperature, the contents 
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of the vial were transferred to an NMR tube and analyzed using 1H NMR spectroscopy (see 
Figure 3.2c). 
3.4.2.6. Neopentyl Glycolato Boron “Ate”–Pinacol Exchange 
 
In a glovebox filled with argon, an oven-dried 2-dram vial equipped with a 
magnetic stir bar was charged with 5,5-dimethyl-2-phenyl-1,3,2-dioxaborinane (28.5 mg, 
0.15 mmol, 1 equiv) and anhydrous Et2O (0.3 mL), sealed with a septum cap, and removed 
from the glovebox. Outside the glovebox under positive nitrogen pressure, the vial was 
cooled to 0 ºC in an ice-water bath, and vinyllithium solution in THF (0.15 mmol, 1 equiv) 
was added dropwise with stirring to form the “ate” complex 3.53. The reaction vial was 
allowed to warm to room temperature and stir for 30 minutes. The solvent was carefully 
removed from the “ate” complex under reduced pressure, and the “ate” residue was kept 
under vacuum for 30 minutes before being brought back into the glovebox. In the glovebox, 
the “ate” residue was re-dissolved in anhydrous deuterated THF (0.6 mL) and pinacol (17.7 
mg, 0.15 mmol, 1 equiv) was added. The vial was sealed with a polypropylene cap and 
electrical tape, brought out of the glovebox, and the reaction was stirred at 60 ºC for 12 
hours. After cooling to room temperature, the contents of the vial were transferred to an 
NMR tube and analyzed using 1H NMR spectroscopy (see Figure 3.2d). 
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3.4.3. Sonogashira Cross-Coupling Procedures for the Preparation of Substituted 
Propargylic Alcohols 
3.4.3.1. Method A: Procedure with Copper Co-Catalyst 
 
Following a literature procedure:61 An oven-dried vial equipped with a magnetic 
stir bar was charged with copper(I) iodide (6 mol %), bis(triphenylphosphine)palladium(II) 
dichloride (2 mol %), triethylamine (4.3 equiv), and arylhalide (1.05 equiv) in anhydrous 
THF (1 M) under nitrogen atmosphere. 2-methylbut-3-yn-2-ol (1 equiv) was added 
dropwise and the mixture was stirred at room temperature. Upon completion as checked 
by TLC, the reaction mixture was quenched with saturated aqueous NH4Cl and extracted 
with Et2O (3 x). The combined organic layers were washed with brine, dried over Na2SO4, 
filtered, concentrated under reduced pressure, and purified by silica gel column 
chromatography to afford pure substituted propargylic alcohol product. 
3.4.3.2. Method B: Copper-Free Procedure 
 
Following a literature procedure:62 In a glovebox filled with argon, an oven-dried 
vial equipped with a magnetic stir bar was charged with aryl halide (1 equiv), 2-methyl-3-
butyn-2-ol (1.5 equiv), palladium(II) acetate (5 mol %), triphenylphosphine (20 mol %), 
                                                            
61 Peng, J.; Gao, Y.; Hu, W.; Gao, Y.; Hu, M.; Wu, W.; Ren, Y.; Jiang, H. Org. Lett. 2016, 18, 5924. 
62 Paegle, E.; Belyakov, S.; Petrova, M.; Liepinsh, E.; Arsenyan, P. Eur. J. Org. Chem. 2015, 20, 4389. 
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and anhydrous K3PO4 (1.2 equiv) in anhydrous DMSO (0.5 M). The vial was sealed, 
removed from the glovebox, and stirred at 80 °C for 12-24 h. After cooling to room 
temperature, the reaction mixture was quenched with EtOAc (15 × volume) and water (2 x 
volume) and stirred for an additional 30 min. The mixture was transferred to a separatory 
funnel and the aqueous phase was separated. The organic phase was washed with brine (4 
x), dried over Na2SO4, filtered, concentrated under reduced pressure, and purified by silica 
gel column chromatography to afford pure substituted propargylic alcohol product. 
3.4.4. Procedures for the Preparation of Substituted Methyl Propargylic Carbonates 
3.4.4.1. Method A: Propargylic Alcohols and Methyl Chloroformate 
 
An oven-dried vial equipped with a magnetic stir bar was charged with propargylic 
alcohol (1 equiv) in anhydrous THF (0.25 M) under nitrogen atmosphere. The solution was 
chilled to -78 ℃ in a dry ice-acetone bath, and a hexane solution of n-butyllithium (1.1 
equiv) was added dropwise. After 1 hour, methyl chloroformate (1.5 equiv) was added 
dropwise at -78 ℃, and the solution was stirred for 1 hour before being warmed to room 
temperature. Upon completion as checked by TLC, the reaction mixture was quenched by 
addition of water. The reaction mixture was transferred to a separatory funnel, the organic 
layer was separated, and the aqueous layer was extracted twice with hexane. The combined 
organic phases were washed with brine, dried over Na2SO4, filtered, concentrated under 
reduced pressure, and purified by silica gel column chromatography to afford pure 
substituted methyl propargylic carbonate product. 
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3.4.4.2. Method B: Telescoped Acetylide Formation–Nucleophilic Addition to Ketone–
Reaction with Methyl Chloroformate 
 
An oven-dried vial equipped with a magnetic stir bar was charged with alkyne (1 
equiv) in anhydrous THF (0.25 M) under nitrogen atmosphere. The solution was chilled to 
-78 ℃ in a dry ice-acetone bath and a hexane solution of n-butyllithium (1.1 equiv) was 
added dropwise. After 20 minutes, the solution was warmed to room temperature and 
stirred for 1 hour. The solution was then chilled to -78 ℃, ketone (1 or 1.25 equiv) was 
added dropwise, and the solution was warmed to room temperature and stirred for one 
hour. The solution was then cooled to 0 ℃, methyl chloroformate (1.5 equiv) was added 
dropwise, and the solution was warmed to room temperature. Upon completion as checked 
by TLC, the reaction mixture was quenched by addition of water. The reaction mixture was 
transferred to a separatory funnel, the organic layer was separated, and the aqueous layer 
was extracted twice with hexane. The combined organic phases were washed with brine, 
dried over Na2SO4, filtered, concentrated under reduced pressure, and purified by silica gel 
column chromatography to afford pure substituted methyl propargylic carbonate product. 
4-(3,5-dimethylphenyl)-2-methylbut-3-yn-2-yl methyl 
carbonate (3.109). Prepared according to the general 
procedure above (Method A) with 4-(3,5-dimethylphenyl)-
2-methylbut-3-yn-2-ol (1.05 g, 5.58 mmol). The crude product was purified by silica gel 
column chromatography (30% EtOAc in hexanes, stained in KMnO4) to afford a clear, 
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yellow oil (821.0 mg, 60% yield). 1H NMR (500 MHz, CDCl3) δ 7.08 (s, 2H), 6.94 (s, 
1H), 3.78 (s, 3H), 2.27 (s, 6H), 1.78 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 153.6, 137.9, 
130.5, 129.7, 122.1, 88.8, 84.9, 74.9, 54.4, 29.1, 21.1. 
 
methyl {2-methyl-4-[4-(trifluoromethyl)phenyl]but-
3-yn-2-yl} carbonate (3.110). Prepared according to the 
general procedure above (Method A) with 2-methyl-4-[4-(trifluoromethyl)phenyl]but-3-
yn-2-ol (456.4 mg, 2.00 mmol). The crude product was purified by silica gel column 
chromatography (30% EtOAc in hexanes, stained in KMnO4) to afford a clear, yellow oil 
(446.5 mg, 78% yield). 1H NMR (500 MHz, CDCl3) δ 7.63 – 7.49 (m, 4H), 3.79 (s, 3H), 
1.80 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 153.6, 132.2, 130.4 (q, J = 32.7 Hz), 126.4, 
125.3 (q, J = 3.8 Hz), 124.0 (q, J = 272.1 Hz), 92.0, 83.3, 74.6, 54.6, 28.9. 
 
4-(4-fluorophenyl)-2-methylbut-3-yn-2-yl methyl 
carbonate (3.111). Prepared according to the general 
procedure above (Method A) with 4-(4-fluorophenyl)-2-methylbut-3-yn-2-ol (980.1 mg, 
5.50 mmol). The crude product was purified by silica gel column chromatography (30% 
EtOAc in hexanes, stained in KMnO4) to afford a clear, orange oil (1.25 g, 96% yield). 1H 
NMR (500 MHz, CDCl3) 7.45 – 7.39 (m, 2H), 7.03 – 6.96 (m, 2H), 3.78 (s, 3H), 1.78 (s, 
6H). 13C NMR (126 MHz, CDCl3) δ 162.7 (d, J = 249.8 Hz), 153.6, 133.9 (d, J = 8.4 Hz), 
118.6 (d, J = 3.4 Hz), 115.5 (d, J = 22.1 Hz), 89.2 (d, J = 1.5 Hz), 83.5, 74.7, 54.4, 28.9. 
19F NMR (470 MHz, CDCl3) δ -110.73. 
 
386
   
methyl [2-methyl-4-(naphthalen-2-yl)but-3-yn-2-yl] 
carbonate (3.112). Prepared according to the general 
procedure above (Method A) with 2-methyl-4-(naphthalen-2-yl)but-3-yn-2-ol (1.10 g, 
5.23 mmol). The crude product was purified by silica gel column chromatography (30% 
EtOAc in hexanes, stained in KMnO4) to afford a yellow solid (1.00 g, 71% yield). 1H 
NMR (500 MHz, CDCl3) δ 7.97 (d, J = 1.5 Hz, 1H), 7.84 – 7.74 (m, 3H), 7.52 – 7.45 (m, 
3H), 3.80 (s, 3H), 1.84 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 153.7, 133.03, 132.98, 
132.0, 128.6, 128.0, 127.89, 127.85, 126.8, 126.6, 119.8, 89.8, 85.0, 75.0, 54.5, 29.1. 
 
methyl [2-methyl-4-(pyridin-2-yl)but-3-yn-2-yl] carbonate 
(3.113). Prepared according to the general procedure above 
(Method A) with 2-methyl-4-(pyridin-2-yl)but-3-yn-2-ol (261.0 mg, 1.62 mmol). The 
crude product was purified by silica gel column chromatography (30% EtOAc in hexanes, 
stained in KMnO4) to afford a brown oil (227.2 mg, 64% yield). 1H NMR (500 MHz, 
CDCl3) δ 8.53 (d, J = 4.9 Hz, 1H), 7.60 (app t, J = 7.7 Hz, 1H), 7.41 (dd, J = 7.9, 1.2 Hz, 
1H), 7.19 (dd, J = 7.6, 4.9 Hz, 1H), 3.74 (s, 3H), 1.78 (s, 6H). 13C NMR (126 MHz, CDCl3) 
δ 153.6, 150.0, 142.7, 136.2, 127.5, 123.1, 89.3, 83.8, 74.3, 54.5, 28.8. 
 
4-(furan-3-yl)-2-methylbut-3-yn-2-yl methyl carbonate 
(3.114). Prepared according to the general procedure above 
(Method A) with 4-(furan-3-yl)-2-methylbut-3-yn-2-ol (583.7 mg, 3.89 mmol). The crude 
product was purified by silica gel column chromatography (30% EtOAc in hexanes, stained 
in KMnO4) to afford a clear, yellow oil (642.8 mg, 79% yield). 1H NMR (600 MHz, 
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CDCl3) δ 7.63 – 7.57 (m, 1H), 7.35 (t, J = 1.6 Hz, 1H), 6.44 (d, J = 1.9 Hz, 1H), 3.77 (s, 
2H), 1.77 (s, 6H). 13C NMR (151 MHz, CDCl3) δ 153.51, 146.08, 142.74, 112.61, 106.77, 
91.24, 75.83, 74.68, 54.26, 28.85. 
 
4-(furan-2-yl)-2-methylbut-3-yn-2-yl methyl carbonate 
(3.115). Prepared according to the general procedure above 
(Method A) with 4-(furan-3-yl)-2-methylbut-3-yn-2-ol (300.4 mg, 2.00 mmol). The crude 
product was purified by silica gel column chromatography (30% EtOAc in hexanes, stained 
in KMnO4) to afford a clear, yellow oil (205.0 mg, 49% yield). 1H NMR (500 MHz, 
CDCl3) δ 7.37 (dd, J = 1.8, 0.7 Hz, 1H), 6.61 (d, J = 3.4 Hz, 1H), 6.37 (dd, J = 3.4, 1.9 Hz, 
1H), 3.77 (s, 3H), 1.78 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 153.6, 143.9, 136.5, 116.1, 
111.0, 93.7, 75.1, 74.6, 54.6, 28.8. 
 
2,5-dimethylhex-5-en-3-yn-2-yl methyl carbonate (3.116). 
Prepared according to the general procedure above (Method B) 
with 2-methylbut-1-en-3-yne (363.6 mg, 5.50 mmol, 1.1 equiv) and acetone (290.4 mg, 
5.00 mmol, 1 equiv). The crude product was purified by silica gel column chromatography 
(30% EtOAc in hexanes, stained in KMnO4) to afford a clear, colorless oil (801.1 mg, 88% 
yield). 1H NMR (500 MHz, CDCl3) δ 5.30 (dd, J = 2.0, 1.0 Hz, 1H), 5.23 (app p, J = 1.7 
Hz, 1H), 3.76 (s, 3H), 1.88 (dd, J = 1.6, 1.0 Hz, 3H), 1.72 (s, 6H). 13C NMR (126 MHz, 
CDCl3) δ 153.5, 126.2, 122.5, 88.5, 85.7, 74.7, 54.3, 28.9, 23.3. 
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methyl (2-methyl-6-phenylhexa-3,5-diyn-2-yl) carbonate 
(3.117). Prepared according to the general procedure above 
(Method A) with 2-methyl-6-phenylhexa-3,5-diyn-2-ol (650.0 mg, 3.53 mmol). The crude 
product was purified by silica gel column chromatography (30% EtOAc in hexanes, stained 
in KMnO4) to afford a clear, colorless oil (650.2 mg, 76% yield). 1H NMR (500 MHz, 
CDCl3) δ 7.48 (d, J = 6.8 Hz, 2H), 7.36 (t, J = 7.4 Hz, 1H), 7.31 (app t, J = 7.3 Hz, 2H), 
3.79 (s, 3H), 1.75 (s, 6H). 13C NMR (101 MHz, CDCl3) δ 153.6, 132.6, 129.4, 128.5, 121.5, 
82.1, 79.6, 74.3, 73.2, 69.6, 54.6, 28.7. 
 
5-methoxy-2-methylpent-3-yn-2-yl methyl carbonate 
(3.118). Prepared according to the general procedure above 
(Method B) with 3-methoxyprop-1-yne (280.4 mg, 4.00 mmol, 1 equiv) and acetone 
(232.3 mg, 4.00 mmol, 1 equiv). The crude product was purified by silica gel column 
chromatography (30% EtOAc in hexanes, stained in KMnO4) to afford a clear, colorless 
oil (501.5 mg, 67% yield). 1H NMR (400 MHz, CDCl3) δ 4.13 (s, 2H), 3.76 (s, 3H), 3.37 




methyl carbonate (3.119). Prepared according to the general 
procedure above (Method B) with tert-butyldimethyl(prop-2-yn-1-yloxy)silane (681.3 
mg, 4.00 mmol, 1 equiv) and acetone (232.3 mg, 4.00 mmol, 1 equiv). The crude product 
was purified by silica gel column chromatography (30% EtOAc in hexanes, stained in 
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KMnO4) to afford a clear, colorless oil (578.2 mg, 50% yield). 1H NMR (400 MHz, CDCl3) 
δ 4.35 (s, 2H), 3.75 (s, 3H), 1.69 (s, 6H), 0.91 (s, 9H), 0.12 (s, 6H). 13C NMR (126 MHz, 
CDCl3) δ 153.6, 85.2, 83.5, 74.4, 54.4, 51.9, 28.9, 25.9, 18.4, -5.00. 
 
4-(cyclohex-1-en-1-yl)-2-methylbut-3-yn-2-yl methyl 
carbonate (3.120). Prepared according to the general 
procedure above (Method B) with 1-ethynylcyclohex-1-ene (583.9 mg, 5.50 mmol) and 
acetone (290.4 mg, 5.00 mmol). The crude product was purified by silica gel column 
chromatography (30% EtOAc in hexanes, stained in KMnO4) to afford a clear, colorless 
oil (800.0 mg, 72% yield). 1H NMR (500 MHz, CDCl3) δ 6.11 (tt, J = 3.8, 1.7 Hz, 1H), 
3.75 (s, 3H), 2.13 – 2.04 (m, 4H), 1.70 (s, 6H), 1.65 – 1.52 (m, 4H). 13C NMR δ 153.6, 
135.8, 120.1, 86.9, 86.4, 75.1, 54.3, 29.20, 29.15, 25.7, 22.4, 21.6. 
 
methyl [1-(phenylethynyl)cyclobutyl] carbonate (3.121). 
Prepared according to the general procedure above (Method B) 
with phenylacetylene (674.1 mg, 6.60 mmol) and cyclobutanone (498.9 mg, 6.00 mmol). 
The crude product was purified by silica gel column chromatography (30% EtOAc in 
hexanes, stained in KMnO4) to afford a clear, colorless oil (1.32 g, 96% yield). 1H NMR 
(500 MHz, CDCl3) δ 7.55 – 7.42 (m, 2H), 7.35 – 7.25 (m, 3H), 3.80 (s, 3H), 2.75 – 2.62 
(m, 2H), 2.55 (qd, J = 9.7, 2.8 Hz, 2H), 2.10 – 1.89 (m, 2H). 13C NMR (126 MHz, CDCl3) 




   
methyl [2-methyl-4-(thiophen-2-yl)but-3-yn-2-yl] carbonate 
(3.90). Prepared according to the general procedure above 
(Method A) with 2-methyl-4-(thiophen-2-yl)but-3-yn-2-ol (831.2 mg, 5.00 mmol). The 
crude product was purified by silica gel column chromatography (30% EtOAc in hexanes, 
stained in KMnO4) to afford a clear, yellow oil (850.0 mg, 76% yield). 1H NMR (400 
MHz, CDCl3) δ 7.27 – 7.24 (m, 1H), 7.22 (dd, J = 3.7, 1.2 Hz, 1H), 6.96 (dd, J = 5.2, 3.6 
Hz, 1H), 3.78 (s, 3H), 1.79 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 153.6, 132.8, 127.6, 
127.0, 122.4, 93.3, 78.0, 74.9, 54.5, 28.9. 
3.4.5. General Procedure for the Synthesis of β-Hydroxy Allenes by Conjunctive Cross-
Coupling 
 
In a glovebox filled with argon, an oven-dried 2-dram vial equipped with a 
magnetic stir bar was charged with Pd2(dba)3 (4.1 mg, 0.0045 mmol, 0.015 equiv), (SP,SP)-
MandyPhos (11.4 mg, 0.0108 mmol, 0.036 equiv), and anhydrous THF (1 mL). The 
Pd/ligand solution was allowed to stir for at least one hour at room temperature inside the 
glovebox. Meanwhile, a second oven-dried 2-dram vial equipped with a magnetic stir bar 
was charged with 2-aryl(or alkenyl or alkyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.30 
mmol, 1 equiv) and anhydrous Et2O (1 mL). This second vial was sealed with a septum 
cap and removed from the glovebox. Outside the glovebox under positive nitrogen 
pressure, the reaction vial was cooled to 0 ºC in an ice-water bath, and vinyllithium solution 
in THF (0.30 mmol, 1 equiv) was added dropwise with stirring to form the ‘ate’ complex. 
The reaction vial was allowed to warm to room temperature and stir for 30 minutes. The 
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solvent was carefully removed from the ‘ate’ complex under reduced pressure, and the ‘ate’ 
residue was kept under vacuum for 30 minutes before being brought back into the 
glovebox. In the glovebox, the ‘ate’ residue was re-dissolved in anhydrous THF (1 mL), 
and the Pd/ligand solution was transferred into the reaction vial, followed by methyl 
propargylic carbonate (0.60 mmol, 2 equiv), either methanol (38.5 mg, 1.2 mmol, 4 equiv) 
or 2,2,2-trifluoroethanol (80.0 mg, 1.2 mmol, 4 equiv), and anhydrous THF (1 mL, used to 
rinse the Pd/ligand vial). The reaction vial was sealed with a polypropylene cap and 
electrical tape, brought out of the glovebox, and stirred at 60 ºC for 18 hours. After cooling 
to room temperature, the reaction solution was filtered through a silica gel plug with Et2O 
washing and concentrated under reduced pressure. If desired, the residue was purified by 
silica gel column chromatography prior to oxidation. For oxidation to the corresponding β-
hydroxy allene, the β-allenyl boronic ester was dissolved in a THF:H2O mixture (1:1 ratio, 
3 mL), and sodium perborate tetrahydrate (4 equiv) was added. The suspension was 
allowed to stir under air for 12-24 hours before being diluted with water (2 mL) and 
extracted with EtOAc (3 x 3 mL). The combined organic phases were dried over Na2SO4, 
filtered, concentrated under reduced pressure, and purified by silica gel column 
chromatography to afford pure product. 
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3.4.6. Characterization of β-Hydroxy Allene Products 
(R)-5-methyl-1,3-diphenylhexa-3,4-dien-1-ol (3.62). Prepared 
according to the general procedure above with 4,4,5,5-tetramethyl-
2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 0.30 mmol, 1 equiv), 
methyl (2-methyl-4-phenylbut-3-yn-2-yl) carbonate (131.0 mg, 0.60 mmol, 2 equiv), 
(147.8 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude 
product was purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, 
stained in KMnO4) to afford a clear, colorless oil (66.7 mg, 84% yield). 1H NMR (600 
MHz, CDCl3) δ 7.44 – 7.34 (m, 6H), 7.32 (app t, J = 7.7 Hz, 2H), 7.28 (t, J = 7.3 Hz, 1H), 
7.21 (t, J = 7.3 Hz, 1H), 4.91 (dd, J = 7.9, 5.3 Hz, 1H), 2.96 – 2.78 (m, 2H), 2.29 (d, J = 2.7 
Hz, 1H), 1.77 (s, 3H), 1.73 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 202.4, 144.0, 137.6, 
129.7, 128.53, 128.52, 127.6, 126.7, 126.2, 115.4, 100.4, 99.5, 72.8, 40.6, 20.6, 20.3. IR 
(neat) νmax 3316.67 (br), 3028.99 (w), 2979.23 (w), 2904.31 (m), 1951.00 (w), 1595.96 
(m), 1491.53 (s), 1442.43 (s), 1386.35 (m), 1361.01 (m), 1183.57 (m), 1058.33 (s), 1029.08 
(s), 911.34 (m), 757.45 (s), 699.28 (s), 595.27 (m), 549.70 (m) cm-1. HRMS (DART+) for 
C19H19 [M+H–H2O]+ calculated: 247.1481, found: 247.1476. [α]D20: +33.915 (c = 3.20, 
CHCl3, l = 50 mm). 
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Analysis of Stereochemistry: 
Chiral SFC (Chiracel OJ-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-5-methyl-1,3-diphenylhexa-3,4-dien-1-ol (3.62). 
 




   
(R)-3-(3,5-dimethylphenyl)-5-methyl-1-phenylhexa-3,4-dien-1-
ol (3.63). Prepared according to the general procedure above with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 
0.30 mmol, 1 equiv), 4-(3,5-dimethylphenyl)-2-methylbut-3-yn-2-
yl methyl carbonate (3.109, 147.8 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 
mmol, 4 equiv). The crude product was purified by silica gel column chromatography (0% 
→ 30% EtOAc in hexanes, stained in KMnO4) to afford a clear, colorless oil (70.0 mg, 
80% yield). 1H NMR (500 MHz, CDCl3) δ 7.41 (d, J = 7.9 Hz, 2H), 7.36 (app t, J = 7.5 
Hz, 2H), 7.29 (d, J = 7.8 Hz, 1H), 6.97 (s, 2H), 6.86 (s, 1H), 4.94 – 4.84 (m, 1H), 2.91 – 
2.77 (m, 2H), 2.31 (s, 3H), 2.29 (d, J = 2.2 Hz, 1H), 1.77 (s, 3H), 1.73 (s, 3H). 13C NMR 
(126 MHz, CDCl3) δ 202.3, 144.1, 138.0, 137.6, 128.52, 128.51, 127.6, 126.2, 124.1, 
100.5, 99.2, 72.8, 40.9, 21.6, 20.7, 20.4. IR (neat) νmax 3367.62 (br), 3029.13 (w), 2978.28 
(w), 2910.77 (m), 2855.59 (w), 1953.60 (w), 1742.82 (w), 1597.18 (s), 1452.57 (s), 
1376.37 (m), 1184.71 (m), 1057.22 (s), 1036.55 (s), 846.42 (s), 760.61 (s), 698.15 (s), 
600.41 (m) cm-1. HRMS (DART+) for C21H23 [M+H–H2O]+ calculated: 275.1794, found: 
275.1792. [α]D20: +32.277 (c = 1.13, CHCl3, l = 50 mm). 
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Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-3-(3,5-dimethylphenyl)-5-methyl-1-phenylhexa-3,4-dien-1-ol (3.63).  
 






   
(R)-5-methyl-1-phenyl-3-[4-(trifluoromethyl)phenyl]hexa-3,4-
dien-1-ol (3.64). Prepared according to the general procedure above 
with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 
mg, 0.30 mmol, 1 equiv), methyl {2-methyl-4-[4-
(trifluoromethyl)phenyl]but-3-yn-2-yl} carbonate (3.110, 171.8 mg, 0.60 mmol, 2 equiv), 
and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was purified by silica gel 
column chromatography (0% → 30% EtOAc in hexanes, stained in KMnO4) to afford a 
clear, colorless oil (95.6 mg, 96% yield). 1H NMR (600 MHz, CDCl3) δ 7.55 (d, J = 8.1 
Hz, 2H), 7.45 (d, J = 8.2 Hz, 2H), 7.42 – 7.34 (m, 4H), 7.29 (t, J = 6.9 Hz, 1H), 4.89 (dd, J 
= 7.6, 5.6 Hz, 1H), 2.99 – 2.81 (m, 2H), 2.23 (d, J = 7.5 Hz, 1H), 1.76 (s, 3H), 1.71 (s, 3H). 
13C NMR (151 MHz, CDCl3) δ 203.4, 143.8, 141.7, 129.8, 128.6, 128.5 (q, J = 32.4 Hz), 
127.8, 126.3, 126.2, 125.4 (q, J = 3.6 Hz), 124.4 (q, J = 271.8 Hz), 115.4, 100.2, 99.7, 73.0, 
40.2, 20.3, 20.1. 19F NMR (470 MHz, CDCl3) δ -62.39. IR (neat) νmax 3340.32 (br), 
3028.34 (w), 2982.33 (w), 2910.11 (w), 2854.40 (w), 1613.91 (m), 1452.17 (w), 1382.43 
(w), 1324.80 (s), 1163.28 (s), 1120.69 (s), 1066.65 (s), 1013.66 (m), 842.01 (m), 765.36 
(w), 699.49 (m), 549.05 (w) 508.42 (w) cm-1. HRMS (DART+) for C20H18F3 [M+H–H2O]+ 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OJ-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-5-methyl-1-phenyl-3-[4-(trifluoromethyl)phenyl]hexa-3,4-dien-1-ol (3.64). 
 





   
(R)-3-(4-fluorophenyl)-5-methyl-1-phenylhexa-3,4-dien-1-ol 
(3.65). Prepared according to the general procedure above with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 
0.30 mmol, 1 equiv), 4-(4-fluorophenyl)-2-methylbut-3-yn-2-yl 
methyl carbonate (3.111, 94.5 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 
4 equiv). The crude product was purified by silica gel column chromatography (0% → 
30% EtOAc in hexanes, stained in KMnO4) to afford a clear, colorless oil (34.0 mg, 60% 
yield). 1H NMR (500 MHz, CDCl3) δ 7.43 – 7.26 (m, 7H), 7.00 (app t, J = 8.7 Hz, 2H), 
4.88 (app t, J = 6.6 Hz, 1H), 2.84 (d, J = 6.6 Hz, 2H), 2.28 (d, J = 3.7 Hz, 1H), 1.76 (s, 3H), 
1.71 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 202.2, 161.8 (d, J = 245.6 Hz), 143.9, 133.6 
(d, J = 3.0 Hz), 128.5, 127.7, 127.6, 126.2, 115.3 (d, J = 21.5 Hz), 99.7, 99.6, 72.9, 40.7, 
20.6, 20.3. 19F NMR (470 MHz, CDCl3) δ -116.37 (tt, J = 8.3, 5.4 Hz). IR (neat) νmax 
3377.99 (br), 3031.17 (w), 2978.92 (w), 2908.20 (m), 1954.09 (w), 1751.33 (m), 1701.51 
(m), 1601.40 (m), 1506.70 (s), 1446.04 (m), 1362.70 (m), 1228.73 (s), 1158.42 (s), 1032.51 
(s), 911.79 (m), 834.84 (s), 753.10 (m), 699.79 (s), 585.09 (w) cm-1. HRMS (DART+) for 
C19H18F [M+H–H2O]+ calculated: 265.1387, found: 265.1385. [α]D20: +33.402 (c = 1.40, 




Analysis of Stereochemistry: 
Chiral SFC (Chiracel OJ-H, 3% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-3-(4-fluorophenyl)-5-methyl-1-phenylhexa-3,4-dien-1-ol (3.65).  
Enantiomer mixture       Standard conditions 
400
(R)-5-methyl-3-(naphthalen-2-yl)-1-phenylhexa-3,4-dien-1-ol 
(3.66). Prepared according to the general procedure above with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 
0.30 mmol, 1 equiv), methyl [2-methyl-4-(naphthalen-2-yl)but-3-
yn-2-yl] carbonate (3.112, 161.0 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 
mmol, 4 equiv). The crude product was purified by silica gel column chromatography (0% 
→ 30% EtOAc in hexanes, stained in KMnO4) to afford a clear, yellow oil (79.0 mg, 84%
yield). 1H NMR (500 MHz, CDCl3) δ 7.83 – 7.72 (m, 4H), 7.54 (dd, J = 8.6, 1.9 Hz, 1H), 
7.49 – 7.41 (m, 4H), 7.38 (app t, J = 7.5 Hz, 2H), 7.30 (t, J = 7.2 Hz, 1H), 4.99 (ddd, J = 
6.6, 6.6, 2.5 Hz, 1H), 3.01 (app d, J = 6.5 Hz, 2H), 2.30 (d, J = 2.7 Hz, 1H), 1.81 (s, 3H), 
1.76 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 203.1, 144.1, 135.0, 133.7, 132.5, 128.6, 
128.1, 127.9, 127.69, 127.66, 126.26, 126.25, 125.8, 125.6, 123.6, 100.7, 99.9, 72.9, 40.6, 
20.7, 20.4. IR (neat) νmax 3363.50 (br), 3055.00 (w), 2978.55 (w), 2905.64 (m), 1951.38 
(w), 1628.14 (w), 1597.29 (m), 1503.95 (m), 1448.56 (m), 1273.50 (m), 1192.11 (m), 
1063.02 (s), 1019.88 (s), 888.82 (m), 855.40 (s), 817.91 (s), 699.12 (s) cm-1. HRMS 
(DART+) for C23H23O [M+H]+ calculated: 315.1743, found: 315.1732. [α]D20: +33.810 (c 
= 3.64, CHCl3, l = 50 mm). 
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Analysis of Stereochemistry: 
Chiral SFC (Chiracel OJ-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-5-methyl-3-(naphthalen-2-yl)-1-phenylhexa-3,4-dien-1-ol (3.66). 
 







(3.67). Prepared according to the general procedure above with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 
0.30 mmol, 1 equiv), methyl [2-methyl-4-(pyridin-2-yl)but-3-yn-2-yl] carbonate (3.113, 
131.5 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude 
product was purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, 
stained in KMnO4) to afford a red solid (57.1 mg, 72% yield). 1H NMR (500 MHz, CDCl3) 
δ 8.51 (ddd, J = 4.9, 1.6, 0.9 Hz, 1H), 7.60 (ddd, J = 7.8, 7.8, 1.8 Hz, 1H), 7.46 – 7.36 (m, 
2H), 7.36 – 7.28 (m, 3H), 7.19 (t, J = 7.3 Hz, 1H), 7.10 (ddd, J = 7.4, 5.0, 1.2 Hz, 1H), 5.05 
(dd, J = 7.2, 2.9 Hz, 1H), 3.00 (dd, J = 14.2, 3.0 Hz, 1H), 2.89 (dd, J = 14.2, 7.2 Hz, 1H), 
1.76 (s, 3H), 1.74 (s, 1H), 1.46 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 206.1, 157.7, 147.7, 
145.6, 136.7, 128.1, 126.7, 126.0, 122.7, 121.0, 102.2, 98.6, 74.4, 41.5, 20.1, 19.7. IR 
(neat) νmax 3200.40 (br), 3060.03 (w), 3026.75 (w), 2979.43 (w), 2906.69 (m), 2856.51 
(m), 1953.09 (w), 1590.56 (s), 1562.44 (s), 1428.82 (s), 1388.34 (m), 1183.59 (m), 1150.68 
(m), 1089.32 (m), 1061.29 (s), 784.91 (s), 744.08 (s), 698.47 (s), 597.17 (m) cm-1. HRMS 
(DART+) for C18H20NO [M+H]+ calculated: 266.1539, found: 266.1538. [α]D20: +2.086 (c 
= 2.37, CHCl3, l = 50 mm). 
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Analysis of Stereochemistry: 
Chiral SFC (Chiracel ODR-H, 3% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis 
of (R)-5-methyl-1-phenyl-3-(pyridin-2-yl)hexa-3,4-dien-1-ol (3.67). 
 





   
(R)-3-(furan-3-yl)-5-methyl-1-phenylhexa-3,4-dien-1-ol (3.68). 
Prepared according to the general procedure above with 4,4,5,5-
tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 0.30 
mmol, 1 equiv), 4-(furan-3-yl)-2-methylbut-3-yn-2-yl methyl carbonate (3.114, 124.9 mg, 
0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was 
purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in 
KMnO4) to afford a clear, colorless oil (58.6 mg, 77% yield). 1H NMR (500 MHz, CDCl3) 
δ 7.42 – 7.34 (m, 6H), 7.28 (t, J = 7.2 Hz, 1H), 6.34 (dd, J = 1.8, 1.0 Hz, 1H), 4.95 – 4.88 
(m, 1H), 2.73 – 2.60 (m, 2H), 2.32 (s, 1H), 1.74 (s, 3H), 1.71 (s, 3H). 13C NMR (126 MHz, 
CDCl3) δ 201.2, 143.9, 143.3, 138.1, 128.5, 127.7, 126.7, 126.2, 126.1, 124.3, 109.5, 99.2, 
93.2, 72.8, 41.4, 20.7, 20.5. IR (neat) νmax 3370.38 (br), 3059.85 (w), 3026.89 (w), 2977.30 
(w), 2904.64 (m), 2854.55 (w), 1949.97 (w), 1595.60 (w), 1491.86 (m), 1445.66 (m), 
1360.26 (m), 1156.37 (m), 1046.89 (s), 1026.25 (s), 1012.74 (s), 871.11 (s), 751.98 (s), 
696.61 (s), 592.95 (s), 547.86 (m) cm-1. HRMS (DART+) for C17H15O [M+H–H2O]+ 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OJ-H, 7% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-3-(furan-3-yl)-5-methyl-1-phenylhexa-3,4-dien-1-ol (3.68). 
 




   
(R)-3-(furan-2-yl)-5-methyl-1-phenylhexa-3,4-dien-1-ol (3.69). 
Prepared according to the general procedure above with 4,4,5,5-
tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 0.30 
mmol, 1 equiv), 4-(furan-2-yl)-2-methylbut-3-yn-2-yl methyl carbonate (3.115, 124.9 mg, 
0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was 
purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in 
KMnO4) to afford a clear, colorless oil (37.1 mg, 49% yield). 1H NMR (500 MHz, CDCl3) 
δ 7.42 – 7.38 (m, 2H), 7.38 – 7.34 (m, 3H), 7.28 (t, J = 7.2 Hz, 1H), 6.39 (dd, J = 3.3, 1.8 
Hz, 1H), 6.20 (dd, J = 3.3, 0.8 Hz, 1H), 4.91 (dd, J = 8.1, 5.1 Hz, 1H), 2.80 – 2.66 (m, 2H), 
2.27 (s, 1H), 1.77 (s, 3H), 1.72 (s, 3H). 13C NMR (126 MHz, CDCl3) δ 201.0, 151.5, 143.8, 
141.9, 128.5, 127.7, 126.7, 126.20, 126.15, 111.4, 106.0, 100.6, 93.1, 73.0, 40.3, 20.9, 20.6. 
IR (neat) νmax 3425.64 (br), 3029.20 (w), 2973.05 (m), 2929.10 (m), 2911.42 (m), 1951.60 
(w), 1664.66 (m), 1602.89 (m), 1492.25 (m), 1450.84 (m), 1361.07 (m), 1154.51 (m), 
1056.04 (s), 1024.49 (s), 755.89 (s), 699.51 (s), 595.33 (w) cm-1. HRMS (DART+) for 
C17H15O [M+H–H2O]+ calculated: 235.1117, found: 235.1118. [α]D20: +19.318 (c = 1.67, 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 3% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-3-(furan-2-yl)-5-methyl-1-phenylhexa-3,4-dien-1-ol (3.69). 
 





   
(R)-1-(4-methoxyphenyl)-5-methyl-3-phenylhexa-3,4-
dien-1-ol (3.80). Prepared according to the general 
procedure above with 2-(4-methoxyphenyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (70.2 mg, 0.30 mmol), methyl (2-methyl-4-phenylbut-3-
yn-2-yl) carbonate (131.0 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 
equiv). The crude product was purified by silica gel column chromatography (0% → 30% 
EtOAc in hexanes, stained in KMnO4) to afford a clear, colorless oil (78.4 mg, 89% yield). 
1H NMR (600 MHz, CDCl3) δ 7.39 (d, J = 7.2 Hz, 2H), 7.36 – 7.30 (m, 5H), 6.91 (d, J = 
8.6 Hz, 2H), 4.87 (app t, J = 6.5 Hz, 1H), 3.82 (s, 3H), 2.88 (m, 2H), 2.38 (br s, 1H), 1.77 
(s, 3H), 1.74 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 202.5, 159.1, 137.6, 136.2, 131.7, 
128.5, 128.3, 127.4, 126.6, 126.1, 113.8, 100.4, 99.3, 72.4, 55.4, 40.4, 20.5, 20.2. IR (neat) 
νmax 3370.85 (br), 2906.07 (w), 2832.59 (w), 2004.68 (w), 1610.75 (m), 1510.42 (s), 
1442.17 (m), 1246.09 (s), 1175.41 (m), 1034.87 (m), 829.06 (m), 759.38 (w), 693.94 (w) 
cm-1. HRMS (DART+) for C20H21O [M+H–H2O]+ calculated: 277.1587, found: 277.1584. 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 6% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-1-(4-methoxyphenyl)-5-methyl-3-phenylhexa-3,4-dien-1-ol (3.80). 
 
                     Enantiomer mixture                                             Standard conditions 
 
410
   
(R)-5-methyl-3-phenyl-1-[4-(trifluoromethyl)phenyl] 
hexa-3,4-dien-1-ol (3.81). Prepared according to the 
general procedure above with 4,4,5,5-tetramethyl-2-[4-
(trifluoromethyl)phenyl]-1,3,2-dioxaborolane (81.6 mg, 0.3 mmol), methyl (2-methyl-4-
phenylbut-3-yn-2-yl) carbonate (131.0 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 
1.2 mmol, 4 equiv). The crude product was purified by silica gel column chromatography 
(0% → 30% EtOAc in hexanes, stained in KMnO4) to afford a clear, colorless oil (67.6 
mg, 68% yield). 1H NMR (600 MHz, CDCl3) δ 7.62 (d, J = 8.1 Hz, 2H), 7.52 (d, J = 8.1 
Hz, 2H), 7.37 (d, J = 8.1 Hz, 2H), 7.34 (app t, J = 7.7 Hz, 2H), 7.23 (t, J = 7.1 Hz, 1H), 
4.97 (dd, J = 7.9, 5.3 Hz, 1H), 2.94 – 2.76 (m, 2H), 2.42 (d, J = 8.5 Hz, 1H), 1.79 (s, 3H), 
1.72 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 202.4, 147.9, 137.3, 129.8 (q, J = 32.3 Hz), 
128.6, 126.9, 126.5, 126.2, 125.4 (q, J = 3.7 Hz), 124.3 (q, J = 273.3 Hz), 100.1, 99.8, 72.3, 
40.8, 20.6, 20.2. 19F NMR (470 MHz, CDCl3) δ -62.51. IR (neat) νmax 3397.78 (br), 
3059.62 (w), 2977.96 (w), 2931.10 (w), 1688.90 (m), 1617.52 (m), 1447.60 (m), 1411.95 
(m), 1321.00 (s), 1161.87 (s), 1120.08 (s), 1064.33 (s), 1015.07 (m), 906.92 (m), 839.05 
(m), 757.22 (m), 730.14 (s), 692.02 (m), 600.82 (m) cm-1. HRMS (DART+) for C20H18F3 
[M+H–H2O]+ calculated: 315.1355, found: 315.1356. [α]D20: +18.777 (c = 2.93, CHCl3, l 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 6% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-5-methyl-3-phenyl-1-(4-(trifluoromethyl)phenyl)hexa-3,4-dien-1-ol (3.81). 
 





   
(R)-1-(4-bromophenyl)-5-methyl-3-phenylhexa-3,4-
dien-1-ol (3.82). Prepared according to the general 
procedure above with 2-(4-bromophenyl)-4,4,5,5-
tetramethyl-1,3,2-dioxaborolane (84.9 mg, 0.30 mmol, 1 equiv), methyl (2-methyl-4-
phenylbut-3-yn-2-yl) carbonate (131.0 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 
1.2 mmol, 4 equiv). The crude product was purified by silica gel column chromatography 
(0% → 30% EtOAc in hexanes, stained in KMnO4) to afford a clear, colorless oil (93.6 
mg, 91% yield). 1H NMR (500 MHz, CDCl3) δ 7.49 (d, J = 8.4 Hz, 2H), 7.37 (d, J = 7.0 
Hz, 2H), 7.33 (app t, J = 7.7 Hz, 2H), 7.28 (d, J = 8.3 Hz, 2H), 7.22 (t, J = 7.1 Hz, 1H), 
4.87 (app t, J = 6.2 Hz, 1H), 2.83 (app d, J = 7.1 Hz, 2H), 2.39 (s, 1H), 1.79 (s, 3H), 1.74 
(s, 3H). 13C NMR (126 MHz, CDCl3) δ 202.4, 143.0, 137.4, 131.5, 128.6, 127.9, 126.8, 
126.1, 121.3, 100.1, 99.6, 72.2, 40.6, 20.6, 20.3. IR (neat) νmax 3279.08 (br), 3025.20 (w), 
2978.58 (w), 2904.52 (m), 2358.91 (w), 2159.61 (w), 1952.99 (w), 1646.21 (w), 1616.53 
(w), 1588.54 (m), 1489.34 (s), 1443.71 (m), 1267.93 (m), 1182.14 (m), 1068.80 (s), 
1009.41 (s), 759.69 (s), 694.14 (s) cm-1. HRMS (DART+) for C19H18Br [M+H–H2O]+ 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis 
of (R)-1-(4-bromophenyl)-5-methyl-3-phenylhexa-3,4-dien-1-ol (3.82). 
 





   
(R)-1-(2-chlorophenyl)-5-methyl-3-phenylhexa-3,4-dien-1-ol 
(3.83). Prepared according to the general procedure above with 
2-(2-chlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
(71.6 mg, 0.30 mmol, 1 equiv), methyl (2-methyl-4-phenylbut-3-yn-2-yl) carbonate (131.0 
mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product 
was purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, stained 
in KMnO4) to afford a clear, colorless oil (78.0 mg, 87% yield). 1H NMR (400 MHz, 
CDCl3) δ 7.65 (dd, J = 7.7, 1.7 Hz, 1H), 7.43 (dd, J = 8.4, 1.2 Hz, 2H), 7.38 – 7.27 (m, 4H), 
7.25 – 7.17 (m, 2H), 5.32 (ddd, J = 8.8, 3.3, 3.3 Hz, 1H), 3.04 (dd, J = 15.2, 3.9 Hz, 1H), 
2.65 (dd, J = 15.2, 8.9 Hz, 1H), 2.40 (d, J = 2.9 Hz, 1H), 1.82 (s, 3H), 1.78 (s, 3H). 13C 
NMR (101 MHz, CDCl3) δ 202.5, 141.4, 137.3, 132.2, 129.5, 129.1, 128.6, 127.4, 127.2, 
126.8, 126.3, 100.4, 99.8, 69.2, 39.0, 20.6, 20.4. IR (neat) νmax 3381.51 (br), 3060.26 (w), 
2904.44 (w), 1954.13 (w), 1596.02 (m), 1492.05 (m), 1473.44 (m), 1442.16 (s), 1182.42 
(m), 1126.86 (m), 1031.93 (s), 693.73 (s) cm-1. HRMS (DART+) for C19H18Cl [M+H–





   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-1-(2-chlorophenyl)-5-methyl-3-phenylhexa-3,4-dien-1-ol (3.83). 
 





   
(R)-1-cyclopropyl-5-methyl-3-phenylhexa-3,4-dien-1-ol (3.86). 
Prepared according to the general procedure above with 2-
cyclopropyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (60.0 mg, 
0.30 mmol, 1 equiv), methyl (2-methyl-4-phenylbut-3-yn-2-yl) carbonate (131.0 mg, 0.60 
mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was 
purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in 
KMnO4) to afford a clear, colorless oil (44.1 mg, 64% yield). 1H NMR (600 MHz, CDCl3) 
δ 7.37 (dd, J = 8.3, 1.3 Hz, 2H), 7.31 (dd, J = 8.4, 7.1 Hz, 2H), 7.19 (app t, J = 7.3 Hz, 1H), 
3.15 (dddd, J = 8.4, 3.7, 2.0, 2.0 Hz, 1H), 2.80 (dd, J = 15.0, 3.7 Hz, 1H), 2.65 (dd, J = 
15.0, 8.6 Hz, 1H), 1.98 (d, J = 2.4 Hz, 1H), 1.839 (s, 3H), 1.835 (s, 3H), 1.01 (dddd, J = 
9.8, 8.1, 8.1, 4.9 Hz, 1H), 0.58 – 0.48 (m, 2H), 0.41 – 0.34 (m, 1H), 0.29 – 0.22 (m, 1H). 
13C NMR (151 MHz, CDCl3) δ 202.2, 137.8, 128.5, 126.6, 126.2, 100.6, 99.0, 74.8, 38.7, 
20.7, 20.5, 17.4, 2.9, 2.5. IR (neat) νmax 3408.90 (br), 3081.64 (w), 3007.34 (w), 2978.12 
(w), 2930.37 (w), 2096.11 (w), 1716.14 (m), 1597.93 (w), 1447.30 (w), 1272.84 (w), 
1214.54 (m), 1175.87 (m), 1025.30 (m), 961.49 (m), 747.95 (s), 696.99 (s), 665.45 (m) cm-
1. HRMS (DART+) for C16H19 [M+H–H2O]+ calculated: 211.1481, found: 211.1485. 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel AD-H, 6% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-1-cyclopropyl-5-methyl-3-phenylhexa-3,4-dien-1-ol (3.86). 
 





   
(R)-1-[4-(N,N-diphenylamino)phenyl]-5-methyl-3-
phenylhexa-3,4-dien-1-ol (3.84). Prepared according to 
the general procedure above with N,N-diphenyl-4-
(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline (111.4 mg, 0.30 mmol, 1 equiv), 
methyl (2-methyl-4-phenylbut-3-yn-2-yl) carbonate (131.0 mg, 0.60 mmol, 2 equiv), and 
methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was purified by silica gel 
column chromatography (0% → 30% EtOAc in hexanes, stained in KMnO4) to afford a 
dark yellow oil (111.2 mg, 86% yield). 1H NMR (500 MHz, CDCl3) δ 7.68 (d, J = 8.8 Hz, 
1H), 7.40 – 7.29 (m, 4H), 7.28 – 7.15 (m, 10H), 7.09 – 7.05 (m, 2H), 7.03 – 6.96 (m, 2H), 
4.85 (app t, J = 6.6 Hz, 1H), 2.95 – 2.83 (m, 2H), 2.23 (s, 1H), 1.78 (s, 3H), 1.76 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 190.6, 153.5, 148.0, 147.3, 146.3, 143.5, 138.2, 137.6, 
131.5, 130.7, 129.9, 129.3, 129.2, 129.1, 128.5, 127.2, 126.7, 126.5, 126.2, 125.3, 124.3, 
124.2, 123.0, 122.8, 119.5, 100.4, 99.4, 72.6, 40.4, 20.6, 20.4. IR (neat) νmax 3423.95 (br), 
3055.47 (w), 3031.38 (w), 2920.00 (m), 2849.39 (w), 1948.23 (w), 1689.22 (m), 1581.42 
(s), 1505.72 (m), 1486.66 (s), 1447.84 (m), 1313.19 (m), 1270.78 (s), 1161.24 (m), 908.04 
(m), 826.35 (m), 752.93 (s), 693.34 (s), 621.75 (m) cm-1. HRMS (DART+) for C31H28N 
[M+H–H2O]+ calculated: 414.2216, found: 414.2208. [α]D20: +14.524 (c = 5.56, CHCl3, l 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis 
of (R)-1-[4-(N,N-diphenylamino)phenyl]-5-methyl-3-phenylhexa-3,4-dien-1-ol (3.84). 
 
                     Enantiomer mixture                                             Standard conditions 
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(R)-1-(cyclohex-1-en-1-yl)-5-methyl-3-phenylhexa-3,4-dien-
1-ol (3.85). Prepared according to the general procedure above 
with 2-(cyclohexen-1-yl)-4,4,5,5-tetramethyl-1,3,2-
dioxaborolane (62.4 mg, 0.30 mmol, 1 equiv), methyl (2-methyl-4-phenylbut-3-yn-2-yl) 
carbonate (131.0 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). 
The crude product was purified by silica gel column chromatography (0% → 30% EtOAc 
in hexanes, stained in KMnO4) to afford a clear, colorless oil (50.8 mg, 63% yield). 1H 
NMR (400 MHz, CDCl3) δ 7.38 – 7.35 (m, 2H), 7.31 (app t, J = 8.0 Hz, 2H), 7.19 (t, J = 
8.0 Hz, 1H), 5.70 (s, 1H), 4.18 (app t, J = 6.4 Hz, 1H), 2.71 (dd, J = 14.9, 5.1 Hz, 1H), 2.61 
(dd, J = 14.9, 7.9 Hz, 1H), 2.20 – 2.09 (m, 1H), 2.07 – 1.91 (m, 3H), 1.91 – 1.82 (m, 1H), 
1.82 (s, 6H), 1.72 – 1.49 (m, 4H). 13C NMR (101 MHz, CDCl3) δ 202.3, 139.2, 137.9, 
128.5, 126.6, 126.2, 123.6, 100.5, 99.0, 74.8, 36.6, 25.2, 24.0, 22.8, 22.7, 20.8, 20.5. IR 
(neat) νmax 3351.78 (br), 3057.43 (w), 2926.66 (s), 2857.01 (m), 2360.23 (w), 1597.17 (m), 
1492.26 (m), 1445.73 (s), 1359.37 (w), 1236.71 (w), 1182.95 (m), 1086.06 (s), 1057.76 
(s), 1013.18 (s), 919.41 (m), 758.64 (s), 692.99 (s), 623.10 (m) cm-1. HRMS (DART+) for 
C19H23 [M+H–H2O]+ calculated: 251.1794, found: 251.1794. [α]D20: +10.886 (c = 2.32, 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 3% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-1-(cyclohex-1-en-1-yl)-5-methyl-3-phenylhexa-3,4-dien-1-ol (3.85). 
 




   
(R)-5-methyl-1-phenyl-3-(prop-1-en-2-yl)hexa-3,4-dien-1-ol 
(3.70). Prepared according to the general procedure above with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 
0.30 mmol, 1 equiv), 2,5-dimethylhex-5-en-3-yn-2-yl methyl carbonate (3.116, 109.3 mg, 
0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was 
purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in 
KMnO4) to afford a clear, colorless oil (29.1 mg, 42% yield). 1H NMR (500 MHz, CDCl3) 
δ 7.42 – 7.31 (m, 4H), 7.30 – 7.24 (m, 1H), 4.96 (s, 1H), 4.91 (s, 1H), 4.86 (dd, J = 8.2, 5.0 
Hz, 1H), 2.69 – 2.55 (m, 2H), 2.23 (s, 1H), 1.80 (s, 3H), 1.70 (s, 3H), 1.66 (s, 3H). 13C 
NMR (126 MHz, CDCl3) δ 203.3, 144.2, 141.3, 128.5, 127.5, 126.1, 110.4, 102.3, 98.5, 
72.9, 40.0, 22.1, 20.7, 20.4. IR (neat) νmax 3368.30 (br), 3087.61 (w), 3062.64 (w), 3029.31 
(w), 2975.01 (m), 2916.79 (s), 2856.66 (m), 2358.97 (w), 1952.87 (w), 1617.43 (m), 
1450.14 (s), 1374.37 (m), 1184.91 (m), 1058.61 (m), 1034.90 (m), 878.77 (m), 699.15 (s) 
cm-1. HRMS (DART+) for C16H21O [M+H]+ calculated: 229.1587, found: 229.1579. 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel AD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-5-methyl-1-phenyl-3-(prop-1-en-2-yl)hexa-3,4-dien-1-ol (3.70). 
 





   
(R)-5-methyl-1-phenyl-3-(phenylethynyl)hexa-3,4-dien-1-ol 
(3.72). Prepared according to the general procedure above with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 
0.30 mmol, 1 equiv), methyl (2-methyl-6-phenylhexa-3,5-diyn-2-
yl) carbonate (3.117, 145.4 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 
equiv). The crude product was purified by silica gel column chromatography (0% → 30% 
EtOAc in hexanes, stained in KMnO4) to afford a yellow solid (61.8 mg, 71% yield). 1H 
NMR (500 MHz, CDCl3) δ 7.46 – 7.40 (m, 4H), 7.39 – 7.34 (m, 2H), 7.33 – 7.27 (m, 4H), 
5.00 (app t, J = 6.7 Hz, 1H), 2.68 – 2.55 (m, 2H), 2.28 (s, 1H), 1.72 (s, 3H), 1.62 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 208.2, 143.6, 131.6, 128.5, 128.4, 128.2, 127.7, 126.2, 
123.6, 97.9, 90.1, 85.8, 84.4, 73.0, 44.7, 20.5, 20.2. IR (neat) νmax 3351.30 (br), 3030.37 
(w), 2981.47 (w), 2905.88 (m), 2206.29 (w), 1952.35 (w), 1596.80 (m), 1490.50 (s), 
1441.63 (s), 1273.40 (m), 1182.94 (m), 1057.22 (s), 1026.11 (s), 911.91 (m), 690.49 (s), 
580.24 (m), 550.04 (m) cm-1. HRMS (DART+) for C21H19 [M+H–H2O]+ calculated: 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-5-methyl-1-phenyl-3-(phenylethynyl)hexa-3,4-dien-1-ol (3.72). 
 




   
(S)-8-methyl-1,6-diphenylnona-6,7-dien-4-ol (3.87). 
Prepared according to the general procedure above with 
4,4,5,5-tetramethyl-2-(3-phenylpropyl)-1,3,2-
dioxaborolane (73.9 mg, 0.3 mmol, 1 equiv), methyl (2-methyl-4-phenylbut-3-yn-2-yl) 
carbonate (131.0 mg, 0.60 mmol, 2 equiv), and 2,2,2-trifluoroethanol (120.1 mg, 1.2 mmol, 
4 equiv). The crude product was purified by silica gel column chromatography (0% → 
30% EtOAc in hexanes, stained in KMnO4) to afford a clear, colorless oil (59.2 mg, 64% 
yield). 1H NMR (600 MHz, CDCl3) δ 7.38 (d, J = 7.5 Hz, 2H), 7.35 – 7.28 (m, 4H), 7.24 
– 7.18 (m, 4H), 3.86 (dddd, J = 8.3, 8.3, 4.3, 4.3 Hz, 1H), 2.68 (app t, J = 7.7 Hz, 2H), 2.64 
(dd, J = 15.0, 3.9 Hz, 1H), 2.50 (dd, J = 15.0, 8.5 Hz, 1H), 1.97 (s, 1H), 1.93 – 1.87 (m, 
1H), 1.85 (s, 6H), 1.80 – 1.70 (m, 1H), 1.69 – 1.58 (m, 2H). 13C NMR (151 MHz, CDCl3) 
δ 202.0, 142.5, 137.7, 128.6, 128.5, 128.4, 126.7, 126.2, 125.8, 100.7, 99.1, 70.2, 38.8, 
36.6, 36.1, 27.7, 20.7, 20.5. IR (neat) νmax 3446.68 (br), 3056.68 (w), 3024.16 (w), 2974.02 
(w), 2932.82 (m), 2864.76 (w), 2021.99 (w), 1717.95 (s), 1597.95 (m), 1493.08 (s), 
1449.31 (s), 1362.12 (m), 1272.85 (m), 1173.02 (s), 754.85 (s), 698.67 (s) cm-1. HRMS 
(DART+) for C22H25 [M+H–H2O]+ calculated: 289.1951, found: 289.1944. [α]D20: +5.816 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OJ-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(S)-8-methyl-1,6-diphenylnona-6,7-dien-4-ol (3.87). 
 




   
(R)-2,7-dimethyl-5-phenylocta-5,6-dien-3-ol (3.88). Prepared 
according to the general procedure above with 2-isopropyl-
4,4,5,5-tetramethyl-1,3,2-dioxaborolane (51.0 mg, 0.3 mmol), 
methyl (2-methyl-4-phenylbut-3-yn-2-yl) carbonate (131.0 mg, 0.60 mmol, 2 equiv), and 
2,2,2-trifluoroethanol (120.1 mg, 1.2 mmol, 4 equiv). The crude product was purified by 
silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in KMnO4) to 
afford a clear, colorless oil (30.8 mg, 45% yield). 1H NMR (600 MHz, CDCl3) δ 7.37 (d, 
J = 7.3 Hz, 2H), 7.32 (app t, J = 7.6 Hz, 2H), 7.20 (t, J = 7.3 Hz, 1H), 3.60 (ddd, J = 9.0, 
5.0, 3.0 Hz, 1H), 2.70 (dd, J = 15.0, 3.1 Hz, 1H), 2.42 (dd, J = 15.0, 9.3 Hz, 1H), 1.90 (s, 
1H), 1.85 (s, 3H), 1.84 (s, 3H), 1.81 (m, 1H), 1.01 (d, J = 6.8 Hz, 6H). 13C NMR (151 
MHz, CDCl3) δ 202.1, 137.8, 128.5, 126.7, 126.2, 101.0, 99.1, 74.7, 35.8, 33.3, 20.8, 20.5, 
19.1, 17.6. IR (neat) νmax 3459.49 (br), 3056.26 (w), 3022.03 (w), 2955.56 (s), 2928.96 (s), 
2904.91 (s), 2869.80 (s), 1944.99 (w), 1650.42 (w), 1619.12 (m), 1491.51 (m), 1445.32 
(m), 1361.61 (m), 1182.23 (m), 1051.43 (m), 997.64 (m), 908.01 (w), 759.89 (s), 693.01 
(s) cm-1. HRMS (DART+) for C16H21 [M+H–H2O]+ calculated: 213.1638, found: 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel AD-H, 6% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-2,7-dimethyl-5-phenylocta-5,6-dien-3-ol (3.88). 
 




   
(R)-3-(methoxymethyl)-5-methyl-1-phenylhexa-3,4-dien-1-ol 
(3.75). Prepared according to the general procedure above with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 
0.30 mmol, 1 equiv), 5-methoxy-2-methylpent-3-yn-2-yl methyl carbonate (3.118, 111.7 
mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product 
was purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, stained 
in KMnO4) to afford a clear, colorless oil (57.4 mg, 82% yield). 1H NMR (500 MHz, 
CDCl3) δ 7.38 (d, J = 7.5 Hz, 2H), 7.32 (app t, J = 7.6 Hz, 2H), 7.24 (t, J = 7.2 Hz, 1H), 
4.80 (dd, J = 8.3, 4.2 Hz, 1H), 3.87 (s, 2H), 3.39 (s, 1H), 3.31 (s, 3H), 2.51 (dd, J = 14.7, 
4.2 Hz, 1H), 2.42 (dd, J = 14.7, 8.2 Hz, 1H), 1.67 (s, 3H), 1.60 (s, 3H). 13C NMR (151 
MHz, CDCl3) δ 202.1, 144.2, 128.3, 127.2, 126.0, 96.1, 95.3, 75.0, 73.3, 57.6, 41.4, 20.63, 
20.61. IR (neat) νmax 3410.38 (br), 3058.75 (w), 3026.95 (w), 2976.18 (m), 2904.52 (m), 
2852.26 (m), 2815.93 (m), 1492.14 (w), 1448.67 (m), 1401.99 (w), 1360.64 (w), 1186.57 
(m), 1145.15 (w), 1081.72 (s), 1067.50 (s), 943.26 (w), 905.95 (w), 756.09 (m), 699.05 (s), 
582.43 (w), 547.41 (w) cm-1. HRMS (DART+) for C14H17O [M+H–H2O]+ calculated: 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 6% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-3-(methoxymethyl)-5-methyl-1-phenylhexa-3,4-dien-1-ol (3.75). 
 






   
(R)-3-{[(tert-butyldimethylsilyl)oxy]methyl}-5-methyl-1-
phenylhexa-3,4-dien-1-ol (3.76). Prepared according to the general 
procedure above with 4,4,5,5-tetramethyl-2-phenyl-1,3,2-
dioxaborolane (3.54, 61.2 mg, 0.30 mmol, 1 equiv), 5-[(tert-
butyldimethylsilyl)oxy]-2-methylpent-3-yn-2-yl methyl carbonate (3.119, 171.9 mg, 0.60 
mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was 
purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in 
KMnO4) to afford a clear, colorless oil (91.8 mg, 92% yield). 1H NMR (500 MHz, CDCl3) 
δ 7.40 (d, J = 7.1 Hz, 2H), 7.33 (app t, J = 7.6 Hz, 2H), 7.24 (t, J = 7.3 Hz, 1H), 4.82 (d, J 
= 8.6 Hz, 1H), 4.13 (s, 2H), 3.64 (s, 1H), 2.54 (dd, J = 14.6, 3.7 Hz, 1H), 2.39 (dd, J = 14.6, 
8.7 Hz, 1H), 1.68 (s, 3H), 1.62 (s, 3H), 0.94 (s, 9H), 0.12 (s, 6H). 13C NMR (151 MHz, 
CDCl3) δ 200.7, 144.5, 128.3, 127.2, 126.0, 98.5, 96.5, 73.4, 65.9, 41.5, 26.0, 20.7, 20.6, 
18.5, -5.2. IR (neat) νmax 3417.36 (br), 3059.53 (w), 3027.38 (w), 2950.33 (m), 2926.42 
(m), 2902.99 (m), 2853.60 (m), 1754.39 (w), 1460.86 (m), 1360.35 (m), 1253.17 (s), 
1140.77 (w), 1055.66 (s), 835.62 (s), 776.21 (s), 698.59 (s) cm-1. HRMS (DART+) for 
C20H31OSi [M+H–H2O]+ calculated: 315.2139, found: 315.2135. [α]D20: +5.007 (c = 0.85, 




   
Analysis of Stereochemistry: 








   
(R)-3-(cyclohex-1-en-1-yl)-5-methyl-1-phenylhexa-3,4-dien-1-ol 
(3.71). Prepared according to the general procedure above with 
4,4,5,5-tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 
0.30 mmol, 1 equiv), 4-(cyclohex-1-en-1-yl)-2-methylbut-3-yn-2-yl methyl carbonate 
(3.120, 133.4 mg, 0.60 mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The 
crude product was purified by silica gel column chromatography (0% → 30% EtOAc in 
hexanes, stained in KMnO4) to afford a white solid (73.7 mg, 92% yield). 1H NMR (600 
MHz, CDCl3) δ 7.39 (d, J = 7.1 Hz, 2H), 7.34 (app t, J = 7.5 Hz, 2H), 7.28 – 7.24 (m, 1H), 
5.74 (app t, J = 4.1 Hz, 1H), 4.84 (ddd, J = 8.6, 2.9, 2.5 Hz, 1H), 2.62 (dd, J = 15.1, 4.1 Hz, 
1H), 2.54 (dd, J = 15.1, 8.9 Hz, 1H), 2.30 (d, J = 2.6 Hz, 1H), 2.15 – 2.10 (m, 2H), 2.06 – 
2.01 (m, 2H), 1.70 (s, 3H), 1.67 (s, 3H), 1.66 – 1.62 (m, 2H), 1.61 – 1.55 (m, 2H). 13C 
NMR (126 MHz, CDCl3) δ 201.7, 144.3, 133.7, 128.4, 127.4, 126.1, 122.5, 102.5, 98.8, 
72.8, 39.9, 27.4, 26.1, 23.1, 22.6, 21.0, 20.7. IR (neat) νmax 3353.31 (br), 3030.25 (w), 
2977.52 (w), 2924.55 (s), 2855.97 (m), 2832.86 (m), 1948.31 (w), 1446.46 (m), 1360.45 
(w), 1184.23 (w), 1060.09 (m), 1016.94 (m), 914.70 (w), 754.04 (m), 698.65 (s), 599.10 
(w) cm-1. HRMS (DART+) for C19H23 [M+H–H2O]+ calculated: 251.1794, found: 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel AD-H, 7% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-3-(cyclohex-1-en-1-yl)-5-methyl-1-phenylhexa-3,4-dien-1-ol (3.71). 
 




   
(R)-4-cyclobutylidene-1,3-diphenylbut-3-en-1-ol (3.77). Prepared 
according to the general procedure above with 4,4,5,5-tetramethyl-2-
phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 0.30 mmol, 1 equiv), methyl [1-
(phenylethynyl) cyclobutyl] carbonate (3.121, 138.2 mg, 0.60 mmol, 2 equiv), and 
methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was purified by silica gel 
column chromatography (0% → 30% EtOAc in hexanes, stained in KMnO4) to afford a 
white solid (60.0 mg, 72% yield). 1H NMR (500 MHz, CDCl3) δ 7.46 – 7.41 (m, 4H), 7.37 
(app t, J = 7.5 Hz, 2H), 7.33 (app t, J = 7.6 Hz, 2H), 7.29 (t, J = 7.3 Hz, 1H), 7.22 (t, J = 
7.3 Hz, 1H), 4.95 (ddd, J = 7.8, 3.4, 3.4 Hz, 1H), 3.06 – 2.95 (m, 2H), 2.95 – 2.82 (m, 4H), 
2.38 (d, J = 2.6 Hz, 1H), 2.09 – 1.96 (m, 2H). 13C NMR (126 MHz, CDCl3) δ 195.7, 144.0, 
137.4, 128.6, 128.5, 127.6, 127.0, 126.3, 126.1, 105.2, 104.9, 72.7, 40.9, 30.2, 30.0, 17.6. 
IR (neat) νmax 3358.98 (br), 3060.04 (w), 3029.09 (w), 2952.12 (w), 2921.01 (m), 1946.97 
(w), 1596.21 (w), 1493.50 (m), 1451.94 (m), 1415.79 (w), 1021.56 (m), 909.79 (m), 761.50 
(s), 693.23 (s), 594.58 (m) cm-1. HRMS (DART+) for C20H19 [M+H–H2O]+ calculated: 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OD-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-4-cyclobutylidene-1,3-diphenylbut-3-en-1-ol (3.77). 
 




   
(R)-4-cyclopentylidene-1,3-diphenylbut-3-en-1-ol (3.78). 
Prepared according to the general procedure above with 4,4,5,5-
tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 0.30 
mmol, 1 equiv), methyl (1-(phenylethynyl)cyclopentyl) carbonate (146.6 mg, 0.60 mmol, 
2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was purified by 
silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in KMnO4) to 
afford a white solid (60.3 mg, 69% yield). 1H NMR (600 MHz, CDCl3) δ 7.42 (d, J = 7.1 
Hz, 2H), 7.40 – 7.34 (m, 4H), 7.32 (app t, J = 7.7 Hz, 2H), 7.29 (t, J = 7.3 Hz, 1H), 7.20 (t, 
J = 7.3 Hz, 1H), 4.92 (ddd, J = 7.9, 4.5, 2.7 Hz, 1H), 2.92 (dd, J = 15.2, 4.6 Hz, 1H), 2.85 
(dd, J = 15.2, 8.4 Hz, 1H), 2.53 – 2.41 (m, 2H), 2.40 – 2.28 (m, 3H), 1.81 – 1.69 (m, 4H). 
13C NMR (151 MHz, CDCl3) δ 197.9, 144.0, 137.7, 128.6, 128.52, 128.49, 127.6, 126.7, 
126.2, 108.3, 102.9, 72.8, 40.7, 31.4, 31.1, 27.31, 27.27. IR (neat) νmax 3380.51 (br), 
3029.03 (w), 2952.51 (m), 2866.65 (w), 1946.38 (w), 1597.36 (w), 1492.49 (m), 1450.98 
(m), 1390.39 (w), 1309.55 (w), 1197.36 (w), 1022.01 (m), 944.97 (w), 909.70 (w), 755.81 
(s), 693.27 (s) cm-1. HRMS (DART+) for C21H21 [M+H–H2O]+ calculated: 273.1638, 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OJ-H, 8% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-4-cyclopentylidene-1,3-diphenylbut-3-en-1-ol (3.78). 
 




   
(R)-4-cyclohexylidene-1,3-diphenylbut-3-en-1-ol (3.79). 
Prepared according to the general procedure above with 4,4,5,5-
tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 0.30 
mmol, 1 equiv), methyl (1-(phenylethynyl)cyclohexyl) carbonate (155.0 mg, 0.60 mmol, 
2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was purified by 
silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in KMnO4) to 
afford a white solid (78.3 mg, 86% yield). 1H NMR (500 MHz, CDCl3) δ 7.41 (app t, J = 
7.2 Hz, 4H), 7.39 – 7.25 (m, 5H), 7.20 (t, J = 7.3 Hz, 1H), 4.93 (app t, J = 6.6 Hz, 1H), 2.95 
– 2.79 (m, 2H), 2.36 (d, J = 2.6 Hz, 1H), 2.28 – 2.14 (m, 3H), 2.14 – 2.06 (m, 1H), 1.74 – 
1.48 (m, 6H). 13C NMR (151 MHz, CDCl3) δ 198.6, 144.0, 137.7, 128.6, 128.5, 127.6, 
126.6, 126.2, 126.1, 107.0, 100.3, 72.8, 40.9, 31.7, 31.5, 27.8, 26.2. IR (neat) νmax 3363.21 
(br), 3029.35 (w), 2924.69 (s), 2851.29 (m), 1949.82 (w), 1596.36 (w), 1492.15 (m), 
1446.21 (m), 1341.51 (w), 1262.38 (w), 1200.70 (w), 1021.95 (m), 908.97 (w), 759.96 (s), 
694.14 (s), 584.18 (w) cm-1. HRMS (DART+) for C22H23 [M+H–H2O]+ calculated: 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel AD-H, 10% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis 
of (R)-4-cyclohexylidene-1,3-diphenylbut-3-en-1-ol (3.79). 
 





   
(S)-1-cyclohexylidene-2-phenylocta-1,7-dien-4-ol (3.89). 
Prepared according to the general procedure above with 2-but-
3-enyl-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (54.6 mg, 0.3 
mmol), methyl (1-(phenylethynyl)cyclohexyl) carbonate (155.0 mg, 0.60 mmol, 2 equiv), 
and 2,2,2-trifluoroethanol (120.1 mg, 1.2 mmol, 4 equiv). The crude product was purified 
by silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in KMnO4) 
to afford a clear, colorless oil (32.6 mg, 38% yield). 1H NMR (500 MHz, CDCl3) δ 7.39 
(d, J = 7.2 Hz, 2H), 7.31 (app t, J = 7.8 Hz, 2H), 7.19 (t, J = 7.3 Hz, 1H), 5.87 (dddd, J = 
16.9, 10.1, 6.6, 6.6, 1H), 5.06 (dddd, J = 17.1, 1.7, 1.7, 1.7 Hz, 1H), 4.98 (dddd, J = 10.2, 
2.2, 1.3, 1.3 Hz, 1H), 3.93 – 3.82 (m, 1H), 2.64 (dd, J = 15.1, 4.0 Hz, 1H), 2.51 (dd, J = 
15.1, 8.3 Hz, 1H), 2.34 – 2.12 (m, 6H), 1.99 (s, 1H), 1.73 – 1.64 (m, 6H), 1.60 (m, 2H). 
13C NMR (126 MHz, CDCl3) δ 198.3, 138.8, 137.9, 128.5, 126.6, 126.1, 114.8, 106.7, 
100.4, 69.9, 38.8, 36.1, 31.8, 31.6, 30.3, 27.87, 27.86, 26.2. IR (neat) νmax 3384.87 (br), 
2924.43 (s), 2849.95 (m), 1639.02 (w), 1595.76 (w), 1503.86 (w), 1444.76 (m), 1054.09 
(w), 906.84 (m), 758.26 (s), 692.73 (s) cm-1. HRMS (DART+) for C20H25 [M+H–H2O]+ 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OJ-H, 3% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(S)-1-cyclohexylidene-2-phenylocta-1,7-dien-4-ol (3.89). 
 




   
(R)-6,6-dimethyl-2-phenyl-4-(thiophen-2-yl)-3,6-dihydro-2H-pyran 
(3.92). Prepared according to the general procedure above with 4,4,5,5-
tetramethyl-2-phenyl-1,3,2-dioxaborolane (3.54, 61.2 mg, 0.30 mmol, 1 
equiv), methyl (2-methyl-4-(thiophen-2-yl)but-3-yn-2-yl) carbonate (3.90, 134.6 mg, 0.60 
mmol, 2 equiv), and methanol (38.5 mg, 1.2 mmol, 4 equiv). The crude product was 
purified by silica gel column chromatography (0% → 30% EtOAc in hexanes, stained in 
KMnO4) to afford a clear, yellow oil (57.6 mg, 71% yield), which spontaneously cyclized 
to the 3,6-dihydro-2H-pyran. 1H NMR (600 MHz, CDCl3) δ 7.47 (d, J = 7.4 Hz, 2H), 7.39 
(app t, J = 7.6 Hz, 2H), 7.31 (t, J = 7.4 Hz, 1H), 7.17 (dd, J = 4.5, 1.7 Hz, 1H), 7.00 – 6.96 
(m, 2H), 6.11 (d, J = 2.1 Hz, 1H), 4.84 (dd, J = 10.2, 3.6 Hz, 1H), 2.67 – 2.52 (m, 2H), 1.44 
(s, 3H), 1.43 (s, 3H). 13C NMR (151 MHz, CDCl3) δ 145.0, 142.8, 129.9, 128.6, 127.7, 
127.6, 127.5, 126.4, 123.7, 122.3, 74.0, 71.1, 35.3, 29.9, 26.1. IR (neat) νmax 3029.31 (w), 
2972.43 (s), 2926.86 (m), 2029.07 (w), 1643.09 (w), 1604.31 (w), 1494.83 (m), 1452.51 
(m), 1379.22 (m), 1359.59 (m), 1239.14 (s), 1177.62 (m), 1150.63 (s), 1068.24 (s), 1025.19 
(m), 975.53 (m), 913.94 (w), 849.61 (m), 820.38 (m), 750.85 (s), 558.14 (m) cm-1. HRMS 
(DART+) for C17H19OS [M+H]+ calculated: 271.1151, found: 271.1141. [α]D20: +37.694 




   
Analysis of Stereochemistry: 
Chiral SFC (Chiracel OJ-H, 5% IPA, 3 mL/min, 100 bar, 35 °C, 210-270 nm) analysis of 
(R)-6,6-dimethyl-2-phenyl-4-(thiophen-2-yl)-3,6-dihydro-2H-pyran (3.92). 
 





   
3.4.7. General Procedure for the Gold-Catalyzed Cyclization of β-Hydroxy Allenes to 3,6-
Dihydro-2H-pyran Derivatives 
 
Following a modified literature procedure:75 A vial equipped with a magnetic stir bar was 
charged with triphenylphosphinegold(I) chloride (0.15 equiv), silver tetrafluoroborate 
(0.15 equiv), and THF (0.015 M) and stirred for five minutes. A solution of β-hydroxy 
allene (1 equiv) in THF (0.1 M) was added, and the resulting solution was stirred at room 
temperature. Upon completion as checked by TLC, the reaction solution was filtered 
through a silica gel plug with Et2O washing, concentrated under reduced pressure, and 
purified by silica gel column chromatography to afford pure product. 
 
(R)-6,6-dimethyl-2,4-diphenyl-3,6-dihydro-2H-pyran (3.93). Prepared 
according to the general procedure above with (R)-5-methyl-1,3-
diphenylhexa-3,4-dien-1-ol (3.62, 63.8 mg, 0.24 mmol, 1 equiv) in THF 
(2.4 mL), and triphenylphosphinegold(I) chloride (17.9 mg, 0.036 mmol, 0.15 equiv) and 
silver tetrafluoroborate (7.0 mg, 0.036 mmol, 0.15 equiv) in THF (2.4 mL). The crude 
product was purified by silica gel column chromatography (15% EtOAc in hexanes, stained 
in KMnO4) to afford a white solid (51.7 mg, 81% yield). 1H NMR (500 MHz, CDCl3) δ 
7.50 (d, J = 7.1 Hz, 2H), 7.43 (dd, J = 8.4, 1.3 Hz, 2H), 7.40 (app t, J = 7.6 Hz, 2H), 7.35 
(app t, J = 7.6 Hz, 2H), 7.32 (t, J = 7.4 Hz, 1H), 7.28 (t, J = 7.3 Hz, 1H), 6.13 (dd, J = 2.2, 
1.0 Hz, 1H), 4.85 (dd, J = 9.4, 4.3 Hz, 1H), 2.69 – 2.55 (m, 2H), 1.47 (s, 3H), 1.46 (s, 3H). 
13C NMR (126 MHz, CDCl3) δ 143.1, 140.4, 132.8, 131.2, 128.59, 128.56, 127.6, 127.4, 
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126.4, 125.1, 74.1, 71.4, 35.1, 30.0, 26.2. IR (neat) νmax 3082.92 (w), 3056.58 (w), 3025.26 
(w), 2969.36 (m), 2923.97 (w), 2893.73 (w), 2861.82 (w), 1598.69 (w), 1493.71 (m), 
1445.25 (m), 1375.83 (m), 1357.91 (m), 1237.60 (m), 1180.36 (m), 1160.13 (m), 1090.77 
(m), 1067.26 (m), 1027.11 (m), 966.69 (w), 934.61 (w), 878.46 (w), 858.92 (w), 750.27 
(s), 694.99 (s), 562.23 (w), 546.48 (w) cm-1. HRMS (DART+) for C19H19 [M+H–H2O]+ 
calculated: 247.1481, found: 247.1478. [α]D20: +76.464 (c = 2.59, CHCl3, l = 50 mm). 
 
(R)-tert-butyl[(6,6-dimethyl-2-phenyl-3,6-dihydro-2H-pyran-4-
yl)methoxy] dimethylsilane (3.94). Prepared according to the general 
procedure above with (R)-3-{[(tert-butyldimethylsilyl)oxy]methyl}-5-
methyl-1-phenylhexa-3,4-dien-1-ol (3.76, 133.0 mg, 0.40 mmol, 1 equiv) in THF (4 mL), 
and triphenylphosphinegold(I) chloride (29.7 mg, 0.060 mmol, 0.15 equiv) and silver 
tetrafluoroborate (11.7 mg, 0.060 mmol, 0.15 equiv) in THF (4 mL). The crude product 
was purified by silica gel column chromatography (15% EtOAc in hexanes, stained in 
KMnO4) to afford a clear, colorless oil (100.0 mg, 75% yield). 1H NMR (500 MHz, CDCl3) 
δ 7.42 (d, J = 7.0 Hz, 2H), 7.35 (app t, J = 7.6 Hz, 2H), 7.27 (t, J = 7.3 Hz, 1H), 5.64 (m, 
1H), 4.70 (dd, J = 9.2, 4.7 Hz, 1H), 4.08 (s, 2H), 2.21 – 2.06 (m, 2H), 1.35 (s, 3H), 1.34 (s, 
3H), 0.92 (s, 9H), 0.09 (s, 6H). 13C NMR (126 MHz, CDCl3) δ 143.2, 133.7, 128.6, 128.5, 
127.5, 126.3, 73.6, 71.0, 66.3, 33.1, 29.8, 26.12, 26.10, 18.6, -5.0, -5.1. IR (neat) νmax 
3060.87 (w), 3027.00 (w), 2952.96 (m), 2925.73 (m), 2891.60 (w), 2853.66 (m), 1756.84 
(w), 1603.41 (w), 1493.67 (w), 1469.99 (m), 1461.30 (m), 1373.49 (m), 1359.29 (m), 
1251.17 (s), 1199.07 (m), 1176.98 (m), 1127.77 (s), 1065.48 (s), 1004.98 (m), 835.07 (s), 
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775.37 (s), 750.44 (m), 697.12 (m) cm-1. HRMS (DART+) for C20H31OSi [M+H–H2O]+ 
calculated: 315.2139, found: 315.2138. [α]D20: +67.255 (c = 2.02, CHCl3, l = 50 mm). 
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